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Abstract 
The increasing availability of large quantities of digital data (Big Data) and advanced analytic 
tools is driving many industries to change their practices. Currently there are limited 
theoretically informed, in depth empirical studies of the processes and activities that needed to 
leverage Big Data strategically. This research is a response to calls by international scholars for 
more in depth and theoretically informed studies of on Big Data (e.g. Brynjolfsson et al., 2011; 
McAfee et al., 2012; Wamba et al., 2015; Braganza et al., 2017; Mikalef et al., 2017). 
The study frames Big Data as a new resource and adopts the Resource-Based View (RBV) and 
the Dynamic Capabilities (DC) perspective in order to explore the enhancement of existing 
capabilities and development of new capabilities required to leverage this new resource. The 
empirical context of this study is a global pharmaceutical company. Employing a qualitative 
in-depth case-study approach, this research investigates why a Multinational Corporation 
(MNC) in the pharmaceutical industry adopted Big Data adoption and how it identified and 
developed capabilities for this new resource. Data from 24 in-depth interviews and 
observations of Europe, the Middle East and Africa (EMEA) and Global managers in two 
project teams were analysed and synthesised using thematic analysis methods. 
The findings from this study show that the use of Big Data required new and enhanced 
capabilities that were developed through the action of dynamic capabilities, which operated as 
mediators between existing capabilities and the new and enhanced capabilities. Although some 
elements of these dynamic capabilities were embedded in the organisational processes, the 
activities of senior managers played a crucial role in their development and use. Further, the 
findings show that the organisation’s cultural transformation was critical for the operation of 
the dynamic capabilities identified and the new and enhanced Big Data capabilities. In the case 
study company the development of a Big Data capabilities was found to be an incremental, 
extended process. 
ii 
 
The study makes a number of contributions. It provides an in-depth case study of Big Data 
preparation in the specific context of a MNC pharmaceutical company that is of value to both 
academics and practitioners.  It provides a theoretically based and empirically validated model 
of the development of capabilities associated with Big Data adoption. Finally, it makes a 
contribution to academic theory by contributing to the ongoing discussion in the academic 
literature of the utility of the concept of Dynamic Capabilities.    
Keywords:  Big Data, Digital Environment, Operational Capabilities, Dynamic Capabilities, 
Pharmaceutical. 
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Chapter 1: Introduction 
 
1.1 Introduction 
To become or remain competitive in today’s global marketplace organisations are increasingly 
required to introduce and use a vast number of technological innovations. Against this 
backdrop, organisations are embracing the increased accessibility of digitally sourced data (Big 
Data) and the advanced technology required to analyse it. Academics (Bharadwaj et al., 2013; 
Davenport, 2014; Erevelles et al., 2015; Wamba et al., 2015) and practitioners are indicating 
that the biggest challenge faced by organisations today is to combine old and new ways of 
operating businesses in the digital environment. 
Motivated by the recent increase in academic and practical/managerial interest in Big Data and 
the associated phenomenon of developing required capabilities, the aim of this research is to 
identify how Big Data initiatives are currently managed and implemented in order to drive 
innovation, in particular in the pharmaceutical industry. Accordingly, the main academic 
objective was to explore Big Data initiatives, preparation for their adoption, and the required 
capabilities development processes in a particular pharmaceutical company. 
Applying the Resource-Based View (RBV) and Dynamic Capabilities (DC) approach as a 
theoretical underpinning, this research empirically investigated why a Multinational 
Corporation (MNC) in the pharmaceutical industry prepares for Big Data adoption and how 
they identify and develop capabilities for Big Data. This chapter provides an introduction to 
this research. It explains the background and importance of this study (1.2). It outlines the aim, 
objectives and research questions guiding the execution of this study (1.3) and highlights the 
methods and methodologies taken to conduct the research (1.4). Section (1.5) presents the 
study’s contributions to knowledge, while (1.6) presents a structural overview of the thesis. 
 
2 
 
1.2 Background and Importance of the Research 
 
1.2.1 Background 
1.2.1.1 Big Data Vs and working definition   
The introduction of the World Wide Web as an electronic platform for business has brought 
many challenges in terms of market competition in various industries. On a daily basis, 
enormous volumes of user-generated data are transferred and analysed within and across 
different business sectors. Technology offers greater opportunity to capture better quality 
customer data and increase the focus on the customer. However, the large volume and variety 
of data available to organisations from various sources, such as social networks, the Internet, 
and mobile devices, presents the challenge of finding new ways of converting the data into 
actionable insights.  
These new types of data are collectively referred to as Big Data, a term whose origins lie in the 
fact that a huge amount of data is created every day. One of the fundamental reasons for the 
existence of the Big Data phenomenon is the current extent to which information can be 
generated and made available, as well as its potential business value i.e. its ability to give 
organisations a competitive advantage (LaValle et al., 2011; Agarwal and Dhar, 2014; De 
Mauro et al, 2015). In general, Big Data refers to increasingly large data sets that include 
heterogeneous formats: structured, unstructured, and semi-structured data. Big Data has a 
complex nature that requires powerful technologies and advanced capabilities to be 
successfully leveraged (Khan et al., 2014; Oussous et al., 2018). Although there is still debate 
on the exact definition of Big Data, its related issues and opportunities are mainly discussed in 
terms of V’s, even though it has not yet been ascertained how many V’s there are. The model 
continues to be extended to reflect the growing interest and experience with Big Data. 
In the early days of this research (2013/14) the main characteristics about Big Data as discerned 
from the published papers and online research were its sheer size (volume), frequency of update 
3 
 
(velocity), and diversity (variety), also known as the 3Vs. Most data scientists and related 
experts had previously defined Big Data by these three characteristics (Laney, 2001; Manyika 
et al., 2011; McAfee and Brynjolfsson, 2012; Davenport, 2012; Sharma, 2014). As an example, 
Laney (2001) defined Big Data as consisting of large volumes of extensively varied data that 
are generated, captured, and processed at high velocity. The International Business Machine 
Corporation, IBM (2013) likewise defined Big Data as: ‘High-volume, high-velocity, and high-
variety information assets that demand cost-effective, innovative forms of information 
processing for enhanced insight and decision-making.’ Gantz and Reinsel (2012) extended the 
definition of Big Data to 4Vs: volume, variety, velocity, and veracity, where veracity was added 
to describe the accuracy or degree of trustworthiness of the data. The key features of Big Data 
identified by Gantz and Reinsel (2012, p. 910) volume, variety, velocity and veracity - have 
been widely accepted as the ‘4Vs’, or the four key attributes of Big Data. 
Key discussions that were held between academics and practitioners on this subject concluded 
that the size of the data-set is no longer the defining parameter of Big Data, but rather the 
insights and the value that the volume and variety of data offer (George et al., 2014). Dealing 
effectively with Big Data requires one to create value against the 4V’s, although a fifth V, value, 
relates to the desired outcome of processing Big Data.  Value in this case refers to the degree 
to which the data can impart to an organisation a useful business and economic advantage, 
resulting from the organisation using the data to make decisions based on insights that may 
have previously been considered beyond reach (Fan and Bifet, 2016). The value of Big Data 
also lies in its potential to improve an organisation’s operational activities through the 
generation of unique knowledge and insights, which in turn leads to competitive advantage 
(Banasiewicz, 2013). What benefits organisations perceive as a ‘Value’ depends on their 
strategic goals for adopting and using Big Data (Ghoshal et al., 2014, Wamba et al., 2015). 
Certainly, economic value can be measured by an organisation’s increase in profit, business 
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growth, and competitive advantage resulting from Big Data adoption (Davenport, 2006). For 
example, organisations that rely on Big Data to guide organisational strategies and day-to-day 
operations are expected to perform better financially than organisations that do not (LaValle et 
al., 2011, McAfee and Brynjolfsson, 2012). Thus, this research followed a process that was put 
into effect to make sense of this new phenomenon, in which Big Data was defined using five 
Vs: Volume, Velocity, Variety, Veracity and Value, as illustrated on the picture 1.1 below.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Five Vs of Big Data: Volume, Velocity, Variety, Veracity and Value (developed 
based on the source: IBM Big Data platform - Bringing Big Data to the Enterprise, 2014) 
 
It has been suggested (Boyd and Crowford, 2012; Bharadwaj et al., 2013; Davenport, 2012), 
that the 5Vs of Big Data are the main challenge for Big Data management. However, these five 
dimensions are complementary to each other, and as one dimension changes, there is a tendency 
for the others to change too (Laney, 2001; Gandomi et al., 2014; Haider, 2014; Hallman et al., 
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2014). This makes Big Data more complex than the kind of digital data that had been held and 
dealt with by companies in the past.  
- Working Definition   
For clarity, it must be acknowledged that although this research conformed to the existing 
practice of describing Big Data using five Vs as mentioned above, the challenges and 
opportunities associated with each individual dimension of Big Data was not the focus of this 
research. Rather, this research looked at Big Data as a whole, as a new resource (as an 
“information asset”), that requires new technologies and capabilities for its transformation into 
value. Thus, in this research Big Data represents a new resource, characterised by high Volume, 
Velocity, Variety, and Veracity that together demand new capabilities, and innovative forms of 
information processing for enhanced insight and the resulting transformation into Value (De 
Mauro et al., 2015). 
It must also be recognised, that this is a developing field, and by the end of this research  some 
authors  (Emani et al., 2015; Gandomi and Haider 2015; Oussous et al., 2018)  and institutes 
(like the Institute of Electrical and Electronics Engineers (IEEE) refer to yet more V's ( 6Vs; 
7Vs; and in some cases even 10Vs) (Patgiri, and Ahmed, 2016; Firican, 2017) in order to better 
define Big Data.  Additional V's include, for example, Verification (where the processed data 
conforms to certain specifications) (Emani et al., 2014); Validation (where the purpose of the 
data is fulfilled) ( Gao et al., 2016), Visualization (where large amounts of data are rendered 
easy to read and understand) (Wang et al., 2015; Data Technology, 2019); Variability (where 
there are changes in the structure of the data and in how users may wish to interpret that data) 
(Fan and Bifet, 2016; Emani et al., 2014); Volatility (which considers the retention of otherwise 
transient structured data that are produced by everyday transactions) (Khan et al., 2014), and 
Validity (referring to the correctness and accuracy of data with regard to its intended usage) 
(Khan et al., 2014; Patgiri, and Ahmed, 2016).  
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Currently, although there is a great deal of controversy and even confusion about the V’s of 
Big Data, and significant ongoing debate over how many V’s exist in total, this study was based 
on a definition of Big Data that followed the most widely accepted and core V’s, and these core 
dimensions are not likely to change regardless of how many more V's are identified by 
researchers beyond this point.  
From discussed above it can be summarised that Big Data has become a ubiquitous term in 
many parts of business and academia. The business community is fully embracing ways of 
utilising Big Data to its advantage, and from a business perspective Big Data refers to the 
availability to organisations of massive amounts of heterogeneous and continuously-updated 
information that can confer business value – that is, it can generate competitive advantage 
(LaValle et al., 2011; Agarwal and Dhar, 2014; De Mauro et al, 2015). Practitioners agree that 
the availability of such information creates both challenges and opportunities for organisations 
that had never existed previously (Davenport, 2014; Gupta and George, 2016; Wamba, 2016; 
Mikalef et al., 2017). The dramatic increase in the use of digital devices, such as smart phones 
and sensors, has also increased the rate of data creation, with such data offering personalised 
information about customers, such as their location, demographics, and past buying patterns, 
all of which can be analysed in real-time to create real customer value (Gandomi et al., 2014). 
George et al. (2014) highlight that this micro-data provides rich information about individuals' 
behaviours and actions, and real-time customer feedback also makes it possible to monitor and 
understand the areas where a product or service is failing. Furthermore, such information 
allows quicker and more effective responses (McAfee and Brynjolfsson, 2012). For example, 
research findings from the McKinsey Global Institute (MGI) indicate that companies that use 
data-driven decision-making are 5% more productive and 6% more profitable than their 
competitors. Many industries such as (among others) healthcare, finance, retailers, education, 
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and transportation are investing in Big Data to understand the markets and customers, to make 
smart trading decisions, and to improve their operational efficiency. 
The UK Parliamentary Office of Science and Technology (2014) estimates that for its 
efficiencies, innovation and business creation, Big Data was worth £25 billion to UK 
businesses in 2011. Furthermore, they predicted that it would reach an annual value of £41 
billion by 2017. These predictions are currently becoming reality. As the recent findings of the 
world’s leading research and advisory company (Gartner, 2017) suggest, not only is Big Data 
adoption in high demand, but interest is even greater. For example, Gartner’s estimates indicate 
that Big Data investments in the healthcare and pharmaceutical industry accounted for nearly 
$4 billion in 2017 alone, and this investment is expected to grow more than 15% over the next 
three years. Figure 1.2 below illustrates Big Data analytics expected adoption rates by the 
industry by the year 2017. 
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Figure 1.2: Big Data Analytics Adoption Rates by Industry (Research findings based on 
Gartner, 2017) 
As illustrated above there are already many instances where Big Data has proved to be a 
valuable resource for many industries. Procter and Gamble (P&G), is a striking example of a 
company which has successfully embraced Big Data. This company well knows the value of 
understanding consumer behaviour (P&G, 2014) and as a result is adopting Big Data practices 
ahead of many other companies, including its rivals. For the past five years P&G and Google 
have annually exchanged teams of staff, with Google seeking to learn about advertising, and 
with P&G wishing to learn how to make decisions based on the analysis of real-time data that 
are both quick and reliable. In each company, managers and employees are given the 
opportunity to upgrade their digital skills, while business leaders within P&G have identified 
no fewer than 88 business processes that are being redesigned and streamlined to operate in 
real-time (P&G, 2014; Galbraith, 2014). 
Tesco is another company which has successfully made use of Big Data and advanced 
analytics, introducing a loyalty card in 1995 and using it as a vehicle for the systematic 
collection and analysis of shopping data. Tesco realised the value of the insight these cards 
would give with regard to customer behaviour patterns and the company began processing a 
huge volume and variety of data from these cards, enabling them to better segment and target 
the mailings of vouchers and coupons to customers, resulting in a huge increase from 3% to 
70% in the rate of coupon redemption (MGI, 2013). The company has also since gradually 
integrated online and social-media information to support daily decision-making. A case study 
on Tesco carried out by Business Intelligent (BI) shows that the company’s insight-driven 
commercial strategy has contributed to sustained profitability (BI, 2015). 
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However, there are also cases in which Big Data is available but not used. Before moving 
forward on Big Data initiatives, companies typically seek a clearer understanding of the 
potential return on investment (ROI); especially given the perceived high cost of systems and 
resources required to implement Big Data solutions. Figure 1.3 below illustrates the obstacles 
preventing retailers from using Big Data. 
Figure 1.3: Obstacles Preventing Retailers From Using Big Data (Source: 1010data, 2014) 
 
A study undertaken by 1010data (2014) showed that 41% of retailers struggled to achieve 
meaningful and consistent interpretation of data. 38% indicated that an inability to analyse this 
kind of data was the main problem, while 34% struggled with accessing and integrating the 
relevant systems. In addition to the insight that could be delivered from the analysis of Big 
Data, Lukoianova and Rubin (2014) argue that depending on its origin, data processing 
technologies, and the methods used for data collection, the use of Big Data can result in biases, 
ambiguities, and inaccuracies all of which need to be identified to reduce errors and improve 
the accuracy of generated insights. This raises the important issue of Big Data quality and 
trustworthiness, doubts over which can prevent it being adopted or used. 
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On the other hand, the successful adoption of a new resource is often not an easy task to 
achieve, as existing systems and processes need to be built up over many years, and employees’ 
knowledge of the new environment can be limited. The interaction between organisations and 
digital technology is ‘complex’ because it is influenced by many factors, including an 
organisation’s structure, routines, business processes, politics, culture, internal and external 
environment, and management decisions (McAfee and Brynolfsson, 2012). Technology 
companies (Google, Amazon, e-bay, Netflix) are the native collectors and users of Big Data 
because their internal organisation and capabilities are adapted to the use of that resource. 
Conversely, although some companies (pharmaceuticals, insurance, advertising, financial 
services and retailers) from more traditional sectors may have undertaken projects to assess 
this new kind of resource, not all are fully ready to exploit Big Data (Galbraith, 2014). For 
example, the McKinsey Group (2013) states that despite the important role of Big Data in value 
creation, many organisations appear to be at an early stage of learning how to exploit it, and 
have not developed the right capabilities to do so. O’ Reilly and Tushman (2016) suggests that 
they will need to adapt environmental change in order to remain successful. Although Big Data 
science is becoming a reality and may not yet have fully arrived, it is time for organisations to 
get ready for it. There is a need to learn more about the resource of Big Data itself, and to build 
capabilities related to its use. Thus, when resource such as Big Data is freely available 
organisational capabilities to successfully deploy, coordinate, and use this resource are not 
freely distributed (Ethiraj et al., 2005). 
1.2.2 Big Data in Pharmaceutical Industry   
Despite the acknowledged risks, time and costs associated with pharmaceutical development, 
the pharmaceutical industry is highly innovation-driven (Sadat et al., 2014). The industry 
contributes to human well-being by providing new medicines to counter a range of diseases, 
and has grown into a major sector of the global economy (Taylor, 2015). Generally, the 
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pharmaceutical industry consists of number of very large multinational corporations (MNC) 
such as for example AstraZeneca, Merck, Novartis, Roche and Pfizer. These companies are 
collectively known as Big Pharma based on following criteria: the sales per year which should 
be above 2 billion USD; international presence, which includes: presence in USA, Europe, and 
Japan; ongoing Research and Development in several therapeutic areas; marketing in at least 
five different therapeutic areas and; establishment of fully integrated pharmaceutical 
operations, including internal R&D, manufacturing, clinical trials, regulatory considerations, 
marketing, and sales (Chandler, 2005; Hedner, 2012). 
R&D in the pharmaceutical industry is very expensive and time consuming; it usually takes 
about 8 to 12 years from the discovery of a new drug to the time it reaches the consumer market, 
entailing an average cost of $800-900 million (Taylor, 2015). A crucial element of the process 
involves developing the drug, an activity which dominates the overall cost, particularly as a 
result of the clinical trials which follow the pre-clinical development before approval by the 
regulators (Chandler, 2005). In 2004 the US Food and Drug Administration (FDA) introduced 
the Critical Path Initiative (CPI) with the intention of improving the drug development process 
by incorporating recent scientific advances, such as genomics (which relies on knowledge of 
the genome and DNA data of an organism) and other advanced technologies into the process 
(Woodcock and Woosley, 2008; Kumar, 2011). Although still in its early stages, an effort has 
been made by both the pharmaceutical industries and by regulatory authorities to adopt new 
technologies such as: Electronic Data Capture (EDC); innovations in analytics, such as 
predictive modelling (Davenport, 2012; Gandomi, 2014), and new visualisation tools (Costa, 
2014). As such developments continue to accelerate in the industry, so do the opportunities to 
embrace insights from Big Data (Groves, 2013; Liu, 2014; Costa, 2014; Wang et al., 2018). 
The current abundance of Big Data and the availability of useful analytical techniques is 
predicted to enhance future innovation and feed the drug development pipeline in the 
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pharmaceuticals industry (Sadat et al., 2014). It has been predicted (Kumar, 2011; Cattell et al., 
2013; Costa, 2014) that effectively utilising Big Data will help pharmaceutical companies 
accelerate the identification and development of new drug candidates (Liu, 2014), resulting in 
more personalised medicines that will significantly improve patient care, and offering scope 
for reimbursement for their development. However, to qualify for reimbursement, 
pharmaceutical companies are now required to demonstrate through clinical trial results, that 
their new drugs offer significantly more clinical benefit than existing alternatives and also 
reduce the total cost of care (Paul et al., 2010; Ernst and Young, 2010). The approach taken by 
personalised medicine involves integrating genomics technologies (Costa, 2014) and other 
advances with clinical and family histories in order to more coherently tailor therapeutics to 
individual patients (Kumar, 2011). These strategies require new forms of data management 
capable of visualising various data types collected from multidisciplinary knowledge and cross- 
functional interaction (Oracle, 2014; Wang et al., 2018). One particular pharmaceutical 
business transformation with regards to Big Data focuses on cross-functional collaboration, 
whereby knowledge delivered from data can be uniformly leveraged (Kumar, 2011; Costa, 
2014). However, translating basic research into a form that has clinical utility requires a 
unifying IT platform that lets the researchers themselves access, integrate, and analyse 
information from multiple data sources. In addition, it also demands the use of a diverse range 
of tools to derive the knowledge that is needed (Wang et al., 2018). Yet the traditional silo data 
management approach, and the way in which the current use of existing IT infrastructure does 
not encourage internal and external collaboration, limits the ability of pharmaceutical 
companies to integrate Big Data into their operations (Wamba et al., 2015). Instead of providing 
support for the dynamic integration of Big Data thought processes, mostly such traditional 
approaches end up either restricting innovation (Sadat et al., 2014) or rigidly dictating (Kumar, 
2011) how users can extract knowledge from such data. Thus, the ability to manage and 
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integrate data generated at all stages of the value chain, from discovery to real-world use after 
regulatory approval, is a fundamental requirement to allow pharmaceutical companies to derive 
benefit from technology and Big Data trends (Deloitte, 2015). The value chain of 
pharmaceutical innovation or drug innovation as the meaning implies is illustrated in Figure 
1.4.   
 
Figure 1.4: Pharmaceutical Value Chain (Source: Sadat et al., 2014) 
The enormous variety of data (structured, unstructured, and semi-structured) generated from 
pharmaceutical operations including the R&D process itself, clinical trials, and marketing 
makes healthcare data both interesting and challenging. To generate the ability to use and share 
data requires improved linkages across different functions such as, for example, discovery, 
clinical development, and medical affairs. Furthermore, implementing end-to-end data 
integration requires several capabilities, including systems that will allow connectivity 
(Wamba, 2016), people with the ability to establish cross-linkages between different functions 
(Costa, 2014 ;), and analytics to extract value (Wang et al., 2018). In addition, pharmaceutical 
companies must understand and reduce the legal, regulatory, and privacy risks associated with 
a collaborative approach (Sadat et al., 2014). 
Leading consultancy companies (e.g. Deloitte, McKinsey Group, Gartner) are indicating that 
pharmaceutical companies generally avoid overhauling their entire data-integration system at 
once because of the logistical challenges and costs involved. However, very limited empirical 
academic evidence exists to suggest that some innovative companies in the healthcare industry, 
14 
 
including pharmaceuticals, have started to gain access to the promising new trends and 
knowledge that Big Data offers (Groves et al., 2013). Thus, successful Big Data initiatives are 
still rare within MNC in the pharmaceutical sector. It is possible that this scarcity can be 
attributed to the challenges inherent in changing, renewing, and/or innovating their existing 
capabilities (Deloitte, 2015; Teece, 2010) despite their access to resources, market knowledge, 
and key technologies. 
1.2.3 Importance of the Research 
While acknowledging the importance of investment in developing Big Data capabilities, 
differences exist between competitors in the timing of this effort, in the amount of investment 
(Murdoch and Detsky, 2013), in the initiative shown by management (Mikalef et al., 2017), 
and in the internal organisational processes and culture (LaValle et al., 2011) that support these 
processes. Thus, as with any new technology, it is important to understand the process through 
which Big Data initiatives and required capabilities development comes about in a company in 
practice. 
An important discussion over the past years has focused on the opportunities and challenges 
that Big Data brings to organisations (Chen et al., 2012; McAfee et al., 2012; Davenport, 2012). 
Yet, there is less empirical evidence in the literature (discussed in more detail in Chapter 2) 
relating to how to overcome challenges regarding successful implementation of this new 
resource (Bharadwaj et al., 2013; Constantiou and Kallinikos, 2015; Erevelles et al., 2015; 
Wamba et al., 2015). While the published research on Big Data initiatives and required 
capabilities development is limited (Mikalef et al., 2017), some studies (Gupta and George, 
2016) have investigated what organisational resources are necessary for the success of Big Data 
initiatives. Arguably some previous studies which looked at what resources were needed to 
guide Big Data deployment practices provided valuable insight, but little progress has been 
made on elucidating how this process should be approached and how an organisation can 
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develop relevant required capabilities. Importantly, Wamba et al. (2015) note that there are very 
few empirical studies that focus on developing explanatory and predictive studies for a better 
understanding and growth of knowledge in these domains (Big Data and required capabilities). 
Therefore, there is still a need for greater insight into how organisations may prepare for Big 
Data and develop required capabilities in order to benefit from its value. 
From a capability perspective, organisational growth and survival are dependent on how well 
a business can manage its resources through its organisational capabilities (Teece et al., 1997). 
Capability development, on the other hand, is concerned with activities that relate to deploying 
Big Data in combination with other organisational and managerial processes. A common theme 
that emerged from the literature reviewed in Chapter 2 is that capabilities in operation may be 
represented by different coordinated organisational and management processes with a strong 
grounding in organisational routines such as learning (Teece et al., 1997; Eisenhardt and 
Martin, 2000; Wang and Ahmad, 2007; Ambrosini and Bowman, 2009; Easterby-Smith et al., 
2009). Teece et al (1997, p. 518) suggest that organisational and managerial processes may 
describe, ‘the way things are done in the firm, incorporating patterns of current practice and 
learning in the form of routines’. Winter (2002, p. 343) further confirms this suggestion and 
adds that a learned and stable pattern of collective activity through which the organisation 
systematically generates and modifies its operational routines reflects decision-making during 
the production of significant outputs (capabilities) of a particular type.  
By synthesising these views, it can be argued that processes not only have a patterned element 
which can be described by routines, but can also embody management activities, such as 
managerial decision-making. For example, research has identified the critical role managers’ 
activities play in the advocacy of dynamic capabilities through the provision of new deployed 
resources (Helfat et al., 2007; Teece, 2012; Ambrosini et al., 2009; Braganza et al., 2017). From 
this view, it is assumed that managerial activities in deploying Big Data initiatives, based on 
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managers’ perceptions, abilities and choices, will have a profound impact on how Big Data 
capabilities are identified and developed in an organisation. Thus, it can be summarised that in 
general processes are the collections of routine and non-routine activities by which capabilities 
are put into practice. Consequently, developing understanding of Big Data initiatives and the 
required capabilities development process will require an examination of those organisational 
and managerial routine and/or non-routine activities. However, there is less insight in the 
literature about how to structure and leverage these activities, particularly those which relate 
to Big Data initiatives. 
This research is effectively a response to calls by various international scholars for more 
research on Big Data initiatives and required capabilities development, given their growing 
importance in individual industries and in the overall global economy (e.g. Brynjolfsson et al., 
2011; McAfee et al., 2012; Wamba et al., 2015; Braganza et al., 2017; Mikalef et al., 2017). As 
an example, Brynjolfsson et al. (2011) found that there is a limited body of knowledge on the 
organisational capabilities that Big Data exploitation encompasses, and how such capabilities 
can be developed to gain full benefit. Moreover, Braganza et al. (2017) found that the extent to 
which Big Data initiatives are grounded in theory is little addressed in the literature. The 
authors encourage an expansion in the scope for examining Big Data initiatives through a 
variety of theoretical lenses. 
Motivated by the recent increase in academic and practical/managerial interest in Big Data and 
the associated phenomenon of developing required capabilities, the aim of this research is to 
identify how Big Data initiatives are currently managed and implemented in order to drive 
innovation, in particular in the pharmaceutical industry. Accordingly, the main academic 
objective was to explore Big Data initiatives, preparation for their adoption, and the required 
capabilities development processes in a particular pharmaceutical company. 
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Adopting the Resource-Based View (RBV) and Dynamic Capability (DC) perspective (see 
Chapter 2 and Chapter 3) as a way to observe the Big Data phenomenon, and as a means of 
exploring processes, activities, and practices through which Big Data initiatives arise in a 
global pharmaceutical company, the purpose of this study is to contribute to the existing 
knowledge, literature, and practice of Big Data initiatives and the required capabilities domain 
research area. To achieve this, an investigation is needed into how pharmaceutical companies 
perceive Big Data and what capabilities they employ to integrate it within their company 
strategy. 
Big Data as an intangible strategic resource for an organisation is conceptualised in the 
Resource-Based View (RBV) theory while the Dynamic Capabilities (DC) theory is used to 
reflect the dynamism of the digital environment and to conceptualise the capabilities 
development process for Big Data. Each theory overcomes some limitations of the other (see 
Chapter 2 and Chapter 3) and provides the researcher with a comprehensive understanding of 
the phenomena under investigation. 
It has been argued that the Dynamic Capability perspective is well-suited to the study of various 
types of innovation processes (Teece et al., 1997; Makadok, 2001; Bhatt and Grover, 2005; 
Teece, 2017). Conceptual links between Big Data initiatives and Dynamic Capabilities have 
been made by different authors (e.g. Teece, 2007; Wamba, 2016; Akter and Wamba, 2016; 
Braganza et al., 2017) and theoretical development of the Dynamic Capability concept has 
advanced rapidly in the last decade. Accordingly, there has been a call for the dynamic 
capabilities development process to be applied to the domain of Big Data. Moreover, authors 
such as Easterby-Smith et al. (2009), Ambrosini and Bowman (2009, p. 46), and Teece (2012) 
argue that the field is dominated by favour of quantitative approaches, and they propose to 
investigate it by using fine-grained qualitative studies to understand ‘the details of how dynamic 
capabilities are deployed.’ Easterby-Smith et al (2009, p. 6) further suggests that such 
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qualitative studies might provide ‘detailed descriptions of what processes are involved, the role 
of management, the reconfiguration of the dynamic capabilities, and the interaction with the 
environment’. Teece (2012, p. 1400) and Danneels (2010) add that although dynamic 
capabilities, in particular managerial dynamic capabilities, has been traced by using large data 
sets (e.g. Adner and Helfat, 2003), they can best be analysed through in-depth qualitative 
research. As the empirical literature is still at an early stage, and as the research paradigm of 
dynamic capabilities is still relatively new, the author believe that illuminating case studies are 
likely to provide powerful insights. To the best of the researcher’s knowledge, no study to date 
has adopted these suggested approaches and empirically explored how the preparation and 
required capabilities development for Big data initiatives come about in MNC in the 
pharmaceutical industry. 
By conducting a qualitative in-depth investigation of a global pharmaceutical company which 
is engaged with Big Data preparation and adoption activities (the case study) this research 
responds to the above call and makes a contribution to the enhancement and generation of new 
knowledge on the process of capabilities development for Big Data initiatives within the global 
pharmaceutical company. It also draws on the theoretical rationale and gaps in the existing 
literature that are expounded in the literature review in Chapter 2. 
The next section clarifies the research questions and the aims and objectives of this research. 
1.3 The Research Aim, Objectives and Questions 
The lack of empirical studies on the organisational capabilities (operational and dynamic) 
relating to Big Data initiatives that global pharmaceutical companies deploy in response to 
digital change presents the main research gap that this study attempts to fill. By addressing this 
gap the research would also incorporate an explanation of how Big Data initiatives and required 
capabilities are identified and developed in practice. 
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More specifically, to address the gaps and weaknesses identified in the literature review (see 
Chapter 2), the following aim and objectives represent the considerations that the researcher 
addresses in relation to the research questions. 
1.3.1 The Research Aim 
The primary aim of the research is to gather, examine, and explore the evidence reflecting how 
Big Data initiatives and required capabilities come about in MNC in the pharmaceutical 
industry and to make an assessment of the implications that arise from this. 
1.3.2 The Research Objectives 
Deriving from the research aim stated above and the theoretical rationale that is expounded in 
Chapter 2 and Chapter 3, the key objectives of the research are outlined as below. 
1. Conduct a comprehensive literature review of Big Data and Dynamic Capabilities 
(DC), covering the Information Management, Strategic Management, Marketing, and 
Big Data Management journals. This will be used to: 
I. Clarify the theoretical underpinnings adopted in the thesis.   
II. Explore related literature on Big Data initiatives and the required capabilities 
development process, with RBV and DC being used to identify the research 
gaps. 
III. Justify the methodological approach of this thesis. 
IV. Develop the contribution to knowledge and literature. 
2. At the empirical stage: 
I. Investigate and explore those processes which persuaded the company to start 
Big Data initiatives. The main goal for this stage is to observe existing 
organisational resources and competencies/capabilities in order to find ways in 
which companies achieve progress with their Big Data initiatives development. 
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II. Examine and explore those processes that enable the company to adopt Big Data 
practices effectively. In this respect, the study has investigated capabilities 
(operational and dynamic) that are related to a successful Big Data initiatives 
adoption. 
1.3.3 The Research Questions 
To fulfil the aim and the objectives outlined above, the following questions have been 
formulated to guide the execution of this study. 
1. Why did an MNC in the pharmaceutical industry prepare for Big Data adoption? 
RQ1 
And 
2. How did the company approach the issue of using Big Data and how did they 
identify and develop their capabilities for Big Data? RQ2 
I. What new capabilities did they develop? 
II. How did they develop these capabilities?  
1.4 The Methodological Approach 
To guide the research, and address the research questions which underpin it, the study has been 
rooted within the Critical Realism (CR) tradition, employing a qualitative case-study approach. 
As suggested by Maxwell (2005), the research design should incorporate considerations from 
the current literature (among other factors). The chosen approach is therefore generally 
considered a sensible strategy for research in its response to calls for more qualitative research 
in the field of Big Data and capabilities/dynamic capabilities as outlined in Chapter 2. 
Furthermore, Yin (2003) suggests that when a specific topic has not been fully investigated and 
there is a limited body of knowledge surrounding it, such as the study’s domains (Big Data 
initiatives and required capabilities development) a deep examination of the precise context in 
which it occurs can deliver insight and contribute to knowledge. Therefore, taking a single case 
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study approach that allows the researcher to conduct an in-depth examination into a particular 
capabilities development process for Big Data initiatives has been considered an appropriate 
choice of methods for conducting this research. 
The research strategy was executed in fieldwork in Switzerland and US at the case study 
company’s headquarters. The fieldwork extended over a period of six months for the data 
collection (and preliminary analysis). The findings and conclusions were derived from a 
thematic analysis method in which the NVivo 11 tool (Chapter 4) was used to analyse the data. 
1.5 The Study’s Contribution to Knowledge 
Overall, the main contribution of this study is a model of the organisational process in Big Data 
adoption and the deployment of required capabilities (Chapter 5, Figure 5.4). The model was 
at first based on the conceptual framework laid out in the literature (see Chapter 3) prior to the 
data collection stage, and then developed using the empirical findings of this study. 
I. By describing the adoption of the new resource Big Data and the capabilities 
development processes (with associated organisational and managerial activities such 
as: strategic competitive response, learning, reconfiguration, and coordination) the 
model establishes their effect on the company’s existing operational and new 
capabilities development for Big Data. Although the notion of enhancing existing 
capabilities had been acknowledged to close gaps or improve underperforming 
capabilities (Lavie, 2006; Danneels, 2010), the role of dynamic capabilities in this 
process had received less attention in the literature. Furthermore, some scholars are still 
sceptical about the role of dynamic capabilities (Winter, 2003; Zahra et al., 2006). Thus, 
findings from this study shed light between capabilities development and dynamic 
capabilities research by explicating the role of dynamic capability in the Big Data 
capabilities development process. In particular, the study provides an empirical support 
for the underlying assumption of the role of dynamic capability in modifying 
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operational capabilities and developing new capabilities for Big Data (Winter, 2003; 
Helfat and Peteraf, 2003; O Reilly and Tushmann, 2008, p.186; Pavlou and El Sawy, 
2011). By doing so, this study seeks to add insight to the existing research and thereby 
overcome a criticism of dynamic capability – of it being established only at an abstract 
level of description, and lacking empirical grounding (Wiliamson, 1999)  and being 
tautological in nature (Priem and Butler, 2001; Erikisson, 2013). 
II. Beyond confirming that dynamic capabilities such as strategic competitive response, 
reconfiguration, coordination, and learning are enablers for the creation and 
implementation of Big Data initiatives (Teece, 2007; Protogerou et al., 2011; Erevelles 
et al., 2015; Wamba, 2016) this study also illustrates what the additional activities and 
practices were, such as: support from senior managers, networking and partnership, and 
cultural transformation and how they were enacted. Thus, the study also contributes to 
the contextual approach of the dynamic perspective, more specifically to the existing 
literature (Teece, et al., 1997; Zahra, et al., 2006; Tripsas and Gavetti, 2000; Adner and 
Helfat, 2003; Teece, 2007; Eggers and Kaplan, 2009) related to the understanding of 
the role of senior management in capabilities development. As will be seen, senior 
management does indeed play a vital role within the process (Braganza et al., 2017) 
and their ability/skills (Gupta and George, 2016) and active participation are regarded 
as necessary success factors for Big Data capabilities development. The underlying 
importance of management is in line with propositions of the dynamic capabilities 
paradigm, in which entrepreneurial managers play a vital role in identifying 
opportunities and the need for change, and in formulating responses and implementing 
a course of action (Helfat et al.,2007; Teece, 2012). Although some elements of 
dynamic capabilities may be embedded in the organisation, the capability for evaluating 
and implementing changes to the conﬁguration of assets (both within and external to 
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the organisation) rests on the shoulders of senior management (Teece, 2012). Thus, the 
empirical evidence illustrated how purposeful practices and decisions at the senior 
management level influenced the development of required capabilities for Big Data that 
is unlikely to have happened without those ‘managerially-amenable’ practices (Pavlou 
and El Sway, 2011, p. 260). Thus, the findings of this study add insight to the existing 
literature (Gunther et al., 2017; Braganza et al., 2017) by confirming the importance of 
managers' abilities/practices for implementation of Big Data initiatives and developing 
required capabilities. 
III. The study brings an understanding of dynamic capability development for Big Data 
initiatives and highlights the role of networking and partnership during this process. 
The empirical evidence provides insight into tangible means for managers, by which 
managers in this process enhance their company’s dynamic capabilities through 
networking and partnership. This was challenged by the Winter (2003, p. 991) who 
points out that there is doubt that deliberate efforts to strengthen dynamic capabilities 
represent a genuine option for managers. This is mainly because Winter (2003, p. 993) 
believes that a forceful search for such instances can impose additional cost. Winter 
believes that the capability must be exercised: to have dynamic capabilities and no 
occasion for change is merrily to a carry an additional cost. However in the case of a 
fast-moving, competitive Big Data environment that requires continuous modification 
and, if necessary, a complete overhaul to maintain a good ﬁt (Teece, 2012), with the 
ecosystem in which an organisation operates, there is an enhanced need for 
strengthening dynamic capabilities – this is especially true when an innovating 
organisation needs to pioneer new ways of adopting Big Data practices. This study 
provides empirical/practical evidence that managers interested in creating knowledge 
about a new resource through networking and partnership practice help in enhancing 
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dynamic capabilities. This finding complements the conventional approaches to 
strategy that suggest that in Big Data programmes many roles are played by outside 
organisations (Braganza et al., 2017) and that the nature of relationships are more 
transitory. Interaction between multiple factors such as partnership, networking, and 
collaboration with different parties enhance and strengthen the company’s seizing and 
reconfiguration abilities at the preparation stage. Thus, these activities can be 
interpreted as knowledge creation, knowledge acquisition, and knowledge 
dissemination which can be dynamically used to fine-tune Big Data initiatives and to 
formulate responses or transformation activities to face this kind of challenges when 
there is little experience to call upon, and no best practices yet established. 
1.6 Outline of The Thesis 
This thesis contains seven chapters as outlined below. 
Chapter One introduces the background, the motivation, and the importance of the research, 
along with the research aim, objectives, and the research questions guiding the investigation. 
The chapter also highlights the methodological approach for the study and the study’s main 
contribution to knowledge. 
Chapter Two provides a comprehensive review of relevant literature, from which research 
gaps have been identified, some of which are addressed in this research. The chapter further 
assists in positioning the theoretical underpinnings of the research that is summarised in 
Chapter 3. 
Chapter Three introduces the conceptual framework of the study that has been developed 
based on the literature review, prior to the data collection stage. 
Chapter Four describes the methodology guiding the conduct of this study, including its 
philosophical standpoint, along with the methods used to collect and analyse data. The chapter 
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also provides discussion concerning the rationale behind the methodological choices and 
explains the data analysis process used in this thesis. 
Chapter Five presents the findings of the case study. These findings are presented in two parts 
based on the Global (US) and EMEA sites of the company preparing for the Big Data adoption. 
Chapter Six demonstrates the research results and their contributions to knowledge. 
Chapter Seven provides a concluding summary for this thesis along with the research 
limitations, and the theoretical and managerial implications, and offers recommendations for 
further research. 
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Chapter 2: Literature Review 
2.1 Introduction 
This chapter synthesises the existing literature in the field of strategic management research, 
and the Information System (Big Data, RBV and capabilities/dynamic capabilities) that lays 
the theoretical and conceptual foundation for the investigation of this research. Furthermore, 
by reviewing Big Data initiatives and required capabilities development along with related 
challenges and opportunities, the chapter develops the argument on which this thesis is based 
by appraising gaps and weaknesses in the existing literature, some of which are addressed in 
this research. The first section (2.2) begins by looking at what is understood as ‘Big Data’ and 
explains commonly accepted definitions, views, and related business opportunities. The second 
section (2.3) reviews the Resource-Based View (RBV) along with the interpretation of Big 
Data from the perspective of the RBV theory adopted in this study. The third section (2.4) 
discusses the Dynamic Capability (DC) theory that has also been adopted to examine the 
research problem. The next section (2.5) discusses Big Data-related challenges and the required 
capabilities needed to overcome some of those challenges. The fifth section (2.6) reviews 
capabilities and dynamic capabilities for big data in pharmaceutical industry, while the sixth 
section (2.7) identifies research gaps. Section (2.8) provides a concluding summary of the 
literature review chapter. 
2.2 Big Data and Related Opportunities 
The increasing amount of digitally sourced data that is generated around us, and the advanced 
analytic tools that drive many industries to change their practices in order to make sense of this 
data, have in combination become one of the important topics for academics and practitioners 
in the coming years. From a business perspective it has been estimated by the International 
Data Corporation (IDC) that the global data volume will grow from 130 exabytes to 40,000 
exabytes from 2005 to 2020 (Gantz and Reinsel, 2012, p. 16). It has likewise been predicted 
that there will be an increase in demand in the adoption and implementation of Big Data 
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initiatives. Figure 2.1 below illustrates the growing demand of Big Data measured in ZB 
developed by Ghosh (2015) 
 
 
Figure 2.1: Growing Demand of Big Data Measured in ZB (Source: Ghosh, 2015) 
From an academic perspective, the research on Big Data is also rapidly developing and 
becoming  prominent in many research domains, such as science, technology, economics, and 
social sciences, as well as in the business domain. However, while the interest in Big Data is 
increasing, there is no uniform definition of this new asset. One of the earliest definitions of 
the term Big Data comes from information technology research company Gartner, who in 2001 
defined it as ‘challenges and opportunities in data growth’. Doug Laney defined these 
challenges and opportunities in data growth as having three aspects: increasing volume, 
increasing velocity, and increasing variety (Laney, 2001). Later Manyika et al (2011, p. 1) 
defined Big Data as ‘datasets whose size is beyond the ability of typical database software tools 
to capture, store, manage, and analyse’. Similarly, Kaisler et al. (2013) defined it as ‘the 
amount of data just beyond technology’s capability to store, manage, and process efficiently’. 
With these definitions the authors highlight the challenges which accompany Big Data. In 
particular, with more data being generated, it has become difficult for traditional architectures 
and infrastructures to process these amounts of data within an acceptable time-scale. Thus, Big 
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Data challenges the capability and compatibility of existing resources to handle it in ways that 
achieve the desired objectives (Chong and Shi, 2015). 
Big Data may be relatively new for online firms (Google, LinkedIn, Amazon) but many other 
large firms have already been struggling with it for some time (Davenport, 2012). Numerous 
companies have been using large databases and analytics for the last couple of decades 
(Galbraith, 2014; Akter and Wamba, 2016). For example, in some cases transactions are stored 
in data warehouses and analysed with data-mining algorithms in order to extract insights. 
However, in the past this data was mainly derived from transactions and was highly structured 
in format (Bharadwaj et al., 2013, Chen et al., 2014). Credit card companies, for instance, 
stored all of their transactions in a database and analysed them with fraud-detecting algorithms. 
What is new today is the increased accessibility of digital data from various sources (e.g. 
mobile phones, GPS devices, video from surveillance cameras, audio from call centres, e-mails, 
tweets, text messages etc.) along with the ability of database software tools to capture, store, 
manage, and analyse it in real-time (Manyika, et al., 2011; Davenport, 2012; Bharadwaj et al., 
2013; Galbraith, 2014). Many companies have realised that the data they own or have access 
to, and the way they use it, can differentiate them from their competitors. Furthermore, it can 
even provide them with a competitive edge (Davenport, 2012). These developments suggest 
that Big Data is still an evolving phenomenon that is seen to be the next frontier for innovation, 
competition, and productivity, or the next management revolution (McAfee and Brynjolfsson, 
2012; Buhl, et al., 2013; Gobble, et al., 2013; Gandomi, et al., 2014). 
Size and availability are defining characteristics of Big Data. Data volume alone, however, is 
not its most novel characteristic (Boyd and Crawford, 2012). Closely associated with large data 
volumes is the variety of such data, the frequency with which it is updated, the speed by which 
it grows, and its privacy and quality issues (Davenport, 2012). The key features of Big Data 
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identified by Gantz and Reinsel (2012, p. 910) - Volume, Variety, Velocity and Veracity - have 
been widely accepted as the ‘4Vs’, or the four key attributes of Big Data. 
However, recently much attention has been placed on the value (in economic terms) of this 
data for companies. Discussion (IBM, 2014) about the opportunities and challenges of Big Data 
now have centred on the five Vs:  Volume, Variety, Veracity, Velocity and Value. Much of the 
debate about what Big Data developments offer to research and practice has concentrated on 
these dimensions. Thus, the concept of Big Data has attracted vast attention because of its great 
potential in impacting businesses (Chen et al., 2012; George et al., 2014). Increased amounts 
of new and different types of data are believed to have the potential to develop new business 
ecosystems, and to coordinate networks of companies, devices, and consumers that create value 
(Weill and Woerner, 2013). 
2.2.1 Application of Big Data for Business 
Recently, a significant body of the research has been directed to identify the opportunities and 
value that Big Data offers to businesses. It has been argued that Big Data has an open-ended 
potential, to be explored in a variety of ways and to different ends (Boyd and Crawford, 2012; 
Davenport, 2012; Chen et al., 2014). For instance, McAfee and Brynjolfsson (2012) and Chen 
et al. (2014) underline the opportunities that Big Data creates with respect to improving specific 
activities, such as customer relationship management. These authors suggest that immediate 
processing of real-time data should be included in decision-making as part of real-time 
applications, as such rapid insights can provide a competitive advantage for businesses. 
Furthermore, empirical research also confirms the advantages of data-driven decision-making 
and has identified a positive association with firm performance (LaValle et al., 2011; Wamba 
et al., 2016). For example, Kwon et al. (2014) and Ghosh (2015) highlight the positive role of 
Big Data in managing logistics and supply chain management. In particular, the authors 
describe how insights generated from Big Data could play a critical role on the different 
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decisions related to supply chain and logistics operations of the business. Thus, the authors 
confirm that real-time customer feedback makes it possible to monitor and understand the areas 
where a product or service is failing. 
Aaltonen and Tempini (2014) investigated the opportunities Big Data offers for the 
development of new products and services and highlighted that the data pool can be a 
comprehensive collection of user behaviours. In particular the authors looked at how a 
telecommunications operator transforms data from a network into valuable information about 
a new kind of advertising audience. In traditional media, this was achieved by distributing 
separate measurement devices to a small subset of consumers. This collected data therefore 
consisted of carefully planned samples gathered for predefined purposes, whereas in the present 
digital ecosystem the behaviour of the entire user base can be captured implicitly. Aaltonen and 
Tempini (2014) state that such a data pool offers the possibility for a company to create new 
kinds of products and services with which the company can compete against businesses who 
rely on more traditional methods. This argument was later  supported by the findings of 
Woerner and Wixom’s (2015), who demonstrated that use of sensors in products to track actual 
product usage and the mining of social media to discern for customer sentiment, and to 
understand customer preferences and behaviour, afforded end consumer visibility to 
manufacturers. This had previously been impossible; for decades, manufactures had relied on 
trade partners to feed data into their internal product development and customer-focused 
processes (Woerner and Wixom, 2015). 
Moreover, is has been argued (Varian, 2010; Woerner and Wixom, 2015) that Big Data 
facilitates improvements to business models across different industries. Big Data in particular 
permits the formation of new insights, allowing the resulting decisions to be made not only 
faster (Aaltonen and Tempini, 2014) but also more precisely (Davenport et al., 2012). For 
example, Varian (2010) highlights that because transactions are now computer-mediated, it is 
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possible to observe behaviour that was previously unobservable, enabling the development of 
new business models. The author offers the examples of Uber (transport service) and Air BnB 
(hospitality service) as examples of such data-driven business model innovations. Similarly, 
Woerner and Wixom (2015)  present interesting examples of media companies such as Netflix 
and NBC Universal, who overruled the traditional business model and moved to data-driven 
content. NBC Universal now make changes to television programming in response to real-time 
customer sentiment. Within the span of just a few hours - or less - the company can respond to 
feedback from particular market segments, even unanticipated ones. In particular, when the 
company moved a popular show to a later time slot, the change was negatively received by 
families whose children could not stay up late enough to watch the series. The company was 
able to response within minutes, and the show was moved to earlier in the day. This type of 
change would previously have taken weeks (Woerner and Wixom, 2015). 
From a marketing perspective, Pauwels et al. (2009) and Jarvinen et al. (2012) argue that the 
availability of Big Data creates two major opportunities: Firstly, firms have access to an 
enormous range of digital tools which can be utilised for marketing purposes; secondly, the 
digital environment has made marketing more measurable by improving the ability of 
marketers to assess, collect, process, and report data on marketing activities. Online retailers 
such as Amazon and eBay are good examples of businesses successfully using Big Data for a 
range of marketing purposes (Wamba, et al., 2016; Davenport, 2014). Financial institutions 
who had previously relied on a customer's financial history to arrive at a credit score can now 
use Big Data for their marketing activities. External data sources, such as for example social 
networking websites, allow them to collect customers’ non-financial information, such as 
university affiliation, club memberships, and social activities to build more complete and 
accurate credit-rating models (Zhao et al., 2014). 
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Table 2.1 below summarises the alternative definitions of Big Data, and lists the opportunities, 
value, and challenges that Big Data offers to different business domains and industries, as 
discussed above and identified in the literature. (The challenges presented by Big Data will be 
discussed in greater detail later in this chapter.) 
Authors, Date Definition/Opportunities Challenges 
Strategic and 
Organisational Impacts / 
The Value of Big Data To 
Organisations 
Laney, 2001 
Large volumes of 
extensively varied data that 
are generated, captured, and 
proceed at high velocity. 
Processing the data with 
existing architectures 
Developing innovative 
insight, products, and services 
La Valle et al., 
2011 
Massive amounts of 
information 
- Lack of understanding of 
how to use data analytics to 
improve the business 
- Lack of executive 
sponsorship 
- Limited ability to capture, 
aggregate, analyse or share  
insights 
- Sharper and more timely 
insight, operation, and 
production 
-Marketing and sales 
-Financial management 
Manyika et al., 
2011 
Data sets whose size are 
beyond the ability of typical 
database software tools to 
capture, store, manage, and 
analyse 
- Capture 
- Storage and management 
- Analysis 
 
Discovery of new insights 
into products, processes, 
customers, markets, and 
competitors 
McAfee and 
Brynjolfsson, 
2012 
- A management 
revolution 
- Advanced stage of 
digitization 
- Leadership teams 
- Talent management 
- Technology 
- Date “noise” 
- Evidence-based 
decision-making / data-driven 
decisions 
- Competitive advantage 
- Customer relationship 
management 
Davenport et al., 
2012 
An expanding sea of data 
that is either too 
voluminous or too 
unstructured to be managed 
and analysed with the 
existing systems 
- Shortage of analytical 
skills 
- Data storage 
- Data-driven culture 
- More efficient and effective 
operations 
- Optimisation of supply 
chain ﬂows 
- Setting the most proﬁtable 
price for products and 
services 
Chen et al., 2012 
Large volumes of 
unstructured data.  
– Processes 
– Governance 
- Minimizing errors and 
quality problems 
 - Improving customer 
relationships 
- Better understanding of 
business and markets 
Boyd and 
Crawford, 2012 
Cultural, technological, and 
scholarly phenomenon, that 
rests on the interplay of 
technology, analysis, and 
methodology 
- Management 
- Quality 
- Privacy 
- Novel business models 
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Sharma et al., 
2012/2014 
A vast amount of structured 
and unstructured 
data from a variety of 
sources 
- Understanding the insight 
generation process 
- Communicating insights to 
business units 
- Centralized structures 
potentially limit 
communication with and the 
involvement of different 
business stakeholders in Big 
Data projects 
- Enhanced decision-making 
George et al., 
2014 
‘Ever-increasing volumes of 
data, often in tera or 
petabytes worth of storage 
capacity’ 
- Powerful computational 
techniques 
- Sharing, privacy, and 
ethics 
- Narrowing information and 
time gap 
- Granual information about  
customers 
Aaltonen and 
Tempini, 2014 
The sheer amount of data. 
The massive amount of data 
generated by the digital 
infrastructure. 
- The technological capacity 
required to simultaneously 
filter the sheer amount of 
data 
- Ability to target different 
customers 
- Interacting with customers 
in different ways 
- Open-ended potential, to be 
explored in a variety of ways 
and to different ends 
Agarwal and 
Dhal, 2014 
Readily available large and 
complex data sets. 
 
‘Sheer size and variety in 
Variables’ 
- Making sense of 
heterogeneous and 
fragmented information 
 
- Data Networks 
- Ability to conduct 
large-scale experiments on 
social phenomena 
- Ability to communicate with 
the larger community of 
scientists and businesses 
Morabito, 2015 
Big Data is data that 
exceeds the processing 
capacity of conventional 
database systems. The data 
is too big, moves too fast, or 
does not fit structured 
database architecture. 
- Comparable architecture 
- Complexity 
- Marketing services 
Constantiou and 
Kallinikos, 2015 
Large data volumes 
generated and made 
available on the Internet and 
the current digital media 
ecosystems 
Much of Big Data, while 
seemingly valuable, does 
not fit into the recording, 
measurement, and 
assessment systems that 
enterprises have built up to 
aid decision- making. 
- More informed strategising 
- Information-based products 
 
 
Woerner and 
Wixom, 2015 
Big Data can enable 
companies to transform in 
ways that propel them into 
new industries or 
ecosystems and alters 
traditional competitive 
landscapes 
- Uneven distribution of Big 
Data throughout the 
organisation 
- Consolidating and 
simplifying the increasing 
amounts of data that result 
from digitization 
- Improved business model 
- Optimized business 
processes 
- Decision-making 
- End consumer visibility 
Abbasi et al., 
2016 
One can separate Big Data 
and ‘regular-sized’ data 
based on the presence of a 
set of characteristics 
commonly referred to as the 
four Vs: volume, variety, 
velocity, and veracity 
-Storage and management 
- Distributed storage 
architectures capable of 
handling large quantities of 
unstructured data 
- Data quality and credibility 
 
- Key resource of 
organizations’ business 
models 
- Data-driven business models 
- Support self-service and 
real-time decision making. 
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Gunther et al., 
2017 
Large volumes of 
extensively varied data 
- Data access 
- Dealing with stakeholder 
interests such as ethical 
concerns and regulation 
- Lack of quality 
-Discovering new and useful 
insights about products, 
processes, customers, 
markets, and competitors 
Braganza et al., 
2017 
‘Big Data is that data is an 
asset. As with other assets, 
data can be used to improve 
competitiveness, 
innovation, and efficiencies 
in organisations’ 
- No apparent business 
process for Big Data 
initiatives 
- Required resources are 
often outside the 
organisation 
- Big Data has the potential to 
increase economic returns by 
offering deeper insights from 
the oceans of data available 
- Big Data has led to the 
creation of new technologies, 
methods, data capture 
applications, visualization 
techniques, and data 
aggregation capabilities 
 
Table 2.1: Big Data Opportunities, Challenges, and Value for the Business (Author’s own) 
 
As can be concluded from this summary of the opportunities and potential for creating value 
for businesses presented by Big Data, it has been increasingly seen as a strategic new asset 
capable of changing competition by transforming organisational processes with new 
organisational capabilities (McAfee and Brynjolfsson, 2011; Davenport, 2012; Kumar et al., 
2013; Kwon et al., 2014). However, as can also be discerned from the above table and the prior 
discussion, Big Data refers to enormous amounts of data that can no longer be managed by 
traditional approaches. The volume and velocity of such high-dimensional data requires new 
Big Data capabilities, where existing capabilities are of no use. Although initial discussions 
about the phenomenon in both the academic and practitioner literature are characterised by 
opportunities (Clarke, 2016), Big Data optimism and the expectation of benefits on their own 
do not guarantee the gain of actual value. There is a need to investigate how organisations 
prepare themselves to start Big Data initiatives and how they translate, as well as fail to 
translate, its potential into actual social and economic value. Consequently, there is tremendous 
interest in academia and industry to address the challenges and to increase the knowledge 
which surrounds this phenomenon. 
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2.2.1.1 Big Data Adoption in Big Companies  
The adoption of Big Data is a complex process that includes data collection, management, 
storage, analysis, mining, and application (Chong and Shi, 2015; Wamba et al., 2016; Yaqoob  
et al., 2016), which is further complicated by the volumes of data involved, its variety, and the  
rate at which it can be processed. There are many acknowledged requirements for the adoption  
of Big Data such as: well-developed IT infrastructure, the talents of specialist Big Data 
analysts, and special analytical tools to address technical challenges (Gandomi and Haider, 
2015). For example, Wamba et al. (2015) suggest that organisations need to leverage the 
information eco-system arising out of the adoption of Big Data to share real-time information, 
better understand customers, optimise the supply chain, and develop insights for decision 
making. Davenport (2014) highlighted the importance of Big Data technologies, such as 
Hadoop or Natural Languages Processes, to analyse huge amounts of data for cost- reduction 
purposes, to make faster and better decisions, and to improve the products and services being 
offered. Yaqoob et al. (2016) believes that only advanced data-mining and storage techniques 
can make Big Data adoption possible. Together with IT Infrastructure, Brinkhues et al. (2015) 
pointed out additional factors such as data resources, financial support, and the cost of Big Data 
adoption. Likewise, looking at Chinese enterprises, Cheng and Li (2016) proposed factors 
concerning Big Data adoption such as: data talent, technical ability, organisational culture, 
organisational structure, and data policies. Akhtar et al. (2018) suggest bundling different Big 
Data skills in teams and speciﬁc managerial actions. Teams depend on multi-disciplinary skills 
(e.g. computing, mathematics, statistics, machine learning and business domain knowledge) 
help to turn traditional business operations into modern data-driven insights (e.g. knowing real-
time price changes and customer preferences) and leading to specific Big Data actions that 
enhance Big Data adoption.  
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However, as argued by McAfee and Brynjolfsson (2012), as with any new business tool, 
adopting Big Data necessitates change throughout an organisation. Those businesses that have 
been the most successful with their Big Data deployments are those that have embraced these 
changes, transforming their organisations so that the insights gained through Big Data analysis 
can actually make a difference by becoming actionable (McAfee and Brynjolfsson, 2012; 
Davenport, 2013; Wamba et al., 2016). For that to happen, leaders must be willing to invest 
significant amounts of time and energy to make sure that all managers across the organisation 
are fully aligned with the company’s Big Data mission, as well as being aware of the existence 
of the risks inherent in the adoption of new technological solutions (Grover et al., 2018). In 
addition, for some companies the biggest challenge in deploying Big Data may not be the 
technology but how to leverage human capital and organisational culture to support the Big 
Data adoption strategy and entailed operational activities. Looking at Big Data adoption in big 
companies, Davenport (2013) relates the story of Walmart’s successful adoption of Big Data. 
Walmart is one of the largest retailers in the world and the world’s largest company by revenue, 
with more than two million employees and 20,000 stores in 28 countries, and is living evidence 
that adopting a Big Data-driven approach - in particular the timely analysis of real-time data - 
is key to driving business performance. Walmart collects 2.5 petabytes of data from 1 million 
customers every hour. In 2012, the company upgraded the processing capacity and speed of 
their Big Data systems, from a 10-node Hadoop cluster to a 250-node Hadoop cluster so that 
all the unstructured data generated at 10 different websites could be combined and collected 
into a new Hadoop cluster. Since then, the organisation has been accelerating Big Data 
adoption to provide the best e-commerce technologies with the motive being to both deliver 
the best customer shopping experience and to improve its operational efficiency. In addition to 
Hadoop the company use NOSQL technologies to provide internal customers with access to 
real-time, centralised data collected from different sources. In doing so the company creates 
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the world’s largest private Cloud and analytics hub, known as Data Cafe, which pulls 
information from 200 diverse sources. The Data Cafe system has led to a reduction in the time 
it takes from a problem being spotted to a solution being proposed from an average of two to 
three weeks down to around 20 minutes (Davenport, 2013).  
eBay is another good example of a company that has adopted Big Data successfully. One of 
the keys to eBay’s success is its ability to turn its Big Data, more than 250 terabytes (TBs) in 
volume and high streaming data velocity with 6 billion writes and 5 billion reads generated 
daily, into useful business insights that benefit its customers directly. eBay has invested in 
DataStax Enterprise with integrated search and real-time Big Data analytics deployed across 
multidata centres. With substantial data access and analysis capabilities in place, eBay 
emphasises customisation to enhance its customers’ digital experience in order to drive sales 
and satisfaction. In doing so, eBay demonstrates the effect of data Value on its assets, its 
capabilities, and the multiple mechanisms by which it targets consumers and generates strategic 
impact on both financial growth and its reputation for industry leadership (Davenport, 2013).  
In summary, with so many new technologies and processes, and with so much more information 
to take into account, organisations and leaders need to revamp their current strategies to take 
advantage of the benefits that Big Data has to offer. However, despite increasing awareness 
(examples discussed above, successful case studies, and best practise available online) that may 
enable enterprises to consider all the factors that may affect the adoption of Big Data, many 
companies have little or no knowledge of the concept or use of Big Data. Moreover, there are 
still limited numbers of empirical studies about how organisations can re-equip, reconfigure, 
or develop capabilities for the successful adoption of Big Data. 
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2.2.2 Big Data in Pharmaceutical Industry 
2.2.2.1 Background of Pharmaceutical Sector Development 
Since 1980 the healthcare industry, in particular the pharmaceutical segment of the industry 
which is the core of this study, has started integrating modern biotechnology in their research, 
production, and marketing activities (Taylor, 2015). Modern biotechnology refers to a set of 
techniques that involve manipulation or change of the genetic patrimony of living organisms 
(Ramani, 2000). Advances in modern biotechnology have triggered a radical change in the 
nature of the research processes used in the development of new drugs (e.g. creation rational 
methods, genomics, which refer to structure and functions of genes, and randomized design). 
The randomized controlled trial (RCT) is a powerful tool that has provided the evidence-based 
decision for many of the advances of modern medicine (Harvey et al., 2012). Thus, the use of 
genomics and new tools in the pharmaceutical sector has revolutionised approaches to drug 
safety, moving from detection and enumeration to prediction (Woodcock, 2007). They have 
also led to incremental product (drug development) innovations and reduced inefficiency in the 
production of a number of pharmaceutical products (Ramani, 2000). Therefore, biotechnology 
has an increasing influence on the evolution of the global pharmaceutical industry. Moreover, 
support from the U.S. Food and Drug Administration (FDA) which is charged with 
implementing policies that ensure that the benefits of new products will outweigh their risks, 
while simultaneously promoting innovations that can improve health, helped push forward the 
pharmaceutical industry’s market capitalisation above US $1 trillion (Ernst and Young, 2014). 
As has been mentioned earlier in this thesis (Chapter 1) the modern pharmaceutical industry is 
dominated by a few large MNC pharmaceutical companies, known as a ‘Big Pharma’ 
(Chandler, 2009; Hedner, 2012). Through Big Pharma’s integrated approach of exploiting the 
kinds of scientific and technological advances mentioned above, Europe and the US led the 
success of the modern pharmaceutical industry. These companies acquired biotechnology 
capabilities that led to the discovery and development of small molecule and biological drugs, 
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as well as large-scale clinical trials management, management of regulatory approvals, and in 
the marketing and distribution of pharmaceuticals around the globe (Sadat et al., 2014). 
Despite the advances discussed above, drug development programs are still expensive and 
usually require many clinical studies and patient exposures (Groves, 2013). Even with 
increasing investment in pharmaceutical research and development, successful development of 
novel drugs is slowing, and drug development costs per successful entry have increased, 
particularly the costs of clinical trials (Woodcock, 2007; Feldman et al., 2012). Moreover, there 
is still a great deal of uncertainty about the performance of drugs that are new to the market 
(Sadat et al., 2014). In addition, data from long-term use are usually limited (Woodcock and 
Woosley, 2008). Figure 2.2 illustrates a comparison of global pharmaceutical industry 
investment in research and development with the global output of new molecular entities. 
 
 
Figure 2.2: Comparison of Global Pharmaceutical Industry Research and Development 
Investment Versus Global Output (Source: Woodcock and Woosley, 2008) 
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Traditionally, regulatory approval of a new drug based on its safety and efficiency has been the 
biggest barrier to its market entry (Sadat et al., 2014). However, recently the biggest challenge 
for a new drug’s success is whether it would qualify for reimbursement from the payers (Ernst 
and Young, 2014). Indeed the payers are increasingly becoming important in determining the 
value of new drugs. To better demonstrate the effectiveness and value of new drugs to 
regulators and payers, Big Pharma is focusing on the development of personalised medicines 
that work on a specific patient subgroup who express a particular disease characteristic (Burrill, 
2013). Personalised medicine promises prediction, prevention, and treatments that are targeted 
to individuals’ needs (Harvey et al., 2012). Moreover, Big Pharma is also building innovative 
healthcare delivery models in many emerging markets, by engaging doctors, patients, and 
policy-maker stakeholders in various healthcare initiatives. These include raising awareness 
among patients through patient education programs (Ernst and Young, 2014). 
2.2.2.2 Big Data Potential in Big Pharma 
Accompanying the shift in the pharmaceutical industry discussed above, the emergence of Big 
Data and technologies such as social media, smartphone apps, wirelessly connected devices, 
and sensors have become new trends in this industry (Groves, 2013). The vast amount of data 
generated and collected today by the pharmaceutical industry comes in many different forms, 
such as: R&D; clinical trials; insurance claims; physician notes within medical records; patient 
family history; images from patient scans; conversations about health in social media; and other 
monitoring devices (Ernst and Young, 2014). Insights from such vast amount of data have the 
potential to positively affect many aspects of the value chain of pharmaceutical innovation 
(drug innovation) (Sadat et al., 2014). Thus, an integration of Big Data initiatives in the 
pharmaceutical industry as in many other industry currently has been actively promoted and 
debated in the public and private sectors. For example, the National Institute of Health recently 
launched a Big Data to Knowledge Initiative (BD2K) to enable the biomedical research 
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community to better access, manage, and utilise Big Data (Ernst and Young, 2014; Taylor, 
2015). Some pioneering work is also being undertaken through large collaborations such as the 
National Patient-Centered Research Network (PCORnet), and Optum Labs, a research 
consortium that brings together academic institutions, health care systems, provider 
organisations, life sciences companies, and advocacy organisations (Feldman et al., 2012; Shah 
and Pathak, 2014). 
While researchers and practitioners are still debating the definitions and boundaries of Big Data 
in the pharmaceutical sector, some academic studies (e.g. Srinivasan and Arunasalam, 2013; 
Li, et al., 2013; Lopez, et al., 2014) have demonstrated that Big Data applications can play a 
greater role in predicting the impact of disease. In particular, insights from analysis of large 
data sets have the power to help pharmaceutical companies personalise a medicine for each 
patient to ensure better and faster recovery (Feldman et al., 2012; Yaqoob et al., 2016). The 
main advantages of personalisation lie in greater customer satisfaction and higher profits 
(Arora et al., 2008). The aim of these analyses is to understand the outcomes of diseases and 
those risk factors that may affect patient care (Swan, 2013) and accelerate the individualisation 
of medical treatments (Deloitte, 2014). However, Arora et al. (2008) highlighted that even 
though personalisation relies on data, it drives pharmaceutical companies to stretch their data 
collection and management ability. Thus, personalisation is expensive in that it requires both 
data and costly software and hardware tools for implementation, such as computational 
infrastructure and the so-called “360-degree view” for example. The 360-degree patient view 
is the idea that pharmaceutical companies can get a complete view of patients by aggregating 
data from the various touch points that patients may use to contact a company to purchase 
products and to receive service and support (Feldman et al., 2012). Moreover, the effect of 
personalisation depends on the accuracy of the personalisation which in turn depends on 
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transforming the data into insights and operationalising the results (e.g. to be able to offer the 
right product at the right time to the right patient). 
Shah and Pathak (2014) found that in some cases Big Data may generate new patterns for 
increasing the efficiency of randomised clinical trials. Physicians have traditionally used their 
judgment when making treatment decisions, but in the last few years there has been a move 
toward evidence-based medicine, which involves systematically reviewing clinical data and 
making treatment decisions based on the best available information. Therefore, Big Data is 
becoming a valuable resource in advancing understanding of the complex biology that 
underlies personalised medicine. Moreover, a patient’s response to therapy may also help 
pharmaceutical companies to improve drug development, reducing healthcare costs (Srinivasan 
and Arunasalam, 2013) and improving efficiency (Manogaran et al., 2017). Thus the main 
benefits of pharmaceutical companies applying Big Data include saving time and improving 
the overall quality of disease treatment and patient care, while at the same time reducing costs. 
For example, integrating population-scale clinical data sets with genomics data might help 
pharmaceutical companies move closer to getting more and better drugs approved in the first 
place, and more importantly, to getting the right drug to the right patient at the right time 
(Fledman et al., 2012). 
However, challenges ahead include the need to bridge the current capabilities and technology 
gaps in the industry (Costa, 2014) such as, for example, computational infrastructure, new 
methods to interpret high volumes of generated data, and unique collaborative approaches 
between different functions (those capabilities that apply specifically to Big Data in the 
pharmaceutical industry will be discussed in detail later in this chapter). On the other hand, the 
nature of the pharmaceutical industry coupled with the fact that Big Pharma chiefly consists of 
MNCs, also creates challenges. Intra-organisational coordination of MNCs is becoming 
increasingly complex, demanding control of a multitude of factors at headquarters, subsidiary, 
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franchise and managerial levels including: market and customer preferences, global and local 
competitors’ strategies, host-country and home-country regulatory requirements, strategic 
alignments, managerial self-interest and the roles that individual managers play at both the 
headquarters and the franchises (Schotter and Beamish, 2011). 
The pharmaceutical supply chain is a rich example of information that flows to many 
stakeholders. It presents structured and unstructured information, as well as both controlled 
and uncontrolled knowledge dissemination, and therefore it is important to map these 
information flows (Pedroso et al., 2008). Yet, because there are many players, there is no way 
to easily share data among different providers or facilities, partly because of a broad range of 
ethical, legal, and regulatory obstacles that increase the challenges to Big Data initiatives in 
Big Pharma. Thus, even within a single pharmaceutical company, important information can 
remain siloed within one group or department, mainly because of a lack of data integration and 
communication processes (Gover, 2013; Taylor, 2015) 
While more flexible data collection, integration, and communication (along with new analytical 
methods) are crucial to the Big Data movement in the pharmaceutical sector, it has also been 
acknowledged that practical applications will be key to its success (Costa, 2014). For such 
success to be possible, all stakeholders must recognise the value of Big Data and be willing to 
act on its insights. This in turn will require many in the industry to undergo a fundamental shift 
in mind-set and culture, which is difficult to achieve (Kayyali et al., 2013). Therefore, these 
revolutionary changes in Big Data trends require new solutions, new tools and the development 
of capabilities to address such challenges. Thus, more empirical studies are needed to explore 
these processes, as there is currently a limited literature on this context, and as it has been 
highlighted earlier practical implications are key to understanding the process of the 
implementation of Big Data initiatives in the industry. 
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2.3 Big Data and Resource-Based View 
2.3.1 Resource-Based View 
Due to the increased importance of dynamic market environments in the real world, many 
scholars (Barney, 1991; Teece et al., 1997; Grant, 2005; Teece, 2007) have focused on the 
Resource Based View (RBV). The RBV of a firm is central to strategic management research 
and is fundamental to understanding a company’s success. The RBV shifts emphasis away 
from external factors, such as industry position and product development, towards internal 
company resources and capabilities to gain a competitive advantage (Penrose, 1959; 
Wernerfelt, 1984; Prahalad and Hamel, 1990; Amit and Schoemaker, 1993; Grant, 2005). 
The idea of looking at firms as a broader set of resources goes back to the work of Penrose: 
The Theory of the Growth of the Firm (1959) in which Penrose argues that there is a strong 
relation between a firm’s range of resources and the development of ideas, experience, and 
knowledge of its managers. Penrose (1959) suggests that resources consist of a bundle of 
potential services. Analogously, Wernerfelt (1984) argues that viewing firms in terms of their 
resources leads to different immediate insights than the traditional product perspective. 
Wernerfelt (1984) proposes that instead of seeing resources as anything that could be associated 
with a firm’s strengths and weaknesses, resources should be considered from a different 
viewpoint. For example, firms can identify types of resources that can lead to high profits or 
develop new resources to capitalise on better performance. Although Wernerfelt was not 
writing about a particular set of resources, such as IT resources or Big Data, it can be argued 
that companies can capitalise on increasing data volumes to potentially improve their 
performance. 
The debate on the potential benefit of capitalising on resources is taken further by Barney 
(1991) who argues that firms can generate a sustainable Competitive Advantage (CA) from 
their resources. CA refers to a firm’s position when they have implemented a value-creating 
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strategy that is not simultaneously implemented by their competitors (Barney, 1991). It has 
been widely accepted that elements for competitive advantage and value-creating strategies lie 
in a firm’s heterogeneous resources (Wernefelt, 1984; Barney, 1991; Peteraf, 1993; Teece et 
al., 1997). However, it should be acknowledged that not all resources have the same potential 
to generate a sustainable competitive advantage. In order to create a competitive advantage, 
managers have to develop and obtain valuable, rare, inimitable, and non-substitutable resources 
(VRIN) within the firm (Barney 1991). The VRIN framework introduced by Barney, which 
was revised later by Barney and Hesterly (2012, p. 94) as a VRIO where O stands for 
Organisation, has been acknowledged as a tool that can be used to determine a firm’s resource 
competitive potential, although its applicability and practicality has been challenged (Priem 
and Butler, 2001; Kozlenkova et al., 2013), mainly due to a lack of empirical support. For 
example, Armstrong and Shimizu (2007) found that it is difficult to objectively observe 
dimensions such as value and inimitability of resources, and so it is hard to measure them. 
Furthermore, authors such as (Wade and Nevo, 2010; Ambrosini and Bowman, 2009; Barreto, 
2010) highlighted that while a single resource can be viewed as valuable, it is only collaborative 
combination with other resources and capabilities that can result in actual competitive 
advantage. 
Building on the views above, it must be argued that Big Data as a new resource can only be 
leveraged if carefully combined with other existing or new resources and capabilities of the 
firms involved. 
2.3.2 Resource and Capabilities in RBV 
Building upon earlier works, recent literature on the resource and capabilities of RBV can be 
roughly divided into two groups. The first group categorises resources rather broadly, and 
includes all assets, capabilities, organisational processes, firm attributes, information, and 
knowledge (Barney, 1991, p.101). The second group clearly distinguishes the resources and 
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capabilities of a firm (Amit and Schoemaker, 1993; Grant, 2005; Helfat et al., 2007) by arguing 
that resources are ‘the productive tangible (a land, a plant or equipment) and intangible 
(customer relationship, know-how, or brand name) assets that can be traded by the firm’ 
(Grant, 2005, p. 138). As represented in figure 2.2 Grant (2008, p. 131) offers a classification 
of resources as follows. 
 
Figure 2.3: Resource Typology (adapted from Grant, 2008, p. 131) 
 
Capabilities refer to ‘a firm’s capacity to deploy resources for a desired outcome’ (Grant, 2005, 
p.138). While resources or factor inputs are available to all firms, the ‘capability’ to deploy 
them productively is not uniformly distributed (Ethiraj et al., 2005). Furthermore, in contrast 
to resources, it has been argued that capabilities have to be built within the company and not 
brought in (Amit and Schoemaker, 1993; Makadok, 2001). This study adopts the latter 
conceptualisation of resource and capabilities in order to understand how organisations develop 
capabilities to effectively use Big Data as a resource. 
 
2.3.3   Capabilities, Routines, and Competencies 
- Capabilities 
The diverse nature of capabilities, along with the rapid growth of academic literature in this 
area, has led to a complex body of research around the topic. However, Ethiraj et al. (2005) 
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argue that there is still a limited understanding in academic literature about the origins of 
capabilities or how capabilities are developed, maintained, and leveraged. Esterby-Smith et al. 
(2009, p. 4.) argue that the problem of studying organisations' capabilities is associated with its 
nature, ‘Tacit and / or intangible organisational elements,’ such as routines, processes, 
managerial cognition, and knowledge. However, due to the complexity of organisational and 
managerial capabilities, and their importance for both strategic management research and 
practice, there is an opportunity to advance research on capabilities in many areas (Esterby-
Smith et al., 2009). 
According to Winter (2003, p. 991) an organisational capability is ‘a high level routine (or 
collection of routines)’ that, together with its implementing input flows, confers upon an 
organisation’s management a set of decision options for producing significant outputs of a 
particular type’. Following this definition, capabilities have been recognised as a key 
explanatory variable for differences in organisational behaviour and the consequent outcomes 
(Dosi et al., 2000; Eisenhardt and Martin, 2000; Zollo and Winter, 2002). Furthermore, 
resources and experience are seen as inputs to capabilities (Felin et al., 2012). In this study the 
definition of capability follows these ideas. The importance of a firm’s capability is further 
argued in a study conducted by Grant (2010) that demonstrated that capabilities emerge from 
the cooperation and coordination of a set of resources within  a firm and hence a capability is 
a firm’s capacity to deploy resources for a desired outcome (Grant, 2015). Understanding of 
capabilities in relation to the resources and their capitalisation therefore becomes fundamental 
to this study.  
- Routines 
At this point, it is important to bring in scholarly opinions on routines, which have been defined 
as a ‘repository of organisational capabilities’ (Winter, 2003, p. 991). Winter (2003) argues 
that organisational routines are the basis of capabilities and are thus important factors to be 
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considered when building capabilities. Moreover, some scholars argue that routines are 
microfoundations of capabilities and are important because they form ‘the building blocks of 
capabilities’ (Nelson and Winter, 1982; Teece et al., 1997; Winter, 2000; Dosi et al., 2001, p. 
4). Routines has been described as an organisational behaviour: actions that are to be regularly 
carried out (Nelson and Winter, 1982). Consequently, routines can be defined as repetitive, 
recognisable patterns of interdependent actions, carried out by multiple actors or as repeated 
patterns of response (Feldman and Pentland, 2003). Capabilities, on the other hand, can be 
described as the ability of an organisation to take/perform an action. It has been argued that 
routines accumulate past knowledge regarding organisational successes and failures, while 
being embedded in a particular structure, such as a physical space (Nelson and Winter, 1982; 
Winter, 2003). This means that knowledge regarding routines is key to a correct understanding 
of capabilities, and vice versa (Salvato and Rerup, 2011). 
- Competencies 
Other relevant literature relating to resources and capabilities relate to an organisation’s 
competencies. It should be acknowledged that in some cases the terms capabilities, 
competencies, and routines, are defined similarly. Additionally, in some cases the literature uses 
the term capabilities and competencies interchangeably (Grant, 2005. p. 144). However, 
although each of them incorporates a combination of knowledge, skills, abilities, and actions, 
they are not same (Prahalad and Hamel, 1990; Collis and Montgomery, 1997; Dosi, 2003; 
Grant, 2005). For example, Stalk et al. (1992. p. 63) explain that capabilities are applicable to 
the whole value chain, while competencies are limited to functional areas within the 
organisation. Organisation can have an excellent competencies in a narrow area of expertise 
but lack the capability to apply them effectively for example through ineffective marketing, 
distribution, customer service, or information processing (Smith, 2008). However, Prahalad 
and Hamel (1990) suggest that organisations need to understand their core competencies in 
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order to successfully deploy their resources. Core competencies are skills and organisational 
knowledge that are shared across different business units of an organisation. Furthermore, 
competencies are a source of differentiation for the organisation that allow it to create and offer 
unique products and services to customers (Smith, 2008). Lado and Wilson (1994, p. 702) state 
that competencies ‘include all firm specific assets, knowledge, skills and capabilities embedded 
in the organisations’ structure, technology, and processes.’ McGrath et al (1995, p. 254) 
consider competencies as ‘a purposive combination of firm-specific assets (or resources) which 
enable it to accomplish a given task’. Based on these definitions competencies can be 
conceptualised as representative of organisational routines and processes which are enabled 
when firm-specific assets are assembled in integrated clusters across individuals and groups 
(Teece et al., 1997) as the collective learning in an organisation, especially how to coordinate 
diverse production skills (Prahalad and Hamel, 1990), and as integrated multiple streams of 
technologies and organisational knowledge that are shared across different business units of an 
organisation (McGrath et al., 1995, p. 254). Thus, competencies in this research are understood 
as being more than what an organisation does on a daily basis, they are also what the 
organisation is doing particularly well relative to its competitors (Selznick, 1957) in terms of 
continuously improving its performance. In contrast, the term capabilities in this research 
refers to a broad set of abilities in which a company has capacities that are rooted in daily 
operations related to different functions/operations. 
2.3.4 Big Data in RBV 
As seen through the lens of the theoretical perspective laid out in the previous sections, Big 
Data as an intangible resource can be considered as potentially strategic.   
Strategic resources are those that allow you to achieve strategic goals and therefore generate  
sustainable competitive advantage (Barney, 1986). Whether leading to better performance or  
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generating sustainability, Competitive Advantage (CA), Wernerfelt and Barney’s work 
provides a solid foundation for the argument that Big Data, when fully utilised and capitalised, 
can be a strategic resource that can greatly benefit companies. Barney (1986, p. 658) states that 
‘strategic and valuable resource must enable a firm to do things and behave in ways that led 
to high sales, low costs, high margins or in other ways to add financial value to the firm’. As 
an example, today’s biggest companies (Apple, Amazon, Microsoft, Facebook) by market 
capital valuation are data technology businesses. These disruptive innovators use Big Data 
solutions as competitive advantages to reduce operational costs, increase revenue, predict 
behaviour, improve cash flows (Davenport, 2013; Sun et al., 2016). They link Big Data into 
every function of the organisation. However, as previously mentioned, the value of Big Data 
does not come about through its ownership – rather, it only has economic value if it is 
implemented effectively. Moreover, some authors (Bharadwaj et al., 2013; Erevelles et al., 
2015) argue that a digital business environment brings additional dimensions that alter the 
nature of creation, capture, and distribution of business value among competitors. Therefore, a 
more refined and detailed understanding of Big Data as a new strategic resource is critical to 
this study.   
The reason this research refers to Big Data as intangible rather than tangible is that under 
current accounting rules, generally, only items of tangible value purchased by a company are 
listed as an asset (FSAB, 2019). Intangible resources are, unlike tangible resources, not 
documented on an organisation’s financial statements (Grant, 2016, p. 128). While some 
tangible resources such as (stocks, real estate holdings, land, etc) are easy to measure and show 
on a balance sheet, intangible resources (including patents, copyrights, trademarks, and brand 
names) are notoriously hard to objectively value as their value ultimately depends on a 
business’ capacity to use them. Therefore, they are not to be placed on the balance sheet.  
Exceptions arise in relation to goodwill (The value of a company’s brand name, solid customer 
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base, good customer relations and good employee relations). Goodwill is an intangible asset 
associated with the purchase of one company by another. Specifically, goodwill is recorded in 
a situation in which the purchase price is higher than the sum of the fair value of all identifiable 
tangible and intangible assets purchased in the acquisition and the liabilities assumed in the 
process. Goodwill is recorded on the balance sheet as a noncurrent asset meaning it is a long-
term asset similar to fixed assets like property, plant, and equipment. However, the Financial 
Accounting Standards Board (FASB) is guiding how to determine the value of goodwill for a 
company (Wasserman, 2018).  
Although it is common for businesses to refer to data as an asset, since Big Data is routinely 
produced by a business and often is not purchased, it typically is not recorded on the balance 
sheet. Yet, this undeniably valuable resource is currently not established enough to be used to 
its full potential to the same extent as its physical assets counter-parts (Gartner, 2018). This 
lack of maturity means that, currently, data and information are unable to be recognised on 
ﬁnancial statements and are difficult or impossible to officially value. Thus, in 2016 the 
Financial Accounting Standards Board (FASB) assembled a group of researchers to study the 
possibility of updating its accounting rules to potentially record data as an asset. Gartner (2018) 
states that although Big Data arguably meets the formal criteria of a business asset, present-
day accounting practices prevent it from being counted as a tangible asset, therefore before the 
FASB can decide how to best estimate data value and encourage the viewing of data as an asset, 
the accounting rules currently in place will need to be applied.  Short (2018) states that issues 
preventing understanding of how organisations can value its Big Data initiatives can potentially 
be solved using insights from empirical research. By being able to reliably determine the value 
of Big Data resource, organisations will be closer to being able to account for them in their 
balance sheets and other ﬁnancial statements. Furthermore, if an organisation can value its data 
it is then able to make more eﬀective strategic decisions, especially when those decisions relate 
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to their data and information systems (Wamba, 2015). Thus, regardless of whether Big Data is 
currently included on balance sheets, learning to manage, deploy, value, and treat data as an 
tangible asset can help with understanding the ROI of both Big Data Management and Big Data 
investments. 
2.3.5 RBV Applications and Limitations 
While the RBV as a theoretical framework has been acknowledged to help the study of 
organisational resources and capabilities, its practicality and empirical perspective have been 
challenged (Priem and Butler, 2001; Newbert, 2007; Armstrong and Shimizu, 2007). A study 
conducted by Armstrong and Shimizu (2007, p. 975) found that a major challenge for 
researchers in empirically testing the RBV is that of isolation and operationalisation of 
resources. However, while resources are necessary to deliver capability, it has been argued 
(Armstrong and Shimizu, 2007; Nevo and Wade, 2010; Arend and Levesque, 2010) that the 
resource-based view of competitive advantage is too static to explain how firms create new 
capabilities to leverage opportunities within dynamic markets. With fast-changing markets or 
evolving technologies, organisations must develop new capabilities that permit them to out-
perform their competitors. However, routines, competencies, and capabilities are often 
discussed without full consideration being given to such rapidly changing environments. Some 
scholars (Agarwal and Dhar, 2014; Braganza et al., 2017) have questioned the applicability of 
the RBV for Big Data initiatives - in particular, the known limitations of RBV when applying 
Big Data initiatives implementation. Braganza et al. (2017) also suggest that even though RBV 
provides VRIN framework to consider Big Data as a strategic resource and, even more 
importantly, enables discussion of Big Data’s contribution to competitive advantage, RBV may 
not be able to explain management of resources in Big Data initiatives. In Big Data initiatives 
the core resource, data, is not rare. RBV suggests that where organizations have access to scarce 
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resources, they use these rare resources to achieve competitive advantage. Consequently it may 
be difficult to explain the capabilities development process for such initiatives. 
In response to enquiries into how and why certain firms have competitive advantage in 
situations of rapid and unpredictable change, the RBV has been extended to dynamic markets 
by introducing the Dynamic Capability (DC) perspective. Teece et al. (1997) shift the focus 
from the firm’s resource configuration to organisational capabilities that define these resource 
configurations according to the environmental conditions and proposed DC theory. This 
approach extends the resource-based view argument by addressing how Valuable, Rare, 
difficult to Imitate and Non substitutable resources (VRIN) can be created and how a firm’s 
current valuable resources can be leveraged, renewed, and reconfigured in changing 
environments (Teece et al., 1997). 
In brief, the DC theory shares much common ground with the RBV in terms of having an 
internal focus on the purposeful use of resources. However, the mechanism, logic, and 
perspective of the two approaches have pre-eminent differences (Lopez, 2005). Therefore, it 
may make Dynamic Capability more appropriate as a theoretical perspective for making sense 
of organisation’s Big Data initiatives in the turbulent 21st century’s digital business 
environment. Thus, selecting a DC as a main theoretical lens is believed to be the most 
appropriate choice for this research (as will be seen, the next section talks more about the 
justification behind taking a DC perspective). 
2.4 Dynamic Capabilities (DC) Theory 
2.4.1 Different Definitions of the DC 
Research that has been conducted since the introduction of the Dynamic capability theory by 
Teece et al. (1997) has yielded a large array of explanations and definitions of dynamic 
capabilities (Grant, 1991; Teece et al., 1997; Eisenhardt and Martin, 2000; Zollo and Winter, 
2002; Helfat et al., 2007; Ambrosini and Bowman, 2009). However, it must be acknowledged 
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that while there are several alternative definitions of dynamic capabilities, its conceptualisation 
has been heavily influenced by two academic papers Teece, Pisano, and Shuen (TPS) 1997 and 
Eisenhardt and Martin (EM) (2000) (Di Stefano and Verona, 2013; Peteraf et al., 2013). Table 
2.3 at the end of this section summarises alternative definitions, and also those organisational 
and managerial abilities and processes referred to as DC that have been identified in the 
literature. To visualise which definition and approach has been influenced by a particular author 
there are two colours in the table 2.3. Light blue represents definitions and authors that have 
been influenced by TPS, while dark blue colour illustrates EM’s approach. 
In general, DC theory focuses on the organisational perspective, explaining the need for an 
organisation to address the rapidly-changing business environment by developing dynamic 
capabilities. It views the business environment as an overall framework within which the 
organisation operates. The Dynamic capability theory looks at the ways that resources can be 
better utilised to address the changing needs and requirements of a business. It also examines 
the possibility of an organisation to (how an organisation can/might be able to) shape its 
environment to ensure competitive advantage. 
Therefore, both TPS and EM works are complementary in many respects in that they both 
consider managerial and organisational processes, and identify the importance of routines and 
recommend DC as an extension to the resource-based view. However, Peteraf et al. (2013) 
argue that the two approaches have different theoretical underpinnings, and represent different 
approaches for conceptualising dynamic capabilities. Peteraf et al. (2013) also argue that each 
approach employs different types of reasoning, and reach different conclusions. Table 2.2 
below highlights the main differences between the two approaches. 
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Differences 
Teece, Pisano, and 
Shuen (TPS) 
Eisenhardt and Martin 
(EM) 
Differences in 
Definition 
Define dynamic capabilities as a 
firm’s ability 
Define as specific and identifiable 
processes embedded in ﬁrms 
Differences in 
importance of DC 
Acknowledge the importance of 
DC to address rapidly changing 
environments 
Acknowledge the importance of 
dynamic capabilities also in 
moderate environments 
Differences in 
outcome of DC 
Ability to achieve new and 
innovative forms of competitive 
advantage 
Dynamic capabilities do not always 
lead to advanced performance or 
competitive advantage. They can 
be a source of only limited 
competitive advantage 
Differences in 
object of action of 
DC 
Acknowledge DC as a complex 
routines that are more concerned 
with changing existing 
resources and capabilities 
Acknowledge DC as a best practice 
or simple rules that are more likely 
to be involved in developing 
something new in response to new 
opportunities 
Differences in how 
to study the DC 
Study technological and 
environmental changes, firm’s 
performance, and strategy   
Study internal organisational issues, 
practice, processes and information 
system 
Table 2.2: Main differences between TPS and EM approaches (Author's own) 
 
Teece et al. (1997) define dynamic capabilities as a firm’s ability to integrate, build, and 
reconfigure internal and external competencies to address rapidly changing environments. In 
contrast, Eisenhardt and Martin (2000. p.1106) present dynamic capabilities as specific and 
identifiable processes embedded in ﬁrms. Eisenhardt and Martin (2000. P. 1107) state that 
‘dynamic capabilities are integrated processes, and that they consist of identifiable and specific 
strategic routines by which ﬁrms achieve new resource conﬁgurations as markets emerge, 
collide, split, evolve, and die’. Furthermore, Eisenhardt and Martin (2000) also acknowledge 
the importance of dynamic capabilities in moderate environments, where change occurs 
frequently but along predictable paths. For example, the authors explain a firm’s strategic 
decision-making as a dynamic capability in which managers pool their various business, 
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functional, and personal expertise to make choices that shape the major strategic moves of the 
firm (even in a moderate environment). Moreover, by characterising DC as a ‘best practice’ or 
‘simple rules’ and ‘experiential processes’ EM implies that DC can be a source of only limited 
competitive advantage, while TPS states that dynamic capabilities reflect an organisation’s 
ability to achieve new and innovative forms of competitive advantage when operating in an 
environment of rapid technological change (Tecce et al., 1997, pg. 516). 
Beyond differences between the two approaches highlighted above, the relationship between 
DC and an organisation’s performance has been most debated among strategic management 
scholars. While some authors (Tecce et al., 1997; Makadok, 2001; Ambrosini and Bowman, 
2009) believe there is a direct relationship between an organisation’s dynamic capabilities and 
its performance, Eisenhardt and Martin (2000) and Helfat et al. (2007) suggest that dynamic 
capabilities do not always lead to improved performance. Among these views, Zott (2003), 
Protogerou et al. (2011) and Pavlou and El Saway (2011) propose that there is an indirect link 
between dynamic capabilities and performance. For example, Protogerou et al. (2010) found 
that dynamic capabilities have a positive impact on operational capabilities (marketing and IT) 
and an organisation’s performance. The authors argue that the transformation and 
reconfiguration of operational capabilities (which are a firms’ basic functional activities) has 
an indirect impact on a firm’s performance. DC can be seen as higher-order strategic processes 
that integrate, recombine, and generate new technological and marketing capabilities, which in 
turn impact a firm’s performance. This finding was supported by Pavlou and El Saway (2011), 
who also found that DC have an indirect positive effect on performance by reconfiguring 
operational capabilities into new ones that better fit the environment. 
The diverse nature of the capabilities, along with the rapid growth of academic literature in this 
area, has led to a complex body of research around the topic. Understanding how capabilities 
are developed, maintained, extended, leveraged, and adapted has been debated and investigated 
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from the micro and macro perspectives of companies (Teece, 2007; Ambrosini and Bowman, 
2009; Felin et al., 2012). The benefits from the micro-foundation approach lie in a 
consideration of lower-level entities, such as individuals or processes in an organisation and 
their interactions. A micro-foundational approach, however, does not exclude the idea that 
collective-level constructs can offer suitable explanations for understanding routines and 
capabilities (Felin et al., 2012). Some authors (Teece, 2007; Ambrosini and Bowman, 2009; 
Protogerou et al., 2011) suggest that in order to understand dynamic capabilities it is important 
to focus on the processes that underpin them. However, there are many processes that operate 
within an organisation, and it is hard to distinguish which of them has a direct link to dynamic 
capabilities (Protogerou et al., 2011). For example, Zollo and Winter (2002) identify the 
importance of organisational routines of learning mechanisms as an important process for the 
development of dynamic capabilities, such as experience accumulation, knowledge 
articulation, and knowledge codification. Organisational learning is defined as ‘the capacity or 
process within an organisation to improve or maintain performance based on experience’ 
(Nevis et al., 1995, p 73). However, Swift and Hwang (2008) found that the development and 
codification of routines in organisational learning processes critically depend on various social 
and managerial processes, such as supportive leadership, teamwork, and the free flow of 
information across all areas of the organisation. 
Teece et al. (1997) propose a combination of three organisational and managerial processes as 
core elements of dynamic capabilities: 1) coordination/integrating, 2) learning, and 3) 
reconfiguring. These processes support sensing, seizing opportunities, and managing threats, 
and together are thought of as asset “orchestration” processes (Teece, 2007, p. 1341). 
Ambrosini and Bowman (2009) also acknowledge that dynamic capabilities do not appear as a 
fully formed capability. The authors argue that they are an outcome of learning and experience 
within an organisation; however, management cognition also plays a critical role in building, 
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integrating, and reconfiguring the capability base of an organisation. These authors believe that 
dynamic capabilities should have four main processes: reconfiguration, leveraging, learning, 
and creative integration (Ambrosini and Bowman, 2009). 
Table 2.3 below summarises alternative definitions and organisational and managerial 
processes (the way things are done in the firm, or what might be referred to as its routines, or 
patterns of current practice (Teece et al., 1997) of the dynamic capabilities discussed above and 
identified in the literature. 
 
 
Authors, 
date 
Definition 
DC / managerial and 
organizational processes that 
underpin DC (the way things are 
done in the firm, or what might be 
referred to as its routines, or 
patterns of current practice (Teece 
et al., 1997) 
Function, Aim, Goal 
Grant, 1991 
Dynamic capabilities respond to 
changing environments that offer a 
sustained competitive advantage 
 
Develop a sustained 
competitive advantage 
Leonard- 
Barton, 1992 
Dynamic capabilities reflect an 
organization's ability to achieve new 
and innovative forms of competitive 
advantage given path dependencies 
and market positions 
 
Exploration of new 
opportunities 
Teece, Pisano 
and Shuen,1997 
The firm's ability to integrate, build, 
and reconfigure internal and 
external competencies to address 
rapidly-changing environments 
Reconfiguring, learning, integrating, 
and coordinating  
Develop sustainable 
competitive advantage 
Enable firms adapt internal 
and external change 
Eisenhardt and 
Martin, 2000 
Dynamic capabilities are the 
organisational and strategic routines 
by which firms achieve new 
resource configurations as markets 
emerge, collide, split, and evolve 
The firm’s processes that use 
resources – specifically the 
processes to integrate, reconfigure, 
gain and release resources – to 
match and even create market 
change 
Repeated practice and consequent 
experience, past mistakes, and new 
experiences 
Tools that enable the 
reconfiguration of existing 
operational capabilities to 
match and create market 
change 
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Zahra and 
George, 2002 
 
Dynamic capabilities are essentially 
change-oriented capabilities that 
help firms redeploy and reconfigure 
their resource base to meet evolving 
customer demands and competitor 
strategies 
Integration and reconfiguration 
Integrating fundamental 
variations through 
reconfigurations 
Zollo and 
Winter, 2002 
 
Dynamic capabilities are learned 
and stable patterns of collective 
activity, through which the 
organisation generates and modifies 
operational routines 
Dynamic capability is the function 
of three generic learning processes: 
experience accumulation, 
knowledge articulation, and 
knowledge utilization 
Systematic and persistent 
modification of routines 
Winter, 2003 
Dynamic capabilities govern the rate 
of change of resources and ordinary 
capabilities 
Process of changing ordinary 
capabilities 
Ad hoc problem solving 
Helfat et al., 
2007 
Dynamic capabilities have the 
capacity for an organisation to 
purposefully create, extend, or 
modify its resource base 
Purposefully change resource base. 
Identifying needs or 
opportunities for change, and 
accomplishing that change    
Teece, 2007 
Dynamic capabilities can be 
disaggregated into three capacities: 
(1) to sense and shape opportunities 
and threats, (2) to seize 
opportunities, and (3) to maintain 
competitiveness through enhancing, 
combining, protecting and, when 
necessary, reconfiguring the 
business enterprise’s intangible and 
tangible assets 
Process of sensing the environment 
to seize opportunities and 
reconfigure assets 
“Orchestration” of a firm’s  
resources and ordinary 
capabilities that allow it to 
adapt and evolve 
Wand and 
Ahmed, 2007 
Dynamic capabilities as a firm’s 
behavioural orientation constantly 
to integrate, reconfigure, renew, and 
recreate its resources and 
capabilities and, most importantly, 
upgrade and reconstruct its core 
capabilities in response to a 
changing environment to attain and 
sustain competitive advantage 
Dynamic capabilities underline the 
processes of transforming firm 
resources and capabilities into 
outputs in such forms as products or 
services that deliver superior value 
to customers; such transformation is 
embarked on in a swift, precise, and 
creative manner in line with the 
industry’s changes 
Adaptive capability, absorptive 
capability, and innovative capability. 
Source of sustained 
competitive advantage 
Cepeda and 
Vera, 2007 
Dynamic capabilities are about how 
firms develop new skills and 
routines that allow them to 
complete.  
Knowledge management process 
and configuration of knowledge, 
configuration of resources and 
operational routines 
Configuration of functional 
competence to better match 
the changing environment    
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Ambrosini and 
Bowman, 2009 
Dynamic capabilities are 
compromised of four main 
processes: reconfiguration, 
leveraging, learning and integration. 
DC is a process that impacts upon 
resources. They are future-oriented 
 
Reconfiguration, leveraging, 
learning, and creative integration   
Continuous improvement for 
incrementally adjust and 
adapt change (incremental 
change).  
Renew or refresh the resource 
stock to avoid core regicides. 
Move away form previous 
change practices towards new 
one(Regenerate existing 
capabilities ) 
Protogerou et 
al., 2011 
Dynamic capabilities can be seen as 
the capacity of an organisation to 
purposefully and systematically 
create, extend, or modify its 
operational capabilities 
Coordinating/integrating, learning, 
and strategic competitive response 
Sense and strategically 
respond to environmental 
challenges 
Facilitate change within an 
organisation 
Barreto, 2010 
A dynamic capability is the firm’s 
potential to systematically solve 
problems, formed by its propensity 
to sense opportunities and treats, to 
make timely and market-oriented   
Sense the opportunities and treats, 
make timely decisions, make market 
oriented decisions, and change the 
resource base 
Monitor the external 
environment in order to spot 
and address opportunities and 
threats 
    
 
Table 2.3: Dynamic Capabilities (DC) Theory, Definitions, Processes, Aim, and Function 
 (Author’s own) 
 
This research adopts the definition of DC introduced by Teece (2007), who  describes dynamic 
capabilities as a firm’s ability to ‘orchestrate’ its resources and ordinary capabilities in order 
to adapt and evolve to rapidly-changing environments (Teece, 2007, p.1344). What 
distinguishes this definition from others, particularly from the EM’s approach, is that this 
definition identifies DC as relevant to addressing rapidly-changing environments and 
emphasise the firm’s ability to identify and exploit opportunities. This is particularly important 
for this research to reflect the dynamism of the digital environment and conceptualise the 
capabilities development process for Big Data initiatives. 
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Within this definition, Big Data can be viewed as a new resource for modern companies to be 
combined with ordinary capabilities in order to successfully operate in a rapidly-changing 
environment. Furthermore, Teece et al. (1997) explain that a capability has a key function in 
strategic management in appropriately adopting, integrating, and reconfiguring internal and 
external organisational skills, resources, and functional competencies to the requirements of a 
changing environment. This view goes beyond the RBV scholarship, integrating changes such 
as dynamic environments with constantly changing IT resources. 
Another argument about generating value from new resources has been put forward by Penrose 
(1959), who presents a view that the value from a new resource does not only come from 
owning the resource, but how it is deployed and combined with existing resources and 
capabilities. These two separate but related views (Teece et al. and Penrose) justify the 
necessity of integrating, building, and reconfiguring internal and external resources and 
capabilities in the case of implementing Big Data initiatives. 
2.4.2 Hierarchy of Capabilities Operational and Dynamic Capabilities 
Usually, capabilities are categorises by their type and importance, and how they are seen in a 
firm’s value-creating processes (Grant, 2005). Broadly defined, capabilities are formed by 
integrating more specialised capabilities (Grant, 2005). For example, functional capabilities 
such marketing, IT, and management capabilities are the combination of more specialised 
capabilities related to a particular task. These types of capabilities reflect a firm’s ability to 
perform basic functional activities (Helfat and Peteraf, 2009; Winter, 2000). Capabilities that 
are generated to directly support the operational function of the firm are defined as operational 
or ordinary capabilities (Collis, 1994; Cepeda and Vera, 2007; Helfat and Winter, 2011). 
It must be acknowledged that the terms ordinary and operational have been used 
interchangeably in the literature. However, both serve the same meaning. In the interest of 
consistency, this research adopts the term operational as it aims to look at firms two main 
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operational marketing and IT capabilities in relation to Big Data. Furthermore, the definitions 
and explanations that this research adopts and follows mainly use the term operational rather 
than ordinary (Teece et al., 1997; Teece et al., 2007; Ambrosini and Bowman, 2009; Protogerou 
et al., 2011). 
Operational capabilities enable an organisation to perform an activity on an on-going basis. 
Typical operational capabilities serve the firm’s current means of generating revenue and profit. 
These types of capabilities, however, are not responsible for sensing/ the detection of new 
business opportunities. They shape organisations current day to day activities (Teece, 2007). In 
contrast, higher-level capabilities such as dynamic capabilities (strategic decision making, 
resource allocation, alliance, and acquisition) require integration and coordination of lower-
level capabilities. Dynamic capabilities reconfigure operational capabilities in order to achieve 
flexibility (Helfat et al., 2007, p. 7; Newey and Zahra, 2009, p. 82; Teece et al., 1997; 
Protoderou et al., 2011). To understand the differences between different types of capabilities 
some authors such as (Collis, 1994; Winter, 2003) proposed a hierarchy of capabilities. Three 
levels of capabilities have been identified in the literature: first-order, second-order, and higher 
level or ‘meta-capabilities’ (Collis, 1994; Winter, 2003). Collis (1994) names resources 
themselves as a first-order capability, while Winter (2003) referred to them as ‘zero level’. 
Winter (2003) explains that ordinary capabilities are zero-level capabilities without which the 
firm cannot exist – thus making an argument that every existing company can be said to have 
at least some ordinary capabilities. Those capabilities that would change the firm's processes, 
customer relationships, or scale have been described as second-level capabilities (Collis, 1994) 
or as dynamic capabilities according to Winter (2003). Dynamic capabilities govern the rate of 
change of operational capabilities and therefore can be understood as a higher-order constructs, 
that link to an organisation’s ability to sense and then seize new opportunities in a changing 
environment (Collis, 1994; Winter, 2003; Teece, 2007). However, the ability of being able to 
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identify opportunities depends on the organisation's learning capacities. A good example would 
be an ability to learn about a new environment or technological changes (Teece, 2007). Collis 
(1994) believes that capabilities can be renewed endlessly, and that third-order or “Meta 
capabilities” (Collis, 1994) are the result of renewed processes. These are capabilities that allow 
the firm to outperform its competitors. 
Based on the discussion above we can conclude that dynamic capabilities are not capabilities 
in same sense as capabilities in RBV. Rather, they are organisational and managerial abilities 
(the way things are done in the firm, or what might be referred to as its routines, or patterns of 
current practice) (Teece et al., 1997) that impact upon existing resources. Dynamic capabilities 
help firms to extend, modify, and reconfigure their existing operational capabilities into new 
ones that better match the changing environment (Ambrosini and Bowman, 2009; Pavlou and 
El Sawy, 2011). Developing and moderating operational and dynamic capabilities have become 
key facilitators for companies in an emerging changing environment. In particular, the 
relationship between Big Data and dynamic capabilities is important, as Big Data initiatives 
need to be altered over time, as an organisation will need to reconfigure or develop new 
capabilities to achieve the promised results from Big Data initiatives (Braganza et al., 2017). 
However, in order to better understand dynamic capabilities, Pavlou and El Sawy (2011) 
suggested that it is important to recognise their distinction from operational capabilities, as 
dynamic capabilities aim to moderate operational capabilities in order to leverage competitive 
advantage from a new resource. Nonetheless, Zhou and Li (2010) made an important point by 
arguing that the existing literature does not touch on the practical issues that companies face in 
developing their operational and dynamic capability, which represents a significant research 
gap, particularly in the Big Data era. 
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2.5 Big Data Related Challenges and Required Capabilities 
2.5.1 IT capabilities 
Although advantage can be derived from the analysis of Big Data (see Section 2.2), there also 
exist some barriers to its effective use (LaValle, 2009). New types of data, such as geospatial 
data, social media, voice, video, and other unstructured data all have a part to play in 
understanding customers and anticipating their future behaviours. However, the data available 
from these sources are often unstructured. A brief explanation of the difference between 
structured and unstructured data will demonstrate the significance of this problem.  
Structured data are organised in an assigned format that can be managed and used by database 
management systems, such as Microsoft Oracle, and SQL. Such data are a key resource for 
decision-making in many organisations. In turn, unstructured data are unformatted and have no 
predefined standard. It has thus been argued (Setia et al., 2013; George et al., 2014) that 
extracting valuable knowledge from Big Data is more challenging than analysing tasks in 
traditional data warehouses. 
The emergence of new data management technologies and capabilities which enable 
organisations to leverage Big Data in their business processes has become a critical challenge 
for many companies seeking to implement Big Data into their operations (Gandomi, et al., 
2014). It has been suggested (Danneels, 2010, Chen et al., 2012) that to put Big Data into action 
and into specifically-directed initiatives, a firm must have the information technology (IT) 
capabilities. The IT capability reflects an organisation's capacity to employ technologies to 
convert input to output (Wilden and Gudergan, 2014). Furthermore, the notion of IT capability 
emphasises the ability of a firm to organise and deploy IT based resources in combination with 
other organisational resources and capabilities in support of business strategies and 
organisational processes (Bharadwaj, 2000). The importance of IT capabilities in the case of 
the Big Data initiatives has been acknowledged as being particularly acute in their relevance 
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to the process of transforming Big Data resources into potentially competitive assets (Chen et 
al., 2012; Erevelles et al., 2015). Some authors (Grover, 2008; Mikalef and Pateli, 2017) 
suggest that IT capabilities should be measured and examined in terms of the organisational 
processes they enable. In this respect, IT serves as a means through which new organisational 
capabilities can be created or existing ones improved. In fact, Mikalef and Krogstie (2018) 
suggest that fundamental business transformations are often a result of integrating IT into 
business processes. Even though it has been  acknowledged (Bhatt and Grover, 2005) that IT 
capability might not be a source of competitive advantage per se, it can provide value in terms 
of efficient output - thus their absence might create a competitive disadvantage to companies. 
However, it has also been acknowledged that even beneficial IT capabilities might not remain 
valuable in the event of an environmental change (Leonard-Barton, 1992). Chen et al. (2012) 
mention the rise of semi-structured and unstructured data that calls for ad hoc and real-time 
extraction, processing, and analytics in a new technological environment resulting in increased 
demand for advanced IT capabilities. 
2.5.2 Big Data Analytics 
Developing Big Data technology is often mentioned as one of the main areas to solve the Big 
Data challenges (Chen et al., 2012; Wamba, 2017). Such technology is associated with Big 
Data Analytics (BDA) in the literature (Gupta and George, 2016; Garmaki et al., 2016; Wamba, 
2017; Mikalef and Krogstie, 2018), which is on the other hand considered as an advanced IT 
in Big Data environment (although Big Data technology may more correctly be considered as 
advanced IT infrastructure). More properly, BDA are less about hardware and more about 
technologies (e.g. database and data-mining tools) and techniques (e.g. analytical methods) that 
a company can employ to analyse large scale, complex data (Chen et al., 2012; Kwon et al., 
2014) and leverage insights that were not achievable with past technology (Garmaki et al., 
2016). Such technologies can include data management, open-source programming (e.g. 
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Hadoop, MapReduce), statistical analysis (e.g. sentiment analysis), and advanced visualisation 
tools that help structure and connect data to uncover hidden patterns, unknown correlations, 
and other actionable insights (Wamba, 2017). To obtain business value from BDA it has been 
argued that there is a need for investments into Big Data Analytics Capabilities, or BDAC 
(Gupta and George, 2016). Cosic et al. (2012, p. 4) deﬁne BDAC as ‘the ability to utilize 
resources to perform a business analytics task, based on the interaction between IT assets and 
other ﬁrm resources’. Garmaki et al. (2016) highlight the combination of data and IT assets 
and define BDAC as an organisation’s ability to exploit the combination of data and IT 
components with the intention of achieving competitiveness. In recent years, several 
researchers (Gupta and George, 2016; Wamba et al., 2017; Wang et al., 2018; Mikalef and 
Krogstie, 2018) have focused their attention on understanding these capabilities. For example 
Wamba et al. (2017) suggested a model of Big Data analytics capabilities that includes three 
principal factors: expertise capabilities, management capabilities, and technology skills. 
However there are additional capabilities that have been identified in the reviewed literature, 
including a data-driven culture or organisational agility (LaValle, 2009); top management 
support and organisational capabilities (Erevelles et al., 2015; Gupta and George, 2016) that 
are missing from the Wamba’s framework. In the case of Big Data case, for example, Erevelles 
et al. (2015) note that organisations need to establish physical capital resources – a platform, 
software and hardware – that are capable of storing and analysing large amounts (volume) of 
data in real time (velocity) from many different sources (variety). Human capital resources are 
also needed – skilled workers, including data scientists and IT people – who know how to 
extract information from consumer activities, as well as to manage and extract insights from 
Big Data. In addition, authors are highlighting the importance of organisational capital 
resources - including an organisational structure that allow insights to be transformed into 
action. Gupta and George (2016) provide a good grounding for explaining assets and 
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capabilities belonging to BDA. They divide the concept of BDAC into tangibles, intangibles, 
and human skills. The tangibles are sub-divided into basic resources, data, and technology 
which are considered critical for success. Whether authors divided intangibles into two assets 
- organisational learning and data-driven culture - that are viewed as being important 
components in the effective deployment of Big Data initiatives. An organisation's human skills 
are referred to as the employees’ experience, knowledge, business acumen, problem-solving 
abilities, leadership support, and relationships with others (Gupta and George, 2016). Arguably 
considering the combination of data (Big Data) and IT components generally would improve 
and will get a better basis for understanding in Big Data initiatives, however most of the studies 
that examine the effects of a firm's IT capability in relation to BDAC typically base their 
theoretical assumptions on the Resource-Based View (RBV) of the firm, which argues that 
competitive advantage emerges from unique combinations of resources that are economically 
valuable, scarce, and difficult to imitate. Thus, the existing literature mainly defines the 
principal resources that have an impact on the process of Big Data initiatives. Moreover, as 
pointed out by Wamba et al. (2015), the majority of publications in the field of Big Data 
capabilities are, not surprisingly, slanted towards technical aspects as the concept is 
increasingly viewed as a technology issue. However, since Big Data is a relatively new 
phenomenon, the nature of the Big Data required capabilities process requires searching, 
learning, and testing. Gupta and George (2016) note that data analytics does not tell the whole 
story, and organisations with higher organisational knowledge and different organisational 
capabilities will likely have an advantage when making decisions based on or supported by Big 
Data analytics results. 
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2.5.3 Marketing Capabilities for Big Data 
In addition to technological competencies and capabilities Bruni and Verona (2009) note the 
importance of marketing capabilities. They suggest that industries where firms compete on the 
basis of the adoption of new technology, such as Big Data with marketing capabilities, can 
create a source of uniqueness and rarity. Vorhies and Morgan (2005) highlighted that an 
organisation’s marketing capabilities enable to convert its resources to valuable outputs to 
reach target customers and to orchestrate its resources to manage marketing information and 
develop its marketing strategy. Thus it has been suggested that in  order  to  deploy  new  assets  
effectively, the organisation needs to develop sufficient market capabilities to transform them 
into valuable  output  (Morgan  et al.,  2009). In an extension of this notion, Bruni and Verona 
(2009, p. 7) propose the construct of dynamic marketing capabilities that reflect human capital, 
social capital, and the cognition of managers involved in the creation, use, and integration of 
market knowledge and marketing resources. The authors emphasise that these activities involve 
the processes of knowledge diffusion, social network building, the integration of market 
knowledge, and marketing resources in order to match and create market and technological 
change. In the case of Big Data, it implies to an ability of generating high quality knowledge 
regarding customers competitors, future market trends and transforming that knowledge into 
action to meet customers need (Danneels, 2010; Bharadwaj et al., 2013). 
While  resent research (Bruni and Verona, 2009; Borges et al., 2009; Danneels, 2010) in the 
field of technological innovation has acknowledged the importance of marketing capabilities 
in technological adoption few empirical  studies  have  examined  the role of market-related 
capabilities in the face of big data initiatives adoption. Marketing capabilities include all those 
activities involved in the acquisition of information about current and potential customers, 
which also includes dissemination of this information among different departments (Borges et 
69 
 
al., 2009) also might need to be aligned with the changing condition when it come to new 
initiatives.  
2.5.4 Dynamic Capabilities for Big Data 
Helfat et al. (2007) note the firms that lack understanding of their operational capability 
reconfigurations will struggle to align their capabilities to new initiatives. Thus, DC, which 
promote high evolutionary fitness, enable firms to survive and grow in response to changes in 
the external environment, including customer demands and corporate strategy priorities 
(Wilden and Gudergan, 2014). Therefore, DC have grown in importance as the expansion of 
trade has led to more rapid competitive responses (Teece, 2012). To make Big Data initiatives 
work, there is an enhanced need for businesses to develop and maintain new asset alignment 
capabilities that enable ﬁrms to combine Big Data with existing resources and capabilities so 
as to deliver value to customers. Teece (2012) further suggests that if the ﬁrm aims to sustain 
itself as markets and technologies change, three clusters of DC’s activities such as: (1) 
identiﬁcation and assessment of an opportunity (sensing); (2) mobilisation of resources to 
address an opportunity and to capture value from doing so (seizing); and (3) continued renewal 
(transforming) must be performed in a highly skilful or knowledgeable manner. With 
organisations immersed in data (Davenport et al., 2012), it has become essential that they 
develop organisational capabilities - both operational and dynamic - to take advantage of this 
huge heterogeneous flow (Bharawaj et al., 2013). However, while some academics (Boyd and 
Crowford, 2012; Davenport et al., 2012; Bharadwaj et al., 2013; Buhl, et al., 2013; Ekbia et al., 
2014) see a diversity of opportunities and challenges regarding Big Data, practitioners are 
desperately trying to make sense of their own practice. Therefore, understanding Big Data as a 
strategic resource that requires organisational capabilities for its successful implementation is 
fundamental to this study. However, while establishing the importance of different capabilities, 
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the questions of whether companies have such capabilities, and/or how they develop them in 
the case of Big Data remain unanswered. 
In general it has been suggested (Boyd and Crowford, 2012; Bharadwaj, et al., 2013; 
Davenport, 2012), that the five Vs of Big Data are the main challenges for Big Data 
management. However, these five dimensions are complementary to each other, and as one 
dimension changes, there is a tendency for the others to change too (Laney, 2001; Gandomi et 
al., 2014; Haider, 2014; Hallman et al., 2014). This makes Big Data more complex than those 
digital data held and dealt with by companies in the past. It brings various challenges for 
companies attempting to leverage this new resource to their advantage. 
2.6 Capabilities and Dynamic Capabilities for Big Data in the 
Pharmaceutical Industry 
As discussed earlier in this thesis (Section 1.2.2; Section 2.2.2), Big Data initiatives in the 
pharmaceutical sector are driven by the aims of achieving personalised medicine programs that 
will significantly improve patient care (Kumar, 2011; Costa, 2014), reduce the time taken to 
bring a candidate drug to market (Taylor, 2015) and reduce production costs (Paul et al., 2010; 
Ernst and Young, 2014). However, regardless of the predicted impact of Big Data on different 
operations and other areas of the business, large and complex data becomes difficult to handle 
for traditional data processing applications and existing capabilities in Big Pharma. Thus, Big 
Data is triggering the development of new applications and capabilities in the sector, including 
capabilities for Big Data in the management of R&D and clinical trials and in the process of 
gaining regulatory approval, as well as in the areas of Marketing and IT (Costa, 2014; Harvey 
et al., 2012). 
2.6.1Marketing capabilities for Big Data in the Pharmaceutical Sector 
Traditionally, pharmaceuticals have been characterised by significant heterogeneity in terms of 
the organisations' marketing orientations and innovative capabilities (Galambos and 
Lamoreaux, 1997). Pharmaceuticals have made substantial investments over many years to 
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understand market opportunities, develop compelling marketing strategies, and optimise sales 
force deployment to ensure the successful launch of a new product (Taylor, 2015). These 
investments have generated billions of dollars of value for shareholders and helped save 
thousands of patients’ lives (Sadat et al., 2014). However, while the pharmaceutical sector has 
traditionally enjoyed considerable growth as a result of its marketing and production 
capabilities, today’s competitive environment and Big Data initiatives demand a fundamental 
change to the way organisations do business (Coombs and Metcalfe, 2002). Recently Sadat et 
al. (2014) found that the existing integrated operational model in the pharmaceutical sector is 
becoming unsustainable. This is due to a range of internal and external forces, such as: internal 
and external market forces (e.g. payers, like patients and health insurers), advances in 
technology, and government policies (e.g. healthcare reforms and drug price controls). A shift 
is required from the current functionally-divided approach to a data science-enabled approach 
that takes advantage of ongoing digital innovation (Marwaha et al., 2018). In addition to these 
cross-functional interactions, the relationships among global, regional, and local marketing 
groups in the digital age can also harm performance if not carefully orchestrated and managed 
(Teece, 2007). Thus, not surprisingly, the need to identify and build new marketing and IT 
capabilities for Big Data initiatives has become essential for Big Pharma to compete effectively 
in this new, digital environment (Groves, 2013). 
Although Big Pharma is being driven by a changing digital environment to form bridges with 
the scientific, technological, and marketing forces through various responses (e.g. using 
genomics in their product development) to deliver value to patients (Sadat et al., 2014), the 
success of Big Data initiatives is still in its early stages within MNCs in the pharmaceutical 
industry. While some solutions are proposed, there are only a few tangible examples of how 
companies are addressing one of the industry’s one of pressing issues - how they will prepare 
for Big Data adoption and develop required capabilities (Deloitte, 2014). Some studies (Costa, 
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2014; McKenzy, 2014 ) indicate that  the pharmaceutical industry remains heavily reliant on 
traditional research techniques and has been slow to follow the example of other industries 
(e.g. retailers, financial) in employing innovative techniques to generate deep insights from Big 
Data initiatives (Costa, 2014; McKenzy, 2014). For example, even though improved 
technology has allowed for better-targeted design,  which has meant that patient needs have 
become a more important driver in drug discovery, many pharmaceutical brands are still using 
behavioural and demographic (e.g. prescriptions written) segmentations instead of what is 
termed ‘needs-based segmentation’ (Greengrove, 2002 ). This is a process of segmenting the 
market based on understanding the needs of the end user - needs which can be met by the 
products and services available. Using this new method of segmentation can help 
pharmaceuticals demonstrate concentrated value and gain reimbursement at a good price in 
certain distinct market segments (Smith, 2010). 
Smith (2010) defines a value proposition as ‘The complete offer made to, and as seen by, the 
customer, including all its costs, benefits, experiences, and risks’. It is becoming increasingly 
challenging for Big Pharma to use traditional approaches to develop value propositions (e.g. 
innovations, services, or features intended to make a product attractive to customers) in the 
digital age (Ernst and Young, 2014). Once a company has defined its target segments (e.g. 
physicians, patients, or others) it is important that it also develops segment-specific value 
propositions.  
Currently, regulators and other gatekeepers in the industry explicitly request that manufacturers 
supply specific evidence (by segment) to enable them to make decisions on whether to register 
new products, or whether to reimburse them and, if so, at what level (McKenzy, 2014). So 
developing value-added services to targeted segments (e.g. cooperative marketing programs, 
patient education programs, and patient loyalty programs) is important for personalised and 
reimbursed medicine. In addition, customer satisfaction is increasingly important because it is 
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being monitored by state and federal government groups and published by organisations such 
as the Consumers Union (Shah and Pathak, 2014). Moreover, it requires loyalty which is 
brought about by trust, superior service, and, to varying degrees, personalisation (Abbot, 2006). 
Consequently, demonstrating value to stakeholders is probably the most important aspect of 
Big Pharma’s marketing today that needs to be developed to the same extent other additional 
capabilities (Smith, 2010; McKenzy, 2014). 
It has been suggested that, to improve targeting activities, companies can combine patient 
insights with data from different sources (McKenzie, 2014). For example, integrating 
additional data about the patient and his or her environment might provide better predictions 
and help target interventions to the correct patients. Presumably, these data may enhance the 
understanding of the effects of consumer behaviour, which in return may affect the way 
companies design their beneﬁts packages (Smith, 2010). Thus, while Big Data offers great 
potential for revolutionising many aspects of the marketing operations of pharmaceutical firms, 
it has also been suggested that the ability to access new knowledge from out with the boundaries 
of the organisation and to integrate new knowledge flexibly across disciplinary and therapeutic 
class boundaries within the organisation is also particularly important (Henderson and 
Cockburn, 1994). However, it has been acknowledged that prior to this pharmaceuticals will 
need to improve the quality of their internal data management and IT capabilities (Shah and 
Pathak, 2014). This is mainly as a result of data traditionally being used narrowly, within 
individual functions and for specific purposes, such as trial design, patient recruitment, pricing, 
and marketing. 
The recent trend toward using data derived from real-world outcomes to inform marketing 
activities creates the need for closer coordination between different functions and stakeholders 
– meaning that companies must rethink core business processes (such as drug development and 
commercialisation) and seek new ways to increase their productivity (Kumar, 2011; Costa, 
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2014). Thus it has been suggested that by using dynamic capabilities, businesses can become 
adaptable and escape unfavourable path dependencies in a rapidly changing environment 
(Teece, 2007). However, there are few examples in the academic literature relating to how 
MNCs in the pharmaceutical industry face such challenges by using their dynamic capabilities 
to prepare for Big Data adoption. 
2.6.2 IT Capabilities for Big Data in the Pharmaceutical Sector 
As we have seen, the vast amounts of various types of data (e.g. insurance claims, medical 
records, images from patient scans and so on) that are generated around the pharmaceutical 
industry can be exploited for their value in marketing and other operational activities. In 
addition, there is a need for technology that is able to handle and support the analytical 
processing of these fast-moving data (Gupta and George, 2016). The rapidly-growing body of 
potentially valuable information hidden in such volumes of data requires improved 
computational infrastructure (e.g. storage), new methods to interpret and transfer the data (e.g. 
use of new software to analyse the data without losing information), and collaborative 
approaches (Costa, 2014). Thus, as in many other sectors, computational solutions (such as 
cloud-based computing) have been considered to be a new way to store, analyse and transfer 
data generated by different devices (McKenzy, 2014). For example, cloud computing has been 
proposed as a storage model that can provide the elastic scale needed for large-scale storage, 
as in the case of DNA sequencing. However, in addition to improved computational 
infrastructure, Harvey et al. (2012) and  Shah and  Pathak (2014) suggested that, for 
personalised medicine, the key factors in the development of suitable IT capabilities are instead 
data standardisation, integration, and harmonisation. For example, tools and processes for data 
collection and analysis must be standardised across research sites, while research activity at 
different sites must be integrated to maximise synergies (Shah and Pathak, 2014). However, to 
produce standardised data that will accelerate research, there is a need to harmonise the way in 
which data are collected, checked for accuracy, and stored (Harvey et al., 2012). Furthermore, 
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Harvey et al. (2012) suggest that harmonisation will help to improve communication between 
different functions and in other areas impacting on personalised medicine. Such developments 
will help Big Pharma to move from a functionally divided approach to a data science-enabled 
approach. 
2.6.3 Dynamic Capabilities in the Pharmaceutical Sector 
The successful implementation of Big Data initiatives demands the creation and coordination 
of new systems and, in some cases, the reconfiguration of the traditional operational (marketing 
and IT.) capabilities of large pharmaceutical companies (Coombs and Metcalfe, 2002). The 
creation, coordination (e.g. cross-disciplinary and cross-functional specialisations) and 
reconfiguration of existing capabilities has been assumed to be of increasing importance to this 
sector, alongside other dynamic capabilities such as: sensing and seizing new opportunities 
(Groves, 2013, Marwaha et al., 2018), consuming technological changes through learning 
processes (reconfiguration) (Costa, 2014; Sadat et al., 2014), and dynamic marketing 
capabilities (Bruni and Verona, 2009). 
The threats and opportunities associated with Big Data have organisational implications that 
require senior managers to be able to attend to, sense, and seize those opportunities that may 
help their organisations build a data-driven competitive edge (Groves, 2013). This is mainly 
because these abilities determine the speed at, and degree to which, particular resources and 
capabilities can be aligned and realigned to match the requirements and opportunities of a 
changing business environment (Teece, 2012). Furthermore, Levinthal and March (1994) stated 
that the degree to which firms learn about new opportunities is a function of the extent of their 
participation in such activities. Consequently it is clear that all of these changes, set against the 
current global backdrop of digital transformation and business acceleration, have led to a 
growing need for industry leaders in Big Pharma to learn and adapt, where learning in this case 
involves an organisation improving its day-to-day processes and learning how to incorporate 
Big Data analytics into those processes (Teece, 2007). 
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Although suggestions have been made about how pharmaceuticals can approach Big Data 
initiatives, there is a tendency for pharmaceutical companies to avoid overhauling their entire 
data-integration system at once because of the transformation challenges and costs involved. 
Perhaps this can explain why there are so few empirical insights into how the theory behind 
Big Data and required capabilities development compares to such initiatives being at work in 
practice. However, although still in its early stages, Big Pharma’s effort to adopt new 
technologies continues to accelerate in the industry, as do the opportunities to embrace insights 
from Big Data (Groves, 2013; Costa, 2014; Wang et al., 2018).Thus, these offer an valuable  
opportunity to study how Big Data initiatives and required capabilities development are 
approached in practice in the pharmaceutical industry, given their growing importance for the 
industry and the overall global economy (e.g. Brynjolfsson et al., 2011; McAfee et al., 2012; 
Wamba et al., 2015; Mikalef et al., 2017). 
2.7 Research Gap 
Adopting the dynamic capabilities perspective, the purpose of this research is to generate 
knowledge on the process of Big Data adoption within a pharmaceutical company. To achieve 
this purpose, an investigation is needed on how companies perceive Big Data, and what 
capabilities they employ to integrate it within their company strategy in order to extract the 
most value from such an initiative.   
Despite the great interest surrounding Big Data, exploiting its potential value has still not yet 
been fully developed or examined (McAfee et al., 2012). Much attention to date has been on 
the technical aspects of Big Data, such as storing, securing, and analysing the ever-increasing 
volumes of data obtained by organisations. The literature review in this chapter shows that the 
current literature is still at a developmental stage in terms of explaining how organisations, in 
particular MNCs in the pharmaceutical industry, realise value from Big Data.   Examination of 
this shortfall is the core of this study. 
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Even though there are acknowledged opportunities and challenges associated with Big Data 
initiatives in the pharmaceutical sector, there are few examples in the literature of why and how 
MNCs prepare for Big Data adaption in practice and what are obstacles they face during this 
journey. Consequently, there is a limited academic body of knowledge on the organisational 
capabilities that Big Data exploitation encompasses in pharmaceuticals and how they can be 
developed to gain full benefit for the industry (Brynjolfsson et al., 2011). 
As with any new technology, it is important to understand the mechanisms and processes 
through which Big Data can bring business value to companies. Thus, a major discussion over 
the years has focused on the opportunities and challenges that Big Data brings to organisations 
(Chen et al., 2012; McAfee et al., 2012; Davenport et al., 2012). However, there is less 
empirical evidence in the literature relating to how MNCs in pharmaceuticals can overcome 
these challenges. Although suggestions exist that Big Pharma needs to change, renew, and 
innovate its capabilities, and/or fundamentally change existing operational models and enhance 
internal data management capabilities (Deloitte, 2015; Teece, 2010) successful Big Data 
initiatives are still rare within MNCs in the pharmaceutical industry, despite their access to 
resources, market knowledge, and key technologies. Thus, it is not clear what are the required 
capabilities that pharmaceuticals need to develop for Big Data initiatives. 
Agarwal and Dhar (2014. p. 445) looked at challenges and opportunities pertaining to Big Data 
in information systems research and noted that the Big Data phenomenon expanded 
opportunities for inquiry into any type of phenomenon researchers may want to study, ranging 
from all functional areas of the business to the broadest perspective on the enterprise as a whole. 
However, it is important to consider and bring new insight into how the different pieces fit 
together. Various authors suggest that research on today’s data-rich environment should be 
more focused on business transformation and value creation through data, and less on 
algorithms or frameworks without consideration of business value. Adding to this conversation, 
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it is clear from the literature (Bharadwaj et al., 2013; Constantiou and Kallinikos, 2015; 
Erevelles et al., 2015; Wamba et al., 2015) that some current predictions offer valuable ideas 
about how MNCs in pharmaceuticals might approach Big Data initiatives, although these ideas 
need to be explored for greater insight, without being limited to existing knowledge and 
practices.   
It has also been acknowledged (Chen et al., 2012; McAfee et al., 2012; Davenport et al., 2012; 
Galbraith, 2014; Gandomi et al., 2014) that Big Data transforms the way that companies relate 
both to their customers and to the way the companies enact and perform business operations. 
The growing interest in Big Data, however, means there is a need to explore how it can be 
exploited within organisations. Constantiou and Kallinikos (2015) note that decision-makers 
have a limited understanding of how to adopt and implement Big Data initiatives that can drive 
their business strategies. Potential adopters also are struggling to make key decisions in relation 
to Big Data.  For example, recent findings from Woerner et al. (2015) show that many chief 
information officers (CIOs) and business executives have hesitated to make major investments 
in Big Data, specifically after direct experience of disappointing results, or observing other 
firms failing in Big Data investment. Therefore, some industries, including Big Pharma, remain 
heavily reliant on traditional research techniques and have been slow to follow the example of 
other industries (e.g. retail, financial) in employing innovative techniques to generate deep 
insights from Big Data initiatives (Costa, 2014; McKenzy, 2014). This justifies a call for further 
empirical studies that carefully examine how MNCs in pharmaceuticals actually prepare for 
Big Data adoption in practice and how a company may strategically approach the issues of 
using Big Data. For example, there is a need to investigate how MNCs in the pharmaceutical 
industry identify and develop their capabilities for Big Data. Specifically, future research needs 
to empirically examine how different resources and capabilities within organisations work with 
Big Data in practice. 
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While acknowledging the importance of investment in the improvement or development of 
capabilities, there are differences between competitors in the timing of this kind of effort, and 
in the amount of investment, in the managerial undertakings, and in the internal organisational 
culture that supports this process (Kale et al., 2002; Ethiraj et al., 2005). It is also assumed that 
organisations take different positions when it comes to implementing Big Data initiatives, such 
as industry context, organisational size, and the business environment. The nature of the 
pharmaceutical industry, coupled with the fact that most of Big Pharma consists of MNCs 
(Schotter and Beamish, 2011), perhaps differentiates pharmaceutical organisations from those 
who have achieved success in Big Data adoption. There is thus increased demand for more 
empirical approaches that look at what new capabilities MNCs in pharmaceuticals develop for 
Big Data and how they develop it in practice. 
The overall findings from the literature (McAfee and Brynjolfsson, 2012; Davenport et al., 
2012; Chen et al., 2012; Wamba et al., 2015) suggest that managers can realise great benefits 
from establishing a Big Data-driven culture and capabilities. Indeed, Big Data as a resource in 
a vacuum is meaningless. To uncover hidden patterns within data, organisations need to 
develop capabilities around it. Capabilities and organisational processes are interlinked, as it is 
the capability that enables the operational activities in a business process to be carried out (Day, 
1994). With the correct capabilities in place, a firm can better adapt to the digital environment, 
and make better use of Big Data for its operational activities (Marketing and IT.). Ethiraj et al. 
(2005) argue that while a resource like Big Data is available to all firms, the capability to exploit 
it effectively is not uniformly distributed. To meet Big Data requirements there is a need for 
the enhancement of existing capabilities, or investment in developing new capabilities. 
Although dynamic capabilities (organisational and managerial abilities) have been 
acknowledged as a possible tool to enhance organisations’ existing capabilities, they are mainly 
investigated and explored in the context of an organisation's performance. There is a limited 
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body of knowledge on their role in the capabilities development process, especially in the 
context of Big Data. Moreover, Teece (2012) argues that although some elements of dynamic 
capabilities may be embedded in the organisation, the capability for evaluating and 
approaching changes to the conﬁguration of assets rests on the abilities of senior management. 
However, there is only a limited number of studies that directly develop this topic, making it 
an obvious candidate for future research. 
2.8 Chapter Summary 
This chapter synthesised the existing literature that lays the theoretical and conceptual 
foundation for the investigation of this research. Furthermore, the chapter developed an 
argument for this thesis by appraising gaps and weaknesses in the existing literature, some of 
which are addressed in this research. Adopting the theoretical lenses of RBS and DC to examine 
the research problem identified in this chapter, the next chapter sets the theoretical framework 
for this thesis, to investigate the research problem and answer the research questions. 
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Chapter 3: Conceptual Development 
3.1 Introduction 
Applying the Resource-Based View (RBV) and DC approach discussed in the previous chapter 
as a theoretical underpinning to this research, this chapter sets out a conceptual framework for 
an empirical investigation of the following research questions: 
1. Why did an MNC in the pharmaceutical industry prepare for Big Data adoption? 
RQ1 
and 
2. How did the company approach the issue of using Big Data and how did they 
identify and develop their capabilities for Big Data? RQ2 
 I. What new capabilities did they develop? 
 II. How did they develop these new capabilities? 
Big Data as an organisation’s intangible strategic resource is conceptualised in the Resource-
Based View (RBV) theory, while use of capabilities based on Dynamic Capabilities (DC) 
theories is used to reflect the dynamism of the digital environment and conceptualise the 
capabilities development process for Big Data. 
 
3.2 The Conceptual Framework 
As outlined in the previous chapter, the chosen RBV and DC theories look at the ways that 
resources can be better utilised to address the changing needs and requirements of a business. 
Furthermore, these theories focus on the organisational perspective, explaining the need for an 
organisation to address the rapidly changing business environment by developing required 
capabilities. The underlying assumption based on these theories is that the value from a new 
resource does not only arise from owning the resource but from how the resource is deployed 
and combined with existing competencies and capabilities. An organisation should have the 
ability to ‘orchestrate’ their resources and operational capabilities in order to adapt to and 
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evolve in a rapidly changing environment (Penrose, 1959; Teece, 2007; Ambrosini and 
Bowman, 2009; Barreto, 2010; Wade and Nevo, 2010). Within this definition Big Data can be 
viewed as a new resource to be combined with operational capabilities by a modern company 
in order for it to successfully operate in a rapidly changing environment. 
As changes occur in the environment in a time of global markets and advances in technology 
(Pavlou and El Sawy, 2011) companies today must be alert and be able to respond to potential 
threats or opportunities by developing and using dynamic capabilities (Roberts et al., 2016). 
Teece (2007) suggests that, in such a rapidly changing environment, operational capabilities 
can provide an organisation with technical fitness but not evolutionary fitness. Thus, by using 
dynamic capabilities, businesses can become adaptable and escape unfavorable path 
dependencies, thereby achieving evolutionary fitness. Therefore, following the theoretical 
grounds discussed above, figure 3.1 below illustrates the conceptual framework for this 
research. Each box in the figure illustrates concepts that are adopted from the theoretical 
background and which are the subject of an empirical investigation of an organisation’s digital 
environment (Box 1). 
From left to right, Box 2 represents Big Data as a new intangible resource concept. Box 3 
represents an organisation’s existing capabilities (operational (Box 3.1) and DC (Box 3.2.). 
Box 4 demonstrates the development of new or enhanced capabilities in response to Big Data 
opportunities. Understanding these three concepts within an organisation’s digital environment 
will help to evaluate how new or enhanced capabilities for Big Data are developed. Each 
concept is described in detail below. 
  
83 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Conceptual Framework (Authors own) 
 
3.2.1 Digital Environment (Box.1) 
There is no doubt that today's fast-moving world of technological advances has unintentionally 
assisted the digital age in daily generating many gigabytes of business and personal data across 
various channels (George et al., 2014; Davenport, 2014; Wamba et al.,2015). Almost half of 
the world’s population today is online, and many of them have become specifically mobile and 
online consumers (Gandomi et al., 2014) with consequent changes of their needs, behaviors, 
and demands. In addition, nearly all sizes and types of organisations have benefited from the 
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rise of the Internet and the mobile revolution (McAfee and Brynjolfsson, 2011). In such an era, 
the importance of Big Data is rapidly becoming the norm (Manyika et al., 2011). However, 
organisations seeking to profit from Big Data in the evolving digital environment, which is 
characterised by a high degree of market and technological change, are now faced with a greater 
diversity of external factors than ever before (Chen et al., 2012). For example, it was evidenced 
in the literature (Sadat et al., 2014; McKenzy, 2014) that a range of internal and external forces 
alike, such as: internal and external market forces, regulatory bodies, advances in technology, 
and the availability of digital data are all currently driving Big Pharma to make fundamental 
changes. Therefore, investigating the consequences of the digital environment in the case of 
the adoption of Big Data initiatives within MNCs in the pharmaceutical industry would help to 
bring new insight into how and why industries such as pharmaceuticals are preparing for Big 
Data and how they are facing such challenges. 
3.2.2 Big Data as a New Resource (Box. 2) 
The literature reviewed in the previous chapter (e.g. LaValle et al., 2011; Boyd and Crowford, 
2012; Davenport et al., 2012; McAfee and Brynjolfsson, 2012; Bharadwaj et al., 2013; Buhl, 
et al., 2013; Gandomi, et al., 2014;  Wamba et al., 2016) shows that the benefits and 
opportunities of Big Data as a digital resource brings with it additional dimensions that alter 
the nature not only of value creation but also that of the capture and distribution of business 
among competitors. The nature of Big Data and its dimensions (the 5 Vs) challenge the 
traditional ways of using and accessing data, resulting in increased demand for the development 
of new capabilities. Therefore, to create value from a new source organisations first need to 
understand and find ways of deploying it. 
Much of the research to date (Setia et al., 2013; Bharadwaj et al., 2013; Erevelles et al., 2015) 
has demonstrated that Big Data and advanced technologies alone rarely provide direct value to 
organisations. Instead, these technologies are most effective when combined with a firm's other 
resources and capabilities. Teece et al. (1997) highlight the importance of path dependencies 
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(Box. 2. (2.2)) and the need to reconfigure a firm’s resources and capabilities to enable the firm 
to change and evolve. Therefore, it is important to understand an organisation’s intention for 
Big Data initiatives and its existing data management processes. Doing so will shed light on 
how an organisation renews or reconfigures existing capabilities to integrate and manage new 
resources like externally available large data sets (Big Data). 
3.2.3 Existing Capabilities (Operational and DC) (Box. 3) 
In this research an organisation’s operational capabilities are defined as an organisation's day-
to-day ability to ‘make a living’, or to convert inputs into outputs (Wilden and Gudergan, 2015) 
with input in this case referring to Big Data as a new resource (Box 2). It has been argued 
(Bharadwaj et al., 2013; Kiron et al., 2014) that one of the biggest ongoing challenges in the 
Big Data environment is that there is still no clear direction on how to reach business targets 
by aligning it with the existing organisational culture and capabilities. In the vein of academics 
(Pavlou and El Sawy, 2011; Wilden and Gudergan, 2015; Erevelles et al., 2015) who divide 
operational capabilities into marketing (e.g. market knowledge, customer relationships, and 
distribution channels) and technological (e.g. technical expertise and equipment) capabilities, 
for this research the Marketing and IT capabilities (box 3.1.1 and 3.1.2) have been identified 
as among the most important operational capabilities within the firm that governs a strategic 
process by adopting new resources, and which help the organisation evolve (Day, 1994; Grover, 
2005; Morgan et al, 2009; Nevo and Wade, 2010; Protogerou et al, 2011; Erevelles et al, 2015). 
To put Big Data into action and to channel it into specifically directed initiatives, the literature 
(Costa, 2013; McKenzy, 2014; Wang et al., 2018) is clear that pharmaceuticals must have both 
marketing and IT capabilities, which are indispensable to the process of transforming Big Data 
resources into potentially competitive assets (Chen et al., 2012; Erevelles et al., 2015; 
Danneels, 2010). Organisations may view data as a primary business asset (Redman, 2008) in 
organisational sense, but it is the firm's IT function that is tasked with managing and integrating 
data as an enabler of data-driven business processes and decision-making (Chen et al., 2012). 
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On the other hand, an organisations’ marketing capabilities allows it to capture rich and newly 
available sources of information (Big Data) that enable it to realise and strategically act upon 
new gaps in the firm's understanding of consumer behavior.  However, it was also highlighted 
that in the new technological environment, Big Data (the rise of semi-structured and 
unstructured data) calls for ad hoc and real-time extraction, processing, and analytics, which 
increases the demand for a corresponding improvement in IT capabilities (Chen et al., 2012).  
In addition, it was evidenced in the literature (McKenzy, 2014; Costa et al., 2014) that the most 
important aspect of Big Pharma’s marketing in today’s digital environment – of demonstrating 
the value to stakeholders of personalised medicine - requires such developments to be put into 
effect. Therefore, these two operational capabilities are considered to be at the core of this 
study. 
3.2.2.1 Operational (Marketing and IT) Capabilities (Box. 3.1) 
- Marketing Capabilities (Box. 3.1.1) 
In general, a firm's marketing capability is defined as the integrative process by which a firm 
uses its tangible and intangible resources to understand complex and specific consumer needs 
(Morgan et al., 2009. More specifically marketing capabilities are considered to be internal 
processes that allow organisations to become more market-driven (Liu and Ko, 2011). Barrales-
Molina et al. (2014) believe that marketing capabilities have great potential to collect new 
market knowledge and disseminate it throughout the organisation. However, the authors also 
highlighted the need for more empirical studies to explain how marketing capabilities can 
manage such market knowledge, as well as how such knowledge promotes the renewal of an 
organisation's existing resources and capabilities. 
Authors such as (e.g. Day, 1994; Dutta et al., 1999; Song et al., 2007; Krasnikov and 
Jayachandran, 2008) indicate that marketing capabilities include processes that are established 
within organisations (e.g. building sustainable relationships with customers, knowledge of the 
competition, and skills in segmenting and targeting markets) that aid  understanding of 
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customer needs through effective information acquisition, management, and use. The market 
knowledge thus generated should act as a driving force that allows the company to achieve a 
high level of process adaptation throughout the organisation as a whole (Bruni and Verona, 
2009). 
It was evidenced in the literature that processes mentioned above play significant roles in the 
management of Big Data within MNCs in the pharmaceutical industry. However, it was also 
recommended that pharmaceuticals will need to improve, reconfigure, or develop new 
marketing capabilities to effectively manage Big Data (Shah and Pathak, 2014). In particular, 
it was highlighted that the recent trend toward using data derived from real-world outcomes to 
inform marketing activities creates the need for closer coordination between different 
stakeholders, and for the improvement of existing targeting and segmentation activities 
(Kumar, 2011; Costa, 2014). Therefore, it is important to investigate these activities in practice. 
-  IT Capabilities (Box. 3.1.2) 
Along with marketing capabilities, the literature (Bhatt et al., 2005; Nevo and Wade, 2010) 
shows that IT capabilities are also competitive necessities, and their absence might result in a 
competitive disadvantage to companies. Piccoli and Ives (2005) note that an organisation’s IT 
capabilities and IT strategic initiatives consist of identifiable competitive moves that depend 
on the use of IT to be enacted, and which are designed to lead to sustained improvements in a 
firm’s competitive position (Porter, 1985). Examples of such activities include business process 
re-engineering, integration of required IT into appropriate business processes (Wilden and 
Gudergan, 2015), customer relationship management (CRM) (Payne and Frow, 2005; Coltman, 
2012; Wang and Feng, 2014) electronic commerce, new resource adoption, and digital data 
management (Vitari et al, 2012). 
In general, IT capabilities are defined as the ability of an organisation to assemble and deploy 
IT-based resources in combination with its other existing resources and capabilities (Bhardwaj, 
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2000). For example, Drnevich and Croson (2013) found that the importance of IT for the 
success of a business is significant as it directly affects the mechanisms through which a 
business creates and captures value. Furthermore, Drnevich and Croson (2013) also note that 
IT grants a firm the flexibility to focus on the rapidly changing digital environment and both 
enhances the organisation’s current (operational) capabilities and the development of new 
capabilities. While IT capabilities are integral to operations at the functional level of the 
organisation they also play an important role in business-level strategy by enhancing existing 
non-digital capabilities while enabling new digital capabilities to create and capture value 
(Drnevich and Croson, 2013). 
3.2.2.2 Dynamic Capabilities (Box. 3.2) 
As related in the literature review conducted for this study, (Cepeda and Vera 2007; Protogerou 
et al., 2010; Wilden and Gudergan 2015; Braganza, et al., 2017) suggested that in a digital 
environment where technological innovation necessitates fast organisational responses to be 
made, dynamic capabilities become a tool that allows a firm to build and renovate operational 
capabilities faster and cheaper than its competitors. For example, Wilden and Gudergan (2015) 
note that when organisations face environmental changes even valuable marketing and IT 
capabilities can become liabilities, widening an organisation's capability gap. In such a case 
authors (Leonard-Barton 1992; Day 2011; Wilden and Gudergan, 2015) argue that dynamic 
capabilities become important because they reflect an organisation’s ability to ‘engage in 
market-based learning and use the learned insight to reconfigure existing resources and 
enhance its capabilities in a ways that reflects organisation’s dynamic environment’ (Morgan 
2012, p. 108).  
This study conforms to the standard set by Teece (2007, p.1344) who defined dynamic 
capabilities as consisting of a series of managerial and organisational processes that 
‘orchestrate’ the firm’s resources and ordinary capabilities in order to adapt and evolve to 
rapidly changing environments. As illustrated in figure 3.1, Box 3.2, this research explores an 
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organisation’s managerial and organisational processes (strategic competitive response, 
learning, reconfiguration, and coordination) that are likely to better match the digital 
environment and make effective use of Big Data for their operational activities (Teece, 2007; 
Ambrosini and Bowman, 2009; Protogerou et al., 2010). Making connections between dynamic 
capabilities (strategic competitive response, learning, reconfiguration, and coordination) and 
operational (Marketing and IT) capabilities in the adoption of Big Data initiatives within MNCs 
in the pharmaceutical would help explain how the company prepared for Big Data adoption 
and how it identified and developed its capabilities for Big Data. 
-Strategic Competitive Response (Box. 3.2.1) 
Adopting the term strategic competitive response from Protogerou et al. (2010), whose 
definition incorporates sense, seize, and transformation abilities (Teece, 2007), this study holds 
that, as a core process of dynamic capabilities, strategic competitive response (box. 3.2.1) is 
particularly important in relation to the Big Data initiatives adoption process. Protogerou et al. 
(2010, p. 619) explain that strategic competitive response is the firm’s ability to scan the 
environment, identify new opportunities, assess its competitive position, and respond to 
competitive strategic moves. In other words, strategic competitive response grants 
organisations the ability to sense new opportunities (Teece, 2007) offered by Big Data. The 
seize ability enables the mobilization of resources to address such opportunities and to capture 
value from doing so (Teece, 2007), and to maintain competitiveness through enhancing, 
combining, and reconfiguring (where necessary) an organisation's existing resources and 
capabilities (Teece, 2007). 
Sensing is an important part of dynamic capabilities. The ability to sense threats and 
opportunities helps to identify new market opportunities, evaluate competitors, and recognise 
resource and capability gaps (Roberts et al., 2016). Therefore, it has a significant impact on a 
firm’s capacity to redefine its operational capabilities for Big Data initiatives. The seizing 
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ability is an equally important characteristic of dynamic capabilities that implies evaluation of 
various options to accommodate the identified opportunity (Protogerou et al., 2010). Thus, 
these abilities are important as they enables the firm to reconfigure (creating, extending, and 
modifying) certain capabilities before they become core rigidities (Teece et al., 1997; 
Eisenhardt and Martin, 2000). 
Dynamic capabilities have an inherently transformative ability, in that they allow a company 
to adjust its capabilities in response to change (Wilden and Gudergan, 2015). To benefit from 
sensing and seizing activities, a company's asset orchestration must be reconfigured 
appropriately (Teece, 2007). In digital environments, where technological innovations are 
introduced by external sources, it is important to constantly scan and learn from the 
environment and to respond to detected changes. Thus, to look at how an organisation 
identifies, drafts, and carries out potential solutions in response to threats and opportunities that 
emerge from Big Data initiatives it is important for this study to explain how the company 
approached the issue of using Big Data and how it identified and developed its Big Data 
capabilities. 
-Learning (Box. 3.2.2) 
Organisational learning is defined as ‘the capacity or process within an organisation to improve 
or maintain performance based on experience’ (Nevis et al., 1995, p 73). It has been argued 
(Teece, et al., 1997; Winter, 2003; Ethiraj et al., 2005) that capabilities reflect the evolutionary 
process of experiences that firms engage. Teece et al. (1997) suggest that learning is a very 
important process which through experimentation and repetition leads to quicker and better 
resolution of specific problems, and which at the same time enables firms to identify new 
opportunities. 
Learning processes that promote, enhance, and renew technological knowledge are critical to 
the success of Big Data transformations in high-technology industries like Big Pharma (Helfat, 
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1997).  This is especially true of sharing and combining new knowledge with  existing skills 
and experience within an organisation, and cross-functional teams have been acknowledged to 
have a positive impact on the transformation and recombination of marketing and technological 
capabilities (Protogerou et al., 2010; Pavlou and El Sawy, 2011; Wilden and Gudergan, 2015). 
Therefore, examination of these processes will be important to this research. 
-Reconfiguration (Box. 3.2.3) 
The introduction of new resources like Big Data and advanced technology enhances a firm’s 
efforts to use dynamic capabilities in order to reconfigure those operational capabilities that are 
most likely to support the ongoing development of valuable products and services.  
Reconfiguration is an organisation’s ability to extend and modify existing capabilities in 
response to changes introduced in the market and technologies that are generated through new 
knowledge based on Big Data (Teece, 2007; Kwon, et al., 2014). It was evidenced in the 
literature that reconfiguration of existing marketing and IT capabilities was necessary for the 
MNCs in the pharmaceutical industry in order to implement Big Data opportunities in their 
operational activities. On the other hand, as has been explained several times in this thesis, in 
a digital environment the potential value of dynamic capabilities lies in enabling firms to renew 
and reconfigure their operational capabilities and introduce new configurations that better fit 
shifting environmental conditions. Therefore, looking at the reconfiguration ability is central 
to this study and its goal of explaining what new capabilities are needed for Big Data. 
-Coordination (Box. 3.2.4) 
Teece et al. (1997) suggest that efficient coordination of different resources and tasks may help 
an organisation overcome some of the challenges introduced by the digital environment. 
Moreover, one of the most suggested solutions for the Big Data transformation in the 
pharmaceutical sector was the coordination ability (e.g. cross-disciplinary and cross-functional 
specialisations). It was assumed that this capability would help Big Pharma to shift from the 
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current functionally-divided approach to a data science-enabled approach to take advantage of 
continuing digital innovation (Marwaha et al., 2018). Protogerou et al. (2010) argue that 
coordination processes connect and interface single activities through communication, 
scheduling, task assignment, collaboration, and other related activities. This capability is an 
effective means of dealing with a changing business environment, especially in the case of Big 
Data, about which most firms have neither substantial experience nor established 'best 
practices' to call on. 
3.2.4 New or Changed Capabilities in Response to Big Data Opportunities (Box. 4) 
While capabilities development may be enhanced by benefiting from a diverse range of inputs 
(resources, learning, experience) (Dosi et al., 2000; Eisenhardt and Martin, 2000; Zollo and 
Winter, 2002; Felin et al., 2012) this process is challenging and depends on many internal and 
external factors, such as project size, the level of hierarchy, and coordination (Rockart and Dutt, 
2013). Taking together all the concepts as illustrated in the framework 3.1 and investigating 
them empirically would help to better explain connections between these concepts and arrive 
at new insight about which of them were adapted or innovated in response to Big Data 
opportunities. 
The purpose of this conceptual framework is to provide an academic foundation for this thesis.   
The framework was developed based on an extended literature review and the research 
questions of this study. All the elements of the framework are extensions of established 
principles and represent key constructs in the research area. Implementing an empirical study 
and analysis of the resulting data would help to explain the connections between the concepts 
in the model and address the research questions. 
Looking at the company’s operational and dynamic capabilities which together constitute 
organisational capabilities (Helfat and Peteraf, 2003; Teece, Pisano and Shuen, 1997) will help 
to incrementally develop understanding and shed new light on the capabilities development 
process for preparation for and utilisation of Big Data initiatives in a pharmaceutical company. 
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As organisational capabilities are necessary for business transformation in the case of Big Data 
initiatives, investigation of capability possession, deployment, and the upgrading process for 
Big Data through the lenses of the RBV and DC theories is fundamental to this study. 
3.3 Chapter Summary 
Adopting the theoretical lenses of RBV and DC to examine the research problem identified in 
Chapter 2, this chapter positioned the Conceptual Framework (CF) for this thesis to investigate 
the research problem. The conceptual framework identified the following concepts: Big Data 
as a new resource; Existing Data Management Capabilities (Operational and DC) that are the 
subject of an empirical investigation in this research within an organisation’s digital 
environment. In particular, operational (Marketing and IT) capabilities and DC (strategic 
competitive response; Learning; Reconfiguration; and Coordination) have been identified as 
the main concepts for the investigation. This conceptual framework guided a preliminary 
research set-up for the execution of the case study research and helped to define the research 
design and methodology that are discussed next in Chapter 4. 
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Chapter 4: Methodology 
4.1 Introduction 
This chapter discusses the research design and methodology that were followed in the 
investigation of the research problem and in the fulfilment of the objectives of this study that 
were identified in the previous chapters. The purpose of the first part of this chapter is to explain 
the relationship between the ontological, epistemological, and methodological approaches (4.2) 
within the study and to justify how they collectively informed the choice of overall qualitative 
case study research strategy (4.3), the unit of analysis (4.4), the choice of empirical sample and 
data collection (4.5), and the ethical consideration (4.6). The second part of the chapter outlines 
the methods used for data analysis (4.7). 
4.2 Research Approach and Rationale 
Social science research is generally grounded around two methodological traditions - 
qualitative and quantitative methodologies, which define how researchers identify and gather 
certain kinds of data, along with the method or methods of analysing that data in order to 
appropriately address research questions. Each of these traditions is also further underpinned 
by philosophical foundations. A given research philosophy represents the researcher’s guiding 
assumptions about the nature of the world (Easterby-Smith et al., 2008). The researcher’s 
philosophical view about the nature of the world (ontology), how it operates, what they choose 
to study, and how they learn about it (epistemology) guide the research questions, 
methodological choices, and research activities (Crotty, 1998; Easterby-Smith et al., 2008). 
Different paradigms contain inherently differing ontological and epistemological views, and so 
make different assumptions about reality and knowledge. Traditionally, social science research 
has been approached from two contrasting philosophical traditions: positivism, which is 
usually referred to as the quantitative or objectivist approach, and social constructionism, also 
known as the qualitative, subjectivist or interpretivist tradition (Hussey and Hussey, 1997; 
Easterby-Smith et al., 2008). 
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Easterby-Smith et al. (2008) argue that understanding the philosophical issues of research 
design is of central importance for three reasons. First, knowledge of research design 
philosophy can enable the researcher to clarify what kind of evidence is required and how it is 
to be gathered, as well as providing answers to the basic questions being investigated in the 
research. Second, this knowledge can help the researcher to recognise which research designs 
will work and which will not. Third, this knowledge can help the researcher to identify, and 
even create, research designs which may be beyond the researcher's experience. Thus, 
identifying the most appropriate research ontology at the start of the research process is 
critically important as it determines the choice of research design. The next section will 
compare and contrast the different ontological and epistemological views to shed light on the 
rationale for choosing the critical realism approach (4.2.1) and the qualitative methodology 
(4.2.2) as the basis of this research. 
4.2.1 Ontological and Epistemological Views 
4.2.1.1 Ontology 
In social science, the term ontology refers to a researcher’s view of the nature of reality, that 
is, the phenomena under investigation. Traditionally, there are two ontological perspectives in 
social science - objectivism and subjectivism. Objectivism is the philosophical assumption that 
reality or phenomena exist independently and externally to the researcher and the research 
population (Saunders et al., 2012). Contrarily, subjectivism is an ontological assumption that 
presumes that reality (or the phenomena being researched) are neither external nor detached 
from social actors or the researcher. Thus, subjectivism views reality as emergent and socially 
constructed, arising through the opinions of multiple social actors depending on their lived 
experiences (Bryman and Bell, 2011). 
Considering that the main aim of this research was to explore why and how Big Data initiatives 
and required capabilities come about in a MNC in the pharmaceutical industry, the flexibility 
of the subjectivist approach offers the researcher an opportunity to study how various actors 
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engage with Big Data initiatives in reality, through their potentially diverse views and 
experiences. 
4.2.1.2 Epistemology 
In general, three main epistemological views dominate the literature about the research process 
(e.g. Crotty, 1998; Easterby-Smith et al., 2008; Bryman and Bell, 2011): positivism, 
constructivism, and realism. The different views will be discussed below in terms of their 
underlying ontology, as well as the methods of enquiry and research methods associated with 
them. 
Positivism. The fundamental philosophy of positivism is that the social world exists externally, 
and that its properties should be measured using objective methods, rather than being assumed 
subjectively by use of observation, reflection, or intuition. In investigating a phenomenon, 
positivism makes an ontological assumption that views ‘reality’ in the study of a social 
phenomenon as external and objective (Easterby-Smith et al., 2008). A positivist epistemology 
implies that the goal of research is to produce objective knowledge that is neutral and unbiased, 
based on a view from ‘the outside’, without the personal involvement of the researcher (Willig, 
2001). 
The aim of research is to test a theory’s claims in order to either reject the theory or to retain it 
for the time being. Therefore, theories are tested by deriving hypotheses from them, which can 
then be tested in practice, by experiment or observation (Willig, 2001). Thus, positivist 
epistemology is often partnered with the quantitative research strategy that emphasises 
quantification in the collection and analysis of data (Bryman and Bell, 2011). 
Constructivism. By contrast, the philosophy of social constructivism assumes that reality is 
socially constructed, and is the basis of how people make sense of and view the world, 
especially through sharing their experiences. While positivists seek to uncover the truth, 
constructivists are critical of our ability to know reality with certainty (Trochim, 2006). The 
underlining ontology of constructivism rejects the idea of true and objective knowledge, since 
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each of us experiences a different reality (Saunders et al., 2012; Trochim, 2006). However, this 
does not mean that we can never truly know something, but rather it suggests that there are 
‘knowledges’ rather than ‘knowledge’ (Willig, 2001). 
Because human experience, including perception, is mediated chronologically culturally, and 
linguistically, the same phenomenon or event can be described in different ways, giving rise to 
different ways of perceiving and understanding. Therefore, research from a social 
constructionist perspective is concerned with identifying the various ways of constructing 
social reality that are available in a domain, to explore the conditions of their use, and to trace 
their implications for human experience and social practice (Willig, 2001). For instance, many 
constructivist researchers believe that the best way to understand any phenomenon is to view 
it in its context and to become immersed in it. Thus, it can be best paired with a qualitative 
research strategy that, in contrast to a quantitative method, emphasizes words rather than 
numbers in the collection and analysis of data (Bryman and Bell, 2011). 
Realism The philosophy of realism in general is defined by Phillips (1987, p. 205) as ‘the view 
that entities exist independently of being perceived, or independently of our theories about 
them’. In philosophical terms, realism could be regarded as a synthesis of positivism and 
constructivism. Its underlining ontology holds that while reality is real, all theories about the 
world are grounded in a particular perspective and worldview, meaning that all knowledge 
(epistemology) is necessarily partial, incomplete, and fallible (Willig, 2001). 
According to Miles and Huberman (1994), a realist researcher thinks that social phenomena 
exist not only in the mind but also in the objective world and that some plausible relationships 
are to be found between them. There are two major forms of realism: Empirical Realism (ER), 
which believes that by using the appropriate methods reality can be understood, and Critical 
Realism (CR), which recognises the reality of the natural order and the events of the social 
world (Bryman and Bell, 2011). In contrast to Critical Realism, Empirical Realism fails to 
98 
 
recognise that there are permanent structures; physical (e.g. atoms or organisms), social (e.g. 
the market or the family) or conceptual (e.g. categories or ideas) and generative mechanisms 
that underline and produce observable phenomenon and events (Bashkar, 1989. p. 2). Thus, 
Empirical Realism is usually identified as being equivalent to empiricism as it identifies the 
real with the empirical, that is, with what we can experience, as if the world just happened to 
correspond to the range of our senses and to be identical to what we experience (Sayer, 2000. 
p. 11). In other words, an empiricist recognizes only events which can be perceived, whereas 
for a Critical Realist only events that have a causal effect on the world can be said to exist, 
regardless of perceptibility. The concept of causality is a key difference between the two, 
referring 'to the relationship between an action or thing (cause) and the outcome (effect) it 
generates (Wynn and Williams, 2012, p. 789) Critical Realism recognises the existence of a 
variety of objects of knowledge (e.g. material, conceptual, social, and psychological) each of 
which requires different research methods to be understood, as well as observation, especially 
in the social world (Mingers, 2004, p.100). 
However, the concept of causality, and especially criteria for testing knowledge claims about 
causes, has been one of the focuses of criticism from adherents of the positivist approach 
towards CR. The positivist who attempts to ‘explain’ a phenomenon by hypothesizing a 
relationship between conceptual entities assumes a flat ontology that reduces reality to a 
Humean conjunction of cause with effect and has little regard for the mechanisms which link 
them (Joseph 1998). The Humean model of causation that relies merely upon correlations 
between observed events combined with statistical methods does not meet the explanatory 
criteria of CR (Lawson, 1997; Sorrell, 2018). Moreover, the positivist believes that CR lacks 
concrete guidelines to be followed when evaluating causal claims against each other, and 
questions the possibilities of detailed explanations without evaluating empirical evidence 
according to systematic and agreed-upon criteria (Mingers 2004). In other words, this criticism 
99 
 
emphasises the lack of a systematic methodological tool to deal with (ontological) causal 
complexity that CR does not seem interested in providing.  
However, from the CR perspective, a request for there to be fixed methodological criteria by 
which we can evaluate causal claims is unconvincing since such criteria are not appropriate in 
the social sciences, where the primary objectives of social scientific research are not to predict 
or to interpret but to explain (Sorrell, 2018). Within CR, causation is not based on regular 
successions of events or a correlational assessment of event regularities (Sayer 2000). CR 
instead shifts the focus to the explicit description of causality by detailing the means or 
processes by which events are generated by structures, actions, and contextual conditions 
involved in a particular setting. This view of causality is reflected in the ontological and 
epistemological assumptions upon which CR is founded, as well as in the methodological 
principles (Mingers et al., 2013).  
In contrast to social constructivists, realism researchers do not believe that reality is 
structureless. Thus a realism approach allows for the use of quantitative as well as qualitative 
and hence can exploit the advantages of both. For example, Maxwell and Mittapalli (2007) 
state that a realist position is quite compatible with the key characteristics of qualitative 
research as it: 
✓ Recognises the reality and importance of meaning, as well as of physical and 
behavioural phenomena. 
✓ Emphasises the importance of the context of the phenomena studied, rather than seeking 
only a general understanding independent of specific conditions. 
✓ Supports the importance of investigating the processes by which an event or situation 
occurs, rather than simply attempting to demonstrate an association between variables. 
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In addition, critical realism also seeks explanations for singular events and situations through 
case studies, rather than requiring that the explanation be based on observable patterns or 
‘general laws’ (Maxwell, 2004). 
4.2.2 Rational for Choosing Critical Realism and Qualitative Methodology 
4.2.2.1 Critical Realism 
The Critical Realism approach, which seeks to provide clear, concise, and ‘empirically 
supported statements about causation’, especially for how and why enquiries (Wynn and 
Williams, 2012, p.789), is proposed as a means by which the researcher could investigate the 
research questions for this study, which seeks to identify why the MNC in the pharmaceutical 
industry prepared for Big Data adoption and how it identified and developed its Big Data 
capabilities. The research questions are consistent with the Critical Realism approach rather 
than the positivism approach that is associated with producing objective knowledge based on 
facts but without the personal involvement of the researcher (Willig, 2001), or the 
constructivism approach that – in contrast to positivism - is associated with subjectivism in that 
it rejects the idea of true and objective knowledge, since each of us experiences a different 
reality (Saunders et al., 2012). 
The Critical Realism approach formulated by Bhaskar (1975, 1989) has been acknowledged as 
one of the most commonly accepted models in qualitative research (Bryman and Bell, 2011, p. 
17). The approach partners a realist ontology with interpretivism to provide new perspectives 
for developing knowledge (Volkoff et al., 2007; Easterby-Smith et al., 2008). The real promise 
of the Critical Realism approach lies in its potential to allow researchers to identify the specific 
causes of the events under study. Beyond simply providing statistical evidence that a causal 
relationship exists, the critical realist shifts the focus to explicitly describing causality by 
detailing the means or processes by which events are generated by structures, actions, and 
contextual conditions involved in a particular setting (Winn and Williams, 2012). Thus, the 
explanatory power of the chosen approach, rather than the use of flawed and possibly biased 
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reasoning alone (Pawson et al., 2005; Winn and Williams, 2012) allowed the researcher to 
examine multiple realities. 
A key aspect of the CR approach is the stratification of reality into three main domains 
(Bhaskar, 1975), as shown in table 4.1 
 
 Real Actual Empirical 
Mechanisms 
/ Powers 
✓    
Events and 
Behaviours 
✓  ✓   
Experiences ✓  ✓  ✓  
 
Table 4.1: A Stratified View of Reality (adapted from Bhaskar (1975, p. 41)) 
According to Bhaskar (1975; 2010) understanding and then changing the social world are only 
possible by identifying: (1) underlying structures and mechanisms that generate events and 
discourses (Real domain), (2) events and behaviours that may (or may not) occur (Actual 
domain) and (3) experiences that we can (or cannot) experience (Empirical domain). Baskar 
(1975) argued that because social actors operate within social structures that feature 
institutionalised positions and practices, these actors obtain abilities from unequally distributed 
resources. Thus, relationships between different social structures tend to generate specific 
social behaviours and events. These relationships are termed generative mechanisms. 
Mechanisms are ways of enacting things, or of enabling or limiting what can happen within a 
given context (Bashkar, 1975, p. 14; Smith, 2006). The occurrence of generated events and 
behaviours can be observed, rather than merely perceived, in the actual domain, while such 
events and behaviours can be said to be experienced in the empirical domain. 
In the context of this thesis, this stratified view of reality helps to describe what 
organisational/managerial processes are able to do in the case of Big Data initiatives (their real 
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mechanisms, causal powers or tendencies); what they actually do (their impact on events in 
actuality), and the partial view of events available to the researcher (through sensory experience 
in the domain of the empirical). Based on the literature review in Chapter 2, it can be argued 
that the development of required capabilities for Big Data refers to the unconditional potential 
of organisational and managerial abilities (dynamic capabilities) in the domain of the real; to 
processes that refer to the realised activities of dynamic capabilities in the domain of the actual, 
and to the perceived nature of events held by managers (participants) that are rooted in the 
domain of the empirical. 
4.2.2.2 Qualitative Methodology 
Rather than relying on quantitative methods, which often involve large surveys that are rigorous 
in terms of theory testing and generalization (Hewege and Perera, 2013), the qualitative 
research strategy that was adopted enabled the researcher: 
I. To understand the practical issues that the case study company was facing in developing 
Big Data capabilities in the challenging digital environment. 
and 
II. To examine and explore processes that enabled the company to adopt Big Data practices 
effectively. 
Qualitative methods, allied with the CR approach, were also of greater relevance than 
quantitative methods would have been because they enabled greater practitioner engagement, 
which consequently helped identify and describe structured interactions between the complex 
phenomenon of Big Data and the required capabilities development processes. 
As suggested by Bryman and Bell (2011), people and their institutions cannot be studied in the 
same way that other objects in the physical world are studied. When research intends to 
investigate capabilities, abilities, values, perceptions, and motivations – in other words, the 
factors that explain human behaviour – then the research should ask questions and collect data 
in the form of words rather than numbers. Words can yield valuable insight into the motivations 
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behind the adoption of Big Data initiatives, whereas figures would give a detached account of 
behaviour patterns without insight into the reasoning that underlay it (Brayman and Bell, 2011). 
Therefore, a qualitative approach was judged to be most appropriate for this study, fostering as 
it does a better understanding of the lived experiences of the participants and their perceptions 
of how they prepared for Big Data adoption and developed required capabilities. 
One particular criticism that can be levelled at qualitative research is that when these kinds of 
details are available - such as the first hand experiences, or perceptions - it can be hard to 
determine what the generalisable themes may be. However, the aim of this research, as in the 
case of many qualitative researchers rooted in the CR approach, is about generating rich 
descriptions of phenomena that explain, identify, and verify the existence of sets of mechanisms 
which are theorised to have generated the phenomena under study (Winn and Williams, 2012). 
Indeed, one of the most important purposes of good qualitative research is to create new ways 
of understanding processes by discovering or tailoring new concepts and theories that have 
both originality and utility (Corley and Gioia, 2011). 
4.3 Choice of Research Method 
4.3.1 Rational for Choosing a Case Study Methodology and its Research Methods 
This section seeks not only to provide the rationale for choosing a case study methodology for 
this research, but also to provide greater understanding of this method. While a specific 
recommended research methodology for the CR approach does not exist, several critical 
realism researchers, especially in the IS research domain, have identified the case-study method 
as the best approach to explore the interaction of structure, events, actions, and context to 
discover and explain causal mechanisms of the events in question (Miles and Huberman, 1994; 
Morton, 2006; Volkoff et al., 2007; Bygstad, 2010; Easton, 2010; Winn and Williames, 2012). 
Wynn and Williams (2012, p. 803) for example suggest that the case study is the ‘primary 
research design in critical realist paradigm’ as it allows the in-depth explication of the causal 
mechanisms in operation in specific contexts. Thus, the case-study methodology makes it 
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possible to examine phenomena in their complexity, without reducing the object of the research 
to just a few variables (Yin, 2003). This method ‘involves investigating one or a small number 
of social entities or situations about which data are collected using multiple sources of data 
and different techniques for collecting data’ (Easton, 2010 p. 119). Therefore, conducting a 
case study was considered to be the most appropriate research strategy to achieve the research 
purpose and objectives for this study. Arguably, a deep empirical examination of the precise, 
real-life context in which the researched phenomena occur can deliver insight and contribute 
to knowledge (Yin, 2003). However, some aspects of case-study research had particular 
relevance and influence in the justification for a qualitative case-study strategy for this 
research. 
Firstly: With consideration to the CR approach, in which research seeks to explain how and 
why specific, complex events occur in a particular context, the research question must ask 
about the causes of specific events, instead of merely describing the events in theoretical terms, 
testing existing theories, or proposing a predictive model. As a result, this research is targeting 
the how and why questions associated with explanatory case research (Wynn and Williams, 
2012). Considering that the context of this research is to ‘illuminate key features of explanatory 
issues’ Gray (2014, p. 267) of the capabilities development process for Big Data initiatives, it 
would be difficult to capture and explain the true causes of such an initiative without 
considering and investigating the context within which it took place. Therefore, the research 
context (the global pharmaceutical company), and more specifically the company’s Big Data 
adoption project setting, in which the company’s Big Data capabilities were developed and put 
to use, was considered the most suitable focus of the investigation, of how the company 
approached the issue of using Big Data strategically and how it identified and developed its 
capabilities for Big Data. 
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Organisational processes, systems, and structures were thought to be the best starting point to 
identify the organisational/managerial activities and processes (operational and dynamic 
capabilities). This was chiefly because of the well-acknowledged fact that capabilities are 
routines and processes that depend on managerial activities, practices, and which remain 
hidden until exercised (Teece, 2007; Easterby-Smith et al., 2008; Danneels, 2010). Moreover, 
it is ‘not just how one plays the game; it is also a function of the assets that one has to play 
with and how these assets can be deployed and re-deployed in a changing market’ (Teece et 
al., 1997. p. 529). This is consistent with the CR paradigm that states that what should count as 
an adequate explanation of a phenomenon does not depend entirely on the nature of that 
phenomenon and/or on the current state of relevant theory, but also depends on the particular 
purposes for which, and the context within which, the explanation is being developed (Pawson 
and Tilley, 1997. p. 69). Hence, as Yin (2003, p. 13) states the case-study approach is ideal for 
‘investigating contemporary phenomenon within its real-life context, especially when the 
boundaries between phenomenon and context are not evident’. This is true of the case under 
discussion, of the phenomena of Big Data and the development of required capabilities. Thus, 
the case-study approach was believed to be the best way to uncover a relationship between the 
development of required capabilities for Big Data and the context in which it occurred, by 
focusing on the experiences, abilities, and knowledge of a variety of professionals trying to 
make use of Big Data and develop required capabilities in the real-time context of global 
pharmaceutical company. Reflecting on the personal experiences of people working within a 
Big Data project helped to provide a first-hand insight to practical issues, such as how the 
company approached the issue of using Big Data strategically, and how it identified and 
develop its capabilities for Big Data (Chapter 5 and Chapter 6). 
Secondly: One of the benefits of a case-study approach is that a theoretical/conceptual position 
can be developed in advance of the study, in order to assist and direct data collection and 
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analysis (Gray, 2014). Since qualitative enquiries are typically oriented towards grounded 
theory development in the case of many qualitative studies, a theoretical framework may not 
be articulated upfront. However, Baxter and Jack (2008) state that conceptual frameworks for 
case study designs developed beforehand can increase the feasibility of the completing the 
project, as it gives the researcher flexibility to manage the limits of the scope of the study to 
meet the timeframe of the research. A conceptual framework like this that had been prepared 
before the data collection began (figure 3.1) was synthesised from a number of related concepts 
(digital environment, Big Data, operational capabilities, dynamic capabilities) and was based 
on an inductive approach to the literature review, with both theoretical and empirical 
perspectives guiding the researcher throughout the research stages: data collection (4.5), data 
analysis (4.7), and structuring the findings and discussions (chapter 5 and 6). 
Thirdly: The case selection - typically, case study research focuses on an intensive examination 
of events occurring within a single structure, such as an individual company (Bygstad, 2010), 
or a composite structure, such as multiple divisions (Morton, 2006) or sites (Volkoff, et al., 
2007) within a firm. However, the selection of a case usually reflects the existence of events 
which are representative of the phenomena a researcher is attempting to explain (Wynn and 
Williams, 2012). 
-The Research Context of This Study. The Case Study Company 
The empirical context of this study is a $13 billion revenue, integrated, global multinational 
Pharmaceutical Corporation headquartered in New Jersey, USA, whose mission is to discover, 
develop, and commercialise innovative therapies for the treatment of cancer and inflammatory 
diseases through next generation solutions in protein homeostasis, immuno-oncology, 
epigenetics, immunology and neuro-inflammation. With more than 6,500 employees based in 
over 50 countries including Europe, Latin America, Middle East, Asia/Pacific, and Canada, the 
company has a strong presence in the worldwide markets, working with a variety of affiliates, 
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franchises, partners, and distributors. Both the company’s international headquarters and a drug 
product manufacturing facility which performs formulation, encapsulation, packaging, 
warehousing, and distribution are located in Switzerland. 
Hundreds of clinical trials take place at major medical centres worldwide evaluating 
compounds from the company, and the company’s medicines are available in more than 70 
countries. The company’s therapeutic products are subject to rigorous preclinical testing and 
clinical trials and other pre-marketing and post-marketing approval requirements of the FDA 
and regulatory authorities in other countries. Review and approval procedures outside of the 
United States are undertaken in virtually every other country comprising the market for the 
company’s products. The approval procedure and the time required for approval vary from 
country to country and may involve additional testing. In certain countries such as the EU 
countries, and in Canada and Australia, regulatory requirements and approval processes are 
similar to those in the United States, where approval decisions by regulators are based on the 
regulators’ review of the results of clinical trials performed for specific indications. 
In most countries, companies promote their products through their own sales organisations 
under mandatory risk-management distribution programs tailored to meet local authorities’ 
specifications to provide for their safe and appropriate distribution and use. According to the 
case study company’s internal 2016 survey, over 500,000 patients were treated with the 
company’s medicines around the world, while more than 293,000 patients received patient 
support, including disease education and health-system navigation, through the company’s 
patient support programs. Across Europe, the company provides support to organisations and 
initiatives that make a positive impact on its patients and their communities. Support for patient 
organisations in Europe is the responsibility of the company’s local office in the country in 
which the patient organisation is based and is dependent on local laws and regulations. Patient 
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organisations who provide services in European countries are accountable to the company’s 
(EMEA) international headquarters. 
As a result, over the years the company's focus on using its products and innovations to deliver 
value to patients - defined as improved health outcomes and quality of life - has been especially 
evident in the case of multiple myeloma, where the company played a lead role in bringing 
forward significant advancements in patient outcomes, as Figure 4.1 below illustrates: 
 
 
Figure 4.1: Patients’ improved outcomes after the company’s treatment (source, the 
company’s annual report, 2017) 
Currently utilising innovative platforms for data management and analytics capabilities, the 
company has made a transition to value-based, personalised healthcare. This transformation 
was enabled by focusing on the consistent and coherent integration of Big Data initiatives. The 
company’s senior management team believed that a cloud-first platform strategy, with 
enterprise information management, served as the foundation for leveraging Big Data to 
improve understanding of disease and to develop targeted therapies and treatments (Annual 
report, 2017). 
Using collaboration as a source of innovation, the company was making investments not only 
to harness the data that is generated across the enterprise, but also the real-world healthcare 
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data generated by its expanding network of partners. However, throughout these processes, the 
company experienced numerous challenges and changes, beginning in 2013 and continuing to 
the present day. The company’s commitment to and involvement in an innovative approach for 
Big Data management, particularly in the Information Knowledge Utilization (IKU) projects 
(at the Global and EMEA sites) for Big Data initiatives, offered an excellent empirical grounds 
for this research to inquire into the company’s Big Data capabilities development processes. 
As discussed in the literature review (Chapter 2), although the development of a capability may 
be enhanced or developed by the diversity of a firm’s experience, this process is challenging, 
and depends on many internal and external factors. Taking a single case-study approach 
allowed the researcher to conduct an in-depth examination of a particular case about 
capabilities development in the Big Data implementation process within the company. A 
comprehensive investigation of how the company learned more about the resource of Big Data 
itself, and how to build capabilities related to its use, helped the researcher to shed more light 
on what is still unknown and has not yet been explored. Ultimately, this was an important path 
to the generation of knowledge about Big Data and the development of required capabilities. 
4.3.2 Research Quality 
Although the case-study approach was seen to be the most suitable choice for this study, it was 
important to consider and address certain issues associated with research quality throughout 
the process. In particular, the choice of a case study meant that the attributes most strongly 
associated with it, as discussed by Yin (2003), Eisenhardt (1989), Walsham (1993), Creswell 
(2012) and Miles and Huberman (1994) such as its generalisability, validity, reliability, and its 
units of analysis, needed to be accounted for in order to ensure the quality of this research. 
Generalizability- In essence, generalizability is a measure of how well the conclusions of 
research can be applied to the population as a whole. 
Although critics of the qualitative case-study approach claim that findings derived from case 
studies cannot be generalised on the grounds that individual cases are not representative, and 
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that there is an insufficient sample size from which to draw statistically meaningful results, 
Walsham (1993) points out, that generalizability from case studies is possible. It is possible 
because the validity of an individual case or cases ‘depends not on the representativeness of 
such cases in a statistical sense, but on the plausibility and strength of the logical reasoning 
used in describing the results from the cases, and in drawing conclusions from them’ (Walsham, 
1993, p. 15). Similarly, Stake (1980) stated that a process of natural rather than statistical 
generalization results from recognising the similarities of the objects and issues in different 
contexts and by understanding changes and differences as they present themselves (Stake 1980 
in Sturman 1997, p. 69). However, for this kind of generalization to be possible, it is essential 
to ensure that both the silent and salient features of the case are documented, so that new 
situations can be enhanced by a very thorough understanding of a known case (Sturman 1997, 
p. 63). Holding a similar position, Easton (2010) pointed out that the strongest grounds for 
generalizability in qualitative case study research begin with rigorous attention to the study’s 
design and methods for gathering and analysing information-rich data (Yin 2003); its attention 
to validity, reliability, and triangulation (Patton, 2002); a well-developed theory emerging from 
the findings, and in establishing a trail of evidence from data collected to the theory that is 
developed (Eisenhardt,1989). 
In addition, generalizability has particular significance in the CR and requires further 
elaboration relative to case study research. Generalizability in a CR setting provides a means 
to leverage existing statements of causal mechanisms to explain events observed within the 
specific context of the new setting as opposed to predicting outcomes based on the 
generalization of theory to a new population or context (Wynn and Williams, 2012).  This 
serves to validate the explications of causal tendencies and the interplay of mechanisms and 
context and helps to refine our theories. For example, given the highly-complex nature of Big 
Data and the required capabilities development phenomenon it would be impossible to expect 
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identical or even highly similar outcomes if a given study were to be replicated in a different 
organisational, industrial, regional, or cultural setting (Wynn and Williams, 2012). Rather, the 
intent of this research, conducted under the CR settings as explained in the previous section, 
was to generate detailed causal explanations of the phenomenon in a given setting to obtain 
insights as to how and why a similar mechanism could lead to different, or perhaps similar, 
outcomes in a different setting (Becker, 1990). Hence the generalization within CR-based case-
study research is more generalization to theory (Lee and Baskerville 2003; Yin 2003) rather 
than a measure of how well the conclusions of research can be applied to the population as a 
whole. Thus, theoretical validity is crucial (Maxwell,1992). Any theory has two components: 
the concepts of categories that the theory employs, and the relationships that are thought to 
exist among these categories. Corresponding to this are two aspects of theoretical validity (the 
‘fit’ of data, and theoretical explanation) that according to Maxwell (1992) are crucial for 
generalizability. 
The selection of a case study organisation for this research was followed by theoretical 
sampling techniques rather than statistical sampling due to nature of the research. Theoretical 
sampling attempts to discover categories and their elements in order to detect and explain 
interrelationships between them (Eisenhardt, 1989). A priori specification of a theoretical 
concepts is valuable because it permits researchers to measure constructs more accurately. If 
these constructs prove important as the study progresses, then researchers have a solid 
empirical grounding for the emergent theory. A theoretically-based and empirically-validated 
model (Figure 5.4) of this research, which establishes a credible trail of evidence between the 
data collected and theoretical propositions, ensures the plausibility and cogency of the results 
derived by this case study's research design and, hence, overcomes the criticisms in terms of 
generalization from the case study approach. The initial conceptual model of this study served 
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as a guide for the data collection and analysis phases. The emergent model is proposed as a 
guide to organisations embarking on a Big Data initiative. 
In addition, Eisenhardt (1989) highlights the importance of comparison of the emergent 
concepts, theory, or hypotheses with the extant literature. This involves asking what is this 
similar to, and what does it contradict, and why. Literature discussing similar findings is crucial 
as is strengthens the confidence that the findings are valid and generalizable because others 
had similar findings in a very different context (Eisenhardt,1989; Leonard-Barton, 1990). Thus, 
this linkage with a variety of literature in other contexts raises the reader's confidence, as well 
as allowing the conceptual level of findings to be elevated to the more fundamental level of 
punctuality and strengthen their likely generalizability to other project teams. 
The findings and contributions (see Chapter 5 and 6) of this study are discussed in line with 
both the empirical and the theoretical literature, ensuring the validity of the findings and the 
contribution to knowledge and strengthening the generalizability of this case-study research. 
Validity is a measure of how well the results can be justified and considered to be a true and 
accurate reflection of reality (Yin, 2003). To overcome subjective judgement issues the research 
used multiple sources of data (data sources will be discussed in detail later in this chapter) in 
order to improve overall validity. In addition, a number of tactics were used during the data 
analysis and presentation stages in order to increase internal validity. For example, to minimise 
interpretation bias, the collected data is presented whenever possible in the respondents' exact 
words, with direct quotations of interviewees being used to justify the resulting interpretations. 
Furthermore, for the critical realist, internal validity is concerned with establishing a chain of 
evidence that the generative mechanism is a possible cause of the events occurring in the study. 
Having two units of analysis - the company’s Big Data adoption and capabilities development 
projects for each site of the company (Global and EAMA) - allowed the researcher to 
decompose the data into periods, consisting of different phases (planning, building, 
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operational) thus enabling the explicit explanation of how action in one phase and/or project 
led to action and changes in Big Data adoption and the capabilities development processes in 
another phase and/or project within the case study company. Furthermore, to increase construct 
validity and the reliability of the information, every step of the research study was documented, 
and these documents are attached as an Appendixes to the final work. 
Reliability is a measure of the extent to which a set of results can be regarded as being 
dependable (Yin, 2003). In order to increase reliability the case study protocol and interview 
guide were used, and a database of collected data was developed. The case study documents 
were stored in the cases database, and all interviews were recorded, transcribed, and 
documented. 
Table 4.2 below presents a summary of the different tactics, including their explanations and 
the recommended case study actions (Yin, 2003; Creswell, 2012), and the measures that were 
undertaken at different stages of this research to maintain the quality of the case study. 
Test Explanation Case study tactic Phase of the research 
Generalizability 
A measure of how well 
the conclusions of 
research can be applied 
to the population as a 
whole. 
The selection of a case 
study organisation for this 
research was followed by 
theoretical sampling 
techniques rather than 
statistical sampling due to 
nature of the research. 
 
A theoretically-based and 
empirically-validated 
model (Figure 5.4) of this 
research, which establishes 
a credible trail of evidence 
between the data collected 
and theoretical 
propositions, ensures the 
plausibility and cogency of 
the results derived by this 
case study's research design 
and, hence, overcomes the 
criticisms in terms of 
generalization from the 
case study approach. 
The findings and 
contributions (see Chapter 
5 and 6) of this study are 
discussed in line with both 
Data Collection, Data 
Analysis,  Discussions and 
contributions  
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the empirical and the 
theoretical literature, 
ensuring the validity of the 
findings and the 
contribution to knowledge 
and strengthening the 
generalizability of this 
case-study research. 
Validity 
A measure of how well 
the results can be 
justified and considered 
to be a true and accurate 
reflection of reality (Yin, 
2003). 
To minimise interpretation 
bias, the collected data is 
presented when possible 
based on exactly what the 
respondents said. 
Furthermore, direct 
quotations of interviewees 
are used. 
 
To avoid conclusion bias, 
the interview results were 
checked by supervisors. 
Data analysis 
External Validity 
A measure of how well 
the conclusions of the 
research can be applied 
to the population as a 
whole 
 
Empirical data was 
compared with theoretical 
findings. 
Data analysis 
Reliability 
Demonstrate that the 
operations of a case 
study can be repeated 
with similar results 
Research procedures were 
documented. Some 
materials are attached as an 
appendixes. 
 
An interview guide was 
prepared. 
 
All interviews were 
recorded, transcribed, and 
documented. 
 
Collected data were 
documented and archived. 
 
To avoid influencing 
interviewees, open-ended 
questions facilitated an 
appropriate condition to 
obtain the respondents’ 
own words and opinions. 
 
To avoid incorrect 
interpretation and likely 
bias, the author’s 
interpretation was checked 
by supervisors. 
 
Data collection 
Data collection 
 
 
 
 
 
 
 
 
Data analysis and writing 
up stage. 
Table 4.2: The Quality Measure of the Case Study. (developed by the researcher based on 
source Yin, 2003) 
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4.4 The Units of Analysis 
As mentioned above, one of the important aspects of ensuring the quality of the case study 
design is the unit of analysis, defined as the area of focus for the study (Yin 2003). Informed 
by the research strategy described in the previous sections, the framework for collection of data 
was an in-depth case study of a global pharmaceutical company. Accordingly, the units of 
analysis were the company’s Big Data adoption and capabilities development projects for each 
site of the company (Global; EAMA). Presenting the timeline and stages that were involved in 
the adoption of Big Data initiatives, and in the process of development of required capabilities, 
the next sections (4.4.1 and 4.4.2) highlight similarities and differences between the projects in 
different phases (planning, building and operational). It must be noted that during the 
interviews, the planning and building phases in both sites of the company had already been 
conducted, while the operational phase was in progress for both sites. 
4.4.1 The Company’s IKU Project at the Global (US) 
The Big Data initiatives adoption project at the company was recognised as a journey that the 
company was embarking on to transform how the company would and utilize Big Data and 
develop required capabilities for its effective use. The Big Data initiatives planning at the 
company’s global headquarters initially started around 2015 with the question of what Big Data 
means for the healthcare industry and for the company, which gradually progressed into a 
strategic initiative in mid-2016 when the company started identifying more precise questions, 
such as where the company stood in the ongoing Big Data revolution environment, and what 
strategy was going to be used to implement Big Data initiatives, and where the company has 
to be and how they would get there. When the company arrived at a more defined Big Data 
initiative strategy it assembled a small team called the IKU champions, supported by a strong 
partnership with Coverage HEALTH (a unit of Deloitte). The team designed a Big Data 
program called IKU (the Global project) which included the development of an overall strategy, 
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as well as plans to invest and develop platforms and external partnerships, and to develop new 
capabilities for Big Data, data governance, and harmonisation (planning phase). 
The project was shaped around five work streams, as presented in figure 4.2 below. 
 
 
 
 
Figure 4.2: The Five Essential IKU Work Streams (ID04) 
The objective of the project was to shift to more value-based healthcare. This would be 
achieved in partnership with organisations that are experts in data and technology that would 
complement the company’s ability to develop the capabilities to use electronic healthcare data 
that was generated many years ago. 
Figure 4.3 below shows the stages of the IKU (Global) project and a timeline of the 
implementation processes. 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Stages of IKU Project and Timeline of Implementation Processes at the Global 
site of the Company. (Based on researcher’s synthesis of multiple data sources) 
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4.4.2 IKU Project at the Company’s EMEA Site 
The company’s EMEA IKU project also follows five essential work streams, as identified by a 
Global team. However, the IKU project at the EMEA site started in January 2017 when the 
Synapse platform went live. Therefore, planning and building phases were slightly different. 
Figure 4.4 below illustrates the stages of EMEA’s IKU project and highlights the timeline of 
the implementation process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Stages of IKU project and Timeline of Implementation Processes at the EMEA 
site of the Company. (Based on researcher’s synthesis of divers data sources) 
The main goal of the EMEA project was to put in place a program that started at the global site 
of the company, as well as create awareness of the IKU/Big Data project within the company. 
The project members (IKU champions) were senior members from the company’s EMEA 
headquarters and the company’s different European franchises (Affiliates). The first step at the 
EMEA project was to increase awareness of the project and about Big Data thinking within the 
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company. After building the technological platform to address connectivity challenges, the IKU 
champions started going to different departments to identify projects where Big Data could 
help, and developing capabilities to communicate these insights across the company to increase 
cross-functional coordination. The aim was to support the interaction of data sets across the 
company by breaking the silo mentality that separated internal functions, and enhancing 
collaboration and coordination. A great deal of attention was paid to the discovery of new 
opportunities, checking that the science was sound, and then entering business partnerships 
with academics and small companies who were experts in Big Data. 
4.4.3 The Choice of Empirical Sample   
This research assumed that professional opinions regarding Big Data as a strategic new 
resource, and the capabilities needed to meet the challenge of the new digital environment, 
were crucial to answer the research questions. Danneels (2010) argues that managerial views 
of an organisation’s resources and capabilities are essential to explaining how organisations 
manage resources to create value. Therefore, this study used a ‘judgement sampling’ technique 
when selecting the appropriate research participants, which is a type of sampling technique 
where the researcher selects participants based on their knowledge and professional experience. 
The participants in this research were selected based on their perceived experiences of a Big 
Data environment, along with their ability to provide rich insights about the Big Data initiatives 
project. Moreover, these participants consisted of several levels of managers from both sites of 
the company, including project team leaders, as well as external partner members. All 
participants had direct day-to-day decision-making responsibilities for the projects and were 
immersed in the Big Data capabilities development processes. 
4.4.4 Negotiation of Access. 
Access to the case study company at the initial stage was negotiated between the researcher 
and the company’s Vice President (VP) who was also directing the IKU/Big Data project. After 
some information exchange about the research context (Appendix 1) (via emails) and a face-
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to-face meeting in Switzerland at the company’s EMEA headquarters, access was initially 
approved. After the meeting in Switzerland negotiations progressed to the next stage, resulting 
in completing the agreement. This was followed by signing the Confidential Disclosure 
Agreement (CDA) with the Company (Appendix 2); the researcher was then given a list of 
recommended employees, along with their contact details, who were held to be suitable 
participants for the research. 
An introductory email, along with a brief summary of the research (see Appendix 3) and an 
information sheet outlining key practical and ethical considerations with a consent section 
attached (see Appendix 4 and Appendix 5) were sent directly to the recommended participants 
by email. The interviews were arranged directly with the participants to suit their availability. 
4. 5 Data Collection 
4.5.1 Method of Investigation 
To achieve valuable insight, this research used multiple sources of evidence and triangulation 
techniques to establish the validity of the findings. Triangulation is often defined as ‘a 
combination of methods used to study the interrelated phenomena from multiple and different 
angles or perspectives’ (Yin, 2009, p.18). The research collected primary data from the 24 
semi-structured interviews. The company’s documentations and meeting observations were 
used as additional data sources. 
Having access to the working environments of both the company’s EMEA and Global 
headquarters, and being able to observe how project members were immersed in their daily 
routines, offered the researcher the opportunity to observe and understand the participants' lived 
experiences. Talking to project members and attending meetings (discussions regarding Big 
Data initiatives and project progress) helped the researcher to investigate and explore those 
processes which persuaded the company to start Big Data initiatives. Furthermore, having 
access to multiple sources of information was helpful to provide an in-depth picture of the ways 
in which the company achieved progress with its Big Data initiatives development. 
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4.5.2 Primary Data 
Primary data was obtained from 24 semi-structured interviews. Interviews were conducted 
during face-to-face meetings with managers from both the company’s EMEA and Global sites, 
all of whom were personally involved in a Big Data utilisation (IKU) project and had an 
accurate assessment of the context. Skype and WebEx interviews were used to reach the 
company’s leaders from several different European countries (Italy, the Netherlands, Germany, 
and France). Interviews were conducted with managers at several levels from both the EMEA 
and Global sites of the company, including 3 Vice Presidents (VPs), 3 executives, 15 senior 
directors, general managers, and project team leaders, as well as 2 external partners who were 
helping the team develop capabilities for Big Data. Interviews typically lasted 40-60 minutes. 
All interviewees had direct day-to-day decision-making responsibilities for the project. As the 
project is ongoing, the interviews were conducted during the capabilities development period 
when the events were still recent and active topics in the interviewees’ minds. 
The interviews were semi-structured and open-ended. Senior managers were asked about the 
processes of developing capabilities and the challenges of implementing Big Data initiatives 
(see Appendix 6). Questions were also posed about the company’s existing resources and 
capabilities, such as: people, processes, and technology. Particular attention was given to the 
technology they have built and were building as part of the IKU project to drive business value 
and develop Big Data required capabilities. It should be noted that all interviewees were 
professionals with long-term experience of working within the pharmaceutical industry on 
different Big Data-related projects both within and outside the company. Therefore, they were 
a most suitable sample for this study. 
Table 4.3 below provides an overview of the primary data of this study. 
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Interview 
Code 
Order Title of Informant Specific Unit Company’s 
Business Unit 
Interview type 
IG01 
 
 
 
IG02 
 
 
 
IG03 
 
 
 
IG04                      
 
 
 
IG05 
 
 
 
IG06 
 
 
 
IG07 
 
 
 
 
IG08 
1 
 
 
 
2 
 
 
 
3 
 
 
 
4
 
 
 
5 
 
 
 
6 
 
 
 
7 
 
 
 
 
8 
Exclusive Director 
 
 
 
Vice President, 
Global  
 
 
Director Alliance 
manager 
 
 
Director, Knowledge 
Utilization 
 
 
Vice President  
  
 
 
Senior Director, IT 
Enterprise 
Architecture 
 
External partner in 
data management 
technology 
 
 
Executive Director. 
Data management 
 
Information 
Knowledge Utilization 
(IKU) 
 
Planning & 
Technology 
Operations 
 
Information 
Knowledge Utilization 
(IKU) 
 
Information 
Knowledge Utilization 
(IKU) 
 
Information 
Knowledge Utilization 
(IKU) 
 
IT GOS 
Administration 
 
 
Deloitte 
 
 
 
 
Information 
Knowledge Utilization 
(IKU 
Global (Summit. 
NJ) 
 
 
Global (Summit. 
NJ) 
 
 
Global (Summit. 
NJ) 
 
 
Global (Summit. 
NJ) 
 
 
Global (Summit. 
NJ) 
 
 
Global (Summit. 
NJ) 
 
 
Global (Summit. 
NJ) 
 
 
 
Global (Summit. 
NJ) 
 
Face-to-face 
interview 
 
 
Face-to-face 
interview 
 
 
Face-to-face 
interview 
 
 
Face-to-face 
interview 
 
 
Face-to-face 
interview 
 
 
Face-to-face 
interview 
 
 
Face-to-face 
interview 
 
 
 
WebEx 
Conference 
Interview 
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Interview 
Code 
Order Title of Informant Specific Unit Company’s 
Business Unit 
Interview type 
IE01 
 
 
 
IE02 
 
 
IE03 
 
 
 
IE04 
 
 
 
IE05 
 
 
 
IE06 
 
 
 
IE07 
 
 
IE08 
 
 
IE09 
 
 
 
IE10 
 
 
 
 
IE11 
 
 
 
 
IE12 
 
 
 
 
IE13 
 
 
 
 
 
 
9 
 
 
 
10 
 
 
11 
 
 
 
12 
 
 
 
13 
 
 
 
14 
 
 
 
15 
 
 
16 
 
 
17 
 
 
 
18 
 
 
 
 
19 
 
 
 
 
20 
 
 
 
 
21 
Senior Director 
 
 
 
Associate Director, 
IT 
 
Senior Director, Data 
Science  
Director 
 
Associate Director, 
Market Insight 
 
 
Director, Knowledge 
Utilization 
 
 
Vice President 
 GM Italy 
 
 
Global Medical 
Director 
 
Global Clinical 
Director 
 
Director, Statistician 
 
 
 
Corporate Affairs 
Communication, 
Government 
Relations. 
 
Vice President, 
Global Planning & 
Tech Operations 
 
 
Senior Director, IT 
Enterprise 
Architecture 
 
 
General Manager, 
Converge Health 
 
Information 
Knowledge Utilization 
(IKU) 
 
IT EA and Information 
Management 
 
Information 
Knowledge Utilization 
(IKU 
 
Market Research and 
Competitive 
Intelligence. 
 
Information 
Knowledge Utilization 
(IKU) 
 
Information 
Knowledge Utilization 
(IKU) 
 
Medical Research 
 
 
Clinical Research 
 
 
Principal 
Biostatistician 
 
 
Information 
Knowledge Utilization 
(IKU) 
 
 
Information 
Knowledge Utilization 
(IKU) 
 
 
IT & Communication  
 
 
 
 
Information 
Knowledge Utilization 
(IKU) 
 
EMEA (France)  
 
 
 
EMEA 
(Switzerland) 
 
EMEA 
(Switzerland) 
 
 
EMEA 
(Switzerland) 
 
 
EMEA 
(Switzerland) 
 
 
EMEA (Italy) 
 
 
 
EMEA 
(Switzerland) 
 
EMEA 
(Switzerland) 
 
EMEA 
(Switzerland,  
Prague) 
 
EMEA 
(Switzerland) 
 
 
 
EMEA (Germany) 
 
 
 
 
EMEA 
(Switzerland) 
 
 
 
EMEA 
(Switzerland) 
 
WebEx 
Conference 
Interview 
 
Face-to-face 
interview 
 
Face-to-face 
interview 
 
 
WebEx 
Conference 
Interview 
 
Face-to-face 
interview 
 
 
Skype for 
Business 
Interviews 
 
Face-to-face 
interview 
 
Face-to-face 
interview 
 
Skype for 
Business 
Interviews 
 
WebEx 
Conference 
Interview 
 
 
WebEx 
Conference 
Interview 
 
 
Skype for 
Business 
Interviews 
 
 
Skype for 
Business 
Interviews 
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Interview 
Code 
Order Title of Informant Specific Unit Company’s 
Business Unit 
Interview type 
 
IE14 
 
 
 
IE15 
 
 
 
IE16 
 
22 
 
 
 
23 
 
 
 
24 
 
Executive Director, 
Media Affairs & 
Communications 
 
Vice President, 
Global Planning & 
Tech Ops 
 
External partner in 
data management 
technology 
 
Netherlands Medical 
Affairs 
 
 
Information 
Knowledge Utilization 
(IKU) 
 
Deloitte 
 
EMEA 
(Switzerland) 
 
 
EMEA 
(Switzerland) 
 
 
EMEA 
(Switzerland) 
 
WebEx 
Conference 
Interview 
 
WebEx 
Conference 
Interview 
 
WebEx 
Conference 
Interview 
 
 
 
Table 4.3: An Overview of the Primary Data of this Study 
4.5.3 Observations 
Attending the project’s formal meetings at the EMEA site (two meetings) and the corporation-
level meeting at the Global site between July and October 2017 allowed the researcher to obtain 
a first-hand observation of the project members’ activities within the context of the 
development of Big Data initiatives. The presence of the researcher during the meetings also 
permitted the understanding of different activities and processes, such as how communication 
between the Global site and its affiliates was conducted, and how the tasks for the next meeting 
were identified and aligned in a real-time context. Being immersed in these activities also 
assisted with the visualisation of senior management involvement and interaction during these 
processes, and enabled the researcher to observe ‘heightened awareness about social 
processes’ (Saunders et al., 2012, p. 299) which was reflected during the data analysis and 
writing up stage of this research. 
4.5.4 Secondary Data: Documentary Evidence 
The annual reports of the company, along with those documents that were given to the 
researcher about the project, constituted the major source of documentary evidence for this 
research. In addition, other documentary data such as information from the company’s websites 
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and the company’s senior members’ (CEO; Executive Director Government Affairs and Global 
Health Access) publicly available interviews further added to the evidence used in this study. 
Table 4.4: demonstrates the secondary data that was obtained for this study 
Data 
Code 
Order Title of Information Specific Unit/ 
Title  
Years of 
published 
materials 
D001 
 
 
 
D002 
 
 
 
D003 
 
 
 
 
 
D004                      
 
 
 
 
D005 
 
 
MN01 
 
 
 
MN02 
1 
 
 
 
2 
 
 
 
3 
 
 
 
 
 
4
 
 
 
 
5 
 
 
6 
 
 
 
7 
 
Published 
Interviews 
 
 
Project strategy 
 
 
 
Published 
Interviews 
 
 
 
 
IKU project  
presentation 
  
 
 
Annual Reports 
 
 
Managers Meeting 
Note  
 
 
Managers Meeting 
Note  
 
CEO 
 
 
 
Vice President 
IKU 
 
 
Executive Director 
Government Affairs 
and Global health 
access  
 
 
Information 
Knowledge 
Utilization (IKU) 
 
 
The company 
 
 
EMEA (Switzerland)  
 
 
 
EMEA (Switzerland) 
 
 
 
 
 
 
 
2016 
 
 
 
2016 
 
 
 
2015 
 
 
 
 
 
2016 
 
 
 
 
2015-2017 
 
 
2017 
 
 
 
2017 
 
Table 4.4: The Secondary Data Sources of the Study 
4.6 Ethical Considerations 
Ethical protocols were carefully considered and adhered to during all stages of the research. 
Due to the nature of this research, there was a possibility that the data gathered would include 
sensitive information of the kind which requires ethical consideration. Therefore, the study 
followed the ethical standards and the code of practice established by the Higher Education 
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Institution  (HEI). Accordingly, the researcher was guided by the ethical principles outlined in 
the table 4.5 below, as suggested by Easterby-Smith et al. (2008), as a way of maintaining both 
professionalism and ethical conduct throughout this research. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Step Principles 
1 Ensuring no harm comes to participants 
2 Respecting the dignity of research participants 
3 Ensuring a fully informed consent of research participants 
4 Protecting the privacy of research subjects 
5 Ensuring the confidentiality of research data 
6 Protecting the anonymity of individuals or organisations 
7 Avoiding deception about the nature or aims of the research 
8 Declaration of affiliations, funding sources and conflicts of interest 
9 Honesty and transparency in communicating about the research 
10 Avoidance of any misleading, or false reporting of research findings 
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Table 4.5: Key Principles in Research Ethics 
 
In addition to the ethical guidelines in the table above, the researcher formally sought ethical 
approval of this research from the Open University’s Human Research Ethics Committee 
(HREC) (see Appendix 6). 
4.7 Overall Research Design 
Table 4.6 below summarises the overall research design for this study, while the part of the 
chapter that follows discusses the methods of data analysis used in this study.   
 
 
Main Research 
Questions 
 
RQ1: Why did the MNC in the pharmaceutical industry prepare for 
big data adoption? 
RQ2: How the company approach the issue of using big data 
strategically and how they identified and develop their capabilities for 
big data?  
I. What new capabilities do they develop? 
II. How do they develop these new capabilities? 
 
 
Research Method 
 
Qualitative Case Study. 
 
 
Data Collection Methods 
 
Primary data sources: Semi-structured interviews 
 
Secondary data sources: Observation, annual reports, documentation of 
case study organisations,  
 
Unit of Analysis 
 
Big data adoption and capabilities process in case study Company’s both 
(Global and EMEA) projects. 
 
 
Sample 
A “judgement sampling” technique. Interviews were conducted with 24 
managers at several levels from both EAMA and Global site of the 
company including 3 Vice Presidents (VP) 4 executives, 15 senior 
directors, general managers and project team leaders as well as two 
external partners that were helping the team to develop capabilities for 
big data 
127 
 
 
Technique for Data 
Analysis 
 
The Thematic Analysis  
 
Table 4.6: Summary of the Research Design for this Research 
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Chapter 4 Section 2 Data Analysis 
4.8 Methods of Analysing Data 
 
The data analysis process is one of the central parts of every qualitative research study. 
However, as an analytical method, qualitative data analysis is still undergoing challenges, and 
there is no single predominant approach (Strauss and Corbin, 1998; Easterby-Smith, 2008; 
Charmaz, 2006). Therefore, there is no single right or wrong way to analyse qualitative data. 
This study is thus informed by broader literature on the principles of qualitative data analysis 
(Strauss and Corbin 1998; Willigs, 2001; Broun and Clarke, 2006; Yin, 2009; Gioia et al., 
2013). The study, however, mainly draws on the main principles of thematic analysis ‘a 6-
phase guide to doing thematic analysis’ explained by Broun and Clarke (2006), coupled with 
the general principles of case study data analysis proposed by Yin (2009) and coding structure 
(organising themes by categories) closely linked to the approach of Gioia et al. (2013). 
During the analysis stage, the key aim was to identify and present an approach that would be 
consistent with the methodological (case study) and philosophical (critical realism) choices 
embedded in the broader research design (qualitative) of the study (Easterby-Smith et al., 2008, 
p.172). The structure for the data analysis was anticipated to reflect the conceptual framework 
of this study and research questions (see Chapter 3). Yin (2009) notes that one important 
practice during the analysis phase of any case study is the return to the propositions/concepts 
of the study, as: 
✓ It leads to focused analysis and allows one to stay within the scope of the research 
questions 
✓ It supports the exploration of concepts when attempting to provide an alternative 
explanation of a phenomenon 
✓ It leads to increased confidence in the findings 
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As with any other, the conceptual framework of this study carried with it a number of 
assumptions about the nature of the data, what it represent in terms of ‘reality’ (Broun and 
Clarke, 2006), and this allowed the researcher to start  the analysing process with a ‘start list’ 
of pre-set codes. However, a number of codes also emerged from reading and further analysing 
the data. Through the theoretical freedom of thematic analysis, which acknowledges the ways 
individuals make meaning of their experience and, in turn, the ways the broader social context 
impinges on those meanings (Willig, 2001) it was possible to  consider those emergent codes 
and to sensitise the researcher to the idea of letting ‘data speak for itself’ (Easterby-Smith et 
al., 2008, p. 173). 
The aim of this study is to identify common, as well as conflicting, truths in the experiences of 
a number of individuals involved in a Big Data utilisation project who experience the 
capabilities development process within a global pharmaceutical company. Although thematic 
analysis has been criticised for not identifying with any epistemological position, Braun and 
Clarke (2006) suggest that this represents a strength, in that it can be applied more flexibly to 
determine a rich and detailed account of data. Therefore, thematic analysis was considered an 
appropriate methodology for this study, to analyse and synthesise analysis of a large amount of 
data from multiple participants into a meaningful account. 
Figure 4.5 illustrates the systematic approach adopted in this study for developing codes and 
themes from the interview data and then subsequently aggregating them for theoretical 
discussion (Appendix 7). Following the working analytical framework (coding structure) 
helped to achieve clarity around the analysing process, to guide new insight, and arrive at a 
visual diagram for the data analysis and structure. 
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Figure 4.4: The Working Analytical Framework (coding structure) (Based on researcher’s 
synthesis of diverse sources of literature on data analysis techniques:  Broun and Clark, 
2006; Yin, 2009; Gioia et al., 2013) 
 
4.8.1 Data Analysis Process for this Study 
The data analysis process for this study was supported using the NVivo 11 software package. 
As Braun and Clarke (2009) note, (supported by the researcher’s previous experience) this tool 
is useful in operationalising the chosen methodology’s transparency, validity, and reliability. 
This tool was particularly useful when capturing the initial research design, and when 
integrating and interrogating all project materials (data) in one place (Silver and Lewins, 2014). 
The software package was available in the university system, and training for using the 
software was undertaken by the researcher. As was mentioned above, the process of data 
analysis was guided by Braun and Clarke’s (2006) six guidelines for phases of analysis, as 
follows: 
Familiarisation with data - Given the time limit within which to complete the project, instead 
of waiting for the fieldwork to be over the researcher started to transcribe interview data in 
parallel with fieldwork activities. Transcribing data immediately after each interview (when it 
was possible) gave the researcher the opportunity to become immersed in the data and to 
improve the quality of the subsequent interviews. 
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The ‘Listen N Write’ software for transcribing audio recordings helped ensure transcription 
quality. However, as the process of transcription proved time-consuming even with this 
support, half of the interviews were transcribed by the Way With Words professional service 
company. Once all of the data had been transcribed, for accuracy all the transcripts were 
checked against the original audio recordings and the interview transcripts made anonymous 
before there were installed into the Nvivo 11 ‘Big data capabilities KG’ project. 
The transcripts were read over several of times in the interests of becoming familiar with the 
data, and initial ideas were noted down and saved as memos. While reading the transcriptions 
the researcher was aiming to identify extracts at the semantic, or explicit, level (Braun and 
Clarke, 2006), as opposed to a latent level that requires more interpretation of meanings. 
However, the semantic nature of the data analysis meant that the researcher was not aiming to 
interpret the participant’s experiences, merely to group them thematically according to their 
semantic meaning, based on prior identified concepts (e.g. Digital environment, Big Data as a 
new resource; Other resources; Existing  capabilities (Marketing, IT); DC). Different analytical 
notes (memos) were developed based on each interview within each unit of analysis (Global, 
EMEA). Generated memos were grouped under relevant themes for every concept. Once all 
transcriptions had been read and organised, a data analysis plan was created for each research 
question to guide the analysis process. 
Generating initial codes - This phase involved organising the data into meaningful groups. 
Using NVivo 11, codes/nodes were identified manually or by using text search queries. 
Transcripts were read line-by-line, and extracts or ‘chunks’ of meaningful text were 
highlighted. The aim of this step was to build up a list of relevant topics that arose from the 
interviews and that was initially considered important to the subject under investigation. 
Informants’ terms, phrases, or meanings that were common between the interviewees were 
grouped (Appendix 8) with the aim being to answer the research inquiries such as: 
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• How does the company engage in Big Data initiatives activity? 
and 
• How does this in turn influence Big Data capabilities development? 
 
In order to achieve further insight, coding data were explored between data and preliminarily 
identified concepts (from the conceptual framework and from the literature), like deductive 
codes, and other interesting occurrences relevant to the research queries and codes that emerged 
from the data. Having completed the initial coding of all transcripts, the component elements 
of each code were considered for consistency or overlap with other codes. This provided the 
opportunity to begin defining the codes, and to link these together into groups. Some initial 
codes were abandoned or merged at this stage due to overlap with others. The resultant codes 
were then compared against the research questions in order to ensure that only the codes that 
significantly contributed towards the research were pursued. 
By this point, a total of 30 deductive codes/nodes had been established, and a further 23 
codes/nodes had emerged from the data, which were kept in separated folders (see Appendix 
10 for  of Nvivo 11 codes). 
Searching for Themes - After the initial coding, the next phase involved sorting the different 
codes into potential themes. Careful consideration was given to identifying the relationship 
between codes and sub-themes that were developed from the coding groups, linking the data 
together, and also meaningfully linking back to the research questions. Using the Nvivo 11 
mind-map (Appendix, 11), themes were re-arranged according to the semantic content of the 
codes, and then a deeper exploration of their meaning was explored. A semantic approach is 
consistent with the critical realism epistemological position in that it limits over-use of 
subjective interpretation and focuses on identifying common semantic themes within and 
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between the transcripts. This study focussed on providing a description of the patterns in 
semantic information in the dataset, and then summarising, interpreting, and theorising around 
the broader meaning and implications of the patterns found. 
As Braun and Clarke suggested, deciding on themes is a question of prevalence, ‘in terms both 
of space within each data item and of prevalence across the entire data set’ (2006, p. 82). 
However, although there is a need for there to be a number of extracts for a theme across the 
data set, a higher prevalence does not necessarily make the theme more important to the 
research. As there is no set rule for the proportion of data or number of themes, frequency for 
this research was considered as the number of participants commenting on a specific issue, 
rather than the frequency of codes related to it. This again involved discarding themes due to 
insufficient data, or merging two themes into one. Initially, the themes were influenced by the 
concepts from the study’s conceptual framework, literature, and research questions. 
However, it must be acknowledged that the top-down and the bottom-up processes of 
identifying themes were interactive in some way, because even though the researcher was  
specifically interested in identifying themes, after reviewing the themes and their subcategories 
other important themes emerged from the interview data, such as: e.g. Increase awareness and 
building trust; Shaping organisational culture; Networking and partnership. This was achieved 
as a result of discovering in the data certain repeating patterns which related to research queries 
but which were not fully covered in the conceptual framework. It became apparent that some 
terms were repeatedly brought up during discussions. Instances of newly-emerged themes such 
as: Developing shared Big Data vision; Shaping the organisational culture, and; Networking 
and partnership were themselves broken down into categories to capture the richness of the 
phenomenon. 
Defining and Naming Themes - At this point the researcher identified the essence of each 
theme and determined which aspect of the data each of them represented. Themes were 
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continually reviewed until they were judged to be consistent across all participants and, at the 
individual level, supported by quotes and named appropriately. The identified themes are 
intended to provide a rich and detailed description of the overall case. Chapter 5 provides 
detailed information about the final themes and the analysis of research data within them. 
Producing the report - This phase involved writing up the report about research data to 
convince the reader about the validity of the analysis. Braun and Clarke’s (2006) suggest that 
the report should provide sufficient evidence (data extracts) of the themes within the data to 
demonstrate prevalence of the theme. All the themes reported in the data findings in Chapter 5 
are supported with valid examples or extracts which capture the essence of the point that the 
theme represents. On the other hand, Baxter and Jack (2008) state that due to its complexity, 
reporting a case study is a difficult task and it is the researcher’s responsibility to choose a 
comprehensive format to deliver a reflexive report to ensure transparency of the analysis 
process. Some suggested ways to deliver a quality report are: 
✓ Tell the readers a story, by delivering a chronological report about the case 
✓ Write a rich description of the case (who were the actors, what was their interaction, 
perceptions etc.) 
✓ Deliver the report by addressing and describing themes within and across the case 
The next Chapter (5) provides a synthesis of the above suggestions and presents a description 
of the data interpretation that informed the themes. 
 
4.9 Chapter Summary 
This chapter discussed the research design and methodology that was followed to investigate 
the research problem and to fulfil the objectives of this study as identified in Chapter 2 and 
Chapter 3. The first part of the chapter provided justification for the choice of overall qualitative 
case study research strategy, the unit of analysis, the choice of empirical sample and data 
collection, while the second part of the chapter outlined the methods used for data analysis. 
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The next Chapter (5) presents the findings based on a description of the data interpretation that 
informed the themes. 
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Chapter 5: Findings 
5.1 Introduction 
This chapter presents the findings of empirical research that utilised interviewing and 
secondary data analysis methods within a case study company. The main focus of this study 
was to understand how the company prepared for the adoption of a new resource like Big Data. 
The case study approach was used to investigate the influential factors that persuaded the 
company to consider and to introduce Big Data initiatives. 
The findings are presented in two parts, with one based on the findings made at the Global 
(US) site and the other based on the EMEA site of the company preparing for the adoption of 
a Big Data initiative. As the project was originally planned at the Global site, the US site was 
found to be more advanced in its Big Data adoption than the rest of the company. 
Section 5.2 presents the analyses of the company’s overall approach to preparing for the 
innovation, including discussions on the processes they introduced and carried out. This section 
also presents findings of the planning and building phase of the project that initially took place 
on the Global site and which was later rolled out to the EMEA site. The findings from the 
EMEA site are presented in section 5.3. A generic model based on the overall findings is also 
presented in this chapter. This model is then used to highlight major similarities and differences 
between the two sites in terms of building Big Data capabilities and other influential factors in 
the Big Data adoption process. Section 5.4 then evaluates these similarities and differences and 
summarises the findings chapter. 
The findings for both sites are guided by the components of the Conceptual Framework (CF) 
that was developed based on the research questions of this study, with the same themes also 
informing the data analysis. For this reason, in order to demonstrate how the findings align 
with the main themes of the CF, the same numbering system is used when presenting them. For 
example, the Digital Environment is number 1 in the CF (see Figure 3.1) and the corresponding 
theme is presented as CF1. 
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The associated findings for the operational/existing and DC capabilities derived from the 
presented data are shown in tables (see tables 5.1, 5.2, 5.3, 5.4, 5.6 and 5.7 for the Global site 
and 5.7, 5.8, 5.9, 5.10, 5.12 and 5.13 for the EMEA site). 
5.2 Global Site Findings 
The findings in this section are based on a set of interviews (marked as (IGXX)) and the 
company’s secondary data, such as annual reports, CEO reports and project planning 
documents. Quotations from the secondary data are marked as (DOXX). Overall, there were 
eight interviewees representing senior management and the leadership of the company’s Global 
site. The Global site was the first to prepare, introduce, and adopt Big Data initiatives to the 
company, initially deployed at the US site then rolled out to the EMEA site. 
5.2.1 Digital Environment (CF.1) 
The proliferation of smart devices and the sheer amounts of diverse types of data being gathered 
and explored in the entire healthcare ecosystem, and across the rest of the world, has resulted 
in the case study company exploring and developing Big Data initiatives. Indeed, the company 
- whose mission is to discover, develop, and commercialise innovative therapies for the 
treatment of cancer, immune-inflammatory, and other diseases -  requires and is well-positioned 
to leverage the information generated by both existing digital platforms and new smart devices 
across the health care systems. The Global site team of the company had the overall 
management and leadership responsibility for the entire organisation and was the first to 
identify the opportunity represented by Big Data and advanced analytics to strengthen the 
company’s core business. The project that was the focus of this study was the firm's very first 
attempt to introduce and adopt a large-scale Big Data initiative. An ever-advancing and 
challenging digital environment in which the company operates significantly influenced the 
company’s decision to explore Big Data initiatives. As the CEO of the company commented: 
 We are living in an exciting era of scientific breakthroughs coupled with technology 
 convergence. This creates both disruption and opportunity. The explosion and 
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 availability of data, the cloud, analytics, mobility, artificial intelligence, cognitive 
 computing, and other technologies are accelerating data collection and insight 
 generation, opening new pathways for collaboration and innovation. DO02 
The trends witnessed in the digital environment, such as digital health, digital patient records, 
and personalised medicine were recognised as advances in the company’s operational 
environment, influencing new initiatives. 
As the Director of Knowledge Utilisation for the project remarked: 
 Trends that were happening in the industry around new players and during the 
 health  care market, like Apple and Google and then this whole like proliferation of 
 health  data, either between electronic medical records, more access to claims data, 
 on social media, etc. That is what our leadership recognised, and they said if we 
 don't get our hands around this, other people are going to get smarter than us IG02 
A fundamental requirement for developing a digital vision and associated strategy is to possess 
an understanding of the digital environment in which the company expects to be operating in a 
few years’ time. The company’s intention to understand and obtain access to the digital 
environment, particularly at the planning phase of formulating its Big Data strategy, was 
captured in respondents’ views - for example, the Senior Director of Data Governance of the 
project, who stated that: 
  Big Data's the next thing to happen… When you look through history of the world, 
 you know this right, data is the thing that's happening now in our world. So what role 
 do we want to take, and the company I think wants to be at the forefront of this and 
 understands the need to be successful. Are we going to be able to shift to technology 
 and be technology-focused, as opposed to perhaps pharmaceutical-focused? Right? 
 IG04  
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Furthermore, within the company there was a widely-held belief that the wealth of data that are 
available around patients would continue to grow. The integration of data from various data 
sources, including the Internet, social media, and the so-called Internet of Things is a very 
important aspect of data utilisation. However, the question was how that was going to be linked 
to successful outcomes for disease detection and prevention, and to regulatory or market access. 
To remain competitive in the digital market environment it is important to consider the 
consequences of the new digital world in advance. As the Vice-President of the project 
explained: 
 If you didn't think about it in advance, what do you as an industry need to do or be 
 ready for? you're going to have a problem. Do we build the foundational elements 
 within the company to be able to start operating in this new future world? And be 
 able to start connecting and creating insights around our patients in a world where 
 we have all these different data sources and the potential for all of these different 
 analytic techniques to enable us to do that, more cost effectively than ever before. 
 IG05 
Talking about the future of the healthcare ecosystem, the Senior Director of Data Science IKU 
also opined that: 
 It will be a world where we need to, you know, be much more precise in the 
 development of our medications, such that we can identify biomarkers, and we are 
 very clear on the patient populations, that our compounds can help. So kind of that 
 precision medicine world. We will clearly be operating in a world of value-based 
 reimbursement and if we don’t get our hands around this, other people are going to 
 get smarter than us. IG07 
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New technologies and regulations are constantly emerging, supporting and shaping the digital 
transformation ahead. Ongoing economic pressures on the healthcare ecosystem, the FDA, and 
some of the regulatory authorities that started to promote and embrace Big Data initiatives also 
had an impact on the company’s decision to plan for and develop Big Data capabilities. As the 
Senior Director, IT Enterprise Architect commented: 
 You cannot doubt that it is influenced by what’s happening externally. Whether that is 
 what our own competitors are doing or whether companies completely out of the 
 industry. Or just thinking about you know, some of the things that FDA and some of 
 the regulatory authorities are starting to say and embrace in this digital world that 
 we are all living in. IG03 
Management support for the competent implementation and utilisation of Big Data, as well as 
the external factors discussed above, have been identified as influential factors in the adoption 
and use of Big Data in the case study company, particularly at the preparation stage. However, 
it was also evidenced that without senior management support the project would not progress 
to the next stage. 
In a world where much more personalised and customised information engagement is expected, 
the company’s global leaders anticipated the need to leverage Big Data initiatives alongside 
competing internal priorities. This led to the recognition of the company’s ability and 
willingness to exploit the new asset of Big Data in order to develop new strengths and 
capabilities. One of the respondents expressed this view: 
 To be a pre-eminent company in pharma, we needed to treat data as an asset. You 
 know and that was the push from our executives, to find out what role the company 
 wants to play in this evolution that's in front of us. IG04 
 
141 
 
There was a common understanding between the participants that the most attractive and 
innovative opportunities would not be utilised easily. The process of implementing Big Data 
initiatives is incremental and develops gradually. However, the strategic choice was made, as 
a result of the number of synergies and opportunities that were identified, to create more 
enterprise-wide solutions (D001). The aim was to transform the company into a more data-
driven, personalised, and digitalised enterprise, that would lead to value-based healthcare. As 
the CEO of the company established: 
 The company should first focus on providing technologies and platforms that support 
 seamless information sharing. In the process, the company should constantly be 
 looking at information flows through an enterprise lens—real value is created when 
 information is connected across all functions. Last, there is need to recognise that 
 every job description will include data and information skills. This is an especially 
 exciting time to be in IT because the digital capabilities we provide increasingly 
 affect every function and role. We need to help people develop the skills they need to 
 take advantage of what we can offer now and in the future. DO02 
The strategic decision made at the senior leadership level influenced the future directions of 
the company and how it would operate in the challenging digital environment. 
5.2.2 Resources (CF.2) 
5.2.2.1 Big Data as a New Resource (opportunities and challenges) (CF. 2.1) 
- Big Data Opportunities 
The interviewees’ perceptions of the benefits of Big Data to the company were identified as the 
critical determinants of Big Data adoption throughout the project. In particular, at the 
preparation phase, Big Data was expected to be the driving force for the digital transformation 
of their business by creating market opportunities, enhancing operational efficiencies, and 
reducing the timing and costs of the entire business cycle (from research and development to 
the market). It was acknowledged by almost all participants that Big Data, as a new resource, 
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has the potential to completely change the traditional way of undertaking research and 
discovery, the way in which the company commercialises its products, and the way in which 
the company serves its patients. Informants believed that implementing Big Data solutions 
would enable the company to accelerate and reduce the cost of the entire business operations 
cycle. The Senior Director of Data Governance from the Global site shared the following view: 
 Big Data is big opportunity for a company like us, which is focused on sort of 
 personalised medicine. You know getting insights about our patients and about the 
 diseases. Operate in real world and optimise our drugs that are already in the 
 market. That’s a great opportunity. IG04 
It should be acknowledged that the personalised medicine being referred to by the above 
participant might also be termed genomic medicine or precision medicine. However, they all 
refer to an approach that emphasises the ways in which patient disease risks are unique and 
different, among other characteristics. Those disease risks are based on the predispositions 
written into patient’s genome at birth, combined with his/her lifestyle and environment (Costa, 
2014). 
Big Data as a new resource was perceived to influence early R&D phases. For example, with 
modern genomic data, participants believed that what previously would have taken months or 
years to develop in a research lab, can now be made available in a significantly shorter time. 
For example, the Vice President of IKU for the project expressed the view that: 
 Big Data is everything under the sun, you know we can get better at drug discovery, 
 faster, do it more economically, but the biggest impact that we can make as a 
 company is currently anchored around patient data. IG05 
Regarding the precision of patient data, participants believed that Big Data analytics would 
enable the company to look into a patient’s DNA and identify how biomarkers responded to 
their drugs, or to monitor the effects of a particular drug, with significant consequences for 
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drug development. Here, a biological marker refers to a broad subcategory of medical signs - 
that is, objective indications of medical state as observed from outside the patient which can 
be measured accurately and reproducibly (Strimbu and Tavel, 2014). 
As the Senior Director, IT Enterprise Arch, IT Admin within the company explained: 
 Drug development has to be much more data-driven and has to expand far beyond 
 randomised clinical trials to start embracing these different datatypes that are now 
 proliferating and available. We said it is clear we as company need to get much 
 better at being able to connect data and apply analytics to glean insights around our 
 patients. IG03 
However, despite Big Data being a critical corporate asset, its value is tied to its ultimate use. 
The ability to manage and integrate data generated at all stages of the business cycle, from 
discovery to real world use, after regulatory approval, is a fundamental requirement to allow 
the company to gain benefit from Big Data trends. 
- Big Data Challenges 
When introducing Big Data initiatives, the size and global operational environment of the 
company resulted in specific challenges being posed, such as having to deal with numerous 
legacy systems, and cultural differences. Other examples included data privacy and security, 
budget, operating capabilities, and system integration (some of which will be discussed later in 
this chapter). 
However, one of the most challenging issues to be overcome during the preparation and 
building phases were identified as the legal, data coordination, and harmonisation issues. As 
the Senior Director, Data Science IKU explained: 
 So one challenge is the legal aspect for getting access to data in Europe for example 
 is very difficult and there’s many limitations around data protection and 
 anonymization and consent and all those kinds of things. So, that’s on two levels, the 
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 first issue is Legal issues and the second issue is… I think it’s coordination because 
 every country within the company bubble is already doing their own thing and 
 already have relationships locally with data providers, universities, governmental 
 registries, whatever. IG07 
Despite the recognised opportunities and challenges, participants acknowledged that the 
subject of Big Data is very new and complex. “Best practise” guidance on adoption and 
implementation of Big Data initiatives is yet to be developed as Big Data remains a relatively 
new phenomenon. 
 Big Data is new phenomenon, the ecosystem is learning. It's a good starting point, 
 let's now identify what else we need, and collaborate with our partners and see how 
 we can get there. So that is one observation. The other observation I've seen is, all 
 this data or collaboration that we have, none of them have a business model, to be 
 blunt. I think it's a new industry that's evolving, and it's defining itself, so probably in 
 the next few years I think you'll see new types of companies emerging. IG05 
5.2.2.2 Other Resources (CF.2.2) 
Recent studies on the creation of new capabilities for Big Data argue that in addition to tangible 
resources such as data and analytical platforms, senior managers and technical staff should also 
be viewed as resources crucial to overcoming Big Data challenges (Gupta and George, 2016). 
Indeed, a firm’s value-creation strategy lies in its heterogeneous resources (Wernrfelt, 1984; 
Barney, 1991; Peteraf, 1993). This was clearly evident in the case study company. The 
important role played by the senior managers at the planning and preparation stages in order to 
overcome Big Data challenges was highlighted by a number of participants. Senior managers 
who had a clear vision for the Big Data project teamed up to form the “IKU Champions” group 
to lead the project to success; participants referred to these individuals as Big Data evangelists. 
The main idea of the IKU/Big Data project at this stage was to identify opportunities for Big 
Data within the business and to pioneer a new way of working by utilising this new resource. 
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In particular, to help the company learn how to embed Big Data into their functions/franchises 
and day-to-day activities. 
The Executive director of the project recalled: 
 It was a group of 20 individuals across 7,500 global individuals, where we're trying 
 to influence and change the way we think. Right? And what we've found in this 
 journey is we will not be successful with an approach of forcing people to do this. 
 Where we’ve found success is finding what we refer to as like-mindedness. Start with 
 the people, having many conversations, right, and meetings and communication plans 
 and things, but start to attach ourselves to those people who think alike, think like us 
 start to show the return on investment. IG01 
However, at the beginning it was the senior leadership team who strategically approached the 
Big Data initiative and set out a vision for its implementation. The Vice-President of the project 
commented that: 
 Definitely decided at a strategic level, and we mangers aligned on, okay if that’s the 
 world we want to be in, how do we get there? We’ve made a strategic choice is to 
 build these foundational capabilities, which are really around the Big Data platform, 
 around certain strategic partners, that we think we need to have. IG05 
The Executive director of the project also added: 
 A senior leadership team that identified this as a priority, and I think without that it 
 would be very difficult to do anything, purely because there's so many competing 
 priorities within the organisation. In order to create a transformative capability, you 
 need the most senior-level people saying okay, I know we have a lot of things going 
 on, but this is one thing that I want you to make sure that you try to embrace, and you 
 try to see the applications of this within our organisation IG01 
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- Increasing Awareness and Building Trust 
One of the obvious findings from the data was that the case study company had achieved 
commitment to the project from both the key members of staff and others throughout the 
organisation. The importance of all members of the organisations participating in new 
initiatives in addition to the commitment made by senior management has also been widely 
argued and agreed on in the literature (Ryals and Knox, 2001; Rigby and Ledinghan, 2004). 
This kind of universal commitment can be achieved by increasing the awareness of the benefits 
and the value of such initiatives. Participants pointed out the importance of improving the 
awareness of Big Data opportunities at every level of the company. They believed that it was 
important that everyone clearly understood what a new initiative could bring, and its benefits 
to each function of the company such as marketing, development, and clinical trials. 
As the Associated Director of IT, IT EA and Information Management explained: 
 It is less about training but it's more about awareness and education. And so, then it's 
 going to the business leaders and the business teams to say hey, when you have these 
 types of questions, we've now built skillsets along with the technology within your team 
 to answer these in a new and different way. IG02 
The same participant added: 
 What ended up happening though, is that as we started to increase the awareness 
 about that foundational capability that we were building, people really started to 
 really hear about the project. We started to do education across the company, and 
 that’s when the business opportunities started coming. And then at some point they 
 started coming, like a lot of them, in which we actually had to build out a 
 process.IG02 
This widespread awareness was achieved by clear and increased communication, education 
and, training activities. For example, the Director of Knowledge Utilisation believed that: 
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 I think communication is critical for showing the business value, right. So the way 
 IKU program started is we compiled a list of business opportunities across all of the 
 company as part of the strategy project. And then we prioritised them, and started 
 working on the top priority one, and started to show some value. So I think that is 
 how we got buy in from, you know, certain business areas, where we were able to 
 deliver value. Saying hey, this is interesting. I'm interested in continuing to invest. 
 IG02 
In other words, knowing what could be gained from a new solution makes it easier to 
understand what capabilities need to be developed in order to implement the change. For 
example, during the implementation process, project members provided real-time updates on 
the status of the development via dashboards. This practice helped the project team demonstrate 
the progress of the IKU project and to communicate business opportunities to the company. 
At the same time, participants also highlighted that all communications should be considered 
carefully, as at the early stages of the project there tends to be resistance, or even objections of 
one kind or another. For example, the Senior Director Data Governance IKU pointed out that: 
 I think the greater opportunity is sharing the vision and what does it mean for them. 
 However, one of the challenges I think is you have to be careful about gloating or 
 being too positive, right, because not everything is working and we're learning from 
 the journey, so your communication has to be very pinpointed in the beginning, but 
 you also have to be aware that there's people that are going to say or bring negativity 
 on this type of programme. IG04 
In addition, education, training, and skills development in Big Data initiatives helped to win 
the trust of employees when new resources and processes were introduced within the 
organisation. 
The Vice-President of Global Planning and Tech Ops, IT GOS Admin believed that: 
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 As well as the education, the training, the communications to start building the 
 acumen of people around the organisation so that they know enough about what these 
 new resource and capability’ are. And they can just connect the dots on maybe where 
 they might be places that can think differently about how we currently do things and 
 apply this to do it differently. IG06 
The importance of increasing awareness and demonstrating value was also highlighted by the 
Executive Director. She explained that: 
 Because we have fixed capacity we want to make sure it’s something that that part of 
 the organisation feels like is appropriate for them, and something that they feel it is 
 worth allocating their business opportunity to. And that if we answer that, if we work 
 on that, that part of business will have a good understanding of what this opportunity 
 is, so that they can start building it within their part of the business. IG01 
With fixed capacity the informant was referring to the company’s silo data management 
approach across different factions and franchises (this will be discussed in later sections).  She 
believed that influential factors for in the development or the enhancement of existing 
capabilities for effectively using Big Data are: awareness, commitment and shared vision. 
 You know, while there was a realisation in certain parts of the company, a lot of 
 people who are day to day saying, my world is okay. I mean, we are delivering, we 
 are growing, like what are you trying to change? So there is a mind-set shift that is 
 required for people to give up their data, and accept and commit in governance, and 
 think differently, right? Become more data driven. IG03 
With regards to this point the Associated Director of IT, IT EA and Information Management  
added: 
 So we went through a positioning effort and really identified that we want to enable 
 the teams. We want to change their mind-set. We want to change how they integrate 
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 data into their day-to-day work flow. We need shared vision. This is the new model 
 going forward, and if they don't, and if we don't create this as a sustainable 
 capability, this will fall. It will just be the next fad, and we will actually not have the 
 uptake and the transformation that we want to see.IG02 
 
-Path Dependencies  
In addition to the factors laid out above, such as tangible and human resources, increasing 
awareness, and effective communication, interviewees also credited the company’s culture 
with supporting challenging initiatives and developing new capabilities. A collaborative spirit, 
based on flexibility and focus on company values, were found to be positive drivers for the 
project. 
As the Senior Director Data of Governance, IKU expressed: 
 I think the culture generally is very collaborative good ideas and sort of different way 
 of approaching things is generally acceptable. So those are strengths. It’s also a very 
 consensus driven culture meaning we strive hard to get everyone’s buy in. IG04 
Still on the subject of recognising the value of the organisational culture helping the  company 
to achieve technological changes, the same participant explained: 
 I mean our core is passion for the patients. We are producing drugs and positive 
 outcomes for patients, but technology may be the way for the future for that to happen 
 for patients. And that’s what’s different about our company culture. We focus on the 
 patient, and good things will happen if we focus on the patient. IG04 
Although some of the informants emphasised the importance of the general organisational 
culture, it has been acknowledged that national trends and other boundaries created cultural 
differences within the corporation, making it a challenge to convince everybody to accept 
innovative ideas and change. 
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The Senior Director of Data Science, IKU acknowledged that: 
 Communication between different countries is very tricky problem as we operate 
 multiple time zone and culture. Sometimes there are people with individual 
 objectives. So communication and sharing ideas are significant challenge. IG07 
However, the Executive Director of IKU also believed that: 
 I think the company has had a culture that's been very entrepreneurial. It's 
 challenging now because as we grow. But there's a lot of empowerment of individual 
 teams and people to take risks, to try things that are new. You know you make a 
 mistake once, and that's okay, you make a mistake maybe two or three times, then we 
 should look at it. And so that allows you to do these types of transformative things 
 because people have an appetite for it or a desire to do it. IG01 
Organisational culture appears in this case to have stimulated some aspects of the pursuit of an 
innovative cross-functional Big Data project while inhibiting others.  The company culture 
was, perhaps paradoxically, considered the biggest commonly-acknowledged challenge for the 
project. The ability of the company's culture to adapt and transform in response to the 
opportunities and challenges presented by Big Data emerged from the data as an essential factor 
for the successful adoption of new Big Data capabilities. 
Opportunities provided by new technological approaches and solutions, like the company’s 
new data connectivity platform, 'Synapse', along with skills and data analytics (which will be 
discussed later) had a transformational impact on the application of data initiatives within the 
company. However, the greatest challenge that emerged from the data did not involve 
technology and required skills, but rather was the process of cultural transformation at the 
planning stage. 
151 
 
The issue of cultural transformation was related to people who were not prepared to change 
their mind-set regarding data silos and the acceptance of new Big Data initiatives. The Director 
of Knowledge Utilization shared her thoughts as below: 
 I think the biggest challenge is changing the culture and breaking down the silos in 
 order to really gain operational efficiencies. And I think the third is having people be 
 able to understand what this is and see how it can truly transform and think 
 completely differently in how they do what they do. IG02 
With regards to this issue the Exclusive director of IKU also expressed her concern as: 
 We are already a silo organisation, which makes breaking this barrier and changing 
 this mind-set even harder. We're not there, and that's I think… Unfortunately it's 
 something that's so critical to get right. Unfortunately like there's so many other 
 things that we always need to do that it doesn't get enough resources. IG06 
Almost all informants identified changing people’s mind-set regarding data silos as a major 
ongoing challenge for cultural transformation. Analysis of the data bears out the idea that for 
an organisation to become more data-driven there would need to be a shift in mind-set 
throughout the company. The biggest breakthrough made by this company in this regard was 
to break down the existing “silo” mind-set within the organisation as a whole, and an example 
of the activities pursued to this end was the company’s immersion/experience practice (which 
will be discussed in detail in section 5.6) that was conducted as part of the learning activities. 
The Senior Director of Data Science commented that: 
 Important is changing peoples' mind set, because you know, a lot of the times… You 
 know, while there was a realisation in certain parts of the company, a lot of people 
 who are day to day saying, my world is okay. I mean, we are delivering, we are 
 growing, like what are you trying to change? So there is a mind-set shift that is 
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 required for people to give up their data, and sort of participate in governance, and 
 think differently, right? Become more data driven. IG07 
As we have seen, shaping the Big Data culture depends on changing the mind-set of people, 
which itself is influenced by the existing organisational culture. Development of a Big Data 
culture is an incremental process, and the need to enhance or develop new capabilities to 
effectively use this new resource emerges from this gradual process. Analysis of the data 
indicated that having a suitable mind-set would allow people to collaborate and participate in 
data governance, to use data more efficiently, to think differently, and to change the way they 
integrate data into their day-to-day workflows. Participants believed that connectivity, clear 
communication, and coordination would avoid duplication of activities within different 
functions and different countries. As the company's Vice- President concluded: 
 It all starts with pioneering a new mind-set with how data management and 
 technology come together to impact and inform various ways of working. We are 
 launching a number of different communication, education, and collaborative 
 communities of practice to help increase the knowledge on the Big Data initiatives. 
 IG05 
5.2.3 Existing Capabilities (CF.3) 
Alongside the challenge of cultural transformation discussed above, another ongoing concern 
that emerged from the data was that of arranging and matching the existing organisational 
capabilities effectively within the digital environment. 
Different organisational capabilities (e.g., management, technology, marketing, HR) are 
grounded and mutually supportive in achieving a firm’s different operational activities (Akter 
and Wamba, 2016). As has been indicated several times in this report, one of the biggest issues 
that was highlighted by the participants was the company’s silo data management approach. 
Every department (e.g. medical affairs, commercial, market access, IT) had their own data sets. 
Each function had different goals, priorities, responsibilities, and systems. Thus, each function 
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was focused on delivering their own business outcomes, and although this was highlighted as 
one of the core strengths and capabilities, all participants agreed that in the case of Big Data 
initiatives even the company’s very strong existing operational (marketing and IT) capabilities 
for discovering, developing, and commercialising compounds needed to be reviewed. 
5.2.3.1 Marketing Capabilities (CF. 3.1.1) 
Marketing researchers have conceptualised marketing capabilities in terms of a firm’s ability 
to use available resources to perform marketing tasks in ways that achieve desired marketing 
outcomes (Morgan et al., 2012). They therefore represent the integrated processes in which a 
firm uses its tangible and intangible resources to define, develop, communicate, and deliver 
value to its target customers (Morgan et al., 2012). The integrated processes mentioned above 
were clearly evident in the case study company’s documents and participants' responses. 
The company sought out talented people and creative partnerships from more than 50 countries 
to grow their business. This enabled the company to develop collaborative solutions to bring 
together patients, healthcare providers, and policymakers to find solutions for better treatments 
and to deliver value to its target customers. 
As one of the interviewees highlighted: 
 One of the things that I think is really apparent. You know we're a $100 billion-plus 
 market cap company with 7,500 employees globally. So you have a lot of different 
 hats, a lot of different responsibilities, and it's really, at the core of it is an 
 entrepreneurial type of atmosphere. One of the advantages of the company is ability 
 taking that across the entire lifecycle of what we do is also sharing that with partners. 
 IG04 
The ability to bring different talents together to serve targeted markets was also acknowledged  
in one of the company's documents as a crucial factor in being successful. 
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 Our success is dependent on our ability to develop effective collaborative solutions 
 from an “ecosystem of innovation” – bringing together patients, healthcare 
 providers, industry, academia, payers and policymakers – to find solutions that can 
 change the world for the better. DO01 
Furthermore, regardless of the challenges linked to the Big Data cultural transformation, other 
good examples of the company's marketing capabilities were its ability to operate globally, to 
develop knowledge of different markets, to spend time experiencing different local cultures to 
understand complex needs and behaviours of customers (Day, 2011), to successfully launch 
new products and customer relationships (Ryals and Knox, 2001), and to create successful 
marketing approaches (and to overcome the setback of unsuccessful marketing approaches). 
As one of the participant pointed out: 
 The main strength I think is… You mentioned a few things there. I think it's a little bit 
 of all of that. For example, segmentation is just one part of it, you know, the 
 marketing paradigm and segmentation in therapeutics is going to be very significant, 
 right? I mean, we’ve made a drug… we’ve just released a drug a month ago which 
 targets probably about 15,000 patients in the world, you know, of the 7 billion 
 patients. So, that’s based on one tiny mutation, the IDH mutation, in acute… in a 
 leukaemia.  IG03 
In total the company’s discovery and development of innovative life-enhancing therapies were 
established in four major market segments and service areas; namely, Hematology/Oncology, 
Inflammation, Immunology, and Cellular Therapeutics. These biopharmaceutical and 
healthcare market segments served the global patient population through the specific products 
in each segment (Annual report, 2016). 
The ability to offer patients different options for enhancing their quality of life was the strongest 
marketing capability within the company. Perhaps the ultimate example of this ability was their 
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bringing to market a new product called ‘Revlimid’ for patients who have serious rare diseases 
and few treatment choices. ‘Revlimid’ is an oral immunomodulatory drug approved in the 
United States and many international markets (Annual report, 2016) and has become a key 
element of the treatment of multiple myeloma. 
Furthermore, delivering innovative therapies to different markets that lack proper infrastructure 
and pursuing regulatory approval of new options in the treatment of rare diseases are other 
great examples of the company’s existing marketing capability. Another of the company’s 
treatments, ‘Otezla’, has after three years on the market established itself as an advance for 
physicians and patients in the care of plaque psoriasis and psoriatic arthritis (Annual report, 
2016). Reflecting on the product’s 116% increase in sales in 2016 to a total of more than $1.0 
billion (DO03), it was believed at the company that this treatment reshaped the way these 
diseases are treated in their early stages and met a previously unmet clinical patient need. It 
was evident in one of the company’s documents that, with persistence and creativity, the 
company was able to transform some of the drugs and treatments into new hope for patients in 
need. As the document stated: 
 Underlying each of our development programs is a clear mission to create novel, life 
 changing therapies that have a substantial impact on the most critical health needs 
 facing society. In 2016, our efforts to improve the lives of patients worldwide led to: 
 More than 500,000 patients receiving at least one of our seven medicines. DO03 
The company also went further, not only using a particular product to create a sustainable 
relationship with customers, but also providing them with different services. These included:  
up-to-date and precise information about their drugs and services; online product resources; 
and information and publications to doctors, scientists, and healthcare professionals. Figure 5.1 
below presents a summary of the company’s customers and related activities. 
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Figure 5.1: The Case Study Company’s Customers and Related Activities (source, the 
company’s Responsibility Report, 2016) 
Engaging in active communication with customers and providing them with up-to-date 
information are believed to be important in creating trust and maintaining customer loyalty. 
Furthermore, as the Senior Director, IT Enterprise Architect explained, to insure that the 
company’s products and services are safe and customers are well informed, the Global Drug 
Safety and Risk Management (GDSRM) department was involved in every step of these 
processes, from inspection to marketing. 
As one of the documents indicated: 
 Giving them information that is helpful to them will help them remember you as a 
 trusted, valuable resource. An easy way to do this is to send a regular email 
 newsletter that helps, not sells, to them. DO03 
During the interviews most of the participants highlighted the importance of social media for 
communication with customers, as well as monitoring brand success, or that of competitors. 
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Referring to social media as a source of communication, the Senior Director of Data Science 
commented that: 
 There are various ways you can use social media to leverage customer satisfaction. 
 You can monitor brand mentions, use them as a customer support channels, and even 
 hold live interactive sessions with customers. IG07 
Furthermore, the company’s engagement with patients via the company’s Twitter or Facebook 
pages as a means of developing strategies according to customers’ needs demonstrated the 
company’s understanding of the trajectory of those needs through effective information 
acquisition, management, and use. The company’s efforts in the continuous improvement of 
environmental, social, and economic performance included innovative methods for patient 
support and advocacy, personal interactions, and support for new programs in local 
communities. 
Examples included: 
1.  Directing patients to navigate the challenges of insurance and Medicare coverage to 
 ensure they have access to the medicine they need 
2. Launching in 2011 the successful program ‘Patients’ Partners’ in which the company 
works in close collaborative partnership with patients and professional Advocacy 
organizations to share ideas and discuss how the company and advocates can work 
together to improve the lives of patients and their families worldwide 
3. Activities for risk management. The company introduced a number of innovative 
features to support prescribers, pharmacies, and patients. One of the interesting 
examples of this activity was that upgrades into their internal call centre technology 
reduced the time taken to complete Risk Evaluation and Mitigation Strategy (REMS) 
enrolments and surveys. Furthermore, successful launch of a pharmacy Web portal 
resulted in more than 80 percent of all the company’s pharmacy REMS tasks being 
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fulfilled online. 
As the Executive Director of IKU commented: 
 We have an unrelenting passion to provide world-class customer service to those 
 completing the company’s REMS tasks, and we’ve launched additional innovative 
 technologies, such as a REMS mobile application, to achieve this goal. IG01 
It has been argued that advances in technology and organisations’ existing marketing 
capabilities allow organisations to capture rich and newly-available sources of information (Big 
Data) that help identify gaps in their understanding of consumer behaviour and utilise it 
strategically (Erevelles et al., 2015). The company’s ability to recognise such gaps was made 
evident in the interview data. Speaking about the company’s marketing capabilities and the 
potential of Big Data, the marketing director explained that the company currently holds 
clinical data at the patient level and has a controlled distribution process for some of their drugs, 
meaning that interaction with patients is conducted in a controlled manner. For example, in the 
US, market access to drugs, and payment for those drugs, are often controlled by third parties, 
resulting in an arrangement whereby drugs are only prescribed or paid for if they meet certain 
criteria. With the use of an additional source of information like Big Data, she believed that the 
company could better demonstrate that their drugs will work in a certain patient type and that 
achieving those results could prompt increased transformation of the target market. (Target 
market here denotes the end consumer to which the company wishes to sell its end products). 
Although some concerns had been expressed about the cost of getting a drug to market and the 
need to guarantee a return on that investment, she explained: 
 I see the market transforming. It is going to be a pay-for-performance type of 
 environment going forward. But if you think about the cost of getting a drug to market 
 and the return on that investment, and if we're not able to shorten that, costs are 
 going to continue to grow. And as a result of that, the markets are becoming smarter 
159 
 
 and data I think will help us be more targeted in again whether something's going to 
 work for a patient or not. You pay for performance. IG01 
One of the company's first focused uses of Big Data involved obtaining a “360 degree view” 
of the patient - clearly indicating the company’s customer orientation. This refers to a holistic 
profile of the patient, including the patients’ tasks, treatment timelines, progress, and future 
appointments. This enhances decision-making, supports optimal treatment, reduces avoidable 
errors, and improves outcomes (Frost & Sullivan, 2017). Lockrey (2015) suggested that the 
market orientation of a company, which defines how it is focused in relation to customers, 
competitors, and departmental dynamics to deliver success, defines the effectiveness of an 
organisational strategy and organisational capabilities. Thus, the company’s dedicated 
customer orientation can be viewed as inseparable from its strong marketing capabilities. 
Moreover, monitoring and managing competitors was another marketing orientation that was 
captured in the participants' statements and the company’s documents. For example, during the 
interview Director Knowledge Utilization recalled: 
 We were trying to understand, like, how is our drug performing against our 
 competitors’ drugs, or how can we prove to the insurance that our drug is more 
 effective than our competitors drugs. IG02 
Departmental coordination, which was linked to the change of mind-set regarding data silos, 
was a “work in progress” marketing activity within the company. Almost all participants 
acknowledged that what they were missing was the ability to coordinate different functions and 
franchises (Marketing, IT, policy, different countries). For example, they believed that with an 
ability to combine CRM data with what physicians were saying with real-world data, they could 
generate different types of insight. Furthermore, they believed that if data from randomised 
trials (that is, information about every patient who took their drugs when testing a new 
treatment) were combined with real-world data, they could obtain greater insight into patient 
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behaviour. Early signs of such activities were discovered at the operational phase, after the 
implementation of the Synapse platform (which will be discussed later in this chapter). 
The company’s marketing capabilities are summarised in Table 5.1. 
  
Definition (marketing 
capabilities) and 
examples in the 
literature (Authors) 
Operational 
Capability 
Appearance in 
the Case  Study 
Direct quotes 
(comments) from 
interviews and 
secondary data  
comments 
Marketing capabilities are an 
integrated process (e.g. building 
sustainable relationships with 
customers, having knowledge of 
competitors, and possessing 
skills in market segmentation 
and targeting) in which the firm 
uses its tangible and intangible 
resources and capabilities to 
understand the trajectory of 
customer needs via effective 
information acquisition, 
management, and use (Day, 
1994; Dutta et al., 1999; Song et 
al., 2007; Krasnikov and 
Jayachandran, 2008; Morgan et 
al., 2009) 
 
Integrated process, in 
which the firm uses 
its tangible and 
intangible resources 
 
Offer patients  
different options  for 
enhancing their 
quality of life 
 
Build sustainable 
relationships with 
customers 
 
 
 
Communication with 
customers via social  
media 
 
-Operating globally, in over 
50 countries 
-Creative partnership to 
grow the business 
 
Delivering innovative 
therapies to different 
markets. 
 
 
 
Add value to 
people’s/patents’ lives by 
not only providing a service, 
but also giving them 
information that is helpful to 
them. 
 
 
 
 
Ability to develop effective 
collaborative solutions from an 
“ecosystem of innovation” – bringing 
together patients, healthcare providers, 
industry, academia, payers and 
policymakers – to find solutions that 
can change the world for the better. 
DO01 
 
With persistence and creativity, the 
company was able to transform this 
maligned drug into new hope for cancer 
patients in need. DO03 
 
Giving them information that is helpful 
to them (not only to your business) will 
help them remember you as a trusted, 
valuable resource. An easy way to do 
this is to send a regular email 
newsletter that helps, not sells, to them. 
DO03 
 
 
Understand complex 
customers’ needs 
 
 
 
 
 
Understand the 
trajectory of 
customer needs 
through effective 
information 
acquisition, 
management,  and 
use 
 
Experiencing different local 
cultures, customer needs and 
behaviours. The company’s 
engagement with the 
patients via the company’s 
Twitter and Facebook pages 
 
Listening to what the 
customers are saying on 
their Facebook and Twitter 
pages, and developing 
strategies accordingly 
 
Communicate, communicate, 
communicate Social media is key. 
Today, more and more customers 
connect with a brand through social 
media platforms. There are various 
ways you can use social media to 
leverage customer satisfaction.  You can 
monitor brand mentions, use them as a 
customer support channels, and even 
hold live interactive sessions with 
customers.ID03 
 
 
Knowledge of the 
competition 
 
Monitor brand 
success and 
competition 
Monitoring and managing 
competitors 
We were trying to understand, like, how 
is our drug performing against our 
competitors’ drugs, or how can we 
prove to the insurance that our drug is 
more effective than our competitors 
drugs. IG02 
 Skills in segmenting 
and targeting 
markets 
Controlled distribution 
process for some of their 
drugs. For example,  in the 
US the market access to 
drugs and payments for 
those drugs are often 
controlled by third parties, 
Segmentation is just one part of it, you 
know, the marketing paradigm and 
segmentation in therapeutics is going to 
be very significant, right? I mean, we’ve 
made a drug. we’ve just released a drug 
a month ago which targets probably 
about 15,000 patients in the world, you 
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resulting in an arrangement 
where drugs are only 
prescribed or paid for if they 
fulfil certain criteria 
know, of the 7 billion patients. So, that’s 
based on one tiny mutation, the IDH 
mutation, in acute… in a leukaemia. 
IG03 
 
Table 5.1: The Company’s Marketing Capabilities (CF 3.1.1) (Author's own) 
5.2.3.2 IT Capabilities (CF. 3.1.2) 
An organisation’s IT ability, in combination with other organisational resources and 
capabilities, a significant role in the assembly and deployment of IT based resources such as 
Big Data. Such an ability enhances the organisation’s current (operational) capabilities and 
enables new capabilities development (Bhardwaj, 2000). Examples of such abilities include 
business process re-engineering, integration of the required IT into the appropriate business 
processes, customer relationship management, electronic commerce, adoption of new 
resources, and management of digital data (Bhardwaj, 2000; Gupta and George, 2016; Wamba, 
2015 ). 
The Senior Director of IT Enterprise Arch, IT GOS Admin explained that IT capabilities as an 
integrated on-site function was one of the core capabilities of the company. For example, 
engaging in e-(electronic) commerce with suppliers was given as a good example of the 
company’s effective IT capability, while so-called E-sourcing allowed the company to achieve 
consistent and transparent global processes. Furthermore, data quality checks and good 
information management, along with CRM capabilities, were highlighted as important IT 
capabilities at the company. Another example was that of the company’s wide data access 
protocols, put in place to ensure data security and to minimise the risk of data being used 
inappropriately. As a participant explained, the company’s IT capability had previously been 
limited to supporting interactions with business partners and related stakeholders, but there was 
an identified need for an end to end, integrated IT solution that would let the company 
collaborate, connect, and share Big Data solutions with others in the organisation and across 
the supply chain. Even though the existing structured data management processes for clinical 
trial management and data capture were given as examples of the company’s existing IT 
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capabilities, it was widely agreed that there was a need for the enhancement or development of 
new capabilities to support Big Data initiatives. 
As the Senior Director of IT Enterprise Arch, IT GOS Admin commented: 
 We have a basic building blocks of the capabilities and I mean there is a room to 
 grow  all , I mean we have IT infrastructure in place data science  expertise  are there 
 and  we have a core data scientist expertise you know we need to build that out and 
 continuously build it into business as well. IG03 
In addition to the company’s existing capabilities, implementation of the Synapse platform was 
a fundamental step in the Big Data adoption process. Incorporating a new cloud-based platform 
into the company’s existing environment entailed an evolving learning process, and 
demonstrated the efficiency of the company’s new resource adoption and resource management 
capabilities (another important IT capability). As one of the senior leader related: 
 So I look at it as, as you build the foundation capability, you make incremental 
 operational efficiencies. As you move along the curve of establishing your 
 foundational capability, and really getting it off the ground, that is when in the longer 
 term you can start to see transformation. IG05 
Regarding data management, the IT and data governance director explained that some of the 
important steps for data taxonomy, data quality checks or good information management were 
already in place. For example, a controlled distribution process for some drugs that allows the 
company to work directly with the patients through a controlled process. However, participants 
also acknowledged that the growing complexity of the data - whether involving molecular 
structures, genomics, electronic medical records, or payment information demands – demanded 
the use of different skill sets. Therefore, in many cases it is important that a company advances 
existing IT capabilities. As he commented: 
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 We have a very nice data footprint in the company however there are the gaps. I 
 mean that’s what we are doing coactively to identify what are the gaps and how we 
 will go out and how we exactly will build them. IG03 
With regard to other IT capabilities, it was acknowledged that technological foundations 
needed to be developed or enhanced that would lead the company to support an analytic 
environment and improved data governance and data management skills. 
 
- Ability to lay the technical foundation and connectivity 
Empirical investigation confirms that different experiences can result from the use of Big Data, 
with some being the consequence of the use of different technologies, and others the result of 
benefiting from the opportunities Big Data offers. It has been pointed out that in order to make 
full use of Big Data with its volume, variety, and velocity, investment has to be made into new, 
capable tools and technology, as existing IT platforms are not always designed to address Big 
Data-related technological challenges (Morabito, 2015). 
A traditional data infrastructure of the sort that relies on centralised warehouses of structured 
data and which is optimised towards addressing a specific problem for a particular business 
unit does not allow much connectivity with different part of the business. Even more 
importantly, it does not allow a cultural move away from the traditional data silo mentality to 
more open thinking. 
Novel solutions, such as cloud-based Big Data platforms, are starting to gain ground as 
promising new approaches to informatics, resulting in a drive away from traditional data rule-
based statistical approaches to more powerful machine learning, data-driven approaches. 
Findings from research have suggested that a platform that can work across functions, which 
can consolidate diverse data assets, and which features useful analytical tools, would represent 
a vital foundation for building Big Data capabilities within a company. The case study company 
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found for itself that a connectivity platform that supported data harmonisation, data 
governance, data standards, and data privacy and security helped enable the company to build 
Big Data capabilities. 
 Data Harmonization and our Big Data Platform, Synapse, will become the standard 
 that connects all data environments across the company enabling the company to 
 easily connect disparate data sources to generate data-driven insights at our 
 fingertips. Data Harmonization is the backbone to be able to deliver on data-driven 
 decision making the ability to connect data. DO01  
Indeed, as the Senior Director of IT Enterprise Arch, IT GOS Admin stated: 
 We didn't have a cloud-based analytic environment, and even like a service catalogue 
 where you could say, if I have a data question do I actually know what data we have? 
 It's the beta system. Same thing as data governance, didn't exist, or even if it existed it 
 wasn't really, there was no discipline around it, so it's basically the same end result. 
 So that's what we've put in place. IG03 
Various informants agreed that development of this type of platform was a fundamental step in 
the Big Data adoption process. The logical next step would be to identify what else would be 
required to carry on with successful implementation of the process. As one of the participants 
asserted: 
 So I look at it as, as you build the foundation capability, you make incremental 
 operational efficiencies. As you move along the curve of establishing your 
 foundational capability, and really getting it off the ground, that is when in the longer 
 term you can start to see transformation. But it's not until you have the foundational 
 capability in place, that's [unclear], the data, the skillsets, that you can achieve that 
 transformation. So I think where we are in the process, we are starting to see 
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 operational efficiencies within the business, but the transformational changes is still 
 work in progress. IG01 
 
- New Skills 
The introduction of a new IT platform and related technology would require the development 
of new skill sets in any organisation. Without correct knowledge and capabilities to utilise the 
new technology and the vast data sets it would make available, this project would not have 
progressed into the operational stage. As one of the consultants commented: 
 I think it’s not technology that would be a challenge it’s a talent issue because. this is 
 new space data scientists are not like you  know easily available and managing this 
 type of environment is different that managing the traditional IT computer 
 environment so I thing, that challenge is there will come will be based on business 
 demeaned and greater that domain the challenge will be in terms of talent peoples 
 skills IG08 
Another participant also opined: 
 So, if you have the greatest tool and technology but you have no-one actually knows 
 how to work with it, it's just the greatest tool, and basically it will go by the wayside. 
 Pharma even does not has the skills to evaluate this new technologies so it is which 
 talent gap that pharma needs to answer it IG06 
Indeed, the talent gap was highlighted at this stage as one of the obstacles, although opinions 
varied between participants about the best way to fill this gap. One of the senior leaders 
believed that although staff training was an effective solution, the dominant practice was to 
hire or recruit new skilled talent. On this subject the following opinion was offered: 
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 Learning can be piece of it but I personally think that for pharma it’s better to get this 
 new talents who look at world in an different way and they has been trained 
 differently to looked at data through different lens than to try train people IG07 
However, during the interviews it was also acknowledged that, together with bringing in new 
skills, investment must be made to support staff training and learning. Therefore, some 
managerial and organisational processes, such as re-configuration, learning, coordination, etc., 
had their part to play in supporting Big Data transformation in the company. 
The company’s key IT capabilities are summarised in Table 5.2 below 
 
Definition (IT 
Capabilities) 
Examples in the 
literature (Authors) 
Operational 
Capability 
Appearance in the 
Case Study 
Direct quotes (comments) from 
Interviews and Secondary 
Data Comment 
An organisation’s IT ability, 
in combination with other 
organisational resources and 
capabilities, a significant role 
in the assembly and 
deployment of IT based 
resources such as Big Data. 
Examples of such abilities 
include business process re-
engineering, integration of 
the required IT into the 
appropriate business 
processes, customer 
relationship management, 
electronic commerce, 
adoption of new resources, 
and management of digital 
data (Vitari et al, 2012; Chen 
et al., 2012; Wilden and 
Gudergan, 2015). 
 
 
Integrate required IT into 
appropriate business 
processes 
 
 
 
 
 
 
 
 
 
E-commerce 
 
 
 
Ability to lay the 
technical foundation and 
connectivity 
 
 
 
 
 
New resource adoption 
and management 
 
 
 
 
 
 
 
 
IT capabilities as an 
integrated function of the 
allow end to end visibility 
across the value chain. This 
enables the company to 
connect processes and 
platforms across all functions 
 
Data quality checks or good 
information management. For 
example, the company had 
company-wide data access 
protocols to ensure data 
security and to minimise the 
risk of data being used 
inappropriately 
 
E-sourcing, doing business 
with suppliers. Speeds up the 
process by shrinking sourcing 
cycles. Maintains 
transparency in their process. 
Results in a consistent global 
process 
A suitable platform in place 
that has the capability of 
working across functions, 
which consolidates various 
data assets, and which 
features useful analytical 
tools, was found to be an 
essential foundation for 
building Big Data capabilities 
within the company. 
The Synapse platform was a 
fundamental step in the Big 
Data adoption process. 
Implementing the new cloud-
based platform into the 
company’s existing 
environment was an evolving 
and learning process, but 
 
I mean we have IT infrastructure in place 
data sciatic expertise  are there and in 
some extend we have a core data 
scientist expertise you know we need to 
build that out and continuously build it 
into business as well.  IG03 
 
As a part of the company’s Strategic 
Sourcing process we look forward to 
employing best in practice tools and 
methodologies. For example E-sourcing 
helps us evaluate all relevant business 
criteria’s and not just cost. ID03 
 
 
So I look at it as, as you build the 
foundation capability, you make 
incremental operational efficiencies. As 
you move along the curve of establishing 
your foundational capability, and really 
getting it off the ground, that is when in 
the longer term you can start to see 
transformation. But it's not until you 
have the foundational capability in 
place, that's [unclear], the data, the 
skillsets, that you can achieve that 
transformation. So I think where we are 
in the process, we are starting to see 
operational efficiencies within the 
business, but the transformational 
changes is still work in progress. IG01 
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indicated the efficiency of the   
companies existing IT 
capabilities. 
 
 
 
 
Table 5.2: IT Capabilities (CF 3.1.2) (Author's own) 
5.2.4 Dynamic Capabilities (CF.3.2) 
5.2.4.1 Strategic Competitive Response (CF. 3.2.1) 
As was outlined in the literature review (Chapter 2), in a digital environment, where 
technological innovations require fast organisational responses and changes, dynamic 
capabilities become a tool that allows firms to build and renovate operational capabilities 
(Danneels, 2010; Teece, 2007; Pavlou and El Sawy, 2011; Protogerou et al., 2011; Braganza, 
et al., 2017). One of the important aspects that was captured from the interviews is that the 
company had an existing ability to scan the business environment, identify new opportunities 
offered from Big Data, assess its competitive position, and forge a link between needs and 
solutions. The way participants recalled how they started Big Data initiatives confirms that the 
company was able to scan and seize such new opportunities. As the Executive director of the 
IKU project recalled: 
 IKU probably started seriously about two years ago, so 2015, and it really was the 
 result of a lot of hallway conversations between very senior leadership, saying there's 
 a lot of noise going on about you know Big Data and you know we have a sense of 
 what it is but not really a good sense of what it means for us. What we should do 
 about it, if anything. And then they assembled a very small team. And really what our 
 task was, was to figure out this world of Big Data and tell us what we need to do 
 about it. IG01 
The interview data analysis confirms that within the company a lot of strategic thinking and 
proactive conversations regarding Big Data were taking place before the project started. For 
example, the Director Knowledge utilization recalled: 
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 So we did a little bit of diligence. And that diligence resulted in over you know it was 
 150 use cases across the organisation. So we had a good idea that there was a lot, 
 that it seemed like our teams thought that we could do with this. That this was 
 something that could fuel a lot of different areas. And we also knew that there were a 
 lot of questions. IG02 
Strategies tended to focus on predicting the environment, positioning the project planning, and 
establishing the effects of initiatives. This combination helped achieve understanding of what 
was needed and what needed to happen in order to drive the project forwards. For example, 
some of the identified needs were as following: new skillset, data scientists, and data vendors, 
along with strategic partnership and education. 
 We need the right skillsets, like the data scientists, like the data wranglers, the 
 taxonomists, the Big Data IT professionals within the organisation. [IG03] We need 
 strategic partnerships with certain data and analytics vendors.[IG01] We need kind 
 of a way to educate the organisation, to just embrace this capability.[IG02] And we 
 need to have the right incentives in place to be able to embrace this kind of 
 pioneering mind-set, which can… Often you run into this innovator's dilemma. 
 [IG06] 
Alternatively, project members tended to focus on controlling environment including defining 
the main requirements of initiatives and its operational reliability. For example the Vice-
President, Global Planning and Tech Ops, IT GOS Admin expressed the view: 
 Our customers are going to get smarter than us, and our competitors are going to get 
 smarter than us. So how do we try to get ahead of the game? And that's where the 
 concept of creating something around Big Data was born and then as we brought 
 Deloitte on board to help us really strategize and figure it out, that's how we moved 
 into building and identifying capabilities. IG06 
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(As was mentioned earlier, the company engaged with the Deloitte consultancy to support the 
new initiatives.) 
Regarding the above point, the Executive Director also recalled: 
 It was kind of strategy maybe meets operations, is that you're executing…If you had 
 this Big Data capability, what would you use it for? What kinds of things would you 
 like to do with it? It might not even be realistic, but what things come to mind that we 
 could do differently that we could fuel? What value would it have, or impact might it 
 have for us? And do you know the data? Like is the data available? And is the 
 analytics available today? IG01 
Once the threats and opportunities from the Big Data asset (section 5.2.2) were carefully 
elucidated during the preparation phase, the response strategy was adopted accordingly in the 
building phase. As the Director of Knowledge Utilization outlined: 
 We've put some of the partnerships in place to start getting access to the data, and 
 some of the skill sets, data science, alliance management, and all this kind of thing. 
 So that's what we've been focusing on the last 12 months, really get the basis in place, 
 so we can actually start leveraging these types of data beyond the research area. 
 IG02 
The overall strategic competitive response, referring to the ability of the company to understand 
and adapt to environmental trends (Protogerou et al., 2011), was acknowledged as one of the 
key strengths of the company. This ability incorporated timely responses to competitive 
strategic moves, the systematic formulation of long-term strategy, and the flexible adaptation 
of competitive changes, as related by the Executive Director of IKU: 
 A senior leadership team that identified this as a priority, and I think without that it 
 would be very difficult to do anything, purely because there's so many competing 
 priorities within the organisation. In order to create a transformative capability, you 
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 need the most senior-level people saying okay, I know we have a lot of things going 
 on, but this is one thing that I want you to make sure that you try to embrace, and you 
 try to see the applications of this within our organisation. So those are the things I 
 think would be our strengths. IG01 
As suggested in the literature (Teece, 2007; Protogerou et al., 2010) an effective strategic 
response to a new environment must be followed by an appropriate change in the internal 
reconfiguration of an organisation, as the new business environment may demand a completely 
different scientific and technological foundation, and often a different mind-set, and marketing 
systems (Johannesson and Palona, 2010). While recognising opportunities at the strategic level, 
and the importance of increasing awareness regarding identified opportunities, both played an 
important role, so did the company’s cultural transformation. The company’s reconfiguration 
ability, particularly in terms of networking and partnership, also had important roles to play in 
defining and building required capabilities for Big Data within the company. 
The company’s strategic competitive response capabilities are summarised in the table 5.3 
below. 
Definition (Strategic 
Competitive Response 
Capabilities) Examples in 
the literature (Authors) 
Dynamic 
Capability 
Appearance in 
the Case Study 
Direct quotes (comments) 
from Interviews and 
Secondary Data  
Comment 
Strategic competitive response 
capability is the firm’s as the 
ability to sense/scan the 
environment, identify new 
opportunities, assess its 
competitive position, and respond 
to competitive strategic moves.  
(Teece, 2009, p.200; Protogerou et 
al., 2010). 
Sensing (and shaping) 
new opportunities are 
very much a scanning, 
creation, learning, and 
interpretation activity 
(Teece, 2009). 
The IKU project was 
the result of a lot of 
hallway conversations 
between very senior 
leadership, to make 
sense of what the Big 
Data environment 
meant for the company 
A lot of noise going on about you 
know Big Data and you know we 
have a sense of what it is but not 
really a good sense of what it 
means for us. What we should do 
about it, if anything. And then 
they assembled a very small team, 
and really what our task was, was 
to figure out this world of Big 
Data and tell us what we need to 
do about it. IG01. 
 Seizing refers to the 
organisational strategy 
and infrastructure for 
making appropriate 
decisions and absorbing 
and integrating resources 
to create and capture 
value from opportunities 
(Teece, 2009). 
Lots of discovery, 
strategic thinking, and 
proactive strategic 
conversations 
regarding Big Data 
before the project 
started 
So we did a little bit of diligence. 
And that diligence resulted in 
over you know it was 150 use 
cases across the organisation. 
So we had a good idea that there 
was a lot,that it seemed like our 
teams thought that we could do 
with this. That this was something 
that could fuel a lot of different 
areas. IG02 
 Respond to competitive 
strategic moves. Maintain 
competitiveness through 
enhancing, combining and 
Strategies tended to 
focus on predicting the 
environment, 
positioning the project 
We need the right skillsets, like 
the data scientists, like the data 
wranglers, the taxonomists, the 
Big Data IT professionals within 
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reconfiguring (when 
necessary) an 
organisation's existing and 
new resources and 
capabilities. (Teece, 
2009). 
planning, and 
establishing the effects 
of initiatives. This 
resulted in identifying 
needs and activities to 
proceed the project 
further 
the organisation.[IG03] We need 
strategic partnerships with 
certain data and analytics 
vendors.[IG01] We need kind of a 
way to educate the organisation, 
to just embrace this 
capability.[IG02] And we need to 
have the right incentives in place 
to be able to embrace this kind of 
pioneering mindset, which can… 
Often you run into this innovator's 
dilemma.[IG06] 
 
 
Table 5.3: Strategic Competitive Response (CF.3.2.1) (Author's own) 
5.2.4.2 Reconfiguration (DC) (CF.3.2.3) 
The empirical investigation suggested that, in terms of IT technology, some of the company's 
marketing and connectivity capabilities were enhanced as a result of its reconfiguration ability. 
For example, through networking and partnership, the company was able to identify different 
internal work streams, resources, and capabilities that had to be reengineered within the 
organisation in order to fully leverage Big Data. One of the company documents indicated: 
 Through our Network of Strategic Partners, the company is cultivating a community 
 of new expertise – both centrally and embedded in the business, where data scientists, 
 digital experts, data stewards, taxonomy experts, epidemiologists, and business 
 development/alliance managers will cultivate and help build new skillsets to embrace 
 our expanding data, advanced analytics, and technology capabilities. These new 
 skillsets and expertise enable us to realize the value of data across the organization 
 and help increase the entire organization’s acumen around data and analytics. DO01 
An interesting insight from the data suggested that the Big Data environment was evolving and 
defining itself. There were not many cutting-edge directions, and to successfully innovate the 
development of internal capabilities it was important to collaborate and form partnerships with 
experienced data management experts. Furthermore, as the Vice-President of the project 
explained, engaging in networking and establishing partnerships not only accelerate access to 
the skill-sets required to develop new capabilities, but also facilitate in-house learning, which 
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enables immediate value delivery. For example, the Vice President of the project believed that 
setting up a 'Two-in-a-Box' structure with partners was an effective choice as this approach 
allowed the company to obtain access to and also learn required skills. 
 Because certain skills that we didn't have access to, we set up a Two-in-a-Box, one to 
 accelerate the access to the skill sets, so we don't have to wait delivering a use case, 
 because on day one you have access to it. But in parallel, because of the Two-in-a-
 Box structure, you accelerate the learning. IG05 
Moreover, he added that the most important way in which this approach was effective was that 
it enabled the company to access the knowledge required to proceed with such initiatives. 
 You get the knowledge in-house, so you can immediately start delivering value, and 
 you team it up with the internal process, so actually both parts become multi-factor. 
 One is learning, around the new skill set, but they come with the knowledge of the 
 company. The other one has the skill set, the technical skills for example, but they 
 don't know how the company works, so you put them together and they complement 
 each other. IG05 
A good example of the company's ability to use networking and partnership to build new Big 
Data capabilities was their new digital platform, a cloud-based data environment which enables 
connectivity of different functions and scales up as required for analytical needs. Collaboration 
with organisations that possess expertise in Big Data and technology also complemented the 
company’s ability to identify the different internal work streams, resources, and capabilities 
that have been re-engineered within the company to fully leverage Big Data. As the Vice-
President of the project explained: 
 When we started, we had zero capabilities. Some of the data science capability was 
 sitting in the research shelf where it naturally sits, or it starts. When we started at an 
 enterprise level, it was by design, it's in collaboration with IT but it's not in IT, which 
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 I think is a differentiating factor. We, by design, did a very broad and deep 
 engagement with an expert in this field to help us accelerate building the capability, 
 and there was both the technical side, but also some of the data science. IG05 
On the same topic, the Executive Director of Data Governance explained that building 
capabilities through partnership helped the company to more quickly and cheaply respond to 
the changes required by Big Data. As he highlighted: 
 We have built what we need to do this right now, but we have built it a lot through 
 partnership too. Like we have not hired in all of these skillsets, because to be honest 
 we believe that in order to do that and to find the right people, it is costly, will take 
 time, and a significant amount of time. IG01 
Another interesting insight from the interview data was that in addition to benefiting from 
partnerships and external expertise, it is important for a company to develop its own in- house 
capabilities. It is important to effectively communicate changes and innovations internally to 
increase awareness of such efforts, which helps to promote learning and best practice. 
The company’s reconfiguration capabilities are summarised in the table 5. 4 below. 
 
Definition 
(Reconfiguration 
Capabilities) 
Examples in the 
literature (Authors) 
Dynamic 
Capabilities   
Appearance in The 
Case  Study 
Direct Quotes (comments) 
from Interviews and 
Secondary Data Comment 
Reconfiguration (Box. 3.2.3) 
is an organisation’s ability to 
extend and modify existing 
capabilities in response to 
changes introduced in the 
market and technologies that 
are generated through new 
knowledge based on Big 
Data (Teece, 2007; Kwon, et 
al., 2014). 
Ability to identify 
different internal work 
streams, resources, and 
capabilities that had to be 
re-engineered within 
organisation. 
 
Collaboration and 
partnership with leaders 
in this space 
Collaboration and partnership 
with leaders in this space 
 
 
 
Setting up a Two-in-a-Box 
structure with partners. 
 
 
 
The company’s new digital 
platform, a cloud-based data 
environment, which enables 
connectivity of different 
functions and scales up as 
required for analytical needs 
These new skill-sets and expertise enable 
us to realize the value of data across the 
organization and help increase the entire 
organization’s acumen around data and 
analytics. ID01 
Because certain skills that we didn't have 
access to, we set up a Two-in-a-Box, one 
to accelerate the access to the skill sets, 
so we don't have to wait delivering a use 
case, because on day one you have 
access to it. But in parallel, because of 
the Two-in-a-Box structure, you 
accelerate the learning. IG05 
We, by design, did a very broad and deep 
engagement with an expert in this field to 
help us accelerate building the 
capability, and there was both the 
technical side, but also some of the data 
science. IG05 
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Table 5.4: Reconfiguration (CF. 4.3) (Author's own) 
5.2.4.3 Learning Capabilities (DC) (CF. 3.2.2) 
Organisational capabilities are suggested to be able to evolve through learning (Teece et al., 
1997; Eisenhardt and Martin, 2000; Zollo and Winter, 2002; Helfast and Peteraf, 2003). On the 
other hand, introducing innovation such as new resources and technology involves promoting 
and shaping the learning process. In the case study company, a ‘trial and error’ learning process 
fostering the development of capabilities emerged from the Big Data project. By facing a new 
situation and difficult problems the company engaged in learning. Before finally achieving 
success, the case study company experienced a learning process that took it from knowing very 
little to understanding how Big Data could benefit the organisation. Despite the challenge this 
represented it was acknowledged that learning is a very important process, which through 
experimentation and repetition leads to better and quicker resolution of specific problems and 
at the same time enabling firms to identify new opportunities (Teece et al., 1997). 
The project members were fully committed to a long learning journey. As the Executive 
Director of the project recalled: 
 When I came on this team, I had never worked in Big Data before, you know I am 
 marketing person I’ve led market access teams, I’ve led product development teams, 
 but this whole area been new to me. And I think that’s the case for most people that 
 are on the team, and is somewhat good in that we’re able to keep a business 
 framework or mind-set, but you have to come up the learning curve quite a bit on the 
 technology and on the data, and just what this space is.  IG01 
The project members made continuous efforts to remain engaged with the learning process. 
For example, participants spoke about their positive experience of immersion in the new world 
of Big Data, and of learning through trial and error. They believed that full exposure and a 
'hands-on' approach enhance experience and knowledge, leading to better understanding of the 
benefits and impact of the innovation. Furthermore, by constantly setting new tasks and 
175 
 
objectives, project members presumed that they were experiencing incremental learning 
throughout the process. 
As part of the immersion/experience practice the company introduced globally, at different 
phases, several immersive activities. The aim of this was to expose and demonstrate different 
ways of how the Big Data ecosystem was evolving and what this would mean to the people 
within the company. Different techniques, such as 3D videos, virtual reality, and use cases were 
used to help people within the company to visualise Big Data opportunities. (A use case is a 
methodology used in system analysis to identify, clarify, and organise system requirements). 
Participants believed that these activities were particularly helpful in increasing awareness 
during the planning phase of the opportunity presented by Big Data. As the Director of 
Knowledge Utilisation put it when explaining the goal of such practices: 
 “So, that it's almost imagine If”…experience. And we've used 3D videos, virtual 
 reality, our deep-dive use cases networks, so we've done a couple of those globally. 
 This helped us extend the team, which is all the likeminded people at the company 
 that have an interest in this capability. IG02 
Furthermore, as part of this practice, a large-scale event called The Immersion Experience was 
organised by the project members at the building phase, after the new cloud-based platform 
was put in place. (The building phase had completed before the interviews were conducted for 
this study). 
 So we wanted to immerse people in the company in what Big Data can do for them. 
 Specifically for the company, and for pharma industry, right? So that was a big event 
 planned in K Building, where about 400, 500 people showed up. And they would go 
 through the various booths just to get immersed into, like, hey here is the art of the 
 possible. And this is what we are trying to do with this platform, right. And show them 
 some of the insights we have generated from the platform in the process. IG02 
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This provision of updates via immersion events, or real-time updates using dashboards and so  
demonstrating the value of previous tasks enabled project members to monitor how the project 
was progressing. Moreover, participants believed that taking this approach had helped them to 
achieve the desired result. 
Other positive effects were also recognised in the project as being the result of learning from 
the use of systematic analysis in the search for new solutions, meaning that such efforts tended 
to be self-reinforcing. This was a gradual process that led to new discoveries which helped 
widen the scope of the project members’ thinking. One of the participants shared her 
experience: 
 We started to realise in our two-plus year journey of this it’s a gradual process. You 
 know we started in one area and then people get excited and you start to expand and 
 go in a different direction, but focus on some core activities and then start to replicate 
 that for other types of similar questions.  And reuse that analyses perhaps to answer 
 other questions in other business areas. IG01 
Teece (2007) suggests that analytical systems and techniques such as scenario planning or joint 
decision-making can help overcome cognitive limitations and framing biases in learning which 
lead to local adaptation. An instance of this theory being observed in practice was that of the 
Business Council, which is the company’s active communication team and a good example of 
the company’s in-house joint decision-making practice. For example, the Vice-President 
explained that: 
 As we build the platform, that's run by leaders that have been nominated from across 
 our business. The Business Council and active communications team, make sure that 
 the whole company just knows it.  So we're not making any decisions in the absence of 
 a business person saying that that would provide value to that part of the 
 organisation. IG05 
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Another good example of joint decision-making being used to facilitate learning was the 
company's App Vision Steering Committee, which was made up of senior-level people from 
across the organisation. 
More evidence of the company’s efforts to make the learning process more effective could be 
seen in its initiative to set up a community of practice. Regular community of practice meetings 
helped the company to create a sense of community, and also helped to ensure that the process 
they were engaged in was reliable. Participants explained that the community of practice 
session made up part of the company's training, although it was mostly presented and 
coordinated around a use case or data set. Use case analysis helped project members think 
ahead, and critical analysis helped them think more broadly, helping to recognise when new 
skills or strategies were needed. Moreover, there was a common belief that regular discussion 
centred on analysing mistakes and successes alike helped prevent other errors and led to 
improved learning by project members. The Vice-President spoke of the degree to which this 
practice was helpful: 
 Especially in the data science area, and also in the digital, we've it (Regular 
 community of practice meetings). So, they meet at least monthly, where either the data 
 science community goes to, well we just got Truven in, so Truven does a learning 
 session about what is a data set. Or they just did a use case, they shared a use case 
 with the community of practice. We learn as we go. At least right now this year on our 
 tools, and then next year on other tools, other things that are more industry-focused. 
 IG05 
Further findings indicate that applying leadership skills from different parts of the business, in 
combination with new learning, enables the identification of capabilities that would be relevant 
to each function for the next stage. As an example one of the participants explained: 
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 Different managers give us feedback on what disease areas do we focus on, what 
 should these apps look like, what should they do, what functionality do they need, 
 etc.? They also nominate people to actually work on the working group, to actually 
 build it, with our team. So like on the apps, that's just one example. We do it with the 
 teams and then we provide updates to virtually every single leadership team at as well 
 as at the most senior level to the CEO and we do a lot of communication on our 
 website, etc. IG06 
However, it must be acknowledged that even though there were positive implications for the 
ability to identify and develop capabilities through the learning processes mentioned above, 
most of the informants were also clear that in order to speed up some processes it was necessary 
to invest in the development of new skills. 
The company’s learning capabilities are summarised in the table 5.5 below. 
 
Definition (Learning 
Capabilities) 
Examples in the 
literature (Authors) 
Dynamic 
Capability 
Appearance in the 
Case Study 
Direct quotes (comments) from 
Interviews and Secondary 
Data Comment 
Learning (Box. 3.2.2 CF) is 
defined as ‘the capacity or 
process within an 
organisation to improve or 
maintain performance based 
on experience accumulation, 
knowledge articulation and 
knowledge codification 
(Nevis et al., 1995, p 73, 
Zollo and Winter,2002).  
Experience accumulation 
refers to the central 
learning process by which 
operating routines have 
traditionally been thought 
to develop. Incremental 
improvements can be 
accomplished through the 
tacit accumulation of 
experience and acts of 
creativity (Zollo and 
Winter, 2002) 
Continuous efforts to remain 
engagement with the learning 
process 
 
Experience of immersion in 
the new world of Big Data 
and learning through trial and 
error 
 
Setting constantly new tasks 
and objectives 
 
The immersion/experience 
practice 
 
At different phases the 
company introduced several 
immersive activities globally 
So, that it's almost imagine 
If”…experience.. And we've used 3D 
videos, virtual reality, our deep-dive use 
cases networks, so we've done a couple 
of those globally. This helped us extend 
the team, which is all the likeminded 
people at the company that have an 
interest in this capability. IG02 
 
So we wanted to immerse people in the 
company in what Big Data can do for 
them. Specifically for the company, and 
for pharma industry, right? So that was a 
big event planned in K Building, where 
about 400, 500 people showed up. And 
they would go through the various booths 
just to get immersed into, like, hey here is 
the art of the possible. And this is what 
we are trying to do with this platform, 
right. And show them some of the 
insights we have generated from the 
platform in the process. IG02 
 Knowledge articulation 
The process through 
which implicit knowledge 
is articulated through 
collective discussions, de-
briefing sessions and 
performance evaluation 
processes. By sharing 
Providing updates with the 
immersion events 
 
Real-time updates through 
dashboards 
 
Demonstrating the value of 
previous tasks 
As we build the platform, that's run by 
leaders that have been nominated from 
across our business. The Business 
Council and active communications 
team, make sure that the whole cell just 
knows it.  So we're not making any 
decisions in the absence of a business 
person saying that that would provide 
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their individual 
experiences and 
comparing their opinions 
with those of their 
colleagues, organisation 
members can achieve an 
improved level of 
understanding of the 
causal mechanisms 
between the actions 
required to execute a 
certain task and the 
resulting performance 
outcomes (Zollo and 
Winter, 2002) 
 
The Business Council and 
active communications team 
 
The App Vision Steering 
Committee that company had 
for the senior-level people 
from across the organisation 
 
Regular community of 
practice meetings to create a 
community sense, and also to 
ensure that process reliable 
 
Use case analysis 
 
Regular discussion and 
analysis of mistakes and 
successes 
value to that part of the organisation. 
IG05 
Especially in the data science area, and 
also in the digital, we've it. So, they meet 
at least monthly, where either the data 
science community goes to, well we just 
got Truven in, so Truven does a learning 
session about what is a data set. Or they 
just did a use case, they shared a use 
case with the community of practice.  We 
learn as we go. At least right now this 
year on our tools, and then next year on 
other tools, other things that are more 
industry-focused. IG05 
 Knowledge codification 
Knowledge codification is 
a step beyond knowledge 
articulation. It  aims  
uncovering the linkages 
between actions and 
performance outcomes  
most of them are intended 
simply to provide 
guidelines for the 
execution of future tasks 
Systematic analysis and 
search for new solutions 
 
Risk assessment management 
 
Focus on some core activities 
and then start to replicate that 
for other types of similar 
questions 
As we build the platform, that's run by 
leaders that have been nominated from 
across our business. The Business 
Council and active communications 
team, make sure that the whole company 
just knows it.  So we're not making any 
decisions in the absence of a business 
person saying that that would provide 
value to that part of the organisation. 
IG05 
 Managers should be open-
minded to new ideas 
Anticipated the need to 
leverage Big Data initiatives 
alongside internal competing 
priorities 
 
 
Table 5.5: Learning (CF 3.2.2.) (Author's own) 
5.2.4.4 Coordination (CF. 3.2.4) 
Although the Big Data project seemed to be progressing well, project members had some 
concerns regarding how this innovation would be coordinated across different functions 
(Marketing, IT, policy) and franchises (different countries - EMEA). The implementation of 
new configurations of operational capabilities requires the effective coordination of a variety 
of tasks and resources and the synchronisation of different activities (Collis, 1994; Helfat and 
Peteraf, 2003). Thus, participants pointed out that there was a need for additional resources to 
be embedded in each function, together with advanced analytics skill-sets. 
 Data scientists are in high demand. We need to embed individuals with those 
 specialised skills in functions from R&D to supply chain and commercial. In different 
 functions you have some gaps and we need to bring in capacity and capabilities in 
 house so not to be over dependent on external partners. IG06 
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Even though efforts had been made to coordinate in the process of innovation, and although 
this effort had been assisted by the deployment of the connectivity platform, successful 
coordination between different functions and franchises was an ongoing obstacle at the time of 
the interviews. However, to ensure that silos did not remain obstacles, the project members 
were providing regular (e.g., weekly, monthly) cross-organisational updates to different 
management teams. This was highlighted as a valuable way of ensuring that progress was made 
on an ongoing basis. The coordination capabilities found within the company are summarised 
below: 
Definition (Coordination 
Capabilities) Examples 
in the literature 
(Authors) 
Dynamic 
Capability 
Appearance in the 
Case Study 
Direct quotes (comments) 
from Interviews and 
Secondary Data  Comment 
Coordination (Box. 3.2.4) 
Capabilities/processes connect 
and interface single activities 
through communication, 
scheduling, task assignment, 
collaboration and other related 
activities. This is an important 
capability to deal with the 
changing business environment 
especially in Big Data case when 
there are fewer experiences and 
less good practice implications.  
Protogerou et al., (2011) 
 
Ability to connect and 
interface single activities 
through communication 
 
 
Scheduling, task 
assignment 
Effectively communicate the 
change internally and 
increase awareness of the 
ongoing efforts, in order to 
promote learning and best 
practice 
 
The additional resources to 
be embedded in each 
function together with 
advanced skill-sets around 
analytics 
 
 
Data scientists are in high demand. We 
need to embed individuals with those 
specialised skills in functions from 
R&D to supply chain and commercial. 
In different functions you have some 
gaps and we need to bring in capacity 
and capabilities in house so not to be 
over dependent on external partners. 
IG06 
Table 5.6: Coordination Capabilities (CF. 3.2.4) (Author's own) 
5.2.5 Changed Capabilities in Response to New Opportunities (CF. 4) 
As a result of the ongoing learning efforts, the reconfiguration ability, and the improving ability 
to coordinate, the company was able to develop new capabilities. As an example, one of the 
milestones was the establishment of Big Data catalogue, followed by the Big Data connectivity 
platform, Synapse. As the Vice president explained: 
 Synapse is the connective technology at the heart of our efforts to remove cross-
 functional and cross-therapeutic silos by connecting data assets, analytical tools, and 
 expertise across the company. Synapse is the company’s Big Data platform with tools 
 to search, access, and analyse data collaboratively to generate insights for the 
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 business in more efficient ways and using newer methodologies that allow us to 
 calculate and triangulate data like never before. IG05 
Discussing the new platform and its ability, the IT and data governance director explained more 
in dilates that Synapse enabled the company to quickly search through a catalogue of data sets 
in a way that would have previously taken days and in many cases even weeks to accomplish. 
 Synapse Explorer enables you to search through a catalogue of data sets, studies that 
 generated those data sets, and the strategic partners we have. Applications on 
 Synapse Analyzer allow you to easily assess feasibility of that data in seconds – where 
 in the past this could have taken weeks. The high-compute environment with Synapse 
 Analyzer gives you the ability to connect and analyze large, disparate data sets with 
 advanced analytical tools IG03. 
As has been outlined several times in this report, the company’s initial focus on Big Data was 
to arrive at a 360-degree patient view. This kind of holistic patient profile included information 
about patients' tasks, treatment timelines, progress, and future appointments to help the 
company understand how their drug was performing against their competitors' drugs, or how 
the company could prove to insurers that their drug was more effective than that of their 
competitors. The project members believed that introduction of the Synapse platform enabled 
the company to achieve some of those objectives: 
 You know, the Big Data platform enabled us to do that. We were typically outsourcing 
 those things. Right? And we would get a PowerPoint. But then you lose the iterative 
 sort of natures. And your way, it answered this question, but can it answer now this? 
 And we didn't have any ability to do that. Like, it would take months. So we gave them 
 that ability at the tip of their fingers. IG05 
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Talking about new enhanced capabilities, the Executive Director of the project, for example, 
gave some indication about what they had achieved from the marketing perspective since the 
connectivity platform went live: 
 Now it is starting to expand into other areas. So commercial, getting sales, and  
 marketing insights. Like how effective is my marketing campaign? You know, why do I 
 see a dip in the drug sale in a particular month? What's the reason for that? We were 
 unable to do so… Or can I predict that I'm going to see a dip in the drug because of 
 certain market forces? So those are the kinds of analysis we are able to do, or 
 contemplate now, that we were not able to do before IG01 
These were only the first steps of the operation phase, but it was already being proven that the 
preparation and building phases had been well-executed. 
Data harmonisation was another key foundation that enabled the company to connect and 
protect their data by establishing essential company-wide policies and processes, such as data 
governance and enterprise standards in accordance with the new platform. Participants believed 
that: 
 The success of embedding a new capability in the organisation is dependant on how 
 we as an organisation are open to working and pioneering new ways. As we move 
 from building the foundation to enabling the business to learn about these new 
 capabilities and collaborate. I mean we have delivered on the strategy too, right? So 
 we have the platform, it's up and running. We have people using it. IG05 
The company’s changed or new capabilities in response to new opportunities are summarised 
in the table 5.7 below. 
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Enhanced or New 
Capabilities   
Marketing and IT 
Capabilities 
Direct quotes (comments) 
from Interviews and 
secondary data Comment 
A service catalogue   
 
 
Big Data connectivity platform, 
Synapse. 
 
 
A cloud based environment 
 
 
 
Data harmonization 
Ability to reduce the data 
duplication and cost 
 
Ability to connect 
different operations and 
functions 
 
Ability to more quickly 
search through 
catalogues of data sets. 
Ability to deliver data-
driven decisions. 
 
Ability to get 360 degree 
patient view. 
 
Synapse is the connective technology 
at the heart of our efforts to remove 
cross-functional and cross-therapeutic 
silos by connecting data assets, 
analytical tools, and expertise across 
the company IG05 
 
The high-compute environment with 
Synapse Analyzer gives you the ability 
to connect and analyze large, disparate 
data sets with advanced analytical 
tools IG03. 
 
Table 5.7: changed or new capabilities in response to new opportunities (CF. 4) 
The findings presented in this section have been organised in line with the conceptual 
framework of this study. Figure 5.2 describes the key aspects of the findings from the Global 
site. 
As presented in the model (Fig 5.2), the findings suggest that in the case study company, in 
response to changes in digital environment for the adoption of Big Data initiative, processes 
such as sensing, seizing, learning, and coordination all had a positive impact on the 
reconfiguration of the company’s operational (IT and Marketing) capabilities. Furthermore, 
managerial and organisational processes such as: strategic competitive response, learning, 
reconfiguration, and coordination guided the overall Big Data innovation process in the 
company. Together they played a major role in identifying, moderating/enhancing, or 
developing new capabilities at every stage of the Big Data project. 
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2. Big Data as a New Resource 
 
1. Digital Environment 
 
 
3.2.1 Strategic Competitive Response  
• Hallway conversations, mind mapping, discovery, ad-hoc sessions, individual insight or senior management 
incentive and cross- functional communications (Sensing) 
• Identify gaps, strategic thinking, predicting the environment, positioning the project, determine a need for the 
reconfiguration. (Seizing) 
• Partnering with external experts, re-establishing required processes and capabilities (Seizing) 
Organisational and Managerial Practices and Processes for Big 
Data Initiatives 
3.2 Dynamic capabilities 
 
3.2.2 Learning   
Knowledge creation, acquisition, articulation, integration and codification practices and activities:  
• Series of regular workshops and practices. The immersion/experience practice. 
• Real-time updates through dashboards. 
• Systematic analysis and search for new solutions.  
• Holding ad-hoc discussions and meetings. 
              - Setting up a community of practice. 
              - Use case analysis. 
              - The Business Council.  
              - The App Vision Steering  
 
3.2.3 Reconfiguration 
(Networking & Partnership)  
• Cultivate a community of new expertise: data scientists, digital experts, taxonomy experts, epidemiologists, 
and business development/alliance managers. 
• Build new skillsets to embrace expanding data, advanced analytics, technology capabilities and 
3.2.4 Coordination  
Implementing new elements/capabilities corporation level (Synapse platform, Data harmonization) reinforced 
configuration and coordination of existing resource and capabilities (coordination) 
 
3.1 Existing Operational 
capabilities  
3.1.1 Marketing  
• Collaboration for Innovation 
• Operating Globally/Different 
Markets  
• Build Sustainable 
Relationships with Customers 
• Understand Complex 
Customer Needs 
• Knowledge of the Competition 
3.1.2 IT 
• Integrated IT into Business 
Processes. 
• CRM 
• Silo (data) Management 
• Data Security 
 
4. Enhanced or New 
Capabilities (Marketing & 
IT) 
 
• A Service Catalogue (Reduce 
the duplication & Cost) 
• Digital Platform 
• A Cloud-Based Data 
Environment 
• Data Harmonisation. (ability 
to deliver on data-driven 
decision making) 
• Data Access  
• New Kill Set: data scientists, 
digital experts 
• Ability to get the patient 360 
degree view 
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Figure 5.2: The Key Aspects of the Findings from The Global Site (Author's own. Developed 
based on the CF and on the findings of this study) 
 
5.2.6 Summary of Global Findings 
While the digital environment served as an enabler for the Big Data initiative, the company’s 
internal competencies and capabilities (IT, Marketing) (Fig. 5.2, section 3.1) had a major 
influence in successfully progressing the project (DO01; DO03; IG01; IG04; IG07).   
However, it was also found that the nature of Big Data required reconfiguration and further 
development of such capabilities. The data indicated that the preparation process for Big Data 
initiatives in the case study company was triggered by sensing (IG01; IG06; IG02) the 
opportunities, followed by the development of a first initial idea to seize (IG01; IG02; IG03; 
IG05; IG06) the opportunity to adopt and implement this idea. 
Drawing on their dynamic capabilities (Fig. 5.2, section 3.2) for sensing Big Data opportunities 
with a creative approach (mind mapping, discovery, hands-on experience, ad hoc sessions, 
individual insight, or senior management incentive and cross-functional communications) the 
company was able to identify capabilities gaps (silo approach, connectivity, data management 
skills) and determine a need for the reconfiguration of existing resources and capabilities. 
For example, the ability to capture and recognise the gaps mentioned above requires a stream-
lined data management approach, and the biggest issue (highlighted by the participants) was 
the company’s silo approach of data management, which was not compatible with the new 
initiatives (IG02; IG05; IG06). An ability to coordinate different functions and franchises 
(Marketing, IT, policy, different countries) was also necessary for progress to made in Big Data 
initiatives. 
Development of the initial idea to seize the opportunity (identifying gaps, strategic thinking, 
predicting the environment, positioning the project, determining a need for reconfiguration) 
was largely influenced by engagement with the expertise in the field at the case study company. 
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It was evident (IG01; IG02; IG07; IG08) that the interaction between multiple factors such as 
partnership, government promotions, and networking enabled the company to seize the 
opportunity and to gain new knowledge about Big Data initiatives. This led to the development 
of new capabilities which helped to fill the existing gaps. 
The implementation of new capabilities (Fig. 5.2, section 4) such as the cloud-based 
environment, the data service catalogue, and the Synapse platform was followed by the 
introduction of new elements such as a stream-lined data management approach, and improved 
coordination. This was accompanied by the reconfiguration of the company’s existing 
marketing and IT capabilities. 
The new data connectivity platform Synapse and the cloud-based digital environment had a 
significant operational impact, such as: the reduction of the silo approach of moving and 
processing data (data management), improved storage ability, improved data accountability, 
and data harmonisation (data governance). A service catalogue reduced the duplication of data, 
which consequently reduced the cost of acquiring and managing data. Thus, building these 
foundational capabilities allowed incremental operational efficiencies. Most importantly, the 
company was able to get a 360-degree view of customers, which helped improve customer 
relationships. These new capabilities enabled the company to realise the value of data across 
the organisation and helped increase the entire organisation’s acumen concerning data and 
analytics. 
It was also evident (IG01; IG02; IG05; IG06) that specific learning activities/practices (Fig. 
5.2, section 3.2.2) triggered capabilities development and guided the overall Big Data adaption 
process at the case study company. 
This model will now be used to assess the findings from the EMEA site, which are presented 
in the next section. 
  
187 
 
5.3 EMEA Findings 
5.3.1 Introduction 
As discussed in the previous sections, there is empirical evidence that Big Data initiatives (the 
IKU/Big Data project) brought a transformative change to the Global (mainly US) site of the 
case study company, where the project was originally planned and implemented. 
Analysis of the data from the company’s EMEA site indicates that although the project had not 
progressed as far as at the Global site, the Big Data preparation phase was nonetheless very 
similar between the two. However, as the project at the EMEA location started after the Synapse 
platform had already been adopted by the Global site, this gave workers at the EMEA site the 
opportunity to not only explore (sense and seize) the Big Data opportunities but also to spread 
knowledge about the Synapse platform. This means that knowledge integration and learning 
processes both played an important role during the Big Data preparation process in the EMEA 
site. 
The EMEA project was led by a group of people from different departments and different 
countries, named The Champions, who would in a sense help to ‘evangelise’ what the Global 
site had already achieved. Geographical factors meant that some of the participants had only 
been peripherally involved in the Global project, while most others had not been involved at 
all. 
Participants from the EMEA site believed that deployment of the project in EMEA meant that 
certain changes and extensions to Synapse would be needed, as well as an understanding of 
how to efficiently support this platform. The objectives of the EMEA project were to gain 
insights from the Global project about Big Data initiatives and make the Synapse platform 
visible to different functions. Another important step was to clearly and effectively 
communicate the objectives that the project members were hoping to achieve. This entailed the 
need to convince each of the country's authorities (i.e. the company’s franchises) to 
accommodate new processes that would ensure full usage of the Synapse platform. 
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Analysis of the data indicates that the success of this transformation and the building of new 
capabilities relied on the company's existing skills in knowledge integration, learning, 
reconfiguration, and coordination. These practices were delivered by experienced project 
members, although national boundary factors, regulations, and data policy governance 
presented a greater challenge to the implementation of Big Data initiatives at the EMEA site 
than in the Global. 
The remainder of this chapter presents findings from the EMEA site that are organised under 
the concepts from this study’s theoretical framework (as with the Global site findings), 
followed by discussion of the main similarities and differences between these two parts of the 
case study company in regards to the Big Data adoption process. 
5.3.2 Digital Environment (CF.1) 
The new digital environment had the same influence on the adoption of Big Data initiatives 
and capabilities development in EMEA as in the Global site of the company. However, in 
Europe, data tends to be more commercialised due to different data governance laws and 
ownership. This results in limited access to data, or extremely high data costs. Consequently, 
pressure on healthcare organisations regarding data access is higher in Europe (Deloitte, 2015). 
Although some open modes of data access and sharing are emerging in which data are made 
publicly available to organisations to stimulate innovation and provide transparency (Van den 
Broek and Van Veenstra, 2015) a major barrier in Europe is the higher degree of data privacy. 
The company’s EMEA leaders believed that the evolving digitalised world that can be 
leveraged in the healthcare sector is having a positive impact on and influencing data privacy 
laws in terms of recognising the need for exploring and embracing this potential. 
This new approach was extremely important for the Germany’s franchise leader. It will 
continue to be very difficult, particularly in Germany, to obtain even critical patient data from 
customers and vendors without changes being made to regulations and data privacy laws. 
However, participants believed that the company was able to start using the existing CRM data 
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to test the new platform. It was also believed that using and sharing all the raw data that the 
company owned - the customer data, and sales data from the local service providers - could be 
used to answer business questions, speeding up the time between the basic research stage to 
the market. 
Furthermore, project members believed that on top of the regulations and privacy laws, which 
are more apparent in Europe than in the US, there is also social pressure (e.g. peer pressure, 
academic pressure, socio-economic pressure) in gerent in the system. The digital changes that 
are happening in the world, and the transformational impact that sharing personal data has to a 
patient’s life, are incrementally forcing changes such as data sharing to become the norm. 
A prominent example of this was offered by the project’s director when he explained how 
sharing data and using advanced technology can, in some countries, allow a patient who has a 
particular illness and a specific genetic make-up, for example, to search for and find patients 
with similar circumstances in order to communicate, share, and understand more about 
available drugs and treatments. This ability would also allow patients to monitor which drugs 
or regimes have or have not worked in order to inform their own decision-making. Such a 
system would be a valuable one for pharmaceutical companies to aspire to, and the participants 
believed it to be not only feasible but actually already being practiced in various parts of the 
word. However, a major barrier in Europe is the lack of data-sharing, and the result of this is 
increased social pressures in the system. The impact of social pressure on the system is one of 
the dynamics that allows examination of the political and social environment in which 
companies operate (Shao, 2009). On the positive side, they also believed that such pressures 
will influence the changing of data privacy laws. Participants believed that: 
 It is inevitably going to change, right, for multiple reasons, but it’s mainly the digital 
 world that we are all living in. IE10 
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Recognition at management level of the influence from the external macro-environment 
(political, social, technological), as well as the external micro-environment (customers, 
competitors, distribution channels) fuelled the spirit of innovation that was at the heart of the 
development of Big Data initiatives at the EMEA site. As one of the company's senior leaders 
remarked: 
  It’s just the economic pressure in the system to force change. Yet Big Data also 
 requires a great deal of change. We have to rethink how we access and distribute 
 information, how we interact and coordinate with different departments and data 
 holders and that the evolving digitalised world. That can be leveraged in the 
 healthcare sector will have a positive impact on sort of releasing that economic 
 pressure in the system. IE09 
The pressures mentioned above, as well as patients and payers who are key to the success of 
products and so help determine their price, were stressing global leaders to react more quickly 
than ever before to transform their businesses to compete in the new business environment, to 
react to the market, and to match the speed of technological changes. The Executive Director, 
Information Knowledge Utilization shared his view as below: 
 Our world is changing. Look at the Uber, the Amazon, the company… the Airbnb. So 
 our world is changing, not only our world is changing, our industry is changing. How 
 is it changing? Digitalisations, democratisation of data, differentiation of data you
 know. IE09 
5.3.3 Resources (CF.2) 
5.3.3.1 Big Data as a New Resource (opportunities and challenges) (CF. 2.1) 
- Big Data Opportunities 
As with the Global findings, it is clear from the EMEA data that the perception and 
understanding of the benefits of Big Data were critical determinants of the Big Data initiatives 
implementation process. 
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Participants believed that, in an evolving digitalised world, the company could benefit from 
Big Data in regards to understanding patients and offering them more personalised treatments. 
Consequently, they saw this as a step towards the personalised medicines offered by Big Data 
perspectives and technological advancements. For example, one of the managers expressed his 
expectation as below: 
 We’ve been discovering, developing drugs, commercialising drugs, pretty much the 
 same way for multiple decades, right? What we’re talking about now, in the light of 
 Big Data, and technological advancements, I’ll just draw those parallels again to the 
 like a Uber, transforming the way we travel basically, that’s the sort of 
 transformational change we’re talking about that is going to happen in our 
 healthcare environment, and in our business. IE01   
The opportunities offered by Big Data were also associated with operational effectiveness. For 
example, better connection/coordination of different sources of data, including public data, data 
licensed from outside parties, and the company's own internal research, pre-clinical research, 
or clinical research data. There was a common belief that coordination of different sources of 
data would offer better insights and outcomes in serving patients. As the Director of Clinical 
Trials explained: 
 Big Data is critical for us. for example, let’s say you take like a thousand-patient 
 sample, and you do something with those thousand patients, and then based on 
 information you collect, you deduce what will happen to the entire population. So the 
 bigger your sample is, the more accurate and reliable your results are. You see? So 
 introducing Big Data here, actually helps you to produce better results. IE02 
Respondents also highlighted that the most important objective they were looking to achieve 
through Big Data initiatives was to improve their service to patients by improving and 
extending customer relationships, generating new business opportunities, and speeding up and 
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cheapening the research-to-market process. In line with this point, the Senior Director of the 
company’s Italian franchise commented: 
 Whatever we can do to help the patients to have access to our product is good for us. 
 It means that we can speed up the approval of the drug, we can speed up the 
 reimbursement of the drug, but we can also speed up the evolution of the drug. We 
 can also speed up the knowledge and the acceptance for the treatment by the patient. 
 IE07 
Alongside these recognised opportunities, participants also acknowledged that Big Data 
opportunities should be communicated clearly at each stakeholder level, and that objectives 
should transparent and accurate enough to make it clear what the use of Big Data offers to each 
function of the company (clinical, R&D, market access etc). 
However, understanding of operations from a digital/Big Data perspective presented a unique 
challenge to the company. For example, the participants had concerns regarding putting 
together a systematised data consumption method. Such factors as the frequency of data 
collection, be it public data, data from partners, or even internal data, as well as the way in 
which data is collected by different groups using different instruments, mean that the data may 
not be readily compatible with the Big Data environment. Therefore, the biggest issue was how 
to coordinate, to validate it, and to check it for accuracy and security before making use of it. 
Project members believed that increasing the awareness of new opportunities and routine 
knowledge sharing about this new resource would result in an improved Big Data utilisation 
process. 
 I think Big Data approach is more integrated into team thinking. So, there is still a 
 need for training, but I think it has to link into an actual project. If you just train 
 someone on a theory, I don’t remember it, I don’t really care. If you train them on a 
 project and they have to have that information, then you’re much more successful. 
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 And by demonstrating the value, you then build the interest. By building the interest, 
 you can prioritise budget or resources to do that in the future. On the second side, I’d 
 say it is sometimes manager’s decisions, because if you have a group that understands 
 the value or is dealing with lots of data and has more opportunity now, let’s say, for 
 the IKU support, then there’s already a decision to prioritise those resources. IE14 
5.3.3.2 Other Resources (CF. 2.2) 
- Increase Awareness and Building Trust 
Participants asserted that the company believed that successful implementation of the 
technological changes needed to make use of Big Data had to be driven by people with the  
necessary expertise and business knowledge. Therefore, it was considered an important step 
that the global site and its affiliates had shared consistent standards for strategy and good 
governance. Furthermore, project members believed that practices such as communication, as 
well as education and training, could get people thinking differently such that they could start 
building new capabilities within their part of the business. 
A majority of informants also highlighted that new business insights, attitudes, and views 
through which people experience new situation helped to identify and develop required 
capabilities. For example, one of the European country’s leaders stated that: 
  It is important to increase awareness and train more of each function, or of each 
 country to think about Big Data and think about that approach to answer a question, 
 versus going back to the old-fashioned way. I think that training aspect and that… 
 Training and communication need to be done to help support and prioritise Big Data 
 as a solution and to identify and build required capabilities. IE08 
One of the best examples of such activities, of supporting and prioritising Big Data initiatives, 
was the priority given by project members in every affiliate to promoting the Big Data 
initiatives, to increase awareness and commitment, and to achieve change acceptance. 
Furthermore, by using different techniques such as presenting successful examples of Big Data 
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projects, learning from examples of Synapse usage in the Global site or other franchises, and 
delivering workshops to help affiliates define the value of and objectives for taking on new 
opportunities, the main aim of this initiative was to increase awareness in every part of the 
corporation. 
For example, one of the interviewees spoke about this role as follows: 
 My objective is make first every person in this affiliate aware what Big Data project 
 is, what the opportunities are. I'm doing this by presenting IKU/ Big Data examples 
 of IKU usage in other countries and territories to small teams, to bigger teams and to 
 bring people to use Synapse, the Synapse platform. So my objective is to have, let’s 
 say, half of staff here using Synapse, or at least to be aware and have seen the 
 platform. IE09 
In line with this point the director of the company's French affiliate explained:    
 I mean this is the team spirit that we have here, so I can speak for my affiliate, for our 
 affiliate.  It’s how people cooperate cross-functional. So when I experience this every 
 day in my job, I can talk to market access, marketing, medical people speak about 
 commercial stuff, commercial people speak, are very, very knowledgeable in medical 
 stuff. So the cross-functionality, the... let’s say open-mindedness, the, this company 
 still is very innovative how they approach challenges.  But this is what comes to my 
 mind first, so people, flexibility, speed, innovation.IE01 
Another interesting insight from the data was that the actual demand for data science in general 
in Europe is very low because there is little awareness of how people can benefit from it. 
Therefore, project members were hoping that the kinds of practices mentioned above would 
have a positive impact on changing mind-sets regarding Big Data, and help generate demand 
and commitment. 
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 Most probably we’ll need more than what we currently have. Because typically when 
 you think about the actual demand or data science demand in Europe, it’s very low 
 because there is little awareness of what we can build or what we can have, what 
 people can benefit from. Now in six months, 12 months, years’ time people should be 
 aware of that existing capability and the ones that have the IKU mind-set will start 
 generating demands. Saying I need the data science team to do this or I need your 
 help to do that etcetera and this is where we need to be ready to answer the demands. 
 IE05 
Regarding this point, another European leader also commented: 
 Just thinking for Europe the biggest challenge I see is because we’re just in this 
 process of getting started there’s pressure from the countries to set... show us cases 
 where this could provide value to us. So, that’s one potential threat if we can’t 
 successfully get countries understanding what value this can provide to them. So I 
 think it takes the accumulation of seeing it be useful in a number of projects for it to 
 become generally accepted as a way of doing things, and again that just takes time. 
 IE13 
However, it has been also acknowledged that demonstrating what results can be directly 
attributed to Big Data is a difficult problem, and so people should be given the opportunity to  
understand, discover, and learn more before they commit. 
Great significance was found to be attached to the practices that support learning on an ongoing 
basis, such as enabling employees to share and refine their best practices, or to hire external 
experts to deliver up-to-date learning. For example, a key suggestion about how to support 
problem-solving and creative thinking was to create an interface through which people could 
experience and manipulate novel ways of using this new resource. 
As the Director of IT, IT EA, and Information Management proposed : 
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 To create interfaces through which people, without deep data expertise, can view and 
 manipulate these data and do some simple analyses, so you’re really getting it out 
 there to people.  Because then, you know, they’ll be able to do something on their 
 own, they’ll start to see the benefit, and then they’ll get interested in more complex 
 questions, which they won’t know how to do on their own. IE06 
The EMEA project’s objective, to increase awareness, and to create commitment and a shared 
vision which would become integrated into the corporate culture, was believed to have a 
transformative effect on the company. This has also been considered as a strong influential 
factor for developing new or enhancing existing capabilities for effective use of Big Data at the 
EMEA. As the project’s leader explained: 
 For the vision, for me the project has the potential to be completely transformative, as 
 I said we do trials, we talk to payers, to regulators and ultimately serve our patients. 
 Of course we want to have better outcome for patients by accelerating the time we do 
 trials, by working together with regulators and with payers to make… to have a better 
 value package for drugs. But that’s the longer term objectives but main at the moment 
 is to create a shared vision IE09 
 
5.3.3.3 Path Dependency (CF.2.2) 
- Shaping the Organisational Culture 
Similar to the US project, organisational culture and cultural transformation were also 
considered to be major challenges between the participants at EMEA. However, the positive 
side of the organisational culture - such as an innovative spirit, risk-taking, and flexibility were 
also found to be the main drivers for the project. For example, one of the participants recalled 
that: 
 The spirit of the company. So the spirit is based on the values that you may know. And 
 particularly the focus on the patient and things like this, but also the innovation spirit. 
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 And what I like is that company is not afraid to take risks. I remember one advice that 
 I heard, in my first beginning with project and I think this is exactly summarising the 
 spirit in company… we are not afraid to fail fast because we learn fast. IE04 
The organisational values appears to have both stimulated and limited the pursuit of an 
innovative, cross-unit Big Data project. National trends and boundaries that were evident 
within the corporation represented greater challenges at EMEA, and convincing everybody to 
accept innovative ideas and changes was found to be harder in the European countries. 
The Senior Director of Corporate Affairs explained that: 
 The culture of the company being far from risk-averse, we are open to change, and 
 take those risks to enable potential change. So I think that’s the general culture but it’s 
 not everybody’s. it’s certainly very difficult to convince someone who doesn’t want to 
 be convinced. We have, have almost ….. people, or whatever it is now, in our 
 organisation, obviously not everybody is fully on board, right? It comes back to that 
 mind-set of, this is the way we’ve discovered and developed drugs my entire career, 
 why would we do it drastically different now? IE05 
One of the greatest challenges that emerged from the data was likewise not related to 
technology and required skills, but to the process of cultural transformation. Issues relating to 
a change of culture involved people, open-mindedness, changing mind-sets regarding data 
silos, and the acceptance of new Big Data initiatives. As the Director of IT explained, because 
of its nature, the majority of IT employees in the pharmaceutical industry traditionally have a 
very strong data science background. Before Big Data, and even before the IT revolution, 
pharmaceuticals were very much involved in data processing. While many workers are familiar 
with the established data tools, and work with data on a daily basis, they see it as just an 
extension of their toolbox. However, this means that there is a need to recognise a new demand 
to culturally adopt the new data environment. For example, one participant commented that: 
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 So for them it’s a natural move… It is not about technology and capabilities it is 
 about mind-set and changing culture. IE02 
In line with this point the Executive Director of Global Affairs stated: 
 First is a cultural change within the company, as the company like many other 
 pharmaceutical companies has grown as quite a traditional pharmaceutical company, 
 and so we have to adapt to this new world. It is important at all level to change the 
 mind sets and having us at senior management level and different functions 
 understand that we have to change to leverage Big Data. So that’s a cultural change. 
 IE10 
The need for cultural change and the importance of change acceptance emerged as a strong 
theme from other informants’ data: 
 So, initially for people it’s basically just a time set, right, and so they need to be either 
 desperate enough with their current situation, or, you know, sufficiently open to and 
 sort of interested in the possibilities of working more with data, that they’re willing to 
 put that in.  , You just need some time for people to be able to look at those data, make 
 some decisions based on those data, and ultimately, hopefully see that those decisions 
 are helping.  So, those are the challenges, and it’s really all around acceptance rather 
 than technical things. IE06 
Besides open-minded thinking and change acceptance, almost all informants from the EMEA 
site (similar to the Global site) named changing the data silo mind-set as ongoing challenge to 
cultural transformation. Further findings indicate that an ability to become more data-driven 
requires a mind-set shift within the entire company. Data also suggest that the most significant 
efforts the company made was to break down the silo thinking that appeared to be common 
across different factions, franchises, and countries. 
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For example, the Executive Director of the project explained that implementing and using the 
new connectivity platform was a good example of such efforts. People in certain departments 
had access to certain data sources, which they leveraged only for their own interest and 
function. The same data could have been shared with other departments for their own interest, 
but in many cases different departments had no idea that data were available. Therefore, either 
they never used it, or effort and money had been wasted by obtaining potentially duplicated (or 
at least, similar) data. Analysis of the data indicates that having the right mind-set promotes 
collaboration, and sharing, and hence the efficient conduct of business. Participants believed 
that connectivity, clear communication, and coordination had helped prevent duplication of 
activities (and duplication of expenditure) within different functions and countries, with a 
consequent positive effect on cost-saving. It has been acknowledged that: 
 You need to kind of put your more reasonable hat on as well, and say, that’s wrong to 
 tie that up, right, we need to fuel the ecosystem, because if everybody does that, we 
 will all benefit from the greater amount of data that’s available. So, it’s really deep 
 cultural roots that I think help change that, change that mind-set. IE10 
5.3.4 Existing Capabilities (CF. 3.1) 
The project members believed that, in line with the Global site's existing capabilities that were 
identified and discussed earlier in this chapter (table 5.1 and 5.2), the EMEA site also featured 
good IT and marketing capabilities. However, according to one of the project directors, these 
capabilities had been evolving slowly, and there was also demand for new capabilities. 
 I think what we will be needing is more capabilities. Some of them will be technical. 
 Not everyone needs to have them within IKU. But, we need to have enough people to 
 have those capabilities and scientific analysis is one of them that I mentioned. But, 
 also [unclear] initiation and collaboration skills. You need to be growing to the next 
 level. As I mentioned, there are several things that are held outside the company and 
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 we need to negotiate to get access to that. The capabilities that we have, are evolving 
 and we need to keep this way IE12 
5.3.4.1 Marketing Capabilities (CF. 3.1.1) 
Participants expressed pride in the company’s success in the markets, and believed that this 
was down to having strong marketing capabilities, not only at the Global site but also at EMEA. 
As the Executive Director of the IKU project explained: 
 The company is a highly successful biotech company of 7000 people with a market 
 cap of $100 billion. So if you put this as a ratio and you look at the biotech, it’s 
 remarkable. So we’ve been a highly successful company and that has been mainly 
 through the success of one asset that is called Revlimid IE09 
Although the company was proud of some specific drugs that had come to dominate the market, 
they were clear that their success was due to not relying on one product but, rather, having the 
ability to diversify its portfolio and provide for patients with various conditions. The company 
achieved this diversity, in part, as the result of establishing a new franchise, inflammatory 
immunology. With new assets serving the different market segments (patients with psoriasis, 
psoriatic arthritis, rheumatism, and skin disease) the company demonstrated its ability not to 
rely on one product, in an industry in which unique assets tend to mature and ultimately be 
replaced by 'generics'. This consequently demonstrates the company’s emerging market 
capabilities. 
Moreover, monitoring customers, competitors, and the market itself so that in each case the 
company could react to its own advantage was also identified as an important marketing 
capability at EMEA. 
The company’s EMEA site marketing capabilities are summarised in table 5.8 below. 
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Definition (Marketing 
Capabilities) Examples in 
the literature (Authors) 
Operational 
Capability 
Appearance in the 
Case Study 
Direct Quotes (comments) 
from Interviews and 
Secondary Data  Comment 
Marketing capabilities are Integrating 
process (e.g. build sustainable 
relationships with customers, 
knowledge of the competition and as 
well as skills in segmenting and 
targeting markets) in which the firm 
use its tangible and intangible resource 
and capabilities to understand the 
trajectory of customer needs through 
effective information acquisition, 
management, and use (Day, 1994; 
Dutta et al, 1999; Song et al, 2007; 
Krasnikov and Jayachandran, 2008, 
Morgan, 2009) 
 
 
Integrated process, 
in which the firm 
uses its tangible and 
intangible resources 
to build sustainable 
relationships with 
customers 
 
 
 
 
Ability to identify 
emerging markets 
 
 
 
 
 
Monitoring 
customers and 
competitors 
 
 
 
 
 
 
Ability to create effective 
drugs, going through the 
various clinical trial phases, 
and having the commercial 
infrastructure to 
deliver innovative treatment 
to patients. 
 
 
 
 
The company diversified its 
portfolio, through the 
emergence of a new 
franchise, inflammatory 
immunology.   
 
With new assets, serving 
patients with psoriasis, 
psoriatic arthritis, 
rheumatism, and skin 
diseases, the company 
demonstrated its ability not 
to rely on one product, in an 
industry in which this this 
asset will mature and 
ultimately be replaced by 
'generics' 
 
 
Patients and payers who 
rationalise the price of 
products by making their 
success in Big Data 
environment, were pressuring 
global leaders to react more 
quickly than ever to 
transform their businesses to 
compete in a new business 
environment as the market 
and technologies are 
changing 
 
The company is a highly successful 
biotech company of 7000 people with 
a market cap of $100 billion. So if 
you put this as a ratio and you look 
at the biotech, it’s remarkable. So 
we’ve been a highly successful 
company and that has been mainly 
through the success of one asset that 
is called Revlimid.IE09 
 
 
 
 
 
 
 
 
 
 
Our world is changing. Look at the 
Uber, the Amazon, the company… the 
Airbnb. So our world is changing, not 
only our world is changing, our 
industry is changing.IE09 
Table 5.8: Marketing Capabilities (CF 3.1.2) (Author's own) 
5.3.4.2 IT Capabilities (CF. 3.1.2) 
It was found that the EMEA site was equipped with the IT infrastructure and employees with 
strengths in data science, governance, taxonomy, and other skills needed in order to harness 
Big Data opportunities. However, project members still had concerns related to their IT 
capabilities. These mainly concerned the ability to coordinate change amongst various 
functions and franchises (Marketing, IT, policy, and different countries). At the beginning of 
the project these employees were not sure how different functions and franchises would be able 
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to make use of the processes and IT tools necessary for Big Data adoption that had been 
established by the Global site. 
As the project director explained: 
 I think one challenge that we are currently facing is that now that the capability is 
 being built, the questions come, what will be the operating model? And who shall lead 
 it and how shall it be embedded in the business, functions and franchises? Because 
 you know, once people understand that… what you can do with data science, that you 
 have the right platform and you have the data science available, you don’t need 
 people like me anymore. It could be directly embedded in the business or should it be 
 embedded maybe with IT or specifically? So those are the questions we are having 
 now, what should be the proper operating model? IE05 
Another common concern among the informants related to setting up new initiatives and the 
technological platform that would support them; the Global team had not fully considered how 
such developments at their site would be implemented in outside the US. For example, some 
of the participants highlighted that the new platform was built for US data and so was difficult 
to fully understand and put into operation at the EMEA site, meaning that before it could be 
used some changes would be necessary. As one of the European country leaders explained: 
 I would say we have to find a clear path and strategy how this fits into our business 
 model here locally. And the big challenge here,…, is that it’s not something that’s 
 ready to be rolled out here  The big, big challenge that we are facing with IKU and 
 Synapse is the impression that this is still very, very US focused. Then, so the people 
 that I have motivated to go to Synapse, they look into Synapse, they do it and these 
 are the highly motivated persons and colleagues and they see; oh there is a lot of US 
 stuff, this doesn’t help with my local challenges. IE11 
Another participant from a different country also commented: 
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 Our concern is, still how does IKU fit into our business processes, and operational 
 models, and how to Europeanalise this whole thing.  How to make this really tangible 
 for people sitting here on this side of the pond. IE08 
Participants also identified a need for there to be embedded in each function additional 
resources skilled in analytics, and capable of understanding the benefits of Big Data and how 
new solutions could be linked to their own function. As one of the project members expanded, 
there was a need for additional in-house capabilities: 
 In different functions you have some gaps and we need to bring in capacity and 
 capabilities in house so not to be over dependent on external partners. IE08 
The project director also commented on this topic, adding: 
 Now we are building a centralised kind of team, project team but that ultimately 
 should not be central anymore because it should belongs to the functions and the 
 affiliates and the markets. Therefore we need additional skills imbedded in the 
 functions and franchises. IE05   
Furthermore, participants believed that the successful implementation of a new unfamiliar 
technological system requires suitable processes to be established, and for staff with adequate 
and relevant skills to be available before the system can be put to productive use. As one of the 
external partners who was helping the company with the project explained: 
 This is the skill set you need to start hiring for, because the question you have, we 
 helped you reframe the question to be applicable in this new world, helped you find 
 the data sets, helped you to define the use case, and based on that process you have 
 some kind of a visibility and a skill set you might want to start thinking about getting 
 access to yourself. IE16 
The emergence of new skills that could speed up the implementation process and help different 
functions create a community of practice around new technology and data management was 
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found to be an essential factor for the transformational phase. However, it was also 
acknowledged that it is often impossible to assemble all of the required new skills at the same 
time. Therefore it was agreed that it was important to adapt the existing system to the new 
environment. Overall, participants indicated that for some stages, such as the preparation and 
building phases, the company could rely on internal skills and the experience of external 
partners to enhance and build required capabilities, with it being highly recommended that 
suitable personnel were hired for the operational phase. 
Table 5.9 below summarise the company’s IT capabilities. 
Definition (IT 
Capabilities) 
Examples in the 
literature (Authors) 
Operational 
Capability 
Appearance in The 
Case Study Company 
Direct Quotes (comments) 
from Interviews and 
Secondary Data Comment 
An organisation’s ability to 
assemble and to deploy IT 
based resources in 
combination with other 
organisation’s existing 
resources and capabilities 
Examples of such abilities 
include business process 
reengineering, integrate 
required IT into appropriate 
business processes, customer 
relationship management, 
electronic commerce, new 
resource adoption and 
managing digital data (Vitari 
et al, 2012; Chen et al., 
2012; Wilden and Gudergan, 
2015 ). 
 
 
Integrate required IT into 
appropriate business 
processes. 
 
 
 
 
New resource adoption 
and managing   
The technological 
infrastructure and a group of 
people, with various abilities 
of data science, governance, 
taxonomy, and data ingestion. 
Data quality checks or good 
information management. 
 
Big Data initiatives 
implementation 
 
 
 
 
  
 
Table 5.9: IT Capabilities (CF 3.1.2) (Author's own) 
5.3.5 Dynamic Capabilities (CF. 3.2) 
5.3.5.1 Reconfiguration (DC) (CF. 3.2.3) 
 
The empirical investigation at the Global side suggested that its technological (IT) and 
connectivity capabilities had been enhanced through the company’s reconfiguration ability. 
Through networking and partnerships in particular, the company was able to determine which 
of the different internal work streams, resources, and capabilities had to be re-engineered in 
order to fully leverage Big Data. Findings from EMEA confirmed that increasing awareness 
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regarding Big Data opportunities, as well as the company’s new connectivity platform Synapse, 
played important roles to develop Big Data capabilities at EMEA. However, the company’s 
cultural transformation, its ability to learn through innovation, and emphasis on the value of 
risk-taking, also had important roles to play in defining and building required capabilities for 
Big Data within EMEA. For example, participants described this process as being similar to 
building a house. The connectivity, and an IT platform that could support it, were considered 
to be the foundations. However, once the foundations were laid a further demand for new skills 
and capabilities were identified. 
As the project director explained: 
 There are two foundational elements in our mind, one is what we call your connective 
 tissue. If you don’t have a platform in place that has the capabilities of working 
 across functions, across therapeutic areas, consolidating all the various data assets 
 and analytical tools, then we won’t be able to move away from this very typical silo 
 thinking. and we’ve built a technological platform to address that connectivity 
 challenge. IE02 
These new skill sets, identified as being necessary for innovation, were also developing in 
collaboration with the partnerships. Partnering up with other companies with expertise in the 
field, such as Deloitte (same company as US site), enabled the company to start Big Data 
initiatives even without having all the skills in-house. The IT gap was gradually filled through 
learning and the overall evolving processes. 
Table 5.10 below summarises the company’s reconfiguration ability. 
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Definition 
(Reconfiguration 
Capabilities) 
Examples in the 
literature (Authors) 
Dynamic 
Capability 
Appearance in The 
Case Study Company 
Direct Quotes (comments) 
from Interviews and 
Secondary Data Comment 
Reconfiguration (Box. 3.2.3) 
is an organisation’s ability to 
extend and modify existing 
capabilities in response to 
changes introduced in the 
market and technologies that 
are generated through new 
knowledge based on Big 
Data (Teece, 2007; Kwon, et 
al., 2014). 
Ability to determine 
(seize), the different 
internal work streams, 
resources, and capabilities 
that had to be re-
engineered in order to 
fully leverage Big Data 
 
 
Ability for cultural 
transformation 
Data harmonization. 
 
 
 
The company’s new digital 
platform, a cloud-based data 
environment, which enables 
connectivity of different 
functions and scales up as 
required for analytical needs 
These new skillsets and expertise enable 
us to realize the value of data across the 
organization and help increase the entire 
organization’s acumen around data and 
analytics. ID01 
 
There are two foundational elements in 
our mind, one is what we call your 
connective tissue.  If you don’t have a 
platform in place that has the 
capabilities of working across functions, 
across therapeutic areas, consolidating 
all the various data assets and analytical 
tools IE02 
Table 5.10: Reconfiguration (CF. 4.3) (Author's own) 
5.3.5.2 Strategic Competitive Response (CF. 3.2.1) 
Once the mechanisms for the support of Big Data initiatives established internally, the abilities 
of sensing and seizing allowed the team members to determine whether the company had the 
internal capabilities to address the pre-identified objectives for Big Data. The team members 
spent considerable time - one or two years – engaged in work, talking to business partners and 
commercial partners, getting advice about how to reorganise EMEA. They also engaged with 
policy stakeholders, public institutions, legislators, the European commission, and others. 
In addition, the project members, together with the company's own data scientists, collaborated 
with different stakeholders, such as business owners, functions, and specific groups (clinical, 
R&D) to determine whether the company had enough data and a suitable technological solution 
in-house, or if there was a need to engage in new networking with Big Data partners, and find 
other technological solutions. As one of the senior leaders commented: 
 The IKU/Big Data team is after spending one or two years doing some inward work 
 getting advice to reorganise and talking to business partners and commercial 
 partners, is now getting ready to engage with the broader policy stakeholders, public 
 institutions, legislators, European commission and others, and SGR and this IMI 
 consortium seems to be the right channel. 
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 We still a need and develop a fully-fledged strategy that we can call, you know, the 
 Big Data/health data policy shaping strategy at the company. That should happen 
 between now and the end of the year. So next year we can gauge which key strategic 
 objectives in mind. IE10 
With SGR (Scientists for Global Responsibility) the participant was referring to a UK group 
that promotes the ethical practice and use of science and technology, while IMI stands for the 
Innovative Medicines Initiative, a European organisation set up to improve the competitive 
situation of the European Union in the field of pharmaceutical research. 
Another interesting insight from the data underlined the company’s strategic competitive 
response ability, specifically its ability to be opportunistic in the sensing and seizing of Big 
Data opportunities. The company used this approach when looking for partnerships, not only 
with a specific business question in mind, but rather as a general standard/best practice. For 
example, they sought to collaborate with companies which were successful and could help to 
make a transformational impact not only on the company but also on the healthcare ecosystem 
in general. 
The Executive Director of Data Governance explained: 
 We liaised with an external company that had a lot of experience in dealing with Big 
 Data, to help us set up the capability, all of the technological solutions, so we’re 
 building that network through communicating with experts in that area, and that’s 
 how we really find out about opportunities, solutions, that may help address our 
 business questions IE07 
Another good example was the company’s engagement with the European Huntington's 
Disease  Network (EHDN). Huntington's is a genetic disorder that causes the death of brain 
cells. The EHDN is a non-profit research network committed to advancing research, facilitating 
the conduct of clinical trials, and improving clinical care in Huntington's Disease. Through the 
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EHDN a platform has been created such that scientists, clinicians, patients, and families can 
collaborate on academic and industry studies to fulfil its mission. As one of the participants 
explained, it represents a great opportunity to engage with the EHDN as it was a suitable 
channel to establish and learn from health data infrastructure. 
  EHDN was calling for potential partners for the summer, we thought it was the right 
 time for us to piggyback and enjoy these efforts because not… EHDN and the other 
 IMI consortium are not just interested in shaping policy, but EHDN seems to be the 
 right channel and forum to establish the health data infrastructure. IE10  
Furthermore, in line with findings from the global site, the knowledge integration and learning 
processes played important roles during the Big Data preparation process in EMEA. 
Table 5.11 summarises the company’s strategic competitive response activities that are 
discussed above. 
 
Definition (Strategic 
Competitive Response 
Capabilities) 
Examples in the 
literature (Authors) 
Dynamic 
Capability 
Appearance in The 
Case Study Company 
Direct Quotes (comments) 
from Interviews and 
Secondary Data Comment 
Strategic competitive 
response capability is the 
firm’s as the ability to 
sense/scan the environment, 
identify new opportunities, 
assess its competitive 
position, and respond to 
competitive strategic moves.  
(Teece, 2009, p.200). 
Sensing (and shaping) 
new opportunities are 
very much a scanning, 
creation, learning and 
interpretation activity 
(Teece, 2009). 
The IKU project was the 
result of a lot of hallway 
conversations between very 
senior leadership, to make 
sense of what the Big Data 
environment meant for the 
company 
 
The team members spent 
considerable time – one or 
two years – engaged in work, 
talking to business partners 
and commercial partners 
The IKU/Big Data team is after spending 
one or two years doing some inward 
IE10 
 Seizing refers to the 
organisational strategy 
and infrastructure for 
making appropriate 
decisions and absorbing 
and integrating resources 
to create and capture 
value from opportunities 
(Teece, 2009). 
The project members, 
together with the company's 
own data scientists, 
collaborated with different 
stakeholders, such as 
business owners, functions, 
and specific groups (clinical, 
R&D) to determine whether 
the company had enough data 
and a suitable technological 
solution in-house, or if there 
was a need to engage in new 
networking with Big Data 
partners, and to find other 
technological solutions. 
work getting advice to reorganise and 
talking to business partners and 
commercial partners, is now getting 
ready to engage with the broader policy 
stakeholders, public institutions, 
legislators, European commission and 
others, and SGR and this IMI consortium 
seems to be the right channel. IE10 
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 Respond to competitive 
strategic moves. Maintain 
competitiveness through 
enhancing, combining and 
reconfiguring (when 
necessary) an 
organisation's existing 
and new resource and 
capabilities. (Teece, 
2009). 
An opportunistic approach 
was another innovative 
activity that the company 
took to sense and seize the 
Big Data opportunities 
We liaised with an external company that 
had a lot of experience in dealing with 
Big Data, to help us set up the capability, 
all of the technological solutions, so 
we’re building that network through 
communicating with experts in that area, 
and that’s how we really find out about 
opportunities, solutions, that may help 
address our business questions IE07 
 
 
Table 5.11: Strategic Competitive Response (CF.3.2.1) (Author's own) 
5.3.5.3 Learning (DC) (CF. 3.2.2) 
In addition to the immersion experiences that were organised by the Global site for the entire 
organisation, participants from EMEA indicated that internal knowledge was improved through 
learning by experimentation, innovation, and risk taking. This resulted in the development of 
new Big Data-enabled capabilities within this part of the company. Almost all participants 
believed that taking risks and investing in the ecosystem of learning, and exploring different 
practices – even those not of direct benefit to the company - may have contributed to the 
project’s success. However, that investment needed to be relevant to the innovation and 
required capabilities. A good example was the effort made to identify, provide, and demonstrate 
tangible examples of the use cases to the broader audience. This is believed to have had an 
immediate impact on those individuals who had not been fully engaged with the new evolving 
ecosystem. One of the participants recalled: 
 Taking- risk to gain the first-hand experience gave me lots of freedom to try new 
 things and sometimes didn’t work but was ok, because also our culture said, that 
 within reason we should take risks and accept that not everything is going to work, 
 we’ll learn from those mistakes and then we’ll evolve and move on. IE16 
The Director of Medical Affairs also indicated that: 
 Well it’s… first of all it’s an innovation project. That’s the whole thing about 
 innovation. It’s risk, I saw quite a lot of activities, which were purely in exploration 
 and learning mode to build capabilities, and then now we are trying to figure out 
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 what is the best way to leverage those capabilities in their specific business cases. 
 IE10 
The exploration and learning mode referred to above consisted of several innovative practices 
that were related to new ideas. For example one of the ideas - cross-learning (and sharing 
through: The European in Informed Activity (EIA), was -  focused on the use of real-world 
data, and attracted funding from the European Commission’s programme. Moreover, the 
regular champions' meeting, held every two weeks and led by the director of the project from 
the EMEA site, was a good example of the company’s internal cross-learning activity. At these 
meetings the champions had a chance to get together to address and resolve current issues, and 
as an outcome other employees could obtain regular updates on processes, trainings, 
workshops, and those affiliates in which the champions had identified use cases.  The IKU 
checking team could track the progress of these use cases, and this team reported at regular 
meetings what each affiliate was doing and whether there were any new practices that could be 
shared or learned from. 
One of the European countries' site leaders explained: 
 It’s a top down approach, new idea is presented to the management team, so we meet 
 every week, the department heads. This is a small team, around ten persons. We sit 
 together, we have presentations if new stuff comes in, and this team is discussing how 
 we can implement this through the organisation. IE08 
The 'new stuff' mentioned by the participant referred to a new potential IKU champion from a 
different department or franchise, or a new employee with adequate Big Data knowledge. In 
addition, regarding team meetings and discussions, another senior manager recalled the cross-
functional team meeting discussion, which had a slightly different approach from the team 
meeting discussions mentioned above: 
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 But we also have cross-functional teams, for example, within my life cycle 
 management team function I'm overseeing four core teams focusing on qualities, 
 different pipeline assets. And this is, these are people from all departments, and we 
 are discussing innovative approaches here as well.  So on this angle this is more 
 about another approach. If we deem an idea to be great and now we have a, we 
 present then this to the management team, to the short fix that we have every Monday, 
 and seek for endorsement here.  So we have processes in place to hear all proposals 
 and innovations and take it for decisions how to proceed. IE08 
Analysis of the data showed that innovative practices required an investment of time, in order 
to allow people the chance to experience and observe the relationship between new ideas and 
actions within the business. However, regardless of the required time and risk associated with 
an innovation, it was evidenced that innovative practices were important all the way through 
the capability development process for the Big Data initiatives in the case study company. This 
was acknowledged and accepted by senior leaders. As one of them highlighted: 
 You have to let people play around with this a bit, you see. And you have to accept to 
 invest sometimes in things you do not really fully apprehend from the beginning.  
 That’s the whole thing about innovation. It’s risk. IE02 
With regards to this matter another participant also commented: 
 So, initially for people it’s basically just a time set, right, and so they need to be either 
 desperate enough with their current situation, or, you know, sufficiently open to and 
 sort of interested in the possibilities of working more with data, that they’re willing to 
 put that in. And then of course, as I think I was talking about a little bit earlier, you 
 just need some time for people to be able to look at those data, make some decisions 
 based on those data, and ultimately, hopefully see that those decisions are helping. 
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 So, those are the challenges, and it’s really all around acceptance rather than 
 technical things. IE11 
A risk-taking and innovative approach, combined with learning and trial and error, enabled 
project members to develop new solutions and support Big Data initiatives as they continued 
their day-to-day operational activities (IT or marketing). Despite this, it remained a 
considerable challenge to learn how to integrate and utilise the new connectivity platform with 
internal resources. As the Director of IT explained: 
 The platform is entirely new, it’s like on top of company’s existing capacity from 
 technical point of view. So the challenges, of course we would have challenges, 
 because you have to find ways to integrate it with the company’s existing environment, 
 you have to find the best ways to support it. And then of course you will have to learn 
 how to efficiently support it. IE02 
However, participants showed great appreciation for experiencing those challenges in their 
journey of identifying and defining Big Data required capabilities. Findings from the data 
indicate that when the objective to build transformational capabilities that will stimulate insight 
across the corporation, the application of leadership skills and problem-solving skills from 
different parts of the business enables to the identification of capabilities that will be relevant 
to the next learning curve. 
 It’s kind of an evolving process situation, we’re learning at the same time…you know, 
 I think it’s a better position to be in, that instead of just like, yes, we need lots of 
 people, and we bring lots of people in, and we go, actually, we didn’t need that, it’s 
 better we take the approach of, learn from, you know, on a weekly basis, where the 
 gaps are, and where they are, fill the gaps, in that perspective. IE09 
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However, although the processes described above had positive implications, most of the 
informants were also clear that investment in new skills would be necessary for a 
transformation to be successful. 
 Table 5.12 below summarises the company’s learning capabilities 
Definition (Marketing 
Capabilities) Examples 
in the literature 
(Authors) 
Dynamic 
Capability 
Appearance in The 
Case Study Company 
Direct quotes (comments) 
from Interviews and 
Secondary Data Comment 
Learning (Box. 3.2.2 CF) is 
defined as ‘the capacity or 
process within an organisation 
to improve or maintain 
performance based on 
experience accumulation, 
knowledge articulation and 
knowledge codification (Nevis 
et al., 1995, p 73, Zollo and 
Winter,2002). To develop 
learning capabilities: 
Management should support 
employees for learning, 
Managers should be open 
minded for new ideas, 
knowledge and experiences 
should be openly shared 
within the firm ( Inan and 
Bititci, 2015). 
Experience accumulation 
refers to the central 
learning process by 
which operating routines 
have traditionally been 
thought to develop. 
Incremental 
improvements can be 
accomplished through the 
tacit accumulation of 
experience and acts of 
creativity (Zollo and 
Winter, 2002) 
Internal knowledge was 
improved through learning 
by experimentation, 
innovation, and risk taking, 
which resulted in the 
development of new Big 
Data capabilities within the 
company. 
 
Innovative practices related 
to new ideas. For example 
activity such as Cross 
learning and sharing through: 
the European in Informed 
Activity (EIA), paid by the 
European commission 
focusing on the use of real-
world data. 
 
 
 
Taking- risk to gain the first-hand 
experience gave me lots of freedom to 
try new things and sometimes didn’t 
work but was ok, because also our 
culture said, that within reason we 
should take risks and accept that not 
everything is going to work, we’ll learn 
from those mistakes and then we’ll 
evolve and move on. IE16 
I saw quite a lot of activities, which 
were purely in exploration and learning 
mode to build capabilities, and then now 
we are trying to figure out what is the 
best way to leverage those capabilities 
in their specific business cases. IE10 
 
 
Knowledge articulation 
The process through 
which implicit knowledge 
is articulated through 
collective discussions, 
de-briefing sessions and 
performance evaluation 
processes. By sharing 
their individual 
experiences and 
comparing their opinions 
with those of their 
colleagues, organisation 
members can achieve an 
improved level of 
understanding of the 
causal mechanisms 
intervening between the 
actions required to 
execute a certain task and 
the performance 
outcomes produced 
(Zollo and Winter, 2002) 
Identifying, providing and 
demonstrating tangible 
examples of the use cases to 
the broader audience. 
 
 
 
 
The regular champion’s 
meeting (every two weeks) 
led by the director of the 
project from EMEA site, was 
a good example of the 
company’s internal cross 
learning activity. 
it’s a top down approach, new idea is 
presented to the management team, so 
we meet every week, the department 
heads.  This is a small team, around ten 
persons, and the GM.  We sit together, 
we have presentations if new stuff comes 
in, and this team is discussing how we 
can implement this through the 
organisation. IE08 
 
But we also have cross-functional 
teams, for example, within my life cycle 
management team function I'm 
overseeing four core teams focusing on 
qualities, different pipeline as-sets.  And 
this is, these are people from all 
departments, and we are discussing 
innovative approaches here as well 
IE08 
 
 
 Knowledge codification 
Knowledge codification 
is a step beyond 
knowledge articulation. It 
aims  to uncover the 
linkages between actions 
and performance 
outcomes. Most of them 
are intended simply to 
The IKU checking team who 
had a separate track on the 
progress of these use cases. 
The team was reporting on 
the regular meetings what 
each affiliates were doing 
and whether there were any 
new practice that could be 
shared, from where others 
could learn. 
It’s kind of an evolving process 
situation, we’re learning at the same 
time…you know, I think it’s a better 
position to be in, that instead of just 
like, yes, we need lots of people, and we 
bring lots of people in, and we go, 
actually, we didn’t need that, it’s better 
we take the approach of, learn from, you 
know, on a weekly basis, where the gaps 
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provide guidelines for the 
execution of future tasks. 
are, and where they are, fill the gaps, in 
that perspective.  IE09 
 
 Managers should be 
open-minded to new 
ideas. 
Identifying what the Big 
Data meant for the company 
was an initial learning 
activity as part of the 
learning journey that project 
members went through at the 
early stages of the planning 
phase. 
Help the company learn how 
to embed Big Data into their 
functions/franchises and day-
to-day work in order to 
operate in a new digital 
world. 
 
It was a group of 20 individuals across 
7,500 global individuals, where we're 
trying to influence and change the way 
we think. Right? And what we've found 
in this journey is we will not be 
successful with an approach of forcing 
people to do this. Where we’ve found 
success is finding what we refer to as 
like-mindedness.IE05 
 
Table 5.12: Learning (CF.3.2.3) (Author’s own) 
5.3.5.4 Coordination (DC) (CF. 3.2.4) 
In addition to having the capability to gain appropriate insights from Big Data, it is also vital 
to communicate and coordinate those insights, both internally and externally. The EMEA 
participants had strong opinions on this, believing that coordination is an important ability that 
enhances the linkage between all stakeholders in drug R&D, commercialisation, and delivery. 
It emerged that communication and coordination among different functions was improved and 
maximised via use case demonstrations. 
As one of the senior directors explained: 
 I mean you see some groups/ functions that, because of different use cases we’ve 
 done, see the value and then completely open up and say oh, we must share our data, 
 and to be honest, there are teams that don’t have.. countries for example, they don’t 
 have data and they are willing to open up and help as possible because they know it 
 will enable them to get access to the data that they currently don’t have because the 
 US team keeps it. IE13 
Although the new connectivity platform allowed effective coordination, participants explained 
that there was also a great number of horizontal communication exchanges that took place 
between different franchises within the countries. The company also tried out innovative ways 
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to promote vertical communication in order to align different company functions/operations 
(for example, between sales and marketing). For example, the market access department would 
promote vertical communication with other functions, such as medical, or commerce. 
Participants believed that this streamlined approach would lead to more effective coordination 
of functions across different countries. 
The company’s coordination capabilities are summarised in table 5.13 below. 
Definition (Coordination 
Capabilities) Examples 
in the literature 
(Authors) 
Dynamic 
Capability 
Appearance in The 
Case Study Company 
Direct quotes (comments) 
from Interviews and 
Secondary Data  Comment 
Coordination (Box. 3.2.4) 
Capabilities/processes connect 
and interface single activities 
through communication, 
scheduling, task assignment, 
collaboration, and other related 
activities. This is an important 
capability to deal with the 
changing business environment 
especially in Big Data case when 
there are fewer experiences and 
less good practice implications.  
Protogerou et al., (2011) 
 
 
Processes to connect and 
interface single activities 
through communication 
 
 
 
Scheduling, task 
assignment 
By demonstrating some of 
the use cases participants 
believed that they were able 
to improve linkage among 
different functions and 
maximised internal 
coordination. 
Improve coordination 
capabilities - there were lot 
of exchanges between 
different trades horizontally 
in the country. 
Innovative ways of 
promoting vertical 
communication. In this way 
the project members tried to 
align functions/operations 
across official kind of 
trades. 
 
 
I mean you see some groups/ functions 
that, because of different use cases 
we’ve done, see the value and then 
completely open up and say oh, we 
must share our data, and to be honest, 
there are teams that don’t have.. 
countries for example, they don’t have 
data and they are willing to open up 
and help as possible because they 
know it will enable them to get access 
to the data that they currently don’t 
have because the US team keeps it. 
IE13 
 
 
 
 
 
 
Table 5.13: Coordination Capabilities (CF. 2.3.4) (Author's own) 
5.3.6 Changed Capabilities in Response to New Opportunities (CF. 4) 
As a result of ongoing learning efforts, the project members from EMEA were able to name 
several new capabilities that they had developed that were distinct from and in addition to the 
connectivity platform and data harmonisation capabilities that had emerged as enhanced or new 
capabilities at the Global site. For example, referring to such new capabilities, the project 
director explained that some colleagues in the team had learned how to build dashboards using 
“Tableau”, business intelligence software that helps people visualise and understand data. This 
program also allows users to connect to and share any type of data in minutes. Participants 
stated that this new capability was already in use in some functions/countries, but at their site 
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the company was using PowerPoint presentations or Excel’s manual mapping, preparation of 
which took a great deal of time. The silo data culture was the cause of these different local 
practices at each function or country. 
The creation of a dashboard that had been developed in collaboration with the company’s 
leadership team using some of the latest data management software indicated the effectiveness 
of some of the practices that project members undertook in order to develop Big Data 
capabilities. The project members were proud of achieving such success in quite a short time:   
The Director IKU Data Science EMEA commented: 
 What we have now is huge. We have an AWS platform, Cloud-based system, with 
 multiple the technologies such as Hadoop and Cloudera, both that sit on it. And, than 
 along with the a full integration to a number of different analytical tools of Python, R, 
 SAS. Than along with the a layer of being able to kind of interpret that data to give 
 real-time analytics to folks through these apps, these custom-developed apps what 
 we’ve built And visualising that through Tableau. So to me it’s kind of like an art 
 work, a piece of art, very nicely constricted together. IE05   
Another new capability that was highlighted during the interviews was that of making use of a 
Salesforce-based portal, where different functions and countries were able to search through 
the catalogue of data and previous studies. With regards to changes to existing processes and 
new capabilities the Director of Medical Affairs stated that that the project members had 
conducted a survey across the different teams to understand  the change process, what worked 
with regards to new capabilities, and what had to be done to make such initiatives more 
successful. As he explained, there were incremental efficiencies that project members gained 
in various parts of the business, adding that: 
 This changed the way of the process, yes because now all data sets are merged into 
 one place, one –stop framework. However, really in terms of change management we 
217 
 
 need to have a right sequence of changes and activities internally so that we don’t try 
 to embrace too much. IE10 
The project members believed the new way of treating data, and development of the new work 
model, were progressing well. However, they also highlighted that there was a need to maintain 
it as a sustainable capability to support transformation in the longer term. The next short-term 
plan was to bring those use cases to life more actively as case studies, so that people in the 
organisation could see the transformational effects and become more engaged, and to think 
differently and more transformationally about Big Data initiatives. Use cases are good for 
offering suggestions that describe a particular application for a product or service, and often 
explain exactly how it’s done and why the product or service is the best for the job (Levy, 
2014). However, it is important to apply this knowledge at a macro-level before it can be 
decided whether it represents a good investment. 
The company’s changed capabilities in response to new opportunities are summarised in table 
5.14 below 
Enhanced or New 
Capabilities   
Marketing and 
IT Capabilities 
Direct quotes 
(comments) from 
Interviews and 
secondary data 
Comment 
Dashboards using Tableau 
 
Salesforce-based Platform 
 
 
 
 
 
 
 
 
Ability to connect, 
visualise and share any 
type of data in minutes. 
Ability  for different 
functions and countries 
to search through the 
catalogue of data and 
studies that have been 
conducted before 
 
Than along with the a layer of being 
able to kind of interpret that data to 
give real-time analytics to folks 
through these apps, these custom-
developed apps what we’ve built And 
visualising that through Tableau. So  to 
me it’s kind of like an art work, a piece 
of art, very nicely constricted together. 
IE05   
 
Table 5.14: Changed or New Capabilities in Response to New Opportunities (CF. 4) 
5.3 Summary of EMEA Findings 
The overall findings from the EMEA site are presented on Figure 5.3 The findings that are 
specific to this site are presented in yellow, whereas text in white refers to what EMEA shared 
with or, in some cases, derived from the Global site. Similarities and differences between the 
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Global site and EMEA are discussed in detail in the next section (5.4), while the rest of this 
section summarises the EMEA findings. 
It is clear that the Big Data initiative introduced by the Global site brought a transformational 
change to the site at EMEA, where the site leaders were forced to react quickly to adopt and 
implement Big Data initiatives in their part of the business. Implementing Big Data initiatives 
has been acknowledged as an innovative way of conducting business (IE01; IE07; IE09; IE10). 
Consequently, it was a recognised way towards to the goal of personalised medicines. 
Big Data opportunities at the EMEA site also were associated (IE01; IE02; IE07; IE09) with 
improving the way in which the company was serving its patients, generating new business 
opportunities, and speeding up and cheapening business cycle as a whole. 
However, after implementing fundamental capabilities that has been developed at the Global 
site of the company (Fig 5.2, section 4), understanding operations (clinical, marketing, IT, 
sales) from a digital/Big Data perspective presented a unique challenge to the company. To 
address this challenge a number of key activities, such as: communicate, discover, experience, 
learn and convince others how to benefit from this new resource, were utilised within this site 
(IE02; IE06; IE05; IE06; IE13). 
As expressed in section 3.2.1 of figure 5.3, developing a shared vision about the Big Data with 
the learning processes, which would become integrated into the corporate culture, believed 
(IE06; IE05; IE10) to have had a transformative effect on the company 
 
The emergence of newer skills which would allow both the effective use of new technology 
and the creation of a community of practice around it was found to be an essential factor for 
the transformational phase (IE02; IE08; IE10). 
It was evident (IG05; IG08) that for preparation for Big Data initiatives, the company could 
rely on internal skills, like the combined experience and abilities of the managers, especially 
when complemented with knowledge derived from networking, to enhance and build required 
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capabilities. However, it was also highly recommended that suitable personnel be hired as part 
of the transformation phase.  
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2. Big Data New Resource 
1. Digital Environment 
 
3.2.1 Strategic Competitive Response  
• Adopt and implement big data initiatives in EMEA part of the business. Understanding operations (Clinical, 
marketing, IT, sales) from a digital/big data perspective. Communicate, discover, experience, learn and convince 
others how to benefit from this new resource. (Sensing) 
• Positioning the project, Developing a shared vision about the big data with the learning processes,  integrate data 
driven culture to the EMEA. Hire the right personnel Creating a community of practice around big data for each 
function/ operation, (Seizing) 
• Partnering with external expert to continually update knowledge about the new resource (Seizing) 
Organisational Practices and Processes for Big Data Initiatives 
3.2 Dynamic Capabilities 
 
3.2.2 Learning  
Knowledge creation, acquisition, articulation, integration and codification practices and activities:  
• Series of regular workshops and practices. The immersion/experience practice. 
• Real-time updates through dashboards. 
• Systematic analysis and search for new solutions.  
• Holding ad-hoc discussions and meetings. 
              - Setting up a community of practice. 
              - Use case analysis 
              - The first-hand experience; Cross learning and sharing; Regular updates on processes, trainings. 
3.2.4 Coordination  
Align the organisation to the change/new elements/capabilities (Synapse platform, Data harmonization, 
Stream line data management)  
 
New analytical capabilities facilitated clinical information integration and provided evidence-based clinical practice. 
3.1 Existing Operational 
Capabilities  
3.1.1 Marketing  
• Collaboration for Innovation 
• Operating Globally/Different 
Markets  
• Build Sustainable Relationships 
with Customers 
• Understand Complex Customer 
Needs 
• Knowledge of the Competition 
• Emerging Market Ability  
3.1.2 IT 
• Integrated IT into Business 
Processes. 
• CRM 
4. Enhanced or New 
Capabilities (Marketing & 
IT) 
 
• A Service Catalogue (Reduce the 
duplication & Cost) 
• Digital Platform 
• A Cloud-Based Data Environment 
• Data  Harmonization (ability to 
deliver on data-driven decision 
making) 
• Data Access  
• New Kill Set: data scientists, digital 
experts 
• Ability to get the patient 360 degree 
view 
• Salesforce- Based Platform, 
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Figure 5.3: The Key Aspects of the Findings from The EMEA Site (Authors own. Developed 
based on the CF and findings of this study) 
 
Innovative approaches, such as having an opportunistic approach to respond strategically to 
challenges and opportunities that resulted from the new initiatives, were also found to be 
important activities at the EMEA site. Such abilities included networking and partnership with 
experts in the field to sense and seize Big Data opportunities and create knowledge for use by 
the EMEA site, although sensing and seizing activities at the EMEA site played a greater role 
in education than in strategy development. In particular, to enhance their sense and seize 
capabilities, partners were not chosen on the basis of a specific business question but rather in 
the pursuit of general education or best practice.  Great importance was attached to networking 
and partnership in the continual updating of knowledge about the new resource (IE05; IE07; 
IE10) 
Learning processes/activities such as experimentation, innovation, and risk-taking were also 
prominent at the EMEA site (IE10; IE16). 
Different learning practices such as first-hand experience, immersion practises, Cross-learning 
and sharing new initiatives externally and internally, regular updates on processes (success and 
failure), training, and workshops were identified at the EMEA site. 
 
In addition to fundamental capabilities that were having transformational effects on the 
company’s operations, EMEA project members were able to improve and expand these 
capabilities based on knowledge that had been created through the learning processes. 
It was also evident that (IE05; IE10) new capabilities (Fig 5.3, section 4) such as the Tableau 
dashboard and the Salesforce-based platform replaced old ways (PowerPoint, Excel) of 
managing and visualising data. In particular, these new analytical capabilities facilitated the 
integration of clinical information and provided evidence-based clinical practice. New systems 
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provide solutions to the problems of processing large volumes of data, manipulating it real-
time, and capturing all patients' visual data or medical records. In doing so, this analysis 
enabled the company to identify fresh business insights, leading to the discovery of previously 
unnoticed patterns in patients' related needs and future market trends. In this way the company 
was able to improve both its standards of quality of care and its ﬁnancial performance. Using 
new capabilities also enabled the company to streamline and reduce the time spent engaged in 
data management, and reduced the amount of costly data duplication. 
 
5.4. Global (US) vs EMEA 
Drawing on the findings presented earlier in sections 5.2 and 5.3 this section discusses the main 
managerial and organisational activities and processes that have been undertaken by both 
project teams (Global (US) and EMEA (Europe)) and highlights the similarities and differences 
between them. Table 5.15 summarises the main similarities and differences between the two 
projects’ processes and activities. For the purpose of clarity, there are two colours in table 5.15, 
with light-blue representing similarities and dark-blue denoting differences. 
 
Main Features and 
Processes /Activities 
Similarity  (S) 
Difference (D) 
USA/Global Europe/EMEA 
The company’s Big 
Data Initiative’s 
Aim / Objective 
S The Aim: Transform the company 
into a data-driven, personalised, 
and digitalised enterprise, leading  
to value-based healthcare. 
Objective: Build the fundamental 
and transformational capabilities to 
stimulate insights across the 
corporation: 
Focus on providing technologies 
and platforms that: 
1. Support seamless 
information sharing. 
information flow through 
an enterprise lens-across 
all functions. 
2. Develop digital 
capabilities. Help people 
develop relevant skills. 
 
The Aim: Transform the company 
into data-driven, personalised, and 
digitalised enterprise, that leads to 
value-based healthcare. 
Objective: Build the fundamental 
and transformational capabilities to 
stimulate insights across the 
corporation: 
Focus on providing technologies and 
platforms that: 
3. Support seamless 
information sharing. 
Information flow through 
an enterprise lens-across 
all functions. 
4. Develop the digital 
capabilities. Help people 
develop relevant skills. 
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The Project 
Aim/Objective 
D The main Aim: Identify 
opportunities for Big Data within 
the business and to pioneer a new 
way of working by utilising this 
new resource. 
Objectives: 
1. Pioneer a new mind-set 
with how data 
management and 
technology come 
together to impact and 
inform various ways of 
working. 
2. Launch a number of 
different communication, 
education, and 
collaborative 
communities of practice 
to help increase 
knowledge of Big Data 
initiatives. 
3. Build the foundation 
capability, resulting in 
incremental operational 
efficiencies 
The main Aim: Evangelise what the 
Global site had already achieved 
and help the company learn how to 
embed Big Data into their 
functions/franchises and day-to-day 
work in order to operate in a new 
digital world. 
Objectives: 
1. Exploring (sense and 
size) Big Data 
opportunities as well as 
spreading knowledge 
about the Synapse 
platform. 
2. Gain insights from the 
global project about the 
Big Data initiatives and 
make Synapse platform 
visible to different 
functions. Establishing 
new foundational 
capability. 
3. Communicate the clarity 
of objectives, to convince 
each of the country's (the 
company’s franchises) 
authorities to 
accommodate new 
processes to ensure that 
the Synapse platform was 
adopted. 
 
The Project/s size 
and individuals 
involved in the 
project 
D 10 individuals across the 
headquarters of the company, along 
with a few members form External 
Partners team. 
20 individuals across 7,500 global 
individuals. The EMEA project was 
led by a group of people from 
different franchises/functions and 
different countries. 
The Project 
Timeline 
D The project at the Global site. The 
project initially started in 2015 
The project at the EMEA site 
started after the Synapse platform 
was implemented and went live 
approximately Jun 2017 
Big Data 
objectives/value   
S • Improve operational 
effectiveness and deliver 
value to the organisation 
• New business 
development 
• Improve and extend 
customer relationships, 
generate new business 
opportunities 
• Time and cost efficiency 
• Improve and extend 
customer relationships, 
generate new business 
opportunities, and speed 
up and cheapen the 
whole cycle. 
 
• Improve organisational 
operational effectiveness 
and deliver value to the 
organisation 
• New business 
development 
• Improve and extend 
customer relationships, 
generate new business 
opportunities 
• Time and cost efficiency 
• Improve and extend 
customer relationships, 
generate new business 
opportunities and speed 
up and cheapen the whole 
cycle. 
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Project Related 
Challenges 
   
1.Cultural 
transformation 
 
S Develop data driven culture. 
 
Develop data-driven culture. 
 
2.Data Access, 
Governance, Policy, 
Law. 
D Free access to the patients’ data. The 
US allows access to claims data, 
(almost public information). They 
have access to a risk management 
program’s data. 
 
 
In Europe, data is more 
commercialised due to different 
data governance laws and 
ownerships. This results in limited 
access or extremely high cost of 
data. 
Many limitations around: 
• Data protection and 
anonymization. 
• Legal issues 
• lack of data privacy laws 
 
3.Technology and 
Capabilities   
 
S • Operating capabilities 
• System integration 
• Reconfiguration 
• Silo approach 
 
 
• Operating capabilities 
• System integration 
• Reconfiguration 
• Silo approach 
 
 
Activities/Abilities 
and 
Practices/Processes 
 
   
1.Management 
activities and 
practices: 
 
D -Understand the power of the new 
resource and processes in order to 
align changes. 
• Value estimation. 
• The fundamental 
objectives 
• Develop strategies for 
how to realise the value 
from Big Data 
• Organisational alignment   
 
 
-Understand the power of the new 
resource and processes in order to-
align changes. 
• Inward work, getting 
advice to implement 
opportunities & 
reorganise the EMEA. 
• Engaged with the broader 
policy stakeholders, 
public institutions, 
legislators, European 
commission and others. 
 
Sense, Seize, and 
Learning practices   
 
D Developing Big Data vision and 
data-driven culture. 
 
• Communication & 
engagement. 
• Workshops and practices: 
-The immersion/experience 
practice. 
-Real-time updates through 
dashboards. 
-Systematic analysis and search for 
new solutions. 
-Holding ad hot discussions and 
meetings. 
-Set up a community of  practice. 
-Use case analysis. 
 
-Developing Big Data vision and 
data-driven culture   
 
• Increase awareness of 
Synapse and new 
capabilities. 
• Build trust and 
commitment. 
• Sensing and seizing 
• Communication and 
engagement 
• Provide real-time updates 
of the status of the 
development through 
dashboards 
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2.Organisational 
activities / processes 
 
   
1. Learning 
 
 
 
D -Gaining knowledge about Big 
Data opportunities (Sense and 
seize) 
• Mind mapping, 
• Discovery, hands on 
experience, 
• Ad-hot sessions, 
• Individual insight or 
senior management 
incentive and cross- 
functional 
communication 
 
-Knowledge creation, activities: 
 
-Partnering with external experts in 
the filed for re-establishing 
required processes and capabilities. 
 
-Gaining knowledge about Big Data 
opportunities and New capabilities. 
• New Technology, 
• Skill acquisition. 
• Structure and governance. 
• Knowledge creation, 
activities: repetition, 
experimentation, analysis 
of small mistakes. 
 
3.Transformation 
process: 
Reconfiguration & 
Coordination 
 
D -Knowledge acquisition, and 
dissemination. 
-Networking and partnership: 
-Determine the different internal 
work streams. 
- Cultivate a community of new 
expertise 
-Knowledge codification and 
dissemination (e. g. EMEA 
project’s activities). 
 
-Implementing new 
elements/capabilities corporation 
level (Synapse platform, Data 
harmonization) reinforced 
configuration and coordination of 
existing resource and capabilities. 
-Technological transformation 
changed the way business was done 
but not the business itself and it 
provided a building block enabling 
grow. 
 
 
New Capabilities S • A cloud-based analytic 
environment 
• Big Data service 
catalogue. 
• Big Data connectivity 
platform, Synapse. 
• The patient 360 degree 
view. 
• Data harmonization 
-data governance, 
-data standards 
-data privacy and security 
• Data-driven decision 
making 
 
• A cloud-based analytic 
environment 
• Big Data service 
catalogue. 
• Big Data connectivity 
platform, Synapse. 
• The 360 degree patient 
view 
• Data harmonization 
-data governance, 
-data standards 
-data privacy and security 
• Data-driven decision 
making 
 
 
Table 5.15: The Main Similarities and Differences Between Two Projects’ Processes and 
Activities. (Author's own) 
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-The company’s Big Data Initiative’s Aim/ Objective 
The overall aim of the company’s Big Data initiatives was to build those operational 
capabilities that are needed for the corporation to be able to start operating in the new data 
environment. In particular the aim was to be able connect with and create insights around the 
company's patients, in a world where the availability of different data sources and the potential  
of different analytic techniques means that business can be conducted faster and more cost-
effectively. The decision to implement Big Data initiatives at the case study company was taken 
in early 2015 and was made by the company’s CEO. This was supported by the senior 
leadership of the company and resulted in development of objectives, which were to build the 
fundamental and transformational capabilities for Big Data initiatives and to stimulate insights 
across the corporation. Senior leadership played an important role in developing the US-based 
Global project for the implementation of Big Data initiatives. In its own turn, the EMEA project 
emerged later, with a mission to roll out the innovations and technology that had been 
developed at the Global site. This led to awareness of the company’s ability and willingness to 
exploit the new asset (Big Data) to develop required capabilities. 
- The Projects (Global & EMEA) Aim/Objective 
The overarching aim for both projects was to transform the company to a more data-driven, 
personalised, and digitalised enterprise, and so lead to value-based healthcare. However, the 
difference in the detailed aims and objectives for each project resulted in differences between 
the organisational and managerial processes discussed in the previous sections. As was 
mentioned earlier, the IKU/ Big Data initiatives at the company’s headquarters (Global/US) 
initially started around 2015, where the project was originally planned and delivered. The main 
aim of the project was to identify opportunities for Big Data within the business and to pioneer 
a new way of working by utilising this new resource. Accordingly, the project objectives were: 
to identify potentially valuable synergies and opportunities, to create solutions for Big Data 
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initiatives on an enterprise-wide scale, and to build the foundation capability. Considerable 
attention was given to pioneering a new mind-set regarding how data management and 
technology can come together to impact and inform various ways of working. 
In EMEA, at the time the interviews were conducted (July 2017), the project had only been 
running for approximately a year. Therefore, the IKU project in the Global/US was more 
advanced in terms of time, awareness, and progress. However, besides the timeline there were 
several factors which are important to highlight – for one, the aim and objectives of the EMEA 
project were to evangelise the achievements of the Global site and help the company learn how 
to embed Big Data into their functions/franchises and day-to-day work in order to operate in a 
new digital world. Along with exploring (sensing and seizing) Big Data opportunities for each 
function and franchise, the EMEA project’s objectives were to gain insights from the Global 
project about Big Data initiatives, to make the Synapse platform visible to different functions, 
and to establish new foundational capability. A great deal of priority was attached to 
communicating the clarity of objectives, to convince each of the country's (the company’s 
franchises) authorities to accommodate new processes to ensure that the Synapse platform was 
widely adopted. 
To help ensure the success of the transformation, the EMEA project included a number of 
slightly different dynamic capabilities, such as: learning (knowledge integration and 
dissemination), reconfiguration, and collaborative communities of practice. The intention was 
to gain insights from the Global project about Big Data initiatives and to make the Synapse 
platform visible to different functions/franchises, in particular by focusing on the European 
sites, to help the company learn how to embed Big Data into their functions/franchises and 
day-to-day work in order to operate in the new digital world. On the other hand, the Global 
project was the company’s first attempt at identifying opportunities for Big Data within the 
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business and of pioneering a new way of working by utilising this new resource and develop 
fundamental capabilities. 
- Big Data Objectives/ Value for the Business 
The overarching aim for both projects were to transform the company to more data-driven, 
personalised, and digitalised enterprise and so lead to value-based healthcare. In particular, the 
aim was to improve: 
• organisational operational effectiveness and deliver value to the organisation 
• customer relationships, generate new business opportunities 
• time to market and cost efficiency. 
- Challenges 
The data suggested that the main challenges for both sites during this journey related to the 
internal processes such as: organisational alignment to strategic choices, cultural 
transformation, and right skill-set (capabilities). With the corporation size, and the country 
boundary factors dealing with the multinational culture reflected the problems.  
Two types of issue that posed particular challenges to the development of new processes were:   
I. Technical issues: the technical ability and management of Big Data. 
II. Management issues: organisational alignment, cultural transformation, and the 
right skill-set (capabilities). 
An innovative spirit, based on both company values and flexibility, was found to be a positive 
driver for both projects. However, the challenge of developing a data-driven culture was 
common to both sites. Breaking down the traditional silo approach in order to gain operational 
efficiencies, and changing peoples’ mind-set regarding the data silo approach, was the biggest 
ongoing challenge for cultural transformation. 
However, besides a data-driven culture, there were a few factors such as data governance, data 
regulation, and European data policy law that the project members highlighted as having 
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slowed down the project at EMEA. As discussed in section 5.2, the FDA and other regulatory 
authorities were promoting Big Data initiatives in the USA. On the other hand, in Europe, 
participants were hoping that the economic and social pressure that were the results of 
increasing digitalisation, globalisation, and differentiation of data in healthcare ecosystem 
would prompt changes in the laws surrounding data governance and data policy. Consequently, 
the IKU/Big Data project was also more advanced in the Global site in terms of data 
partnerships and governance. Moreover, fitting the company’s overall Big Data utilisation 
strategy into each European country was an ongoing challenge to the company. 
-Sense, Seize 
The sense, seize, and learning processes have helped the company to reconfigure its operational 
capabilities, which had a major role to play in identifying, moderating/enhancing, or 
developing new capabilities for Big Data at every phase of the project. The specific practices 
of senior management, such as immersive practices at both sites, helped to increase the trust in 
Big Data initiatives of employees when new resources and processes were introduced within 
the organisation. In addition, senior management had an important role in innovating, 
orchestrating, and also participating in the capabilities development process by providing 
directions and guidance in ways that involved the whole organisation. In ways that that 
involved the whole organisation, while on-the-job learning and the insightful development of 
new processes played a large part in the successful adoption of Big Data initiatives. 
Sense, seize, and reconfiguration activities were more intensive (prevalent) at the Global site. 
Drawing on their sensing and seizing capabilities at the preparation stage, the company was 
able to understand the power of the new resource (Big Data) and the processes required to 
implement changes. Project members were able to develop fundamental objectives and 
strategies for realising value from Big Data and, just as importantly, they were able to align the 
organisation to the expected changes, also demonstrating their coordination capabilities. 
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Once the background work had been completed at the Global site, and fundamental capabilities 
had been implemented, the sensing and seizing capabilities at the EMEA site were used more 
for educative purposes. In particular, the sensing capability was used to gather new knowledge 
in order to fully understand Big Data opportunities and the need for change. 
- Learning and Coordination 
Learning activities and processes at the Global site enabled the reconfiguration of existing 
operational IT capabilities. At the EMEA site, however, learning activities and processes 
supported the continuous improvement of the overall project. Having the ability to generate, 
disseminate, and respond to Big Data opportunities (sensing and seizing capabilities), the 
company was able to introduce new methods of managing data.  One of the results of this was 
a new way of managing patients’ data that positively affected the way in which the company 
developed its products and served its patients. According to participants, with this stream-lined 
approach to data management the company was able to improve operational effectiveness (IT 
and marketing capabilities) and reduce costs. With help from networking, the company was 
able to more quickly generate new knowledge (learning capabilities) about new resources and 
technological breakthroughs and to reconfigure existing and build technologically 
sophisticated new technical capabilities (a cloud-based platform, data harmonization 
capability). Reconfiguration activities, supported by knowledge articulated from networking 
and partnerships, were used at the Global site to achieve evolutionary fitness (Teece, 2007) in 
the new digital/Big Data environment, while the coordinating capability helped implement and 
deploy the reconfigured operational capabilities at the EMEA site. 
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5.5 Summary of Overall Findings. Model of Organisational Practices in Big 
Data Adoption and in the Development of Required Capabilities. 
 
From the finding’s frameworks (Fig 5.2 and 5. 3) that were presented in sections 5.2 and 5.3, 
and from table 5.15 (The Main Similarities and Differences Between the Two Projects’ 
Processes and Activities in section 5.4), it can be concluded that in a digital environment where 
technological innovation requires fast organisational response and change, dynamic 
capabilities such as strategic competitive response, learning, reconfiguration, and coordination 
become tools that allow firms to build and renew operational capabilities.  
Figure 5. 4 below merges figures 5.2 and 5.3 into a representation of organisational practices  
in Big Data adoption and in the development of required capabilities. In particular the model  
is derived from the research findings discussed above and the literature-based conceptual 
framework that was developed earlier in this study (See Chapter 3).  
This framework classifies the overall process, for analytical purposes, into processes and 
underlying managerial and organisational activities that were common for both projects and 
confirms the important role played by dynamic capabilities in the development of capabilities 
for Big Data. In the next chapter the model is compared with the current literature (see Chapter 
6) and extends it by providing evidence based reasoning about Big Data capabilities 
development processes. 
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2. Big Data New Resource 
 
1. Digital Environment 
 
 
3.2.1 Strategic Competitive Response  
 
An Ability to generate, disseminate, and respond to Big Data opportunities 
• Sensing Big Data Opportunities 
• Seizing/ Establishing required processes and capabilities  
Organisational Practices and Processes for Big Data Initiatives 
3.2 Dynamic Capabilities 
 
3.2.2 Learning 
Knowledge creation, acquisition, articulation, integration and codification practices and activities:  
Learning experiences: 
• Repetition 
• Experimentation 
• Analysis of small mistakes 
• The immersion/experience practice 
3.2.4 Coordination  
• Effectively articulating and integrating knowledge (increasing awareness about new resource , developing 
shared vision, aligning organisational change ) 
• Good communication and collaboration Ability between the management team, management levels and 
department staff. 
3.2.3 Reconfiguration  
Networking & Partnership  
• Cultivate a community of new expertise. Reconfigure existing and build technologically sophisticated new 
technical capabilities. 
3.1. Existing Operational 
Capabilities  
3.1.1 Marketing  
• Collaboration for Innovation 
• Operating Globally/Different Markets  
• Build Sustainable Relationships with 
Customers 
• Understand Complex Customer Needs 
• Knowledge of the Competition 
• Emerging Market Ability  
3.1.2 IT 
• Integrated IT into Business 
Processes. 
• CRM Capabilities 
• Silo Management of Data 
• Data Security 
 
 
4. Enhanced or New 
Capabilities (Marketing & IT) 
1. Sophisticated Infrastructure 
Capabilities     
• Digital Synapse Platform 
• A Cloud-Based Data Environment 
• Data  Harmonization  
• A Service Catalogue 
• Salesforce- Based Platform 
• Data Visualization Ability 
• Ability to get the patient 360 
degree view 
2. Ability to Reduce Silo Approach. 
(Stream line data management) 
3. Data Driven Culture  
4. New Skill Set: Technical Skills 
data scientists, digital experts, 
Managers skills. 
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Figure 5.4: The Model of Organisational Practices in Big Data Adoption and Required 
Capabilities Deployment (Author's own) 
Even though, as was discussed in the previous section, some differences existed in how 
dynamic capabilities were put to use between the projects, it was evidenced that the company 
gradually used dynamic capabilities (Box 3.2) that were embedded in the company’s 
organisational processes. By using these abilities the organisation modified the company’s 
resource and capabilities configuration and influenced the development of new capabilities 
(Box 4) for Big Data. In response to changes in the digital environment (Box 1) for the adoption 
of Big Data (Box 2), managerial and organisational abilities such as: strategic competitive 
response (Box 3.2.1), learning (3.2.2), reconfiguration (3.2.3), and coordination (3.2.4) guided 
the overall Big Data innovation process in the company. Together they played a major role in 
identifying, moderating/enhancing, or developing new capabilities at every stage of the Big 
Data project. While the digital environment served as an enabler for the Big Data initiative, the 
company’s internal competencies and capabilities (IT, Marketing) had a major influence in 
successfully moving the overall project forward. However, it was also found that the nature of 
Big Data required a certain amount of reconfiguration, and the further development of such 
capabilities. The data indicated that the preparation process for Big Data initiatives in the case-
study company overall was triggered by the company’s strategic competitive response ability 
(Box 3.2.1), which allowed it to first sense the opportunities, an then to seize the opportunity 
that enabled the company to identify capabilities gaps (silo approach, connectivity, data 
management skills), and finally to determine a need for the reconfiguration of existing 
resources and capabilities. It was also evident that specific learning practices and abilities (Box 
3.2.2) triggered capabilities development and guided the overall Big Data adaption process at 
the case-study company. The empirical evidence illustrates how purposeful learning practices 
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and decision at the top management level in both teams influenced the development of Big 
Data required capabilities in a way that would be unlikely to have happened without those 
abilities, support, and practices. As expressed in the above sections, the development of a 
shared vision of Big Data and the learning processes (Box 3.2.2) which would become 
integrated into the corporate culture is believed to have had a transformative effect on the 
company.  
In addition, the ability to coordinate (Box 3.2.4) different functions and franchises (Marketing,  
IT, policy, different countries) was also necessary for progress to made in Big Data initiatives.    
The implementation of new capabilities such as the Cloud-based environment, the data service  
catalogue, and the Synapse platform was followed by the introduction of new elements such as  
a  stream-lined  data  management  approach,  and  improved  coordination.    The  new  data  
connectivity  platform Synapse and  the  Cloud-based  digital  environment  had  a  significant  
operational impact, such as: a reduction in the “silo” approach to moving and processing data  
(data  management),  improved  storage  ability,  improved  data  accountability,  and  data 
harmonisation (data governance). A service catalogue reduced the duplication of data, which 
consequently  reduced  the  cost  of  acquiring  and  managing  data.  Thus,  building  these 
foundational capabilities allowed incremental operational efficiencies to be developed. Most 
importantly, the company was able to arrive at a 360-degree view of customers, which helped 
improve customer relationships. These new capabilities enabled the company to realise the 
value of data across the organisation and helped to increase the entire organisation’s acumen 
concerning data and analytics. 
 
5.6 Chapter Summary 
The chapter presented findings based on an empirical data/ study. The findings are presented 
in two parts based on the Global (US) and EMEA (Europe) sites of the company while each 
was preparing for the adoption of a Big Data initiative. Section 5.2 presented the analyses of 
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the company’s Global site in its preparation for the innovation, including discussions about the 
processes that were introduced and examined. The findings from the EMEA site are presented 
in section 5.3.  Section 5.4 then evaluates differences between the two and summarises the 
findings chapter. The findings for both sites are synthesized and discussed next in Chapter 6. 
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Chapter 6: Discussion and Implications 
6.1 Introduction 
This chapter draws on the findings from Chapter 5 and cross-references with the literature 
discussed in Chapter 2. In addition, the findings are fully expanded and elaborated by reviewing 
and analysing additional literature around domains related to the study (Big Data, required 
capabilities, and dynamic capabilities). The aim of this chapter is to discuss the findings and 
determine the extent to which the research questions of the study have been answered. 
The chapter starts by presenting a short reminder of the research problem and the aims and 
objectives of the research (6.2), followed by discussion of how the research objectives were 
met in relation to the research findings (6.3). It continues with a summary that emphasises the 
contribution that this research represents (6.4). 
The main research questions that underpinned the study were: 
1. Why did an MNC in the pharmaceutical industry prepare for Big Data adoption? 
(RQ1) 
And 
2. How did the company approach the issue of using Big Data and how did they 
identify and develop their capabilities for Big Data? (RQ2) 
I. What new capabilities did they develop? 
II. How did they develop these new capabilities? 
 
6.2 Overview of the Research Problem Aim and Objectives 
Motivated by increased academic and practical/managerial interest, as well as by the increasing 
importance of the Big Data phenomena, this research aimed to identify how Big Data initiatives 
are currently managed and implemented for driving innovation in the pharmaceutical industry. 
While considerable effort has been made to take into account the importance of Big Data as a 
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new strategic resource (Davenport, 2012) and highlighting the open-ended potential of this new 
resource (Boyd and Crawford, 2012; Davenport, 2012; Chen et al., 2012) that can be explored 
in a variety of ways (Wamba, 2017; Mikalef et al., 2017), so far, little is known about the 
processes and structures necessary to orchestrate this new resource into a firm’s existing 
resources and capabilities. In other words, the main focus of the current literature is on the 
resource-picking aspect (Makadok, 2001) of Big Data, but less is known about the activities 
required in order to develop the capabilities required to leverage this new resource strategically 
(Wang et al., 2012). Thus, a lack of understanding of the capabilities development process for 
Big Data is seen as one of the biggest barriers to the adoption of Big Data initiatives (Mikalef 
et al., 2017). 
This study looked at the company’s operational and dynamic capabilities, which together 
constitute organisational capabilities (Helfat and Peteraf, 2003; Teece, et al., 1997). 
Organisational capabilities are necessary for business transformation in the case of Big Data 
initiatives, so investigating what capabilities exist, how they are deployed, and the process by 
which they are upgraded to meet the demands of Big Data was fundamental to this study. The 
purpose of this study was to contribute to the current understanding of how Big Data initiatives 
and required capabilities come about in an MNC in the pharmaceutical industry. The main 
academic objectives therefore were to explore the adoption of Big Data initiatives and the 
practices and processes that supported the development of required capabilities in the 
pharmaceutical company. Thus, the intention of this thesis was to develop a step-by-step 
foundation of understanding and to shed light on the capabilities development process for Big 
Data initiatives, including how the company prepared for and utilised this resource. The 
findings are presented and discussed in this chapter in relation to the research objectives and 
the research questions. It should be noted that in the interests of grouping related themes and 
maintaining flow in this chapter, the second sub-question of RQ2: How did the company 
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develop these new capabilities? is actually discussed before the first sub-question of RQ2: What 
new capabilities did the company develop? 
The main contribution of this study is identified as the model of organisational practices in Big 
Data adoption and in the development of required capabilities discussed in previous section 
(Figure 5.4).  As mentioned before the model was derived from the research findings and the 
literature-based conceptual framework (See Chapter 3) that was developed earlier in this study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
239 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Big Data New Resource 
 
2. Digital Environment 
 
 
3.2.1 Strategic Competitive Response  
 
An Ability to generate, disseminate, and respond to Big Data opportunities 
• Sensing Big Data Opportunities 
• Seizing/ Establishing required processes and capabilities  
Organisational Practices and Processes for Big Data Initiatives 
3.2 Dynamic Capabilities 
 
3.2.2 Learning 
Knowledge creation, acquisition, articulation, integration and codification practices and activities:  
Learning experiences: 
• Repetition 
• Experimentation 
• Analysis of small mistakes 
• The immersion/experience practice 
3.2.4 Coordination  
• Effectively articulating and integrating knowledge (increasing awareness about new resource , developing 
shared vision, aligning organisational change ) 
• Good communication and collaboration Ability between the management team, management levels and 
department staff. 
3.2.3 Reconfiguration  
Networking & Partnership  
• Cultivate a community of new expertise. Reconfigure existing and build technologically sophisticated new 
technical capabilities. 
3.1. Existing Operational 
Capabilities  
3.1.1 Marketing  
• Collaboration for Innovation 
• Operating Globally/Different Markets  
• Build Sustainable Relationships with 
Customers 
• Understand Complex Customer Needs 
• Knowledge of the Competition 
• Emerging Market Ability  
3.1.2 IT 
• Integrated IT into Business 
Processes. 
• CRM Capabilities 
• Silo Management of Data 
• Data Security 
 
 
4. Enhanced or New 
Capabilities (Marketing & IT) 
5. Sophisticated Infrastructure 
Capabilities     
• Digital Synapse Platform 
• A Cloud-Based Data Environment 
• Data  Harmonization  
• A Service Catalogue 
• Salesforce- Based Platform 
• Data Visualization Ability 
• Ability to get the patient 360 
degree view 
6. Ability to Reduce Silo Approach. 
(Stream line data management) 
7. Data Driven Culture  
8. New Skill Set: Technical Skills 
data scientists, digital experts, 
Managers skills. 
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Figure 6.1: The Model of Organisational Practices in Big Data Adoption and Required 
Capabilities Deployment (Author's own) 
6.3 Findings, Discussions and Implications 
The main findings in relation to the first research question and the model can be summarised 
as follows: 
RQ1. Why did an MNC in the pharmaceutical industry prepare for Big Data adoption? 
The first objective of this study in relation to RQ1 was to investigate and explore changes in 
the environment and processes which persuaded the company to start a Big Data initiative.  
This research has found that the major influential factors the company considered in the 
adoption of Big Data were: 
I. Understanding of the digital environment in which the company expected to be 
operating in a few years’ time. The Big Data initiatives project at the case study 
company was triggered by the need to adapt to the dynamics of a new digital 
environment 
II. The value that the company assumed could be obtained from the new resource 
(Big Data) 
III. The crucial support of senior managers in coordinating the deployment of the 
new resource, as well as in innovating, orchestrating, and participating in the 
capabilities development process by providing direction and guidance through 
specific innovative practices, such as immersion/experience practices. 
6.3.1 Digital Environment 
The development of a Big Data initiative and associated strategies at the case study company 
was largely influenced by the understanding of the digital environment in which the company 
expected to be operating in a few years’ time. The Big Data initiatives project at the case-study 
company was triggered by the need to adapt to the dynamics of a new digital environment 
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(Gupta and George 2016). The ways in which this digital environment could be said to be 
dynamic rest on the rate of change in technology (Chen et al., 2012) and the amount of 
industrial innovation this causes (Li and Liu, 2014), as well as consequent uncertainty about 
actions that could be taken by competitors and customers (Wilden et al., 2013). Arguably, 
sensing and responding to the newly-arising opportunities has been acknowledged (Setia et al., 
2018) as one of the important activities needed to achieve evolutionary fitness in the digital 
business environment (Teece, 2018). However, it was also important to evaluate various 
options to accommodate the identified opportunities within the company. The first step in 
achieving this goal was to develop knowledge about the new resource of Big Data and to 
identify required capabilities.  
Prior to the implementation of new Big Data initiatives, the company’s strategic choices existed 
in the forms of intentions, open-minded leadership, and individual and collective minds 
(Mintzberg and Waters, 1985). Intentions were not necessarily well-defined before their 
realisation, but they directed future choices and actions, influenced by different internal and 
external factors. For example, it was evidenced that factors entering from the external 
environment (Belliveau et al., 2002; Helfat et al., 2007) such as economic pressure, the FDA, 
and some of the regulatory authorities that had started to promote and embrace Big Data 
initiatives, offering solutions, consultancy and/or data-driven transformation, enabled the 
company to discover new ideas and direct the innovative initiatives. In particular, the 
recognised advances and trends happening in the new digital environment, such as digital 
health, personalised medicine, and value reimbursement were all influencing the new initiatives 
and the adoption of Big Data in the case-study company. 
The development of Big Data initiatives was also based on the intentions of the company’s 
senior management (Makalef et al., 2017), which served as the foundations of the company’s 
strategic goal and as the basis of the actions that it took in response to the new opportunities 
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offered by Big Data as a new resource and source of economic value (Galunic and Rodan, 
1998). However, as success is not simply a question of making an accounting profit, to be 
deemed successful a new activity must turn out to have been a better use of the firm's resources 
than any alternative use (Penrose, 1959, p.178). This means that the Big Data initiatives have 
to reflect the strategic decisions and long-term vision (Palem, 2014) of engaging with Big Data 
activities, which depends on prior learning experiences, which in turn depends on sensing and 
seizing Big Data opportunities. A Big Data adoption project must satisfy the company’s pre-
established objectives as well as make better use of the organisation’s resources. These efforts 
include technology acquisition (Wamba, 2017), resource development (Gupta and George, 
2014) redesign of existing processes, (Garmaki, et al., 2016) and learning (Tecee, 2007). 
However, first of all, there is a need to understand what the expectations are regarding Big 
Data, and what the company has to do to achieve it (Gandomi and Haider, 2015). In other 
words, the question of what values of Big Data are fundamental for such initiatives for the 
company should be addressed before implementation begins. 
6.3.2 The Value Estimation for the New Resource (Big Data). 
The findings of this study indicate that a Big Data initiative was also strongly influenced by 
the way in which senior managers understood the role of Big Data, and the level of strategic 
relevance that this new resource was believed to have. The strategic thinkers at the case-study 
company clearly felt the need to clarify the value of Big Data, and the extent to which Big Data 
was expected to generate economically valuable insights for the company (Wamba et al., 2015) 
before implementation. This allowed specific measurable targets to be set for given initiatives, 
and by doing so it was possible to evaluate and determine the effectiveness of a chosen 
approach. This finding is in line with Braganza et al (2017), who argue that for Big Data to be 
considered a truly strategic resource, senior leaders need a process that can be implemented to 
ensure that expected benefits are delivered from investments made in organisational resources 
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for Big Data. It's possible that such an approach would also reduce the probability of failure in 
Big Data projects. As indicated in previous studies (McAfee and Brynolfsson, 2012; Gandomi 
et al., 2014), the reason behind the failure of some other Big Data initiatives was that executives 
often simply did not understand which values of Big Data were fundamental to the success of 
their businesses, and were not aware of how much it would cost or how long it would take to 
implement this new resource. Consequently, it is hard to predict the benefits company can have 
from such initiatives. Regarding capability development for such initiatives, similar firms with 
the same level of competencies may develop it in different ways, since their priorities regarding 
Big Data may be different, and their capability development might be contingent upon a range 
of internal and external factors (Mikalef et al., 2017). 
6.3.3 Senior Managers’ Support 
Lack of managerial support is also cited as a critical factor affecting the success of Big Data 
initiatives (LaValle et al., 2014). Arguably, managers should have the ability to understand the 
current and predict the future needs of different business units, customers, and other partners 
(Mata et al., 1995). However, open-minded leadership capable of anticipating the need for 
leveraging Big Data despite other competing internal priorities had a direct impact on the drive 
to begin Big Data initiatives at the case-study company. Senior managerial activities in support 
of the deployment of Big Data initiatives, based on their perceptions, abilities, and choices 
(Teece, 2007; Ambrosini et al., 2009), had a profound impact on how Big Data capabilities 
were identified and developed in the case-study company. Furthermore, senior management 
support and activities had a positive influence not only at the preparation stage of the adoption 
of new initiatives, it also reduced resistance to change (in this sense meaning for the firm to 
become culturally more data-driven) (Duan et al., 2012) at the implementation and 
transformation stages of Big Data initiatives. In addition, such was important because senior 
management could identify the value that Big Data would bring to the company, and had the 
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authority to ensure that resources were allocated as necessary in support of the adoption of Big 
Data (Braganza et al., 2017). 
The objective of the Big Data project in the case-study company was to transform the company 
into a data-driven, personalised, and digitalised enterprise, ultimately leading to value-based 
healthcare. As a further incentive, a number of synergies and opportunities were identified 
during the preparation stage. Understanding and defining the value of Big Data at the company 
was based on three broad sources of benefits: improvement of the organisation's operational 
effectiveness (McAfee and Brynjolfsson, 2012 and Chen et al., 2012); new business 
development (Aaltonen and Tempini, 2014) and improving time-to-market and cost efficiency 
(Srinivasan and Arunasalam, 2013). These factors were further defined as follows: 
1. Improving the organisation's operational effectiveness and delivering value to the 
corporation through the generation of unique knowledge and insights, which in turn leads to 
the ability to make competitively advantageous decisions (Banasiewicz, 2013). Of particular 
value was the inclusion of real-time data in decision-making, which resulted in customer 
information being converted into knowledge useful to the company (McAfee and Brynjolfsson, 
2012), as well as start value-based reimbursement, which is an outcome-driven model that 
focuses on quality-of-care metrics (Swan, 2013). The aim of these analyses was to understand 
disease outcomes and their associated risk factors in ways that would improve patient care. 
 2. New business development; improve and extend the management of customer relationships. 
Accelerate the individualisation of medical treatments and personalised medicine by achieving 
a 360-degree patient view (Yaqoob et al., 2016; Deloitte, 2014). Generate new business 
opportunities and new markets. 
3. Time-to-market and cost efficiency. Speed up and cheapen the entire business operations 
cycle and improve its efficiency (Manogaran et al., 2017), in particular improve drug 
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development time and its associated time to reach the marketplace, thus reducing costs 
(Srinivasan and Arunasalam, 2013) 
The pre-identified values listed above served as the aim and objectives for the company’s Big 
Data initiatives, and as such influenced the process of capability identification and 
development. As has previously been mentioned in this thesis (Chapter 2), the value of Big 
Data does not arise from its being owned; it only has economic value if it is implemented 
effectively, deployed, and combined with existing resources and capabilities. Arguably, there 
is a need to develop strategies for defining and realising value from Big Data which was 
achieved through the sensing and seizing, learning and reconfiguration, and coordination 
abilities at the case-study company. 
RQ2 How did the company approach the issue of using Big Data and how did it identify 
and develop its capabilities for Big Data? 
- How did the company develop capabilities for Big Data? 
The second objective of this study in relation to the second research question was to examine 
and explore the processes that enabled the company to adopt Big Data practices effectively. As 
illustrated in model 6.1, the study investigated capabilities (operational and dynamic) that are 
related to the successful adoption of Big Data initiatives. 
The Big Data initiatives and the development of required capabilities at the company were 
guided by the set of managerial and organisational activities and processes that reflected the 
evolutionary process (i.e. gradual development) of learning in which the company engaged 
throughout the Big Data adoption projects. In particular, the findings with regards to the second 
research question can be summarised as follows: 
1. The major influential factors in determining and developing Big Data capabilities were:  
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I. The processes of sensing and seizing that allowed the company to understand 
the new resource (Big Data) and to develop key objectives for realising value 
from this new resource: 
Interaction between multiple factors, such as partnerships, and networking, 
enabled the company to intensify its sensing and seizing abilities to fine-tune 
the Big Data initiatives and to formulate responses/reconfiguration 
subsequently, which in turn also helped to develop new capabilities. The major 
fundamental capabilities in the case-study company at the preparation stage 
were developed based on knowledge acquired from networking and 
partnerships. 
II. The processes involving learning experiences, including repetition, 
experimentation, and analysis of small mistakes that manifested managerial and 
organisational practices that have helped to identify an opportunity or need for 
change as well as formulating a response to it.  
III. The transformation processes, where reconfiguration and coordination activities 
enabled the company to deliver the Big Data initiative. 
2.  Two key challenges were: 
I. Technical issues - the technical ability and management of Big Data. 
II. Management issues: organisational alignment, cultural transformation, and 
suitable skill-sets. 
o The organisation’s cultural transformation was central to the Big Data-
related changes that needed to be made in the company and had a vital role 
in the adaption and/or development of its capabilities. 
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o Achieving a corporate culture that supports Big Data requires changing the 
mind-set of the people, which itself is influenced by the existing culture. 
Development of a Big Data culture is an incremental process, and 
recognition of the need to enhance or develop new capabilities for this new 
resource emerges as a result of this gradual process. 
 
6.3.4 The Processes of Sensing and Seizing 
Findings show that the process of preparing for Big Data initiatives in the case-study company 
was triggered by sensing the opportunities, followed by the development of an initial idea of 
how to seize the opportunity or respond to the need to adapt, and the subsequent 
implementation of this idea. Sensing a Big Data opportunity, or sensing the need to change, as 
well as formulating a response, all required sophisticated approaches for discovering and 
exploiting new business opportunities (Mikalef et al., 2017). Therefore, the ability of senior 
management to accurately sense changes in the competitive environment (Teece, 2007), 
including potential shifts in technology (Wamba, 2016), competition, customers, and 
regulations (Hirt and Willmott, 2014) was equally important for both projects. Although the 
findings showed that the sensing and seizing activities were slightly different in different 
phases, it was clear that, over all, these activities guided the Big Data initiatives and capabilities 
development processes. For example, it was evident that in the preparation phase, during which 
an opportunity or need for Big Data initiatives was identified at the company's Global site, the 
use of creative approaches (mind mapping, discovery, hands on experience, ad-hot sessions, 
individual insight, or senior management incentives) led to improved understanding of the 
power of the new resource. These activities also led to the identification of capability gaps (e.g. 
technology infrastructure, silo approach for data management, connectivity, data management 
skills) and to the identification of a need for existing resources and capabilities to be 
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reconfigured. However, as this knowledge of the validity of such was not readily available, 
organisations engaged various strategies by which to make it widely known.  In response to the 
lack of knowledge and experience of Big Data the company: 
1. Built a small internal team at the Global site, formed by open-minded senior  managers, 
which focused mainly on building up the fundamental capabilities for Big Data 
initiatives (IT infrastructure, Data governance). 
2. Partnered with external experts (Global and EMEA) in the field for establishing 
required processes and capabilities. 
3. Disseminated the knowledge that they discovered (EMEA project) 
There is little doubt that it is important for a company to work out the details, skills, practices, 
and mind-set needed for the success of a Big Data initiative (Constantiou and Kallinikos, 2015), 
although it can be argued that the overall picture cannot be comprehended in its entirety. 
Therefore, in order to fully understand the opportunity represented by Big Data and the need 
for change that would result, the company considered it useful to systematically present 
learning experiences through the sensing and seizing activities. These included gathering new 
knowledge, seeking advice on how to implement opportunities, and engaging with the broader 
policy stakeholders, public institutions, legislators and others, were all important activities at 
the transformation phase and heavily influenced capability development. 
While project members were primarily tasked with searching for new ideas, insights, and 
solutions, this undertaking also resulted in the engagement of external expert networks. It was 
evident that these external networks provided important complementary knowledge (Polder et 
al., 2010; Rehman, 2017) regarding new solutions. In particular, it was apparent that via these 
external networks the company acquired new knowledge regarding the technology required to 
handle Big Data and, by integrating that knowledge into its internal processes, was thus able to 
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enhance and develop its existing IT capabilities. Big Data calls for novel technologies that are 
able to handle large amounts of diverse and fast-moving data (Gupta and George 2016). While 
data itself is a core resource, it is also important for a company to possess infrastructure capable 
of storing, sharing, and analysing data (Akter and Wamba, 2016). The company’s sensing 
capabilities thus seemed to support the reconfiguration, and consequently the modification 
and/or development new IT capabilities. The major new IT capabilities required by the case 
study company were based on the sensing activities supplemented with the knowledge acquired 
from networking and partnerships. This finding complements Zhang and Wu,’s (2017) 
suggestion that external networks may represent an efficient and cost-effective option when the 
company lacks knowledge about the changing business environment. Thus, based on the 
evidence, the findings confirm that by engagement with the experts in the field the company 
was able to enhance the existing IT, seizing, and reconfiguration abilities (Teece, 2007) quickly 
and cheaply. The company’s networking and partnership activities can be interpreted as 
knowledge creation, acquisition, and dissemination (Zahra and George, 2002) which, on the 
other hand, helped the company identify and implement new Big Data capabilities at the 
corporation level such as: the Cloud environment, the Synapse platform, and data 
harmonization. Implementing new capabilities reinforced the configuration and coordination 
of existing resources and capabilities. 
Based on the empirical evidence it can be suggested that the interaction between multiple 
factors, such as partnerships, government support, and collaboration with different parties 
enabled the company to develop its own dynamic capabilities for Big Data initiatives. This is 
in line with the findings of Mahmood et al. (2011), which suggest that a firm’s business 
networks also represent an important source of capability development. The study also found 
that to enable the potential of Big Data, companies need to coordinate and collaborate with 
other major Big Data actors and users. Different types of networks such as: buyers, suppliers, 
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alliances, market-related networks, technological institutions, whether individually or in 
combination (Rehman, 2017), affect a company’s ability to enhance or create new capability 
development for Big Data. 
Capabilities development required the company to engage in action and to develop experiences. 
These experiences were archived through learning processes. As was indicated earlier, 
engaging with sensing and seizing activities was complemented by learning experiences. 
Interview respondents were clear that their capabilities were developed while they were 
learning about how to find new solutions and to create new knowledge, including repetition, 
experimentation, and the analysis of small mistakes. 
6.3.5 The Learning Processes 
The development and evolution of capabilities are influenced by knowledge creation, 
codification, and integration (Wilden et al., 2015). The creation of knowledge when introducing 
innovation, such as new resources and technology, involves promoting and shaping the learning 
process to evolve existing organisational capabilities (Teece et al., 1997; Eisenhardt and 
Martin, 2000; Zollo and Winter, 2002; Helfast and Peteraf, 2003). However, one side of 
learning processes consists of the ability to reconfigure existing resources and capabilities 
according to changes brought about by external dynamic environmental influences (Teece, et 
al., 1997) and another involves improving an organisation’s day-to-day processes, as well as 
learning how to incorporate Big Data  into those processes (Gupta and George, 2016). This was 
evidenced in the findings of this study. The creation of visual representations of the project's 
key elements was also found to be a highly valued and positive activity (the 
immersion/experience practice). At different phases the company globally introduced several 
immersive activities which helped to expose and demonstrate different ways in which the Big 
Data ecosystem is evolving, and the significance of this to the company. Different techniques, 
such as 3D videos, virtual reality, or use cases were used to help people within the company to 
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visualise and learn about Big Data opportunities. These activities and practices were 
particularly helpful for increasing awareness about the opportunity represented by Big Data, 
and to demonstrate its potential value to the company. Empirical evidence also confirmed that 
a “hands-on” approach enhances experience and knowledge, leading to improved 
understanding of the benefits and impact of this kind of innovation (Backman and Barry, 2007). 
Positive effects were also identified in both projects as being the result of learning efforts that 
tended to involve forms of systematic analysis, and the search for new solutions for the Big 
Data initiatives. These efforts tended to be self-reinforcing, and a gradual process of small 
related recognitions led to new discoveries, which led in turn to a widening scope of project 
members’ thinking. There was therefore broad agreement at the company that it was necessary 
to use and make progress with Big Data in this way (Gupta and George, 2016). Thus, learning 
experiences were equally important and fostered the development of capabilities in both 
projects. In particular, learning activities and processes at the Global site enabled development 
and implementation of new capabilities, while learning activities at the EMEA site supported 
continuous improvement of the overall project. Practices such as: experimentation, cross 
learning, and sharing new initiatives externally and internally, risk-taking experiences, setting 
up a community of practice, and use case analysis were prominent throughout both projects. It 
was evident that in addition to fundamental capabilities that were having transformational 
effects on the company’s operations, EMEA project members were able to improve and expand 
these capabilities based on knowledge that had been created through the learning processes. 
For example, new abilities/capabilities such as data visualisation, which was highlighted (Akter 
and Wamba, 2016) as one of the important capabilities for the management of Big Data, 
developed by the creation of a dashboard using Tableau at the EMEA site. This was based on 
new knowledge that had been acquired after the implementation of fundamental capabilities by 
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the Global site. Essentially, the importance of the ability to visualise Big Data is that it can 
transform raw data into meaningful insights to improve decision-making (Wixom et al., 2011). 
All of these activities can be interpreted as experiential and cognitive learning, that rely on 
many factors, including problem-solving skills, thinking skills, and the perception of learned 
materials aimed at implementing a course of action with the objective of executing and putting 
into operation the new Big Data initiatives. This empirically-grounded evidence of efforts of 
learning suggest that dynamic capabilities are capabilities that can be enacted, and which are 
oriented towards pre-identified strategic objectives. They rely on different practices such as the 
sensing and seizing of opportunities, reconfiguration, and coordination. The processes 
underpinning them include changes to operational and tactical activities to respond to the 
changing environment. 
6.3.6 The Transformation Processes: Reconfiguration and Coordination 
To benefit from sensing, seizing, and learning activities, orchestration of the company's 
resources and capabilities must be reconfigured to achieve better utilization of a new resource 
(Wilden and Gudergan, 2015). The transformational characteristic of dynamic capabilities 
implies that the company must possess the ability to adjust its capabilities in response to change 
(Teece, 2007; Wilden and Gudergan, 2015). It can be argued that the ability of a company to 
transform and reconfigure its resource base is itself a learned skill. It was evidenced that 
through experience and practice, the company was able to determine and manage new 
initiatives and required capabilities. Implementing new ideas and technology required the 
introduction of new elements and was accompanied by the reconfiguration of the existing 
activities and processes. The empirical investigation suggested that technological (IT) and 
certain marketing and connectivity capabilities were enhanced as a result of the company’s 
reconfiguration ability. For example, as was highlighted earlier, through networking and 
partnership, the company was able to determine the different internal work streams, resources, 
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and capabilities that needed to be re-engineered to fully leverage Big Data. In particular, the 
company was able to cultivate a community of new expertise, both centrally and embedded in 
the business, where data scientists, digital experts, taxonomy experts, and business 
development/alliance managers helped the company to build new skillsets to embrace its 
expanding data, advanced analytics, and technological capabilities. These new skill-sets and 
expertise enabled the company to realise the value of data across the organisation and to help 
increase the entire organisation’s acumen with respect to data and analytics. The company was 
able to identify, implement, and develop several technologies and techniques such as: data 
connectivity (Akter and Wamba, 2016;Wamba et al., 2015); data harmonisation, and 
visualisation (Gupta and George, 2016; Garmaki et al., 2016) which on the other hand 
improved the coordination of different departments in support of the transition. In particular, 
connectivity was found to be an important aspect in the management of different types and 
categories of continuously aggregated data. (Data aggregation is a type of data and information 
mining process where data is searched, gathered, and presented in a report-based format to 
achieve specific business objectives or processes and/or conduct analysis (Garmaki et al., 
2016). As such, data harmonisation represented data governance (Cao and Duan, 2014), the 
rules and controls that users, different functions, and departments must comply with when 
performing relevant tasks. It was evidenced that integrating internal and external data despite 
resistance to the idea of merging data across the company was one of the biggest obstacles 
detected in the case study. These problems highlighted the need for support (mentioned earlier 
in this chapter) from business leaders to establish technology, norms, and standards that would 
facilitate more transparent data management. There is some evidence (Wamba et al., 2015; 
Mikalef et al., 2017) in the literature where authors stress the importance of the availability of 
data, as well as having the ability to integrate this data from various sources, which traditionally 
may be siloed due to existing IT architectures and data management abilities. However, the 
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focus in the literature is mainly on the issues of availability of data in order to complement 
analytics and to gain more insight into customers and operations (Mikalef et al., 2017), rather 
than managing such data in a more transparent way. Arguably, the significance of the variety 
of data sources needed in order to derive meaningful insight and to direct strategic initiative 
(Ransbotham and Kiron 2017) is important, although one of the main characteristics of such 
data is to extract meaningful and valuable information from varied data sources requires 
sophisticated infrastructure (adequate hardware and technical software) (Garmaky et al., 2016), 
particularly in cases when the data will not only benefit individual departments, but become 
available to the entire corporation (Gupta and George, 2016). 
The empirical evidence also highlighted that where capabilities are new it is important to 
effectively communicate changes internally and to increase awareness of the ongoing efforts, 
in order to promote learning and best practice. Introducing a new IT platform and related 
technology requires the development of new skill-sets within the organisation. Without having 
the correct knowledge in place and without the capabilities to utilise the new technology and 
exploit the vast datasets, the company’s Big Data project could not have progressed into the 
operational stage. 
6.3.7 Big Data Challenges 
In a good project, implementation goes beyond the technical development of the system 
(Dhillon, 2004). It is important to understand the power of the new resource (Big Data) and 
processes in order to align changes in the structure, systems, people, and culture. Arguably, the 
findings of this study acknowledge that some of the technical challenges, such as 
unsophisticated infrastructure (meaning the platform for storing and sharing data) (Morabito, 
2015); data access (data coordination and harmonisation) (Wamba, 2016), and the system 
integration process (Garmaky et al., 2016) all have a direct impact on the utilisation of the Big 
Data initiative. It was evidenced that new tools and approaches are replacing entire data 
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ecosystems – for example, the use of new statistical techniques and languages like Hadoop and 
R, are emerging and, as they enter the workplace in greater numbers, traditional approaches to 
data management and analytics are gradually being enhanced or even replaced altogether 
(Gupta and George 2016; Makalef et al., 2017). However, the empirical findings suggest that 
the vast majority of the challenges with which the company struggled at any stage of the 
adoption of Big Data adoption were related to people and to the company’s internal managerial 
processes, and not to technology. This findings is in line with LaValle et al (2011), who argue 
that getting data and performing data analysis correctly are not the biggest obstacles in Big 
Data and analytics, but rather the barriers to adoption mostly relate to managerial and cultural 
change. The managerial challenges at the case study company concerned issues such as: 
understanding and extracting value from the new resource (Constantiou and Kallinikos, 2015; 
Gupta and George, 2016); cross-functional alignment of organisational mission, vision, goals, 
and technology (George et al., 2014), management of data privacy and regulation (Mikalef et 
al., 2017), and cultural transformation (LaValle et al., 2011; Gupta and George, 2016). 
Furthermore, the findings of this study highlighted the significance of a data-driven culture and 
the impact upon the connected operations. This is in line with Cao and Duan’s (2014) and 
Gupta and George’s (2016) findings, who also acknowledge the importance of a data-driven 
culture in driving the adoption of Big Data and the development of company-wide Big Data 
capabilities. A data-driven culture sees data and analytics as a central function for promoting a 
cross-functional distribution of data that allows for more fact-based decision-making (Parmar 
et al., 2014). Before organisations can fully employ Big Data there is a need to strengthen data 
acceptance, data reliance (Galbraith, 2014), and analytic capabilities (Gupta and George, 2016) 
within the organisation to arrive at achieve a data-driven culture. This requires the gradually 
introducing the importance of data-driven insights to a breadth of each departments (Gupta and 
George 2016).  A data-driven culture also reduces siloed units, and enables a greater depth and 
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richness of data to be analysed, while also allowing for separate organisational units to work 
collaboratively towards analytics-generated insights (Mikalef et al., 2017). Thus, it can be 
concluded that forming a culture that supports Big Data depends on changing the mind-set of 
the people, which itself is influenced by the existing culture. Development of a Big Data-driven 
culture at the case study company was an incremental process, with realisation of the need to 
enhance or develop capabilities for this new resource emerging from this gradual process. 
Positive effects were found in the case-study company of the use of specific practices in 
establishing the importance of a data-driven culture (Mikalef et al. 2017). Empirical evidence 
highlighted the usefulness of activities such as immersion practice, real time updates through 
the company dashboard, and training programs on increasing awareness and demonstrating the 
importance of the Big Data project. In particular, according to the participants these kinds of 
activities had a greater impact on the company’s existing data management culture (silo 
thinking). Furthermore, the demands of a Big Data initiative are such that the employees 
engage in new activities, and learn different skills. In order to achieve this level of involvement, 
employees have to understand in what direction they headed, and why (Rigby et al., 2002). 
Moreover, it was found that ability to become more data-driven required a mind-set shift across 
the entire company. In order to achieve a shared vision of the value and future of Big Data 
across the organisation, it is necessary to increase awareness of this new resource, to establish 
trust in the potential of the existing opportunities, and to reach shared agreement that it 
represents a vital direction in which the company should go. Some authors (Ryals and Knox, 
2001; Rigby and Ledinghan, 2004) argue that any initiative must have the participation of all 
organisational members, and that it is only possible if top management “buy into” the lead 
initiative. The engagement of senior managers in specific activities, such as immersive 
practices, workshops, and extensive communication to increase awareness of the new resource 
(Big Data) and the development capabilities had a positive impact on the creation of a shared 
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and culturally entrenched vision of this new resource.  These processes included presenting an 
explanation of the new initiatives by the company’s Global IKU/ Big Data project’s members, 
followed by the EMEA project’s members providing information about the new Synapse 
platform and data harmonisation ability. An important step was also to clearly communicate 
the objectives that the project members were hoping to achieve in an effective way, to build 
trust and ensure commitment from each of the country's authorities (the company’s franchises) 
to accommodate new processes that would ensure that the new capabilities (Synapse platform 
and data harmonisation) were adopted. Ford (2003) argued that commitment is based on 
qualitative elements such as satisfaction and trust, and that their development depends on how 
the parties involved in new activities view each other’s capabilities and motives, and how they 
interpret their own actions and those of others. This interpretation can change over time in the 
light of new experiences. Thus, the active involvement of senior managers in developing and 
implementing employee engagement programs helped to gradually develop commitment to 
using the new technology. This further led to an improvement in the company's ability to 
culturally adopt and transform in response to the new opportunities presented by Big Data. 
Overall, the results show that the concept of Big Data initiatives (and the development of 
required capabilities) was developed through the path of dynamic capabilities, which can be 
seen as a mediating factor. By using its abilities, such as sense and seize ability, learning, 
reconfiguration, and coordination, the company became adaptable and escaped unfavourable 
path dependencies, thereby achieving evolutionary fitness (Teece, 2007). 
- Explanation of the arrows on the model. 
The arrows on the model illustrate the mediating effect of dynamic capabilities between the 
existing IT and marketing capabilities and the new Big Data required capabilities. The findings 
from the case study show that dynamic capabilities such as: sense and seize ability, learning, 
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reconfiguration, and coordination positively influence the adoption of Big Data initiatives and 
the development of new capabilities. In a digital environment the enforcement of dynamic 
capabilities was important for adoption of the new resource adoption and development of 
required capabilities - in particular: 
I. Having an ability to generate, disseminate, and respond to Big Data opportunities 
(sensing and seizing capability) meant that the company was able to introduce new 
ways to manage data. Consequently, with a new stream-lined approach to data 
management, the company was able to improve operational effectiveness (IT and 
marketing capabilities) and reduce costs. 
II. By generating new knowledge more quickly (learning capabilities) about new resources 
and technological breakthroughs through networking, the company was able to 
reconfigure existing and build sophisticated new technical capabilities (Cloud- based 
platform, service catalogue). 
III. By effectively articulating and integrating knowledge (increasing awareness of the new 
resource, developing shared vision, aligning organisational change, and coordinating 
capabilities) the company was able to gradually shape the corporate culture and develop 
new data-driven capabilities. 
These findings are aligned with (O’Reilly and Tushmann, 2008, p. 186; Pavlou and El Sawy, 
2011; Protogerou et al., 201o; Erevelles et al., 2015) who show the positive effect of dynamic 
capabilities on the reconfiguration of operational capabilities to match turbulent technological 
environments. Pavlou and El Sawy (2011), for example, confirm the effect of dynamic 
capabilities on a firm’s performance by showing this effect through its ability to reconfigure 
operational capabilities into new ones that better fit the environment. Similarly, Protogerou et 
al. (2010) investigated the relationship between dynamic capabilities and a firm's performance, 
confirming that the relationship is mediated by functional competencies. In this sense, dynamic 
259 
 
capabilities can be understood to be the antecedent strategic processes that integrate, 
recombine, and generate new technological and marketing competencies which in turn shape a 
firm's performance. The findings of this study confirm that interaction between dynamic (sense 
and seize, reconfiguration, coordination, and learning) and operational (IT, Marketing) 
capabilities provided a strong mechanism through which the company was able to identify, 
modify, and/or develop new capabilities for Big Data. 
- What new capabilities did the company develop? 
As illustrated in model fig. 6.1, through the managerial and organisational processes discussed 
above the company was able to identify, develop, and/or enhance capabilities for their Big Data 
initiatives. In particular, new capabilities such as sophisticated infrastructure (the ability of the 
hardware and technical software) such as the Cloud environment, the Synapse platform, and 
data harmonisation were developed by the Global project. These techniques and technologies 
extended the traditional solutions and/or resulted in new such being developed, enabling the 
processing of continuous flows of information in real-time (Wamba et al., 2015). It was 
evidenced that implementing the Synapse data connectivity platform and cloud environment 
had significant operational impacts such as: the ability to reduce the silo approach of moving 
and processing data (stream-lined data management), extending storage ability and data 
accountability (data governance), and reducing the duplication of data with subsequent 
reductions in the cost of acquiring and managing data. Implementing these new capabilities at 
corporation level reinforced further configuration and coordination of existing resources and 
capabilities, as well as developing new ones (data visualisation) by the EMEA project. 
Using new analytics capabilities such as the company dashboard (for data visualisation) and 
the salesforce-based platform facilitated clinical information integration and provided 
evidence-based clinical practice. Participants explained that the new systems provide solutions 
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to process large volumes of data, to manipulate it real-time, and to capture all patients' visual 
data or medical records. In doing so, this analysis offered the company greater business 
insights, leading to the discovery of previously unnoticed patterns in patients' related needs and 
future market trends. In this way the company was able to improve quality of care and ﬁnancial 
performance. 
The empirical investigation also confirms that the use and management of Big Data offers a 
range of different experiences. Along with the new technology and techniques required by Big 
Data, such initiatives also require different skills and the establishment of a data-driven culture. 
For example, technical skills (technical knowledge, referring to skills required to extract value 
or intelligence from Big Data) (Wamba et al., 2017), required further investment and 
recruitment (Chen et al., 2012) at the case-study company. It was evidenced that participants 
were talking about the need for more data scientists, digital experts, taxonomy experts, and 
business development/alliance managers. The managerial skills that the study found at the case-
study company were business knowledge and problem-solving abilities (Gupta and George, 
2016), with good communication and collaboration abilities needing to be demonstrated by the 
management team, management levels, and department staff in order to fully exploit the 
business value of Big Data initiatives. However, it must be acknowledged that this study did 
not investigate individual skills but rather the company’s capabilities overall. 
Building a foundation of capability, such as the connectivity platform, data access, and relevant 
skill-sets, allowed incremental operational efficiencies to be made. Technological 
transformation changed the way business was done at the company and represented a building-
block to further growth. 
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6. 4 Contributions 
The study makes a number of contributions. First it provides an in-depth case study of big data 
preparation in the specific context of a MNC pharmaceutical company that is of value to both 
academics and practitioners (practical implications is discussed in next chapter). Second it 
provides a theoretically based and empirically validated model (Figure 5.4) of the development 
of capabilities associated with Big Data adoption. Finally, it makes a contribution to academic 
theory by contributing to the ongoing discussion in the academic literature of the utility of the 
concept of dynamic capabilities.    
In particular: 
1. The study provides empirical support for the underlying assumption of the role of dynamic 
capabilities in modifying operational capabilities (Winter, 2003; Helfat and Peteraf, 2003; O 
Reilly and Tushmann, 2008, p.186; Pavlou and El Sawy, 2011). In particular, analysis of the 
empirical data established the link between and the effect of dynamic capabilities on the 
adoption of Big Data initiatives and the process of developing required capabilities in the case 
study company. The study also used empirical research to challenge the existing literature, in 
which dynamic capabilities has been criticised for existing only at an abstract level, for lacking 
empirical grounding (Wiliamson, 1999), and for being only tautologically linked to a 
company's performance (Priem and Butler, 2001; Erikisson, 2013). 
Although the practice of enhancing existing capabilities has been acknowledged to close gaps 
and improve underperforming capabilities (Lavie, 2006, Danneels, 2010), the role of dynamic 
capabilities in this process had received less attention in the literature. In fact, some scholars 
are still sceptical about the role of dynamic capabilities (Winter, 2003, Zahra et al., 2006). Thus, 
the findings from this study shed light on the research relating to the development of 
capabilities and on the research surrounding dynamic capabilities alike, by explaining the role 
played by dynamic capabilities in the Big Data capabilities development process. 
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It achieves this, in particular: 
i. by showing the positive effects of the company’s sense, seize, learning, and 
reconfiguration activities on the company’s operational IT and marketing capabilities in the 
context of Big Data initiatives, demonstrating that it is not only reconfiguration capabilities 
that can act to modify existing operational capabilities. The knowledge derived from the sense 
and seize activities was vital to foster the development of operational capabilities at every stage 
of Big Data capabilities development process. This notion complements and strengthens Bruni 
and Verona’s (2009) and Pavlou and El Sawy’s (2011) findings on how market knowledge 
acquired from the sensing activities has sometimes been used to reorganise the product 
development process. In particular, Pavlou and El Sawy (2011) found that having the sensing 
capability to generate, disseminate, and respond to market intelligence about new products 
means that development units are able to develop technologically sophisticated products more 
quickly, by orchestrating resources tasks and activities. In the case of Big Data initiatives, 
knowledge from the sensing activities helped the company to reorganise data management 
processes and capabilities. 
ii. Based on the findings, this study argues that dynamic capabilities enable and foster 
development of existing (market, IT) capabilities and/or new capabilities in support of Big Data 
initiatives. This complements the recent findings of Braganza et al. (2017), who highlight the 
importance of dynamic capabilities in the Big Data adaption processes, which require altering 
over time. This corresponds well with the assumption by Teece (2007) that dynamic capabilities 
are in effect the ability of an organisation to ‘orchestrate’ and/or govern the rate of change in 
its resources and ordinary capabilities in order to adapt and evolve to rapidly-changing 
environments. Moreover, findings from this study bring new insight based on empirical 
evidence, and make it clear that Big Data adoption processes require a company to change over 
time (Gupta and George, 2016) in ways that are self-reinforcing. As was observed in the 
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evidence, a gradual process of small related recognitions led to new discoveries which led in 
turn to an increase in scope of possible subsequent activities. In response to the new resource 
(Big Data) and the resulting change in operational and tactical activities (Braganza et al., 2017), 
the company’s dynamic capabilities also facilitated the development of new capabilities. Thus, 
this finding adds insight to the debates between different streams of the dynamic capabilities 
research about the role it plays in practice. Considering the current discussions about whether 
the role of dynamic capabilities is to change existing capabilities (Adner and Helfat, 2003; 
Zahra et al., 2006; Teece, 2007; Braganza et al., 2017), or to act to create new capabilities 
(Aragon -Correa and Sharma, 2003, p. 73) or whether it can do both, this study confirms that 
in the case of Big Data initiatives it is both: dynamic capabilities can integrate and build upon 
an organisation's current competencies, while simultaneously supporting the development of 
fundamentally new capabilities (Benner and Tushman, 2003, p. 238; O Reilly and Tushmann, 
2008). 
2. Beyond confirming that dynamic capabilities, such as strategic competitive response, 
reconfiguration, coordination, and learning are enablers in the creation and implementation of 
Big Data initiatives (Teece, 2007; Protogerou et al., 2011; Erevelles et al., 2015; Wamba, 2016), 
this study also identified valuable additional activities and practices such as: senior 
management support, networking and partnership, and cultural transformation along with how 
each of them were enacted. 
The study also contributes to the contextual approach of the dynamic perspective, more 
specifically to the existing literature (Teece, et al., 1997; Zahra, et al., 2006; Tripsas and 
Gavetti, 2000; Adner and Helfat, 2003; Teece, 2007; Eggers and Kaplan, 2009) that relates to 
the role of senior management in the development of capabilities. Senior management does 
indeed play a vital role within the process (Braganza et al., 2017) and their abilities/skills 
(Gupta and George, 2016) and active participation are regarded as necessary success factors in 
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the development of Big Data capabilities. The apparent importance of management 
participation is in line with the propositions of the dynamic capabilities paradigm, in which 
entrepreneurial managers play a vital role in identifying opportunities and need for change, in 
formulating responses, and in implementing courses of action (Helfat et al., 2007; Teece 2007). 
o The research findings correspond to the call for more research (Teece, 2012; 
Eriksson, 2014) on how managers explicitly and implicitly influence the 
development of capabilities. The study was conducted with contributions from 
diverse opinions from senior managers and Big Data experts, the majority of 
whom had experience of the capabilities development process for the utilisation 
of Big Data initiatives in a global pharmaceutical company. Thus, the empirical 
evidence illustrated how the purposeful practices of the senior management, and 
the decisions made by them, influenced the development of Big Data required 
capabilities in ways that were unlikely to have happened in the absence of those 
‘managerially-amenable’ practices (Pavlou and El Sway, 2011, p. 260). Thus, 
the findings of this study add insight to the existing literature (Gunther et al., 
2017; Braganza et al., 2017) by confirming the importance of management 
abilities/practices in the implementation of Big Data initiatives and in the 
development of required capabilities. 
o By pointing out the importance of the way in which senior managers understood 
the value of Big Data and the level of strategic relevance that this new resource 
was believed to have, the study contributes to knowledge regarding the 
importance of the realisation of value from Big Data. From the beginning, and 
throughout the research, both the conceptual framework and the empirical 
evidence indicated that it would be incorrect to define Big Data based solely on 
its size and availability.  Instead, it showed that it is important to consider the 
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value of this new resource prior to implementation, particularly with reference 
to the company’s operations and aims. These findings are in line with those of 
Ghoshal’s et al. (2014) and Wamba et al’s. (2015), whose findings indicate that 
what benefits organisations perceive as ‘Value’ depend on their strategic goals 
for adopting and using Big Data. The strategic thinkers at the case-study 
company clearly felt the need to clarify the value of Big Data, and the extent to 
which Big Data was expected to generate economically valuable insights for the 
company (Wamba et al., 2015) before implementation. This allowed specific 
measurable targets to be set for given initiatives, and by doing so it was possible 
to evaluate and determine the effectiveness of a chosen approach. In addition, it 
influenced the process of capability identification and development which was 
achieved through the sensing and seizing, learning and reconfiguration, and 
coordination abilities. This finding is also in line with Braganza et al. (2017), 
who argue that for Big Data to be considered a truly strategic resource, senior 
leaders need a process that can be implemented to ensure that expected benefits 
are delivered from investments made in organisational resources for Big Data. 
It can be assumed that such an approach would also reduce the probability of 
failure in Big Data projects. As indicated in previous studies (McAfee and 
Brynolfsson, 2012; Gandomi et al., 2014), the reason behind the failure of some 
other Big Data initiatives was that executives often simply did not understand 
which aspects of the value of Big Data were fundamental to the success of their 
businesses, and were not aware of how much it would cost or how long it would 
take to implement the changes required to benefit from this new resource. 
o By highlighting the role of networking and partnership during Big Data 
initiatives, this study adds insight into the tangible means by which managers in 
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this process can enhance their company’s dynamic capabilities. This challenge 
Winter (2003, p. 991) who pointed out that doubt exists that deliberate efforts 
to strengthen dynamic capabilities are a genuine option for managers. This is 
mainly because Winter (2003, p. 993) believes that an intended search for such 
occasions can impose additional costs. The author believes that the capability 
must be exercised: for an organisation to possess dynamic capabilities but have 
no occasion to put them into effect is merely to bear an additional cost. 
However, in the case of a fast-moving, competitive Big Data environment that 
requires continuous modification and, if necessary, a complete organisational 
overhaul to maintain a good ﬁt with the ecosystem in which a firm operates, 
there is an enhanced need for strengthening dynamic capabilities, especially 
when organisations need to pioneer new ways of adopting Big Data.  
o This study provides empirical/practical evidence that managers who are 
interested in using networking and partnerships to create knowledge about a 
new resource assist greatly in the enhancement of dynamic capabilities. This 
finding complements the conventional approaches to strategy that suggest that 
in Big Data programmes many key roles lie outside the organisations in question 
(Braganza et al., 2017), and that the nature of relationships are more transitory. 
Interaction between multiple factors such as partnership, networking, and 
collaboration with different parties enhanced and strengthened the company’s 
seizing and reconfiguration abilities at the preparation stage. Thus these 
activities can be interpreted as knowledge creation, acquisition, and 
dissemination which can be dynamically used to fine-tune Big Data initiatives 
and to formulate responses/transformation activities to face the challenges in 
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the event that a firm does not have much experience or best practices to draw 
on. 
 
6. 5 Chapter Summary 
The chapter discussed the findings in relation to the research questions and determined the 
extent to which the research questions of the study have been answered. After presenting a 
short reminder of the research problem and the aims and objectives, discussion followed of 
how the research objectives were met in relation to research findings. The chapter also 
presented the contributions of the research to the existing body of knowledge and theory. 
Chapter 7 now summarises this study, presents the study’s limitations, and articulates its 
implications for future research. 
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Chapter 7: Conclusion and Final Remarks of the Thesis 
 
7.1 Summary of the Thesis 
The study adopted the RBV and the Dynamic Capabilities perspective to explore the activities 
and processes by which Big Data initiatives and the development of required capabilities 
emerge in an MNC in the pharmaceutical industry. Based on a review of the Big Data, 
capabilities, and dynamic capabilities literature in Chapter 2 research gaps were identified and 
research questions were formulated. After this, the initial conceptual framework was designed 
and proposed to guide the empirical stage of the study in Chapter 3. The framework was 
investigated using a case study methodology (Chapter 4), which included collecting and 
analysing data from the case-study company (a global pharmaceutical company). The findings 
in Chapter 5 collectively provided in-depth insight and novel understanding of how a global 
MNC in the pharmaceutical industry approached Big Data initiatives, how it prepared, 
developed, and implemented Big Data capabilities. The proposed model of Organisational 
Practices in Big Data Adoption and Required Capabilities Deployment presented in Chapter 6 
not only enhances our theoretical understanding of such processes, but also offers insights into 
practices that will be of particular value to those at management-level and above. 
7.2 Practical Implications 
It should be noted that the practical implications laid out in this section are based on the findings 
from one case study, and so it must be emphasised that its observations and suggestions about 
how to implement Big Data initiatives and how to develop required capabilities will likely not 
be universally applicable. However, based on the findings of the study and the literature there 
are arguably not yet many standardised processes by which to manage Big Data initiatives. 
Consequently, organisations are recommended (Brynjolfsson et al., 2011; O’ Reilly and 
Tushman, 2016) to actively engage with learning practices to identify and develop various 
capabilities for dealing with continuous changes and the other challenges introduced by this 
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new resource. Some pioneering approaches already exist (McAfee and Brynjolfsson, 2012) but 
they are still in their early stages (McKinsey, 2013). 
This research has implications for practitioners who are either planning to implement Big Data 
initiatives, or who have already started and are in the early stages of implementation. Adopting 
a practical/managerial viewpoint, from the findings of the investigation of the development of 
capabilities for Big Data initiatives the following conclusions can be drawn. First, practitioners 
who wish to start a Big Data initiative have to develop objectives for such an initiative. 
Significant time should be devoted to discovering what Big Data means to the company and 
identifying the path by which the objective could be archived. Great attention also should be 
paid to any skills gap that is identified, and consideration given to ways by which to fill this 
gap. The research suggests that learning and training can help solve this problem - however, 
this will require commitment to appropriate levels of investment, and even then it will likely 
still be necessary to hire skilled resources or talent from outside the company. 
Based on the case-study company's example, preparation for and implementation of Big Data 
initiatives is a highly integrated process that happens concurrently; it incorporates learning 
practices, and hence engaging in action (learning experiences), which is required not only to 
develop the new capabilities, but also to identify transformation and operational challenges. 
This means that the processes for Big Data initiatives cannot be entirely pre-planned. While it 
is vital to provide direction by guiding the organisation and by establishing learning and 
transformation processes, activities, and structures, it is equally important to start building the 
Big Data vision of the people within the organisation as a whole. It is also essential to increase 
awareness of the new resource, and to build trust about the fact that the business should put it 
to use. Clear communication is key when discussing what could be gained from the new 
resource, when encouraging employees to think about how existing standards and practices can 
be improved, and when promoting the acceptance of new initiatives. 
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Based on the case study’s findings, companies must take a long-term view and recognise the 
importance of cultural change in order to successfully adopt Big Data. Significant effort should 
be made to develop a data-driven culture to allow cross-functional distribution of data that 
allows for more data-based decision-making. 
As has been outlined, different capabilities and skills are needed throughout the adoption 
process. While the preparation stage requires a more entrepreneurial mind-set to sense 
opportunities and to formulate responses to seizing them, the implementation and 
transformation phases are likely to require more operational (appropriate IT infrastructure) and 
data management (Data Harmonisation, Data Driven Culture) capabilities. Therefore, 
managers should be prepared to reconfigure and coordinate their teams and functions.  
Although it is likely to be difficult to outline a detailed roadmap, managers should have a “big 
picture” in mind of which activities will be required throughout the process. Such a grand 
overview will provide stability and comfort to themselves and enable them to provide direction 
to the organisation. The model (Figure 6.1) provides an orientation of this process. 
7.3 Research limitations 
While the study offers important insights into why a Multi-national Corporation (MNC) in the 
pharmaceutical industry prepared for Big Data adoption and how it identified and developed 
capabilities for this new resource, it has several limitations. 
The main limitation of this study is the sample size, the lack of intensity of the innovation of 
the Big Data initiatives in the case-study company, and the nature of the industry itself (with 
its comparatively slow business cycle) limited the opportunities to gain access. Therefore, the 
data access strategy was by necessity rather opportunistic. Even though the case-study 
company permitted access to the company’s different sites (EMEA and Global), which allowed 
investigation of different stages of the company’s Big Data projects, these sites were not 
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recognised in the study as being independent cases, but rather as different units of analysis of 
one case study. It would be interesting to see multiple cases in the same industry being 
investigated in order to further expand the sample. Moreover, the interview respondents for this 
study were primarily from the ranks of senior management, along with some external partners. 
Further data could be obtained from the corporation’s general employees to increase the 
validity of those findings. In addition, as the data were collected while the Big Data project 
was still in the development stage it would be interesting to see what was the end result of the 
company’s Big Data implementation effort. 
The study adopted a qualitative methodological approach to conduct the research. While the 
method came recommended and was well-suited to this kind of research, which examines a 
novel research context (Yin, 2009), perhaps some additional data from survey-based method 
would result in more generalisable findings.    
7.4 Further Research 
Having outlined the overall process, and the managerial and organisational activities for Big 
Data initiatives, and the development of required capabilities in an MNC in the pharmaceutical 
industry, many questions regarding the process remain unanswered. As was outlined in the 
beginning of this study, the successful adoption of a new resource is often not an easy task to 
achieve using existing systems and processes. The interaction between organisations and digital 
technology is ‘complex’ because it is influenced by many factors (McAfee and Brynolfsson, 
2012). Further research should investigate the micro-foundations of these processes, and the 
factors that influence these activities. For example, further research could explore how political 
challenges (data governance, data privacy, data management laws) are affecting the 
development of Big Data capabilities, as this was one of the most highly-acknowledged 
challenges in the case-study company. However, it was out of the scope of the research to 
explore this further. Future research could   also, for example, explore how the use of tools that 
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do not have market strategy as their basis, such as: events, demonstrations, networking, 
sponsoring, research, publications, and companies can overcome and reshape the rules of the 
game of Big Data initiatives. It would also be interesting to further explore how pressures 
driven by social media and education affect Big Data transformation and capability 
development in MNCs in different industries. 
Since Big Data initiatives and dynamic capabilities evolve over time (Teece, 2007; Helfat and 
Peteraf, 2009; Wamba et al., 2015; Mikalef et al., 2017) future studies could also adopt a 
longitudinal research design. Such a study design could be helpful in understanding not only 
the process of the implementation of Big Data initiatives and the development of required 
capabilities, but also the effectiveness of new capabilities. Given that the research has identified 
new capabilities for Big Data initiatives for the MNC in a pharmaceutical company, such as 
sophisticated infrastructure capability (the ability of the technology and technical software) and 
a data-driven culture, more research also is needed to understand its applicability i.e. the extent 
to which these capabilities impact other types of firms, for example those of Small and Medium 
Size (SMEs) and those in other industries. 
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Appendix 1: The research Context  
  
 
Big Data Challenges, Opportunities and Required Capability Development in a 
company with the Big Data Project 
 
The research project  
The project aims to consider how big data initiatives are approached in practice. Particularly, how an organisation 
approach the issue of using big data strategically and how they develop their capabilities for big data. As the 
availability of customer data escalates, there is evidence that firms have become more adept in their use of new 
technology to gain reliable insights from that data. Such insights influence how customers are managed and can 
help to shape strategic priorities. However, as well as creating commercial opportunity, this customer data also 
poses significant challenges for those working with it. The successful adoption of a new resource is often not an 
easy task to achieve as existing systems and processes need to be built up over many years, and employees’ 
knowledge of the new environment can be limited. The interaction between organisations and digital technology 
is ‘complex’ because it is influenced by many factors, including an organisation’s structure, capabilities, routines, 
business processes, politics, culture, internal and external environment, and management decisions. For Big data 
as a new strategic resource, this becomes even more complex as data sources bring additional challenges in terms 
of volume, variety, privacy and security. Given the importance of the emerging context of big data, the project 
aims to understand how firms are responding to the challenges, the rewards that they are gaining, what are the 
capabilities required to effectively use big data and how do firms develop capabilities to effectively use big data. 
Relevance to the company International 
The ….. International’s commitment and involvement to an innovative approach for big data management makes 
the firm an ideal site for data gathering. Big data initiatives within the company for better managing patients  in 
the era of data driven medicine exemplifies the potential of enhanced data availability to empower patients, 
generate business opportunities, and strengthen customer relationships.  This research project provides the 
opportunity to study how the project members are handling these opportunities and challenges and how they 
develop big data capabilities:  
• What challenges does company face when capturing and dealing with this kind of new data?   
• How does access to such data alter the relationships between the company and their clients?   
• How is the big data changing working practices?  
• What are the implications for required capabilities to effectively use big data for their operational 
activities and how they develop it. 
In conducting this research, I am committed to aligning academic research in strategy and big data  with the needs 
of business.  
What we seek from you 
I aim to conduct research interviews with project members who are involved in big data management processes. 
(E.g.  decision makers, data specialist, IT and marketing managers, general employers). The interviews would 
cover a range of issues concerning how company capture and handle the available new type of data what 
challenges they face in so doing, what activities they implement to develop required capabilities for new type of 
data and how this is impacting on their ways of working.   
Each interview would take no more than one hour and would be for academic research purposes only. The 
interview will be arranged at a time and on a date suitable for the participant.  Data from the interview will be 
used only for academic research purposes and will not be attributable to the individual supplying it.  The data will 
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be handled in accordance with data protection rules.  The interviews would be conducted by Ketty Grishikashvili, 
a PhD researcher at the Open University.  
I hope there will be the opportunity in the future to develop the research into a larger scale study of the Celgene 
network  
What we can offer in return  
I will happily share research findings regarding big data opportunities and challenges to date with you. I will also 
provide conclusions and an overview of the research finding.  I hope, for example, to offer valuable insights from 
the …….. community about good working practices around the use of client data and also to shed light on some 
of the challenges faced.  These insights might help to shape future training and support for the network, or even 
offer further clues on how to develop required capabilities for effectively management big data.  
 
Ketty Grishikashvili  
PhD Researcher 
BSc, PGD, MSc, MRes 
Open University Business School. 
Walton Hall, Milton Keynes, 
MK 7 6 AA 
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Appendix 2: A Confidential Disclosure Agreement (CDA) with 
Company 
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Appendix 3: Email Text for the Participants  
 
Email text for the participants  
 
 
 
Dear …….. 
This is a follow up to  ………….’s email  regarding the research interviews. 
I am very grateful to the company for agreeing to be the case organisation for my research and 
particularly appreciate each individual’s participation and support. 
As ……. explained in his introductory email, each interview will not take more than an hour 
and will be arranged at a time and on a date to suit you. Interviews could be done in a face to 
face (preferable) format or via Skype/ Phone. Data from the interviews will be used only for 
academic research purposes and will not be attributable to the individual supplying it.  The data 
will be handled in accordance with data protection rules and under a Confidential Disclosure 
Agreement (CDA) with ……….. 
I would be grateful if you could let me know your availability between the 11th of September 
and 6th of October and your preference for the interview format. I can arrange 10 days slot for 
face to face format however the exact dates of the slot will depend on the availability of yourself 
and your colleagues. Please let me know your availability even if it is not within the suggested 
dates. 
I look forward to hearing from you. 
Best wishes, 
Ketty Grishikashvili. 
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Appendix 4: Information Sheet 
 
 
 
 
Information Sheet 
 
You have been invited to take part in a research study. There is some information about the 
project. This will help you to decide whether you would like to part or not. 
 
 
Project Title 
 
Organisational Capabilities for effective utilisation of Big Data 
 
 
Researcher 
 
Ketty Grishikashvili, BA, MSC, PGD, MRes (BM) 
Contact: +44 (0)1908858935. Mob: 07841611621. 
Email: Ketty.Grishikashvili@open.ac.uk. 
The Open University Business School 
Michael Young Building (D1), 
Walton Hall, Milton Keynes, 
MK7 6AA 
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About this study 
 
The data to be collected will be primarily qualitative based on semi-structured interviews.  
Taking part in this research project is voluntary. If participant would like to take part, she or he 
will be given this information sheet to keep and will kindly be asked to sign consent form. 
The research partners will be requested to provide up to one hour of time for interviews. This 
will be at their convenience place and time between May 2017 and September 2017.  
The intention is to record the interviews but the participant has the option to decline the 
recording.  
If you have questions or a complained to make you could contact to senior members of the 
project lead supervisor on following email Elizabeth.Daniel@.open.ac.uk. or The Open 
University Business School’s Director of Research Programmes Prof Emma Bell on the 
following email: Emma.Bell@open.ac.uk.   
 
Confidentiality 
 
The researcher commits to observe any confidentiality of data. Where required, the researcher 
will also honour any requirement to destroy any data materials after ending the doctoral 
research in December 2018.  
The research will not use any personal data. 
Participants have a right to withdraw from the research at any time, with no adverse 
consequence at all.  
There has been a risk assessment in line with rigorous guidelines at the Open University, under 
which risk is reduced to a minimum. The researcher commits to declare any changes in risk 
perception accordingly.  
The study is following the ethical standards and the code of practice established by the High 
Education Intuition (HEI). Ethical approval for this study has been obtained from The Open 
University’s Human Research Committee (HREC) 
http://www.open.ac.uk/research/ethics/human.shtml.  
 
At the end of study 
 
Research partners can request to have a copy of a summary of the research findings after 
completion of the project. 
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Appendix 5: The Consent Form  
 
 
Consent Form  
The Faculty of Business and Law, The Open University 
 
Project Title 
 
 Organisational Capabilities for effective utilization of Big Data 
 
Agreement to Participate 
 
I,                                                                                                                                (print name) 
 
agree to take part in this research project. 
 
I have had the purposes of the research project explained to me. 
 
I  have been informed that  participation in this project is voluntary and I am free to withdraw 
from the research any time simply informing the researcher.  
 
I have been assured that my confidentiality and that of my organisation will be protected as 
specified in the information leaflet. 
 
I agree that the information that I provide can be used for educational or research purposes, 
including publication. 
 
The interview will be audio-recorded. However, I have the option to decline the recording. 
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I understand that if I have any concerns or difficulties I can contact: Ketty Grishikashvili 
at: 01908858935 or ketty.grishikashvili@open.ac.uk  
 
If I want to talk to someone else about any aspect of my participation in this project, I can 
contact Prof Emma Bell, who is the Director of Research Programmes at the Open 
University Business School on her direct number: 01908655669 or by email: 
Emma.Bell@open.ac.uk  
 
I assign the copyright for my contribution to the Faculty for use in education, research and 
publication. 
 
 
 
 
 
 
 
 
Signed:                                                                                         Date: 
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Appendix 6: The Interview Questions  
 
 
 
 
                                 
 
THE OPEN UNIVERSITY BUSINESS SCHOOL 
 
Organisational Capabilities for Effective Utilization of Big Data 
 
 
                                      Interview Guide and Questions 
 
 
 
Researcher 
 
Ketty Grishikashvili, BA, MSC, PGD, MRes (BM) 
Contact: +44 (0)1908858935. Mob: 07841611621. 
Email: Ketty.Grishikashvili@open.ac.uk. 
The Open University Business School 
Michael Young Building (D1), 
Walton Hall, Milton Keynes, 
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MK7 6AA 
Respondents Name  
 
Interview Date  
 
Interview Format  
 
                               
                                 Interview Guide and Questions  
 
 
Respondent Background 
 
 
1. Could you please tell me your current role? How long have you been working with the 
company and what are your main responsibilities? 
 
 
 
2. For how long have you been working in IKU project and what has been changed in in 
your responsibilities? 
 
Companies /Project   Background 
 
 
3. What are the key relationships to the Company, (customers, consumers, suppliers, 
competitors)?  
 
 
 
4. What would you think are the strengths of the company? People, skills technology? 
 
 
 
5. Does the company has any established mechanisms processes to systematically scan 
for new opportunities? How do they look like can you give me one example of it? 
 
 
 
6. What would you say are the major aims and objectives of this ongoing project? How 
big is the project? When did it start and for how long has it been going.  
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    Big Data in the Project  
 
 
 
7. What is the main reason why the company started employing big data initiatives? 
How would you define big data for the project?  
 
 
8. How did the big data idea appear in the company? Who thought of the big data adoption 
idea and why? Who was involved in the decision to adopt big data (inside and outside 
the company)?  
 
 
9. What are the company/ project’s main expectation using big data? Before adopting big 
data did you predict where it could contribute best?  
Do you have any specific objective that you are looking to answer with this project? 
 
 
10. Was there any effort made to analyse and redesign any managerial or organisational 
processes before the adoption of big data initiatives?  
 
 
11. Could you please talk me through one example of any changes are currently going on? 
 
 
 
12. Are there any specific requirements for being part of this project? Who are the project 
participants?  
 
 
 
13. Are there any external experts involved in the project? (IS/IT, data analytics, 
Relationship Marketing consultant, etc.) (Understand need for additional capabilities) 
 
 
 
 
Existing Capabilities (marketing, IT) and other resources on place ( 
experiences, skills) 
 
 
14. Were there any activities taken by the organisation’s management to support, guide, or 
assist the implementation of big data before the project started? /Ongoing? 
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15. How would you describe main abilities (capabilities) company had in place when the 
project started? For example (understanding of customer behavior building good 
relationship with customers, manage market knowledge any established IT project 
software? 
 
 
 
16. What is company’s experience (IT & Marketing capabilities) of working with client 
data? Do you gather data from sources other than the client him/herself? 
 
 If yes   
 
17. What source do you use to gather additional information about your client, do you use 
social media as a source for example? What approaches do you , which data gathering 
tools? 
 
 
18. What is your experience of working with big data? Has access to these data resulted in 
you having a better understanding of customers or has it changed the ways you manage 
your customers? If so could you please give me some examples? 
 
 
19. What is the main novelty of the project? Which processes are involved in the 
adoption/acquisition (developed especially for the company, a software package bought 
in, contracting a consultant, etc.) and why?  
 
 
20. What is the existing IT infrastructure? What other software packages exist in the 
company Data Warehouse, Call Centre, Web site, etc. Which of these systems are 
integrated into big data project?  
 
 
21. Have there been any problems with utilisation this new technology? What could have 
been done to help? 
 
 
 
Current Big data challenges and changes 
 
 
 
22. What are the most important changes which are currently going on? Could you please 
talk me through one example of any changes?  
 
 
23. Does top management create mechanisms to link different organisational teams, 
routines, capabilities related to this project?  
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24. Were there any changes in the processes? What?  
 
 
25. Have there been any changes in the organisational structure related to big data? 
Redesigning of business processes?  
 
 
26. Has it effected strategic level or more tactical/operational? 
 
 
27. What particular challenges have these changes brought?  
 
 
28. Do you think that there are the challenges that might contribute to the failure of the 
project? For example looking at these changes are there any resources or capabilities 
which are no longer needed which are maintained or need further improvement? 
 
  
29. What do you think happening to the capabilities in general of the organisation during 
this project? Do you think there is a need for new capabilities and if yes what kind of?  
 
 
 
30. What would you think are the strengths and novelty of this project? Have there been 
any efforts made to develop any additional capabilities in order to successfully deliver 
this project. Have there any need for additional capabilities been identified? 
 
 
 
Digital Skills 
 
31. What kind of actions are conducted by company’s managers to make the big data 
initiative effective? Can you give me an example? 
 
 
 
32. Were there any activities taken by the company’s’ management to support, guide, or 
assist the implementation of Big Data within company? What kind of activities? Any 
trainings? Additional learning programs? 
 
 
 
33. What kind of training was conducted in the company in relation to big data initiative? 
Who was involved? Who provided the training?  
 
 
 
34. Have there been any periodical training sessions conducted? 
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35. How often do you have training about technical tools and/or software packages that you 
are using?  
 
 
36. Which new packages and technical/practical tools do you use? And how it is different 
from previous one? 
 
 
37. What difficulties do you face when using new approach?  
 
 
38. Do you share information and/or best practice suggestions with other project members 
or concurrent companies?  
 
 
39. What are the communication channels or meeting points available where project 
members can share experiences (positive and negative) about the project? 
 
Closing Questions 
 
40. What are the big (remaining) challenges you face when dealing with new type of data?  
 
41. What are the future perspectives that you are looking at from adopting big data? 
 
42. Is there anything you would like to add at the end of our interview 
 
 
   
 
 
Thank you 
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Appendix 7: The Ethical Aproval 
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Appendix 8: Example of data analysing process, using the 
analytical framework (coding structure). 
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Appendix 9: Data Analysis Plan and Process Examples 
 
Data analysis Initial Plan  
 
 
 
Data Analysis’s process: searching for the terms, phrases or meanings that were 
common between the interviewees. 
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Appendix 10: Nvivo 11 nods and codes examples 
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Appendix 11: Nvivo11 Mind Maps Examples 
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